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ABSTRACT 
Depression is among the most common symptoms of Parkinson’s disease (PD); and its 
estimated prevalence is 35%.  A systematic review revealed that there is insufficient 
evidence to draw strong conclusions about the antidepressant effects of exercise in PD. 
Hence, in order to address this important question, a randomised controlled trial (RCT) was 
conducted in Greece. 
 
To aid the design of the RCT, a patient survey was performed which indicated that PD 
affects both physical function and mental health, even from the first stages of the disease; 
and the most prevalent responses were considered for the design of the RCT. 
 
The RCT, examined whether a community-based exercise and educational programme 
could produce short- and longer-term antidepressant effects in depressed patients with 
PD. Eligible participants were allocated either to a supervised group-based exercise and 
educational programme (intervention group) or an unsupervised individualised home-
based training (comparison group). The findings revealed no significant differences 
between the two groups at the end of the treatment and three-month follow-up period. 
However, one-way repeated measures of ANOVA showed that the depressive scores were 
significantly improved in the intervention group over time (p= .00; t1-t2: p= .00; t1-t3: p= 
.01), and the magnitude of the effect was medium (t1-t2: r= .40; t1-t3: r= .31). Improvements 
in mood were also reported by the participants. The intervention also had positive effects 
on anxiety levels, motor function and quality of life. 
 
The findings of this thesis showed that the treatment potential is high; and a simple 
community-based exercise and educational programme, without the use of expensive and 
sophisticated equipment, can be prescribed for depression in patients with PD.   
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GLOSSARY  
 
Aerobic exercise: movement or activity which primarily utilises the body’s oxygen energy 
system (Whipp et al., 1981). 
Anaerobic exercise: movement or activity which primarily utilises the body’s anaerobic 
system- hydrolysis of creatine phosphate or anaerobic glycolysis (Kleisouras, 1997). 
Exercise frequency:  the number of sessions delivered per week (Shanahan et al., 2015). 
Group exercise: two or more participants in an exercise session (Perraton et al., 2010). 
Individual exercise: exercise performed in a separate area to the other participants in the 
trial and separate from other people who are exercising (Perraton et al., 2010). 
Mode of exercise: the specific sport or activity used (Perraton et al., 2010). 
Multi-modal training: exercise programme that incorporates several types of exercise (e.g. 
resistance, stretch, aerobic) to improve multiple aspects of fitness (e.g. muscle strength, 
endurance, flexibility, aerobic capacity) (Kleisouras, 1997). 
Off-state: the time period the antiparkinsonian medication stops working and the cardinal 
motor symptoms of PD appear (Shulman, 2010). 
On-state: the time period the antiparkinsonian medication is effective and the PD motor 
symptoms are limited (Shulman, 2010).  
Session duration: the length of each session during the rehabilitation programme. 
Supervised exercise: any exercise monitored or watched by one or more persons as a part 
of the trial (Perraton et al., 2010). 
Wearing off: The gradual return of symptoms that occurs at the end of a dose of levodopa. 
This pattern appears when a person with Parkinson's disease has been using levodopa for 
many years (Shulman, 2010). 
 
 
 xxx 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
«Η ολοκλήρωση της διδακτορικής διατριβής συγχρηματοδοτήθηκε μέσω του Έργου 
«Υποτροφίες ΙΚΥ» από πόρους του ΕΠ «Εκπαίδευση και Δια Βίου Μάθηση», του 
Ευρωπαϊκού Κοινωνικού Ταμείου (ΕΚΤ), ΕΣΠΑ, 2007‐2013». 
 
"The completion of the doctoral dissertation was co-funded through the" Scholarships 
IKY "Project from the funds of the OP" Education and Lifelong Learning ", the European 
Social Fund (ESF), NSRF, 2007-2013". 
Chapter 1: Introduction to study 
1 
 
 
 
 
 
CHAPTER 1 
INTRODUCTION TO STUDY 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction to study 
2 
 
1.1. Statement of the problem 
Idiopathic or primary Parkinson’s disease (PD) is a progressive, neurodegenerative, 
movement disorder of the extrapyramidal system; whose aetiology is unknown (Jankovic, 
2008). PD affects all the nations and countries; and the estimated total population of 
individuals affected by PD worldwide is 7.5 million. The prevalence of the disease is relevant 
high in population over the age of 65; and the number of sufferers is expected to increase 
the following decades in Western countries, due to the aging of the population (Pringsheim 
et al., 2014). The disease is characterised by motor and non-motor features, with 
depression being the most common mental disorder, affecting about 35% of PD population 
(Goldman and Postuma, 2014). It is well established that PD affects negatively the sufferers 
and their carers, leading to disability and caregivers’ burden; and increases healthcare 
utilisation. Depression may affect further the impacts of the disease, and it is indicator for 
poor disease prognosis (Lépine and Briley, 2011).  
 
The focus of research has primarily been on the motor symptoms of PD; whereas the non-
motor symptoms, such as depression, have been less studied. Current treatment for 
depression in PD includes mainly pharmacological treatment and psychotherapy. However, 
there is limited evidence about their effectiveness, and the findings of experimental studies 
are mixed (Chen and Marsh, 2013). Therapeutic exercise may be an important adjunct to 
the available pharmacological and psychological treatment for the management of 
depression in PD. However, a limited number of experimental studies were found to assess 
the effects of therapeutic exercise on depressive levels in PD population as primary 
outcome measure.  
 
To our knowledge, there is little research about PD in Greece; a European country where 
the percentage of senior population has gradually increased; and the prevalence of age-
related disorders, such as PD, is expected to be higher in the future. In addition, there is 
need for low-cost treatment approaches, as due to the ongoing debt crisis the Greek 
government and the citizens face difficulties in covering all the health expenditures. 
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1.2. Aims of the thesis 
Based on the gap in the literature, the current study was conducted, whose aims are listed 
as follows: 
1. To evaluate the effects of physical activity on anxiety and depression in patients with 
PD. 
2. To detect and list the impacts of PD on everyday activities and emotional status in 
patients with PD living in Greece. 
3. To design and evaluate a group-based exercise and educational programme to improve 
depression, mobility, quality of life (QoL) and lung function in Greek PD population 
suffering from depression. 
 
A systematic review was conducted to satisfy the first aim of the thesis, a survey the 
second, and a randomised controlled trial (RCT) the third. The gap in the literature that 
arose from the systematic review, indicated the need for a well-designed experimental 
study to assess the effectiveness of a community-based programme to relieve depression 
in a PD population. The survey gave direction as to what was important from patients’ 
perspective.  The results of these two studies then informed the design of the RCT. 
 
1.3. Elements of originality and contribution to knowledge 
The current study was held in Athens, Greece. The overall investigation was under the 
supervision of Manchester Metropolitan University in collaboration with the Hellenic 
Parkinson’s disease Association (HPDA) ‘Epikouros-kinisi’ (Επίκουρος- κίνηση), as this 
organisation seems to have the largest database of Greek PD patients. The study was 
funded by the States Scholarship Foundation (Ίδρυμα Κρατικών Υποτροφιών) of Greece. To 
our knowledge at the time of conduction of the present study, there were no other similar 
studies undertaken or proposed to be undertaken on PD population in Greece. In addition, 
no previous systematic review was founded to evaluate solely the effects of physical 
activity on anxiety and depression in patients with PD. As the research should be linked 
with the clinical practice; the findings of this study would be useful to assist 
physiotherapists working in Greece, to take clinical decisions based on the needs of PD 
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patients, and promote the community-based therapeutic exercise in Greeks patients 
affected by PD. 
 
1.4. Dissertation guidance 
The dissertation is divided into 11 Chapters. Chapters 2-4 provide the rationale behind the 
conduction of the RCT; Chapters 5-7 are referred to the survey, and Chapters 8-10 to the 
RCT. Chapter 11 is the final conclusion of the thesis. The title and content of each Chapter 
are summarised in table 1.1.  
 
Table 1.1. Chapters of the thesis. 
Chapter Title Content 
2 Landscape of Greece Brief description of the country, where the present 
study was conducted 
3 Background of study Literature review on PD and depression in PD 
4 Systematic review Evaluation of the effects of therapeutic exercise on 
anxiety and depression in PD population 
5 Survey-methodology Design of the survey  
6 Survey-results Survey’s findings 
7 Survey-discussion Interpretation of survey’s findings 
8 RCT-methodology Design of the RCT 
9 RCT-results RCT’s findings 
10 RCT-discussion Interpretation of RCT’s findings 
11 Overall conclusion Final conclusions and future directions  
 
Acronyms. PD: Parkinson’s disease; RCT: randomised controlled trial.  
 
Chapter 2: Landscape of Greece 
5 
 
 
 
 
 
CHAPTER 2 
LANDSCAPE OF GREECE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: Landscape of Greece 
6 
 
2.1. Introduction 
As the current study was held in Athens, Greece, this chapter provides a brief description 
of the landscape of Greece. It contains a geographical and demographic description, the 
current status of the country, basic information about the healthcare system and PD in 
Greece; indicating the rationale for conducting the present study in this country. 
 
2.2. Geography of Greece 
Greece is a Mediterranean country of Southern Europe on the southern tip of the Balkan 
Peninsula; located at the crossroads of Europe, Asia and Africa. The official name of the 
country is Hellenic Republic; however, in the current thesis the name Greece was preferred, 
as it is known worldwide. Greece covers 131,944 square kilometers of land; 20.2% of them 
being islands. Greece is the second more mountainous country of Europe; and mountains 
cover 80% of the country. About 30% of Greece is forested. The climate of the country is 
mainly Mediterranean; but due to its landscape, it varies from Mediterranean to Alpine. 
The capital of the country is Athens, located in the southern part of the mainland. The 
geomorphology of the city varies, as it extends from the coastline to the mountains, 
including flat plain zones and hills. The official language is Greek, including several dialects; 
but all the citizens speak demotic Greek (δημοτική γλώσσα), a form of Modern Greek. The 
Greek language has its own writing system, which shares elements with the Latin and Slavic 
alphabet (Encyclopaedia Ydria, 2014). 
 
2.3. Demographic profile 
The total population of Greece was estimated at 11.5 million people on 1st January 2018. 
However, the real population may be higher, as it is believed that the number of 
undocumented immigrants is between 0.4 and 0.5 million. Over 45% of the country’s 
population lives in the two main cities: Athens (4.5 millions) and Thessaloniki (1.1 million). 
The vast majority of Greek citizens are Greek. However, there is a Muslim minority in 
Thrace (~ 100,000) and approximately 170,000 Roma. The percentage of foreign population 
is estimated around 8.3% to the total population; whereas 70% of them are from other 
Chapter 2: Landscape of Greece 
7 
 
Balkan and ex-Soviet Union countries, mainly from Albania. Life expectancy is 80.3 years, 
among the highest in the world. The phenomenon of the aging of Europe is obvious in 
Greece. Greece’s population census of 2011 revealed that 19.3% of the total population 
was above the age of 65 (Encyclopaedia Ydria, 2014). As the total number of the senior 
population is projected to increase greatly the following decades, the prevalence of age-
related disorders (such as PD) is also expected to be higher.  
 
2.4. Administrative divisions  
The country is divided in 13 administrative units (Περιφέρειες) (image 2.1), 51 regional 
units (Νομοί) and the Eastern Orthodox monastic community on Mount Athos (image 2.2, 
p. 8), which is an autonomous self-governing entity. Athens Metropolitan Area occupies 
almost all Attica administrative and regional unit including four urban areas: Athens, 
Piraeus, West Attica and East Attica (Encyclopaedia Ydria, 2014). Both the paper-based 
survey and the RCT were conducted in Athens Metropolitan Area. 
 
 
Image 2.1. Administrative units of Greece (adopted from Wikipedia). 
 
 
1. Eastern Macedonia-Thrace 
2. Central Macedonia 
3. Western Macedonia 
4. Epirus 
5. Thessaly 
6. Ionian Islands 
7. Western Greece 
8. Central Greece 
9. Attica 
10. Peloponnese 
11. North Aegean 
12. South Aegean 
13. Crete 
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Image 2.2. Regional units of Greece and Mount Athos (adopted from Wikipedia). 
 
 
2.5. Modern history 
In the 1900s the country experienced many wars and changes of the government, which 
hindered economic development, and were responsible for a high number of causalities 
and immigration of Greeks to other countries. The Greek Civil War (1946-1949) was the last 
war occurred in the country. After the end of the Greek military junta (1967-1974), the 
Hellenic Republic was established. Greece joined European Union in 1981. It became a 
member of Schengen Area in 2000 and adopted the euro currency in 2002. From 1970s to 
2000s, the economic growth of the country was among in the highest in Europe. In 2000s 
the relative purchasing power of Greeks was almost equal to that of the rest Western 
European countries and the QoL was among the top 20 in the global ranking system 
(Encyclopaedia Ydria, 2014). 
1. Attica; 2. Euboea; 3. Evrytania; 
4. Phocis; 5. Phtiotis; 6.Boeotia; 7. 
Chalkidiki; 8. Imathia; 9. Kilkis; 10. 
Pella; 11. Pieria; 12. Serres; 13. 
Thessaloniki; 14. Chania; 15. 
Heraklion; 16.  Lasithi; 17. 
Rethymno; 18. Drama; 19. Evros; 
20. Kavala; 21. Rhodope; 22. 
Xanthi; 23. Arta; 24. Ioannina; 25. 
Preveza; 26. Thesprotia; 27. 
Kerkyra; 28. Cephalonia; 29. 
Lefkada; 30. Zakynthos; 31. Chios; 
32. Lesbos; 33. Samos; 34. 
Arcadia; 35. Argolis; 36. Corinthia; 
37. Laconia; 38. Messenia; 39. 
Cyclades; 40. Dodecanese; 41. 
Karditsa; 42. Larissa; 43. 
Magnesia; 44; Trikala; 45. Achaia; 
46. Aetoloacarnania; 47. Elis; 48. 
Florina; 49. Grevena; 50. Kastoria; 
51. Kozani; a. Mount Athos.  
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However, since 2009, Greece has been undergoing the most severe debt crisis in its history 
since the end of the Greek Civil War. In 2010, the Greek Government signed a financial 
rescue package with Troika; comprising by the European Commission, the European 
Central Bank and the International Monetary Fund. Capital controls were introduced in 
June 2015, and a referendum took place in July 2015 to decide whether Greece was to 
accept the bailout conditions proposed by Troika. The two last events were occurred during 
the conduction of the current RCT. Since 2015, the financial crisis has been further affected 
by the refugee crisis. The arrivals of refugees by sea from Turkey seeking asylum have 
increased, due to the ongoing Syrian War; and refugee camps have been established all 
over the country (Pelekanou, 2017). 
 
The ongoing crisis had several impacts on the Greek population. In particular, 
unemployment rates reached 28% in 2013, the income of citizens was reduced by 40% from 
2009 to 2014; 22.2% of the population were “severely materially deprived” in 2015, and 
depression rates were increased from 3% in 2008 to 9% in 2009. It is also estimated that 
300,000 Greeks migrated to other countries from 2009 to 2015. In addition, the Greek 
National Health System (NHS) was badly damaged. Before crisis, the Greek NHS was ranked 
14th worldwide in the overall assessment, above from other European countries, such as 
the United Kingdom (18th place). However, healthcare expenditure per capita was reduced 
by 28% from 2009 to 2011, and there is a shortage of staff and medical equipment in public 
hospitals and clinics. Thus, there are indications that the Greek NHS could potentially 
collapse (Pelekanou, 2017). 
 
2.6. Health delivery system 
The health services in Greece are either public, provided by the Greek NHS, or private. 
However, some private organisations are enrolled with the Greek NHS, which covers a part 
of the patients’ expenditure in the private domain.  Physiotherapy services for outpatients 
are provided by hospitals and clinics, physiotherapy centres or home-based physiotherapy 
services in patients’ home. With respect to senior citizens with disability, the majority live 
alone in their own houses or with their children. They receive mainly care by their family 
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or a caregiver, who is mainly a woman for Eastern Europe without any qualification. A small 
percentage lives in nursing homes, due to the stigma of to not taking care the elderly 
parents, and disdain of many people to this kind of care. However, a special public structure 
are Elderly Open Care Centres (KAPI), which are located in all the Greek municipalities. The 
main objective of KAPI is the elderly to stay physically and socially active. These structures 
are open in working days, from morning to evening; and provide a variety of services, 
usually free-of-charge; such as physiotherapy, social support, artistic activities and trips. 
 
2.7. Parkinson’s disease in Greece 
There is little research about PD in Greece, usually genetic studies. Even the exact number 
of PD sufferers is unknown (section 3.2). There are two non-profit organisations to promote 
health and welfare of people living with PD, their families and caregivers: the HPDA 
‘Epikouros-kinisi’ and Northern Greece Parkinson's Disease Association. Both of them are 
members of the European Parkinson's Disease Association (EPDA). The HPDA was founded 
in 2007 and is based in Athens, whereas the Northern Greece Parkinson's Disease 
Association in 2016 in Thessaloniki. The HPDA organises annual symposiums in Athens to 
keep patients and their caregivers updated about the management of the disease. Group 
exercise classes were provided with a minimum cost at the 5th Annual Symposium in 2014, 
and a booklet with exercises in a seated position was delivered to the participants. The vast 
majority of patients were interested to participate in such programmes in the future. 
 
Patients with PD living in Greece face many challenges. The majority of them live in their 
properties and receive care by their family. Due to the geomorphology of Greek cities and 
villages –characterised by downhills, uphills and stairs-, the patients reduce their outdoor 
activities, even from the first stages of the disease. Apart from the pharmacological 
treatment, the free-of-charge services provided by the Greek NHS in outpatient PD 
population is limited.  Thus, the majority of patients have to pay by themselves the 
physiotherapy cost. Due to inability to cover the expenditures, they usually start 
physiotherapy at the middle stages of the disease; when the symptoms and the impacts of 
PD are more apparent. The physiotherapy programmes are almost individualised, as 
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community-based programmes are not popular in Greece. Patients living in small cities and 
rural areas should travel to Athens or Thessaloniki to visit specialist neurologists or PD 
centres, increasing further the indirect cost of the disease. Hence, there is need for low-
cost physiotherapy programmes, such as group-based exercise, easily accessible to the vast 
majority of patients; in order to reduce the treatment cost, maintaining a high quality of 
service.  
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3.1. Introduction 
The literature review provides the background and justification for research (Bruce, 1994). 
The current chapter is a synthesis of the literature about PD and comorbid depression; 
providing an in depth understanding of the prevalence, pathophysiology, symptoms, 
impacts and treatment options.  
 
3.2. Epidemiology of Parkinson’s disease 
PD is the most common movement disorder, and the second most common 
neurodegenerative disease after Alzheimer's disease (Elbaz et al., 2016). Life expectancy is 
between 6.9 to 14.3 years following diagnosis, or 11 years shorter to that of the overall 
population (Macleod et al., 2014). However, it is not clear whether the short life expectancy 
of PD sufferers is due to the disease itself or from accompanying motor and non-motor 
dysfunctions, such as falls and aspiration pneumonia (Macleod et al., 2014). 
 
The disorder affects all the races and ethnic groups; but is somewhat more prevalent 
among Caucasians (100-350/100,000) (Elbaz et al., 2016); whereas less among Asian 
populations (35-176/100,000) (Muangpaisan et al., 2009), and black Africans (20-
30/100,000) (Okubadejo et al., 2006). It is under debate if these differences are related to 
environmental and genetic factors, which are believed to be risk factors for the onset of 
the disease (section 3.3) (Elbaz et al., 2016); or reflect differences in the methodology of 
epidemiological studies. In addition, the low prevalence in Africa may be due to the local 
population structure, as life expectancy and mean age population is generally lower 
compared to European  and Asian countries (especially China and Japan) (Wirdefeldt et al., 
2011). 
 
With regard to the European continent, the most recent review that investigated the PD 
prevalence in European countries was published by von Compenhausen et al. (2005), 
comprising 39 studies from ten countries, but Greece was not included. The highest 
prevalence of PD appeared in Germany, ranging from 713 to 12,500 per 100,000; whereas 
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the lowest (115/100,000) in Sweden (von Compenhausen et al., 2005). The literature 
search did not identify any publication for the prevalence of PD in Greece. However, 
according to the EPDA, the estimated number of PD patients in Greece, based on the 
prevalence rates in other European countries, are 23,439 (EPDA, no date). 
 
The meta-analysis by Pringsheim et al. (2014) revealed that the prevalence rate of PD 
increases steadily with age, being extremely rare in those under the age of 50 years 
(41/100,000) and more common in individuals over 80 years (1903/100,000); probably due 
to the age-related changes in the neurotransmitter system, which may be responsible for 
the appearance of PD symptoms in older ages (Desai et al., 2010). The disease affects also 
mainly male population, and the reported male/female ratio ranges from 1/1 to 3/2 (de 
Lau and Breteler, 2006; Wirdefeldt et al., 2011). The less prevalence of PD in women and 
the later onset, could be explained by higher initial striatal dopamine (DA) levels in women, 
and the protective role of oestrogens against nigrostriatal degeneration (Miller and Gronin-
Golomb, 2010). 
 
3.3. Pathophysiology of Parkinson’s disease 
PD is a neurodegenerative disorder that affects predominantly DA-producing neurons in 
the substantia nigra (SN), a specific area of the basal ganglia (BG). The BG are nuclei of the 
midbrain, within the hemispheres, part of the extrapyramidal system (Steiner and Tseng, 
2010). Their main function is the motor control. In particular, they are involved in voluntary 
and automatic associated movements, and the suppression of unwanted movements. They 
contribute in regulating muscle tone, planning and initiating a movement, performing 
smooth movements, and learning movement patterns. In addition, they are functionally 
linked to emotional processing and cognition (Marsden and Obeso, 1994), and they are 
components of the central mechanism providing control of the lung ventilation 
(Kolesnikova, 2006). 
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The cerebral cortex, in order to initiate a voluntary movement, sends signals to the BG. In 
turn, the BG send signals back to the cortex, especially the motor cortex, via the thalamus. 
The signals from the cortex are sent to the spinal cord, and finally to the skeletal muscles 
for the performance of normal movement patterns. Within the BG, there are two pathways 
for the transmission and processing of signals from the cortex to thalamus: the direct and 
indirect pathway. The balance of activity between the two pathways is modulated by the 
neurotransmitter DA, which is released by the SN pars compacta to stratum (Steiner and 
Tseng, 2010). 
 
In idiopathic PD, the reduced DA levels in the SN pars compacta, due to apoptosis or 
necrosis of dopaminergic neurons, are considered responsible for the onset of the disease. 
Due to the death of DA neurons, the DA action is lost, exciting the indirect pathway, which 
inhibits the movements; and inhibiting the direct pathway, which facilitates the 
movements. Thus, there is an alteration of the signals from the BG to thalamus, and there 
is no controlled normal movement pattern. The PD symptoms become apparent when the 
loss of the neuronal cell is around 80% (Hamani and Lozano, 2003). 
 
Although the aetiology of the death of DA neurons is unknown, researchers have proposed 
some possible causes. For instance, mutations of the enzyme leucine-rich repeat kinase 2 
may cause shortening and simplification of the dendritic trees; high concentration of 
oligomeric α-synuclein protein may decrease DA release; and mitochondrial changes may 
lead to oxidative stress, which distorts the DA neurons, through the creation of free radicals 
(Surmeier et al., 2010). Although there is limited evidence so far, it is believed that 
environment factors; such as living and occupational exposure to some toxics may cause 
the aforementioned damages, which destroy the DA neurons (Noyce et al., 2012). In 
addition, mutations (mainly duplication or triplication) in some genes which encode 
proteins, might be related with the onset of PD (Nuytemans et al., 2010). 
 
As the disease progresses, the degeneration extends beyond the SN. Neuron losses 
resulting in reduced acetylcholine (ACh), serotonin (5-HT), noradrenaline (NA) levels in 
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several areas of the central nervous system. The neurodegenerative process may affect 
specific parts of cortex, thalamus, brainstem, and spinal cord, as well as sympathetic and 
parasympathetic ganglia (Alexander, 2004). 
 
A pathological hallmark that characterises PD is the presence of Lewy bodies, in the SN and 
other parts of the brain, such as in the raphe nuclei, hypothalamus, nucleus of Meynert, 
neocortex and cortex. Lewy bodies have never been identified in patients with other 
parkinsonian syndromes, apart from idiopathic PD. They are spherical, eosynophilic, 
cytoplasmatic, inclusions; which are composed of the protein α-synuclein (40%), associated 
with other proteins, mainly ubiquitin. The function of Lewy bodies is under debate. They 
may represent either a destructive mechanism that initiate the death of DA neurons; or a 
protective mechanism of the surviving cells, by segregating and recycling errant proteins 
(Hamani and Lozano, 2003). 
 
3.4. Symptoms of Parkinson’s disease 
Despite the fact that PD is considered a movement disorder, it is characterised by both 
motor and non-motor symptoms. The progression differs among the patients; and there is 
a wide range of clinical heterogeneity of symptoms, maybe due to its complex 
pathophysiology and the affected damaged brain areas (van Rooden et al., 2011). 
 
3.4.1. Motor symptoms 
In most cases (46% to 85% of PD patients) there is an asymmetric presentation of motor 
symptoms in the early stages of the disease, maybe due to the unequal number of neurons 
in both sides of the SN in healthy population. However, symptoms become bilateral as the 
disease progresses (Maetzler et al., 2009). The main motor symptoms of PD are listed as 
follows: 
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 Bradykinesia. It is the most common clinical feature of PD, is defined as the reduced 
movement speed and amplitude. It is also characterised by increased reaction times 
(Heisters, 2011).   
 Tremor-at-rest. A tremor is an uncontrollable shaking movement that affects a part of 
the body, due to alternating agonistic-antagonistic innervation of distal muscles. It 
usually affects the hands and lower limbs; and rarely the chin and lips. It appears to 
70%-85% of PD cases, it occurs at a frequency between four and six Hertz at rest, and 
is often inhibited during the performance of voluntary movements (Heisters, 2011). 
 Rigidity. Rigidity refers to the stiffness or inflexibility of the muscles, which prevent 
them from stretching or relaxing (Heisters, 2011). It is characterised by increased 
muscular resistance, usually accompanied by the “cogwheel” phenomenon. It may 
affect both extensors and flexors muscles (Jankovic, 2008). Rigidity may decrease the 
range of movement (ROM) of voluntary movements and lead to postural deformities, 
such as camptocormia1 and Pisa syndrome2 (Heisters, 2011). 
 Postural instability or balance impairment refers to the difficulty in maintaining the 
upright position and stability in sitting or when transferring. It is generally a 
manifestation of the late stages of PD (three to five H&Y stages), and usually occurs 
after the onset of rigidity and bradykinesia (Kim et al., 2013). 
 Gait disturbances. The two main characteristics of parkinsonian gait are freezing of gait 
(FOG) and festination. FOG typically manifests as a sudden and transient inability to 
move during specific situations: turning, under environmental constraints (e.g. walking 
through a narrow passage), and step initiation (Heisters, 2011). Festination describes 
the rest characteristics of parkinsonian gait; such accelerating steps with increased 
cadence, shorter stride, longer double support time, flat foot strike, and reduced arm 
swing (Morris et al., 2008).  
 Wearing-off. It is a motor fluctuation, and is considered a complication of levodopa (L-
dopa) therapy, in which the effects of L-dopa are diminished before it is time for the 
next dose. Thus, some types of dyskinesia3 may arise. They can manifest as chorea and 
                                                             
1 Extreme flexion of the thoracolumbar spine 
2 Tilting of the trunk, particularly when sitting or standing 
3 Involuntary movements resulting in fragmented or spasmodic motions 
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dystonia, and rarely as athetosis. Dyskinesia is developed, on average about five years 
after starting L-dopa therapy, in 50% of patients (Caillava-Santos et al., 2015). 
 
3.4.2. Non-motor symptoms 
A plethora of non-motor symptoms are present in PD, grouped in four categories: sensory, 
autonomic, cognitive-behavioural and sleep disorders (Pandya et al., 2008). The survey by 
Barone et al. (2009) revealed that 98.6% of patients with PD suffered from at least one non-
motor symptom; with an average of 7.8 symptoms per patient. The causes of non-motor 
symptoms seem to be multifactorial; associated with the underlying pathophysiology of PD 
and/or being derived from the cardinal motor features (Chaudhuri and Schapira, 2009). The 
fact that some non-motor symptoms appear before the onset of motor symptomatology, 
may be explained by the Braak staging, which is a method to classify the pathological 
process in PD based on the distribution of Lewy bodies. The Braak staging supports that the 
degeneration does not start from the SN; but other brain areas are affected first, which 
may be responsible for the onset of some non-motor symptoms. (Braak et al., 2003).  
Depression is considered one of the most common non-motor symptoms in PD (section 
3.6.1). 
 
3.5. Impacts of Parkinson’s disease 
3.5.1. Falls and fall-related injuries 
PD sufferers have three times greater risk of falls than similarly aged healthy individuals; 
probably due to the motor (e.g. postural instability and gait disturbances) and non-motor 
symptoms (e.g. orthostatic hypotension) of the disease (Rudzińska et al., 2013). Falls in PD 
are a leading cause of physical trauma, hospitalisation, disability, impaired QoL, and 
caregiver stress (Gazibara et al., 2014). Due to the high number of falls, the prevalence of 
hip fractures is four times higher in PD patients compared with age-matched controls 
(Melton et al., 2006). 
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3.5.2. Disability 
PD is a leading cause of disability, as both basic activities of daily living (ADLs) (e.g. dressing, 
bathing) and instrumental ADLs (e.g. shopping, preparing food) are reduced even from the 
first stages of the disease. Among the motor symptoms; gait disturbances, postural 
instability, and bradykinesia have the strongest correlation with disability; whereas tremor-
at-rest has no correlation (Muslimović et al., 2008). The disability is greater during the off-
state, as the motor symptoms are less controlled (Shulman, 2010). A plethora of non-motor 
features have also strong correlation with disability, such as cognitive deficits and fatigue 
(Muslimović et al., 2008).  
 
3.5.3. Social impacts 
An additional impact is the loss and alteration of the individual's social identity4 . The social 
impacts are not always related to the severity of the disease, as they depend on the 
disability arising from the disease’s symptoms, emotional status and support  by others. 
They may affect the working environment and the daily lifestyle (Soundy et al., 2014). For 
instance, patients gradually avoid going out to social events, due to the stigma arising from 
the signs of the disease; whereas dyskinesia seems to be the most embarrassing motor 
symptom. Hypophonia5 impairs the participation in social networks and telephone 
conversation (Khlebtovsky et al., 2012). In addition, patients may be unable to retain a job, 
due to disability. Others reduce the number of working hours, or find an alternative job 
that is not as fact paced or physically demanding (Chiong-Rivero et al., 2011). 
 
3.5.4. Reduced quality of life 
The QoL in PD may be reduced even from the first stages of the disease. PD patients report 
diminished QoL levels when compared to healthy controls or other chronic disorders, such 
as multiple sclerosis and diabetes mellitus (Den Oudsten et al., 2007). It seems that the QoL 
is affected by many factors; such as the signs of the disease and their impacts, socio-
                                                             
4 Individual's knowledge that they belong to a certain social group 
5 Abnormally weak voice 
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demographic features, health status and adverse reaction to treatment. However, as some 
factors are connected via multiple pathways, it is difficult to report the determinants of 
reduced QoL in PD (Schrag, 2006).  
 
3.5.5. Hospitalisation and nursing home admissions  
Although the hospitalisation due to PD is less frequent compared to other chronic 
disorders; the annual number of admissions seems to be higher in the advanced stages, 
maybe due to the complications of the disease (Vosius et al., 2010). The primary reasons 
for emergency hospital admissions are the non-motor symptoms of the disease and 
comorbidities, such as pneumonia and fall-related injuries (Braga et al., 2014). The average 
length of stay in hospitals varies from 2.3 (Mahajan et al., 2016) to 9.7 days (Braga et al., 
2014). Following inpatient hospitalisation; there is an increased nursing home admission, 
due to disability and the lack of dependent care at home.  However, additional strong 
predictors for nursing home admissions are dementia, hallucinations and psychosis 
(Safarpour et al., 2015). 
 
3.5.6. Financial cost 
PD is considered one of the most costly chronic diseases, with high direct and indirect cost 
(Rodríguez-Blázquez et al., 2015). The total annual cost per capita in European countries 
ranges from 2,620 to 9,820 euros, whereas the direct cost ranges between 60% and 70% 
of the total cost (von Campenhousen et al., 2011). Differences in the cost of healthcare 
services, pharmacological treatment and taxies, and the services provided to patients and 
carers by the NHS; may explain the higher direct and indirect cost per capita in Western 
European than Eastern countries (von Campenhousen et al., 2011). 
 
3.5.7. Caregivers’ burden 
Caregivers of PD patients, especially those who are partners, experience a heavy physical 
and psychological burden (Secker and Brown, 2005).  The determinants of caregivers’ 
burden are: cognitive decline, mental disorder (anxiety, depression), sleep disorders, level 
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of disability, PD duration of patients, low social support and total period of caregiving. The 
depression and anxiety levels of caregivers of persons with PD are twice higher compared 
to their peers; whereas they experience diminished QoL (Santos-Garcia and de la Fuente-
Fernadez, 2015). 
 
3.6. Depression in Parkinson’s disease 
3.6.1. Prevalence rates of depression in Parkinson’s disease 
Depression is the most common psychiatric complication affecting individuals with PD 
(Marsh, 2013). The systematic review by Reijnders et al. (2008) resulted that the prevalence 
rates of clinically significant depressive symptoms vary broadly across studies, ranging from 
a low 2.7% to a high of 89%, with a weighted mean of 35%. In addition, more recent 
experimental studies (Riedel et al., 2010; Perrin et al., 2017) and narrative reviews 
(Hemmerle et al., 2012) indicated that the most commonly cited prevalence of depression 
in PD is between 40% and 50%. These variations may reflect differences arising from the 
studies’ methodology, such as: the patient selection procedures (inpatient/outpatient 
population), characteristics of the sample (sociodemographic characteristics and severity 
of PD), the assessment tools for the detection of anxiety and depression (rating scales or 
specific diagnostic criteria), the experience and qualification of assessors (psychologists or 
other healthcare professionals), and the types of depression included in each study 
(Reijnders et al., 2008). 
 
In regard to the severity of depression and the types of depressive disorders in PD; it seems 
that the patients usually appear mild to moderate depressive symptoms, and occasionally 
severe (Marsh, 2013). The systematic review by Reijnders et al. (2008) revealed that 17% 
of the overall PD population suffers from major depressive disorder (MDD), 22% from 
minor depression, and 13% from dysthymia. Similarly, studies that used rating scales with 
cut-off values to assess the severity of depressive symptoms, showed that minor 
depression varies between 36.3% and 40.3%, whereas severe depression between 12.9% 
and 16.7% (Rojo et al., 2003; van der Hoek et al., 2011). 
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Current knowledge supports that PD patients experience higher rates of depression than 
individuals suffering from other chronic diseases, or when compared to controls (Marsh, 
2013). One study (Veiga et al., 2009), showed that the prevalence of depression in 
individuals over 60 years was four times higher in PD (42%), when compared to aged-
matches controls (10%). Similarly, when PD is compared with other neurological diseases; 
the prevalence of depression in PD (20%-45%) is higher than in other neurological 
conditions, such as stroke (10%-34%) and multiple sclerosis (20%-25%)  (Rickards et al., 
2005; Hellmann-Regen et al. 2013). It is unknown whether the higher prevalence of PD 
depression is associated with more severe impacts of PD in patients’ life, or whether it is 
related to the underlying pathophysiology of PD (Marsh, 2013). 
 
3.6.2. Pathophysiology of depression in Parkinson’s disease 
There has been considerable debate over the aetiology of depression in PD, which is 
believed to be complex. Depression is a manifestation of the underlying disease process in 
PD (primary depression), and/or a ‘reaction’ of copying with a chronic, progressive and 
disabling disease (reactive or secondary depression) (Marsh, 2013). Symptoms of 
depression can predate the motor features and the clinical diagnosis of PD, even ten years 
before the diagnosis of PD (Bower et al., 2010). This could be supported by the Braak 
staging, as mood disorders may start at Braak stage two; when dysfunctions occur at locus 
coeruleus, which has connections to amygdala and hypothalamus. On the contrary, the 
motor symptoms appear at Braak stage three, when the degeneration affects the midbrain, 
especially the SN (Jacob et al., 2010). 
 
Biological approaches support that the pathophysiological mechanisms implicated in PD 
depression include abnormalities in the system of neurotransmitters (Eskow Januarjs et al., 
2011); whereas less evidence is available for the role of the hypothalamic–pituitary–
adrenal (HPA) axis (Du and Pang, 2015). Regarding the neurotransmitters, as L-dopa may 
not reduce depression scores, it seems that not solely the dopaminergic system contributes 
to the onset of depression (Marsh et al., 2006). The phenotype of depression in PD reveals 
that the noradrenergic system is affected more, due to difficulties in concentration and 
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diminished attention (Eskow Januarjs et al., 2011). However, post-mortem and 
neuroimaging studies in depressed subjects with PD revealed that the dopaminergic and 
serotonergic system are also involved (Dissanayaka et al., 2014). With respect to the HPA 
axis, Du and Pang (2015) concluded that it may be a dysregulation in the HPA axis in PD, as 
Lewy bodies were detected in the pituitary lobe and adrenal glands. On the contrary, the 
hypothalamus was relatively free of body Lewy formation. In addition, DA deficits in the 
pituitary gland may disrupt its normal function and adrenocorticotropic hormone (ACTH) 
secretion, activating the release of cortisol, causing stress and depressive symptoms (Du 
and Pang, 2015). 
 
Depression may also be a result of the emotional dimensions of coping with a chronic, 
progressive disease; without cure and only symptomatic management (Marsh, 2013). 
Socio-psychological approaches focus on the role of psychological and social factors for the 
development of mental disorders in chronic somatic disease. The dominant models are: 
the psychodynamic, behavioural, cognitive and the sociocultural model. (Borrell-Carrió et 
al., 2004). The psychodynamic model, supports that the pathophysiology of mental 
disorders is caused by internal psychological factors, rather than biological, and the 
mechanisms of dysfunctions arise to conscious mind (Wasserman, 2011). The cognitive 
approaches support that dysfunctional thoughts lead to extreme emotions, which may lead 
to maladaptive behaviours (Weich et al., 2009). According to behavioural approaches, 
abnormal behaviour is learned; whereas the sociocultural approaches describe the 
psychopathology of mental disorders as the result of the interaction between the 
individuals and their cultures (Strongman et al., 1995). Indeed, in PD depressive symptoms 
may arise or worsen during the disease process by a variety of factors, such as: the motor 
fluctuations and off-periods, which lead to mood fluctuations; concerns about the disease 
and its impacts; perceived or actual disability; low social support; stigma; stereotypes about 
the disease; and PD cost  (Marsh, 2013; Pachana et al., 2013).  
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3.6.3. Impacts of depression in Parkinson’s disease 
The presence of depression in patients with PD can worsen the impacts of the disease 
(Chapter 3.5); however the research in this field is limited so far. Although it is not clear 
whether the motor symptoms are a risk factor for the development of mental disorders, or 
if depression may worsen the motor symptoms of PD; Jankovic (2008) believes that 
bradykinesia may be dependent on the emotional state of the patient, due to ‘kinesia 
paradoxica’, a phenomenon where PD patients with akinesia6 may be able to perform quick 
movements after they become excited. The contribution of PD depression in falls has been 
little studied. The study by Ashburn et al. (2001) revealed that higher levels of depressive 
symptoms are associated with increased number of falls. Perhaps, the antipsychotic 
medication and psychomotor slowing may increase gait instability and lead to falls (Iaboni 
and Flint, 2013). 
 
With respect to disability, when PD depressed population was compared with non-
depressed patients, the levels of disability were significant higher in the depressed group; 
probably due to the loss of interest and fatigue, which may lead to physical inactivity 
(Pontone et al., 2016). Although PD depression has not been studied; in general population 
depression may result to social impacts; such as: diminished social activities, less working 
hours, unemployment or dismissal, reduced communication with family and friends, and 
lead to separation or divorce (Lépine and Briley, 2011). The presence of depression may 
increase further the economic burden of the disease, due to direct cost associated with 
antidepressant medication and psychotherapy (Lépine and Briley, 2011). One study that 
was held in Germany indicated that the direct cost was significantly higher in PD patients 
with depression; adding 1,142 euros to the annual cost of the disease (Winter et al., 2010). 
 
In addition, the review by Den Oudsten et al. (2007) indicated that depression is the 
strongest predictive value for poor QoL in PD. This is also confirmed by a more recent study, 
where depression accounted up to 31.5% of impairment in QoL scores (Liu et al., 2015). It 
seems that depressed PD patients, due to loss of interest and reduced motivation, cannot 
                                                             
6 Inability to start an act or motion 
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create strategies to cope with the difficulties arising from PD (Carod-Artal et al., 2007). 
Furthermore, the cohort study by Hughes et al. (2012) showed that depression is an 
important predictor of mortality in PD. Although the reasons of death were not explored 
further; it is believed that the hypercortisolaemia, due to the HPA hyperactivation, may 
redistribute body fat and increase blood pressure by decreasing insulin resistance, 
increasing the risk for coronary artery disease (Hughes et al., 2012). Lastly, the mental 
disorders seem to be a determinant factor for caregivers’ burden in PD (Carod-Artal et al., 
2013; Santos-Garcia and de la Fuente-Fernadez, 2015). In turn, the affected psychology of 
caregivers may have negative feedback to sufferers with PD, exacerbating the patients’ 
symptoms of anxiety and depression (Scazufca et al., 2002).   
 
3.6.4. Diagnosis of depression in Parkinson’s disease 
The gold standard and the most widely used criteria for the diagnosis of depressive 
disorders are the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria, and 
the International Statistical Classification of Diseases and Related Health Problems (ICD) 
criteria by psychologists using semi-structured clinical interviews (Jacob, 2006). The 
appendix 3.1 summarises the types of depressive disorders according to the DSM-IV 
criteria.  
 
There are many barriers to the diagnosis of depression in the general population. Despite 
the fact that both biological and socio-psychological factors are considered responsible for 
the onset and development of depression, the diagnosis is only based on the symptoms 
and not on the aetiology of the disease (Avasthi and Ghosh, 2014). Although some 
laboratory tests –such a blood tests and magnetic resonance imaging- have been proposed 
for the diagnosis of MDD; they are not accepted diagnostic tools, and they cannot replace 
the DSM and ICD criteria. Their aim is to exclude medical conditions with similar symptoms 
or to identify deficits in some brain structures (Anderson et al., 2002; Verma et al., 2012). 
In addition, in semi-structured clinical interviews, the diagnosis is based on patients’ 
responses and the symptoms they present, whereas some patients may cover consciously 
or unconsciously their depressive symptoms (Avasthi and Ghosh, 2014). In particular, males 
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may hide these symptoms, due to stereotypical perceptions about the role of men in 
society (Rochlen et al., 2009). Religious individuals may be skeptical about the role of 
mental health providers, may believe that depression is a part of life and does not 
necessarily require professional intervention (Bryant et al., 2013). The fear of 
stigmatisation in some societies hampers diagnosis and further management of depression 
(Nasir and Al-Qutob, 2005). Lastly, according to psychologists, the diagnosis is particularly 
problematic: in the elderly, patients with chronic somatic diseases, and individuals with a 
different cultural background, due to limited knowledge in these populations; and in 
patients with limited verbal skills, due to the inability to express their feelings (van Rijswijk 
et al., 2009). 
 
Depression in PD may be even more under-recognised, and as hence, poorly treated 
(Marsh, 2013). Indeed, trials have shown that the percentage of depressed PD population 
receiving antidepressant medication varies from 8.6% to 35% (Weintraub et al., 2003; 
Hemmerle et al., 2012). The reasons for its under-recognition are multifactorial. Firstly, PD 
patients and caregivers are less likely to report the non-motor symptoms to their physician; 
as they might be embarrassing, or they ignore that they may be related to their disease 
(Chen and Marsh, 2014). Furthermore, apathy, which often accompanies PD, may decrease 
motivation to seek help (Pachana et al., 2013). Secondly, non-expert neurologists may do 
not have the ability to recognise and diagnose neuropsychiatric symptoms (Chen and 
Marsh, 2014), probably due to diagnostic imprecision; and complexity of diagnosis, as some 
symptoms of depressive disorders overlap with PD symptoms or may be considered part 
of aging (Pandya et al., 2008). However, one study revealed that 67% of PD patients with a 
previous confirmed diagnosis of depression, were detected as depression-free, despite the 
fact that they were examined by experts using the DSM criteria (Bouwmans and Weber, 
2012). This revealed the limitations of diagnostic criteria to detect depression in PD 
population, as patients with PD may do not meet the criteria for defined subtypes of 
depression according to the DSM criteria (Rickards, 2005). 
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Thus, the assessors should also be aware of the phenotype of PD depression, which seems 
to be qualitatively different from depression in general population. Some classical 
symptoms of depression, such as psychotic symptoms in MDD, guilty, sadness, anhedonia, 
suicidal ideation, and changes to appetite may be less frequent in PD depression. On the 
contrary, common reported depressive symptoms among the PD population include: low 
energy, difficulties with concentration, making decisions and hopeless (Ehrt et al., 2006; 
Farabaugh et al., 2009).   
 
3.6.5. Management of depression in Parkinson’s disease 
The management of depression in PD includes pharmacotherapy, psychotherapy and 
supplementary treatments; such as the electroconvulsive therapy (ECT), bright light 
therapy (BLT), acupuncture and physical activity (Chapter 4). 
 
The antidepressant medication in PD does not differ from those types of drugs 
administrated in overall depressed population; including: serotonin–norepinephrine 
reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), tricyclic 
antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs) and atypical 
antidepressants (Marsh, 2013). Drug trials in PD depression have assessed classical 
antidepressants as well as antiparkinsonian medication used to treat the motor symptoms 
of PD. The antidepressant contributions of L-dopa and DA agonists antiparkinsonian drugs 
have not been well established yet, even in cases that the motor features of PD were 
improved (Barone, 2011; Eskow Jaunarajs et al., 2011). With regard to the antidepressant 
drugs; SSRIs and TCAs have been more studied in PD, whereas less evidence is available for 
SNRIs. The antidepressant effects of all these drugs, when compared to placebo, are 
modest; but there are some studies with significant short-term results (Costa et al., 2012). 
However, when antidepressants are administrated in PD patients, special caution is 
needed. Both SSRIs and TCAs are known for their anticholinergic effect, which may 
exacerbate PD-associated non-motor symptoms, such as cognitive disturbances. In 
addition, SSRIs may cause extrapyramidal side effects, such as tremor (Muller, 2012). Lastly, 
the combination of SSRIs with monoamine oxidase B (MAO-B) inhibitors may precipitate 
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the 5-HT syndrome; which is characterised by high body temperature, agitation, tremor, 
sweating and diarrhea (Wishat and Macphee, 2011). 
 
The application of psychological approaches for the treatment of PD depression has 
received little experimental attention, whereas the cognitive-behavioural treatment (CBT) 
is the most studied approach (Chen and Marsh, 2013). However, more evidence is needed 
to conclude if the CBT is effective in alleviating depressive symptoms, especially about the 
long-term effects (Armento et al, 2012). Similarly, more evidence is needed to establish the 
effects of ECT, BLT and acupuncture in depressed population with PD. Although they 
appear to be effective treatments for PD depression, the evidence is provided by a small 
number of studies, which lacked randomisation (Troeung et al., 2013; Cumper et al., 2014; 
Zeng and Zhao, 2016). 
 
3.7. Summary of Chapter 3 
 PD is the most common movement disorder, and the second most common 
neurodegenerative disease after Alzheimer's disease.  
 The reduced DA levels in the SN pars compacta, due to apoptosis or necrosis of 
dopaminergic neurons, are considered responsible for the onset of the PD.  
 PD has several impacts, such as: increased number of falls, disability, social impacts, 
reduced QoL, high direct and indirect cost, and caregiver’s burden. 
 Although PD is considered a movement disorder, it is characterised by both motor and 
non-motor symptoms. 
 Depression is one of the most common non-motor symptoms of the disease affected 
about 35% of patients with PD. 
 The pathophysiology of depression in PD is complex, and it seems that both biological 
and psychosocial factors contribute to its onset and development.  
 Although there is limited evidence, it seems that the presence of depression in PD 
population may worsen the impacts of PD. 
Chapter 3: Background of study 
29 
 
 The findings about the effects of antidepressant and antiparkinsonian drugs on 
depression in PD are controversial; whereas more research is needed to establish the 
effects of CBT, ECT, BLT and acupuncture. 
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4.1. Introduction 
The high prevalence of PD, the increased levels of depression in this population, and their 
impacts are well-established (Chapter 3). In addition, the effectiveness of therapeutic 
exercise as an adjunctive treatment for PD, and the clinically anxious and depressed 
population has been a popular research topic over the last two decades. Thus, the current 
systematic review aimed to synthesise, critically evaluate all the available evidence, and 
conclude whether physical activity is an effective treatment in reducing anxiety and 
depression scores in PD. As an essential component of the evidence-based practice is the 
transformation of theory into practice; an objective was to suggest the best exercise 
parameters to clinicians, based on the selected trials with significant outcomes at the end 
of the treatment. 
 
4.2. Rationale for the systematic review 
Evidence arising from reviews, regarding the effectiveness of exercise in anxious and 
depressed moods among PD patients is lacking. Previous systematic reviews and meta-
analyses have mainly focused on the motor aspects of the disease and QoL. To date, five 
systematic reviews (Goodwin et al., 2008; Adamson et al., 2015; Lamotte et al., 2015; 
McNeely et al., 2015; Cusso et al., 2016) have partially examined the effects of exercise to 
alleviate anxiety and depression in patients with PD. Of these systematic reviews, only the 
review by Cusso et al. (2016) included anxiety as an outcome of interest. 
 
Adamson et al. (2015) examined the role of exercise in depression among patients with 
neurological disorders, including PD patients. Although the review was published recently, 
it included only two relevant RCTs in PD. The other reviews (Goodwin et al., 2008; Lamotte 
et al., 2015; McNeely et al., 2015; Cusso et al., 2016) focused only on PD population. 
However, as depression and anxiety were examined as part of the non-motor symptoms of 
PD; the discussion in this area was limited. Two reviews (Lamotte et al., 2015; Cusso et al., 
2016) did not involve only RCTs, resulting in systematic reviews of non-hight level of 
evidence. Furthermore, Lamotte et al. (2015) assessed only endurance (aerobic) exercise 
training; whereas McNeely et al. (2015) just dance interventions. Lastly, Cussso et al. (2016) 
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did not exclude occupational therapies interventions, in which exercise was just a 
component of the whole intervention. Although the findings of the reviews were 
inconclusive; physical activity was proved to be effective to some degree in improving 
emotional well-being. However, they failed to detect the most effective type of exercise 
and its parameters in PD population with comorbidity anxiety and depression. 
 
4.3. Research aim, objectives and question 
4.3.1. Research aim 
As no previous systematic review focused solely on the effects of therapeutic exercise on 
anxiety and depression in PD sufferers; the aim of this review was to summarise and 
evaluate all the relevant available RCTs, identify gaps, and propose directions for future 
research. 
 
4.3.2. Research question 
The research question of the review could be formulated as follows: 
“Based on the selected trials, could therapeutic exercise significantly reduce anxiety and 
depression levels in PD population?” 
 
4.3.3. Research objectives 
The research objectives of the current review were: 
 To conclude if therapeutic exercise could reduce anxiety and depressive symptoms in 
PD population, and whether the effects persist after the end of the intervention period. 
 To identify the most effective evidence-based type of exercise and its parameters; such 
as exercise intensity, frequency, and total intervention period. 
 To report the safety of therapeutic exercise programmes in this population. 
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4.4. Selection of the appropriate review design 
Between the 14 types of reviews that appear in scientific magazines and assist in the update 
of evidence-based practice (Grant and Booth, 2009), a systematic review was selected for 
the current thesis; because it is a scientific method for identifying, evaluating and 
synthesising large bodies of evidence from primary studies. It also appraises the risk of bias 
within individual studies, and identifies gaps for future research. As it is based on pre-
defined methods, there are less possibilities for bias arising from the review (Grant and 
Booth, 2009; Hoffmann et al., 2013). Systematic reviews are also recommended in the field 
of physiotherapy to examine the effects of interventions and assist treatment decisions 
(Linde and Willich, 2003).  However, a meta-analysis approach was rejected, after the 
identification of all relevant trials; because they were considered to be heterogeneous with 
respect to study population, types of interventions, groups of comparison, and 
measurement tools. In this case, a quantitative analysis may lead to misleading results; and 
only a qualitative synthesis is proposed (Hoffmann et al., 2013). 
 
4.5. Material and methods 
4.5.1. Design of the systematic review 
The current systematic review was conducted in accordance with the recommendations 
and criteria as outlined in Preferred Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) to minimise bias and errors (Moher et al., 2009). The process of study 
selection, data extraction, quality assessment of selected studies, and data analysis was 
undertaken by two independent reviewers -the PhD student (TC) and the leader PhD 
supervisor (AY)-. At the end of each step, the reviewers compared their findings, and 
disagreements between them were resolved by discussion, as recommended by Aveyard 
(2007). However, there was no need for a third reviewer to make the final decision, as 
recommended by Torgerson (2003); because agreement reached 100% after discussion. 
 
 
 
Chapter 4: Systematic review 
34 
 
4.5.2. Eligibility criteria 
The eligibility criteria were determined based on the population, intervention, comparison, 
outcome and study design (PICOS) approach (Aveyard, 2007). To be included within the 
review, studies had to fulfill the following criteria: 
 
Study design 
Only RCTs were selected, due to their high level of evidence (Torgerson, 2003). Their design 
was parallel to facilitate the comparison between the study groups. RCTs with delayed start 
design or crossover design were excluded, except the cases where the first period was 
analysed as a parallel group trial. No restrictions were placed regarding the year of 
publication, to evaluate the whole amount of research done in this area and to indicate any 
changes over the years (Glasziou et al., 2001). Only full-text articles, published in scientific 
magazines, were included; whereas abstracts, summaries, congress reports, dissertations 
and unpublished studies were excluded. Abstracts and summaries were excluded, because 
some key points or details of the whole procedure may be missed; congress reports and 
dissertations, due to limitation of time. Unpublished studies were not included, as some 
parts of the study may have not been completed yet, and may be changed up to the 
publication day. Finally, only articles written in English were selected, as the involvement 
of an official translator to translate the articles would extend the duration of study and 
increase its cost. 
 
Population 
Individuals with PD, irrespectively of their age and disease severity were included. PD 
should had been confirmed by a neurologist/specialist or/and by the use of well-accepted 
diagnostic criteria. There were not any restrictions whether the sample population was 
diagnosed with clinical levels of anxiety or/and depression, using accurate diagnostic tools. 
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Intervention 
The intervention could be any type of exercise -conventional or alternative-. RCTs in which 
the exercise was given as a part of a treatment (e.g. multidisciplinary rehabilitation), or in 
conjunction with other treatments (e.g. exercise and CBT) were excluded, because it is not 
possible to know how each component contributed to the results. The exercise programme 
could be conducted either in the intervention group (IG) or the comparison group (CG) of 
the study. Studies that examined the effects of a single exercise bout were excluded, as the 
current review aimed to examine only the training effects of exercise. The follow-up, could 
be no exercise or any other intervention. 
 
Comparison 
The comparison interventions could be one of the following: (a) no intervention or usual 
care, (b) exercise, (c) other treatment (e.g. CBT), (d) same exercise intervention plus an 
additional treatment (e.g. exercise plus education). 
 
Outcome measures 
The selected papers included at least one outcome (anxiety or depression), to measure the 
response to treatment. Anxiety and/or depression were either the primary or secondary 
outcome measures of the study. The measurement tools could be either patient-reported 
outcome measures (PROMs) or clinician-reported outcome measures (CROMs). Only 
studies that measured anxiety and depressive symptoms – at baseline and at the end of 
the intervention- separately from other mood symptoms were included. Trials reporting 
overall mood disturbances and those with combined measurements of anxiety and 
depression were excluded, unless they reported depressive and anxiety symptoms 
separately. 
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4.5.3. Search strategy for identification of studies 
Electronic (internet) searching 
Two main computerised literature searches were carried out:  a preliminary search and a 
main search. The preliminary search was conducted in March 2015 without any restrictions 
to identify all the relevant research papers, and examine whether the methodology and 
results of the non-RCTs and non-English published papers were similar with those RCTs 
written in English language. This procedure ensures limited possibilities for publication bias 
(Glasziou et al., 2001). 
 
The main search consisted of two steps: the first between 24th and 29th April 2015; and the 
second -an updating of the literature- on 29th November 2016. During the first search, 
studies were searched from the inception of databases until 24th April 2015; and during the 
second search, from 1st January 2015 to 29th November 2016. Some limiters (e.g. English 
language, humans, clinical trial) were selected to restrict the literature. A broad range of 
areas including sports, exercise, psychology and health literature, were searched. The 
literature search was carried out on 11 electronic databases: AMED, ASSIA, CINAHL, 
Cochrane Central Register of Controlled Trials, EMBASE, MEDLINE, PsycINFO, PEDro, 
PubMed, Scopus and SPORTDiscus. Keywords were structured using the PICOS approach 
and are presented in table 4.1 (p. 37). Although exercise is a subcategory of physical activity 
(Pate, 1988), in the literature, the terms ‘exercise’ and ‘physical activity’ are used 
interchangeably (Caspersen et al., 1985). Thus, for the purpose of the present study, both 
terms were used to capture conventional and alternative types of exercise; such as dance, 
Tai Chi and yoga. The keywords were applied using the Boolean operators “AND” (to 
combine keywords of two different columns) and “OR” (to combine keywords of the same 
column).  
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Table 4.1. Keywords applied for the electronic strategy regarding population, intervention and 
outcomes. 
Population Intervention Outcomes 
Parkinson’s disease Physical activity Anxiety  
Parkinson* Exercise  Depression  
PD Physiotherapy  Anxious  
 Physical therapy Depressive  
 Rehabilitation  Mood  
 Occupational therapy Emotional well-being 
 Aerobic training  
 Anaerobic training  
 Resistance training  
 Strength training  
 Balance training   
 Cue* training  
 Dance  
 Tango  
 Yoga  
 Tai Chi  
 Qigong  
 Martial arts  
 
Hand searching 
Hand searching was conducted to identify papers that were not identified through 
electronic searching. Available journals that were most likely to yield the relevant trials 
were searched (Torgerson, 2003).  This procedure was performed on 31st July 2015 at the 
Library of the General Hospital of Athens ‘Evaggelismos’.  Only two Greek Physiotherapy 
magazines, that include some articles in English language, were found and searched: 
‘Φυσικοθεραπεία’ (Fysikotherapeia) (from January 1982 to April-May-June 2015) and 
‘Θέματα Φυσικοθεραπείας’ (Themata Fysikotherapeias) (from January 2002 to May 2003).  
 
Cross referencing  
When all the studies were collected, their references were checked to identify further 
relevant articles that may have been missed (Sim and Wright, 2000; Haidich, 2010). 
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Additionally, the references of the previous systematic reviews (Goodwin et al., 2008; 
Adamson et al., 2015; Lamotte et al., 2015; McNeely et al., 2015; Cusso et al., 2016) in the 
given area were checked to identify additional missing studies (Torgerson, 2003).  
 
4.5.4. Study selection 
There was no blinding to studies’ author(s), place of publication or results during the 
eligibility assessment. However, unblinded reviewers may have prejudices on this 
information (Holly et al., 2012).  Duplicated articles were excluded. In turn, titles and 
abstracts were screened to exclude irrelevant articles. If this was not clear, the full-length 
articles were read carefully to determine whether the eligibility criteria were met 
(Torgerson, 2003).  
 
4.5.5. Data extraction 
A data extraction form was designed to record the key points of each study and facilitate 
the comparison of the selected RCTs (Torgerson, 2003) (Appendix 4.1). 
  
4.5.6. Quality assessment 
The methodological quality of the selected RCTs was rated using the Physiotherapy 
Evidence Database (PEDro) scale, which is designed for physiotherapy and exercise studies 
(Foley et al., 2006). The PEDro scale is simple without multiple items and complex scoring 
system, and quick to complete it. It is also valid and reliable measure of methodological 
quality (Maher et al., 2003; Foley et al., 2006). A brief description of the PEDro scale and 
the quality appraisal tool form are presented in Appendices 4.2 and 4.3 respectively. 
Studies scoring nine and ten were considered to be of ‘excellent’ quality, from six to eight 
of ‘good’ quality, from four to five of ‘fair’ quality, and up to three of ‘poor’ quality’ (Maher, 
2000; Foley et al., 2003). In the current thesis, similar to the systematic review by Adamson 
et al. (2015) and the PEDro guidelines, the seven criterion was not satisfied when self-
reported scales were used for the assessment of anxiety and depression. In trials in which 
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key outcomes are self-reported, the assessor is considered to be blind if the subject was 
blind to the group allocation (Sherrington, 2000). 
 
4.6. Results 
4.6.1. Selection process  
The flow of trials through the selection process is presented in figure 4.1 (p.40).  Overall 
2298 papers were retrieved by electronic searching and cross referencing; none by hand 
searching. Of the 42 full-text articles; 27 were excluded, as they did not meet the exclusion 
criteria (Appendix 4.4). Finally, 15 studies were deemed to be eligible for the review 
(Bridgewater and Sharpe, 1996; Burini et al., 2006; Schmitz-Hubsch et al., 2006; Modugno 
et al., 2010; Smania et al., 2010; Shulman et al., 2013; Nadeau et al., 2014; Cugusi et al., 
2015; Dashtipour et al., 2015; Hashimoto et al., 2015; King et al., 2015; Rios Romenets et 
al., 2015; Schlenstedt et al., 2015; Sharma et al., 2015; Teixeira-Machado et al., 2015). 
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Figure 4.1. Systematic review’s flow diagram. 
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4.6.2. Methodological quality 
The methodological quality of the selected trials is presented in table 4.2. All of them scored 
between three and six, with a mean score of 4.64 (fair quality). The PEDro criteria most 
frequently satisfied were: random allocation of subjects to study groups (criterion two), 
and similar baseline comparability of groups regarding the most important prognostic 
indicators (criterion four). On the contrary, unblinded subjects, therapists and assessors 
(criteria five to seven) were present in all the RCTs.  
 
Table 4.2. Methodological quality assessment of included studies using PEDro scale. 
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It is interesting that the criterion one (eligibility criteria) was not satisfied in two studies 
(Burini et al., 2006; Schlenstedt et al., 2015), because the source of subjects was not 
described. Although the criterion four (baseline comparability) was satisfied in all the trials, 
three RCTs (Bridgewater and Sharpe, 1996; Schmitz-Hubsch et al., 2006; Sharma et al., 
2015) did not report baseline comparison for depression between the study groups. In five 
trials (Burini et al., 2006; Modugno et al., 2010; Nadeau et al., 2014; Dashtipour et al., 2015; 
King et al., 2015), the baseline scores, between the study groups, differed significantly on 
measures of depression and anxiety. Regarding the criterion eight (adequate follow-up), 
only six trials  (Burini et al., 2006; Modugno et al., 2010; Nadeau et al., 2014; Hashimoto et 
al., 2015; King et al., 2015; Schlenstedt et al., 2015) outlined reasons for drop-out up to the 
end of the study. The combined results of these studies are presented in table 4.3. It seems 
that the reasons for drop-out were not related to the exercise programme itself. Lastly, 
despite the fact that one point was awarded in criterion ten, seven trials did not provide 
between-group statistical comparison for depression and anxiety (Bridgewater and Sharpe 
1996; Burini et al., 2006; Schmitz-Hubsch et al., 2006; Smania et al., 2010; Shulman et al., 
2013; Nadeau et al., 2014; Sharma et al., 2015). 
 
Table 4.3. Reasons for drop-outs. 
Reasons for drop-outs Number of subjects 
Medical reasons: pain in joints and injuries*  31 
High number of absences 12 
Family demands 7 
Changes in PD medication 6 
Missed or refusal to participate in the final assessment  5 
Moving to another city 5 
Unwilling to participate in the study 4 
Hospitalisation  2 
Transportation difficulties 2 
Discomfort with exercise 2 
Disappointment not being selected to the intervention (exercise) group  2 
Participation in another training programme during the study period 1 
No clear explanation 1 
 
* not during the exercise session 
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4.6.3. Study characteristics 
Study methods 
Four trials (Schmitz-Hubsch et al., 2006; Modugno et al., 2010; Rios Romenets et al., 2015; 
Sharma et al., 2015) were pilot studies. Of the remaining 11 studies, pilot-work before the 
main study was conducted only in the study by Hashimoto et al. (2015).  
 
Population 
The trials comprised an aggregate of 535 participants at baseline; 58.97% of them were 
males. Although sample population consisted only of PD patients; the Argentine tango 
partners in the IG by Rios Romenets et al. (2015) were healthy volunteers, which were not 
assessed and included in the results. The basic participants’ characteristics are summarised 
in table 4.4 (p. 45). A sample size calculation was not necessary for the four pilot studies 
(Schmitz-Hubsch et al., 2006; Modugno et al., 2010; Rios Romenets et al., 2015; Sharma et 
al., 2015). Of the 11 remaining trials, only four (Smania et al., 2010; Hashimoto et al., 2015; 
King et al., 2015; Schlenstedt et al., 2015) reported sample size calculations.   
 
Intervention 
The basic interventions’ characteristics are summarised in tables 4.5 (p. 46) and 4.6 (pp. 
47-48). Across all the studies, the exercise interventions were clinically heterogeneous in 
terms of exercise mode, and all the exercise parameters. Both conventional and alternative 
forms of physical activity were performed; such as dance, yoga and Qigong. Aerobic 
training was the most common type of exercise used by five studies (Bridgewater and 
Sharpe, 1996; Burini et al., 2006; Shulman et al., 2013; Nadeau et al., 2014; Cugusi et al., 
2015). All the interventions were carried out indoors, apart from Nordic walking (Cugusi et 
al., 2015). Exercise intensity was reported only in the studies that used aerobic training or 
dance as intervention (Bridgewater and Sharpe, 1996; Burini et al., 2006; Shulman et al., 
2013; Nadeau et al., 2014; Cugusi et al., 2015; Hashimoto et al., 2015). The intensity was 
expressed either as a percentage of an individual’s maximum heart rate (HRmax)7 or heart 
                                                             
7 HRmax=220 – age in years 
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rate reserve (HRR)8. Based on the classification of exercise intensity (Appendix 4.5), it could 
being assumed that the exercise intensity was mainly moderate (ACSM’s, 2006). 
 
Comparison  
The exercise intervention was compared with two groups only in four studies (Shulman et 
al., 2013; Nadeau et al., 2014; Hashimoto et al., 2015; King et al., 2015). In nine trials (Burini 
et al., 2006; Smania et al., 2010; Shulman et al., 2013; Nadeau et al., 2014; Dashtipour et 
al., 2015; Hashimoto et al., 2015; King et al., 2015; Rios Romenets et al., 2015; Schlenstedt 
et al., 2015), the IG was evaluated against another exercise training programme. The 
comparison is presented in table 4.6 (pp. 47-48). 
 
Outcomes 
The outcomes relevant to anxiety and depression are summarised in table 4.7 (p. 49). All 
the selected trials (n= 15) reported depression as an outcome measure, whereas, only one 
(Dashtipour et al., 2015) assessed anxiety. All measures of anxiety and depression, besides 
the Hamilton Depression Scale (HAM-D) (Modugno et al., 2010) and the Montgomery-
Asperg Depression Rating Scale (MADRS) (Schmitz-Hubsch et al., 2006), were self-reports 
scales. Only six trials revealed significant improvements at the end of the treatment, using 
within-group comparison tests (Smania et al., 2010; Nadeau et al., 2014; Cugusi et al., 2015; 
Hashimoto et al., 2015; King et al., 2015; Teixeira-Machado et al., 2015).  
 
 
 
 
 
 
                                                             
8 HRR= HRmax – resting heart rate (HRrest) 
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Table 4.4. Characteristics of included RCTs (participants). 
 
First author 
name and year 
of publication 
 
Country 
Participants 
 
Sample  size Gender (%) Mean age        
(in years) 
Mean time 
since diagnosis    
(in years) 
H&Y stage (All) 
Bridgewater 
(1996) 
Australia 26 M: 61.5 
F: 38.5 
IG: 67.3 
CG: 66.5 
IG: 4  
CG: 4 
1-3 
Burini (2006) Italy 26 M:34.6 
F: 65.4 
IG: 65.7 
CG: 62.7 
IG: 11.2 
CG: 10.6 
2-3 
Cugusi (2015) 
 
Italy 20 M: 80 
F: 20 
IG: 68.1 
CG: 66.6 
IG: 7 (median) 
CG: 7 (median) 
1-3 
Dashtipour 
(2015) 
USA 11 M: 45.6 
F: 54.4 
IG: 62.8 
CG: 64  
IG: 2.9 
CG: 4.5 
IG: 1.3 (mean) 
CG: 1.8 (mean) 
Hashimoto 
(2015) 
 
Japan 46 M: 26.1 
F: 73.9 
IG: 67.9 
CG1: 62.7 
CG2: 69.7 
IG:  6.3 
CG1: 7.8 
CG2: 6.9 
2-4 
King (2015) 
 
USA 58 M: 41 
F: 59  
IG: 64.6 
CG1: 64.3 
CG2: 63.9 
IG: 5.2 
CG1: 7.9 
CG2: 5.4 
2.4 (mean) 
Modugno 
(2010) 
Italy 20 M: 50 
F: 50 
IG: 63.2 
CG: 62 
IG: 9.5 
CG: 9.4 
2-4 
Nadeau (2014) Canada 34 M:79.4 
F: 20.6 
IG: 64.0 
CG1: 60.1 
CG2: 64.3 
N/A 1.5-2 
Rios Romenets 
(2015) 
Canada 33 M: 57.6 
F: 42.4 
IG: 63.2 
CG: 64.3 
IG: 5.5 
CG: 7.7 
1-3 
Schlenstedt 
(2015) 
Germany 40 M: 65.6 
F: 34.4 
IG: 75.7 
CG: 75.7 
IG: 10.1 
CG: 9.3 
2.5-3 
Schmitz-Hubsch 
(2006) 
Germany 56 M: 76.8 
F: 23.2 
IG: 64 
CG: 63  
IG:6 
CG:5.6 
Any stage of 
disease 
Sharma (2015) USA 13 M: 46.2 
F: 53.8 
IG: 62.8 
CG: 73.4 
IG: 3.2 
CG: 3.7 
1-2 
Shulman (2013) USA 67 M: 74.6 
F: 25.4 
IG: 66.1 
CG1: 65.8 
CG2: 65.3 
IG: 5.9 
CG1: 6.3 
CG2: 6.3 
1-3 
Smania (2010) Italy 55 M: 52.7 
F: 47.3 
IG: 67.6 
CG: 67.3 
IG: 10.4 
CG: 8.6 
3-4 
Teixeira-
Machado (2015) 
Brazil 30 N/A IG: 60.7 
CG: 61 
N/A 2-3 
 
Abbreviations. CG: comparison group; F: female; H&Y: Hoehn and Yahr; IG: intervention group; M: 
male; N/A: not available; USA: United States of America. 
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Table 4.5. Characteristics of included RCTs (intervention- first part). 
First author 
name and year 
of publication 
Intervention 
Type of 
exercise 
Exercise protocol Setting Exercise 
format 
Supervision 
Bridgewater 
(1996) 
Aerobic 
training  
 
warm-up: ROM & strengthening 
main part: walking with music 
cool-down: stretching 
Hospital  N/A Supervised  
Burini (2006) 
 
Aerobic 
training 
 
Warm up: 10 minutes cycle ergometer of 
low intensity 
Main part: 30 minutes cycle ergometer 
Cool down: 10 minutes cycle ergometer 
of low intensity and stretching 
Neuro-
rehabilitation 
facility 
Group  N/A 
Cugusi (2015) 
 
Aerobic 
training 
 
warm-up 
main part: Nordic walking 
cool-down 
City park  Group  Supervised  
Dashtipour 
(2015) 
LSVT BIG 
therapy 
Large trunk and extremity functional 
motions 
University  N/A Supervised  
Hashimoto 
(2015) 
Dance 
 
Modern dance using elements from 
aerobic, jazz, tango and classical ballet 
N/A N/A N/A 
King (2015) 
 
ABC home-
based Exercise  
6 stations: tai chi, boxing, pilates, lunges, 
kayaking, agility course 
Home  Individualised Unsupervised   
Modugno 
(2010) 
 
Multimodal 
exercise 
 
 
warm-up: breathing & stretching 
exercises 
main part: postural, walking & balance 
exercises 
cool-down: passive mobilisation, 
coordination & breathing exercises 
N/A Individualised Supervised  
Nadeau (2014) Aerobic 
training  
(speed TT) 
                              
 
warm-up 
main part: treadmill walking; initial 
speed at 80% of preferential walking 
speed 
↑ speed by 0.2 km/h per session 
cool-down 
University  Individualised  Supervised  
Rios Romenets 
(2015) 
Dance 
 
 
Traditional Argentine tango for 
beginners. No special techniques for PD 
beginners. Encouragement to participate 
in ‘milongas’ after the dance class and 
socialise with other dancers. 
Dance studio Group  Supervised  
Schlenstedt 
(2015) 
Resistance 
training 
 
 
warm-up 
main part: lower limbs exercises using 
body weight, weight cuffs & elastic 
bands as resistance; 3 sets of 15-20 
repetitions per exercise 
cool-down 
N/A Group  Supervised  
Schmitz-Hubsch 
(2006) 
Qigong Selected exercises from four groups, as 
described in the book of Guorui (2000) 
N/A Group  Supervised  
Sharma (2015) Yoga  
 
 
Iyengar Hatha programme 
Warm-up: breathing and relaxation 
techniques 
Main part: 5-8 yoga poses 
Cool-down: meditation plus 
recommended yoga training at home 
University  Group  Supervised  
Shulman (2013) Aerobic 
training 
Higher-intensity treadmill exercise Medical 
centre 
N/A Supervised  
Smania (2010) Balance  
training 
                        
 
10 exercises of 5-10 repetitions grouped 
in 3 categories: self-destabilisation, 
externally induced destabilisation, 
destabilising activities 
University  Individualised  Supervised  
Teixeira-
Machado 
(2015) 
Feldenkrais 
method-based 
exercise 
Breathing, flexibility, balance and 
strengthening exercises; position 
changes; relaxation 
Hospital N/A Supervised  
 
Abbreviations. ABC: Agility Boot Camp; LSVT: Lee Silverman Voice Therapy; N/A: not available; PD: 
Parkinson’s disease; ROM: range of motion; TT: treadmill training. 
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Table 4.6. Characteristics of included RCTs (intervention-second part- and comparison) 
 
First author 
name and 
year of 
publication 
Intervention Comparison 
 
Programme 
duration     
(in weeks) 
Exercise 
sessions 
per week 
Session 
length       
(in 
minutes) 
Exercise 
intensity 
Type of 
comparison 
 
Description of protocol 
Bridgewater 
(1996) 
12  2  40 - 55  65%-85 % 
HRmax 
‘Internet 
talks’ on 
health issues 
 
Once every 3 wk 
Burini (2006) 
 
7 3 45 50%-60% 
HRR 
Qigong Group exercise, sessions of 50 min,      
3 times per wk 
 
Cugusi (2015) 
 
12  2  60  60%-80% 
HRR 
No 
intervention 
 
N/A 
Dashtipour 
(2015) 
4  4  60  N/A Multimodal 
exercise 
 
Treadmill & trunk and upper limb 
exercises; 4 60-min sessions per wk; 
exercise intensity: 75% HRmax for 
treadmill, and up to 5 on Borg scale 
for limb exercise. 
 
Hashimoto 
(2015) 
 
12  1  60  50%-70% 
HRmax 
Multimodal 
exercise 
(CG1) 
 
 
Warm-up: ROM exercises; main part: 
balance training, walking, transfers; 
cool-down: stretching and breathing 
exercises; one  60-min session per 
wk; exercise intensity: 50%-70% 
HRmax 
No 
intervention 
(CG2) 
N/A 
King (2015) 
 
4  3  60  N/A Individualised 
exercise 
programme 
(CG1) 
ABC programme; similar to the IG, 
but supervised; 3 60-min sessions per 
wk. 
Group 
exercise 
programme 
(CG2) 
ABC programme; similar to the IG, 
but in groups and supervised; 3 60-
min sessions per wk. 
Modugno 
(2010) 
156               (3 
years) 
3 90 N/A Active 
theatre 
Vocal and therapeutic exercises, and 
staging; up to 12 hours per month 
 
Nadeau 
(2014)   
24  3 60 up to 75% 
HRmax and 
BP up to 
200 mm Hg 
Mixed TT 
(CG1) 
Similar to the IG, but ↑1% treadmill 
incline and 0.2 km/h treadmill speed 
alternately; 3 60-min sessions per wk. 
Viactive 
programme 
(CG2) 
 
 
Exercises based on tai chi, latin 
dance, elastic band  &  coordination 
movements; low intensity; 2 60-min 
group supervised sessions & 1 60-
min. home unsupervised session per 
wk 
Rios 
Romenets 
(2015) 
12 2  60  N/A Home-based 
exercise  
 
Daily individualised exercise based on 
a booklet by the PSC entitled 
‘Exercise for people with Parkinson’s’ 
 
Schlenstedt 
(2015) 
7  2   60  Moderate  Balance 
training 
 
Self-destabilisation and externally 
induced destabilisation in different 
directions; 2 60-min sessions per wk 
 
Schmitz-
Hubsch 
(2006) 
24  
(8 wk 
exercise - 8 
wk pause –  8 
wk exercise) 
 
 
1  60  N/A No 
intervention 
N/A 
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First author 
name and 
year of 
publication 
Intervention 
 
Comparison 
Programme 
duration   (in 
weeks) 
Exercise 
sessions 
per week 
Session 
length       
(in 
minutes) 
Exercise 
intensity 
Type of 
comparison 
 
Description of protocol 
Sharma 
(2015) 
12  2  
 
60  N/A No 
intervention 
N/A 
Shulman 
(2013) 
12  3  15-30 from 40%-
50% HRmax 
to 70%-80% 
HRR 
Lower-
intensity 
treadmill 
(CG1) 
15-50 min up to 40%-50% HRR; 3  
sessions per wk 
 
Stretching 
and 
resistance 
(CG2) 
Resistance exercises of lower limbs 
using resistance machines, and 
stretching of the trunk and lower 
limbs; 3 sessions per wk 
Smania 
(2010) 
7  3  50  N/A Multimodal 
exercise                        
ROM, muscle stretching & motor 
coordination exercises; 3 50-min 
sessions per wk 
Teixeira-
Machado 
(2015) 
24 2  60  N/A Educational 
lectures 
 
Instructions for the prevention of 
falls, PD medication, management of 
the ADLs; 1 per wk 
 
 
Abbreviations. ABC: Agility Boot Camp; ADLs: activities of daily living; CG: comparison group; 
HRmax: maximum heart rate; HRR: heart rate reserve; IG: intervention group; min: minutes; N/A: 
not available; PSC: Parkinson Society of Canada; ROM: range of motion; TT: treadmill training; wk: 
weeks.  
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Table 4.7. Characteristics of included RCTs (outcomes). 
 
First author 
name and 
year of 
publication 
Outcomes 
 
Outcome 
measure 
Primary or 
secondary 
outcome 
Assessment 
tool 
Mid-term results Post-
intervention 
results 
Follow-up results 
Bridgewater 
(1996) 
D N/A LPDQ  N/A (4 weeks post-
intervention) 
IG: SI; CG: NSI 
Burini (2006) D primary BDI  IG: NSI 
CG: NSI 
 
Cugusi (2015) D primary BDI-II 
 
 IG: SI 
CG: NI 
 
Dashtipour 
(2015) 
D & A N/A BDI 
BAI 
 D: SI (all) 
A: NSI (all) 
(12 weeks post-
intervention) 
D: SI (all); A: SI (all) 
(24 weeks post-
intervention) 
D: SI (all); A: NSI (all) 
Hashimoto 
(2015) 
D N/A SDS  IG: SI 
CG1: NSI 
CG2: NSI 
 
King (2015) 
 
D secondary GDS  IG: NSI 
CG1: SI 
CG2: NSI 
 
Modugno 
(2010) 
 
D secondary HAM-D (1 year after the start) 
IG: NI; CG: NSI 
(2 years after the start) 
IG: NI; CG: SI 
IG: NI 
CG: SI 
 
Nadeau (2014) D 
 
secondary BDI-II (12 weeks after start) 
IG: SI 
CG1: NSI; CG2: NI 
IG: SI 
CG1: NSI 
CG2: NSI 
 
Rios Romenets 
(2015) 
D secondary BDI  IG: NSI 
CG: NSI 
 
Schlenstedt 
(2015) 
D secondary BDI  IG: NSI 
CG: NSI 
(4 weeks post-
intervention)) 
IG: NSI; CG: NSI 
Schmitz-
Hubsch (2006) 
D secondary MADRS (12 weeks after start) 
N/A 
Reductions in 
both groups 
(24 weeks post-
intervention) 
Reductions in both 
groups 
Sharma (2015) D 
 
secondary GDS (6 weeks after start) 
N/A 
IG: NSI 
CG: N/A 
(6 and 12 months 
 post-intervention) 
N/A 
Shulman 
(2013) 
D 
 
secondary BDI  IG: NI 
CG1: NSI 
CG2: NI 
 
Smania (2010) D 
 
secondary GDS  IG: SI 
CG: NI 
(4 weeks post-
intervention) 
IG: NSI; CG: NI 
Teixeira-
Machado 
(2015) 
D primary BDI  IG: SI 
CG: NI 
 
 
A: anxiety; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; BDI-II: Beck Depression 
Inventory-II; CG: comparison group; D: depression; GDS: Geriatric Depression Scale; HAM-D: 
Hamilton Depression Rating Scale; IG: intervention group; LPDQ: Levine-Pilowsky Depression 
Questionnaire; MADRS: Montgomery-Asperg Depression Rating Scale; NI: no improvement (from 
baseline); N/A: not applicable; NSI: non- significant improvement from baseline (p> .05); SDS: Zung 
self-rating Depression Scale; SI: significant improvement from baseline (p< .05). 
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4.6.4. Effective exercise types and parameters 
The current section looked solely at the trials that reported exercise to be effective (either 
in the IG or CG), in order to recommend the type and the specific dosage parameters of 
exercise to improve anxiety and depressive symptoms in PD. The exercise characteristics 
of these studies are summarised in Appendix 4.6.  
 
4.7. Discussion 
4.7.1. Findings and interpretation 
To our knowledge, this is the first systematic review focusing solely on the effectiveness of 
physical activity interventions on anxiety and depression in PD population. This is 
surprising, as anxiety and depression are among the most prevalent non-motor symptoms 
in PD (Goldman and Postuma, 2014), which may worsen the impacts of the disease. In 
addition, growing evidence suggests that physical activity is an effective intervention for 
depression, and probably for anxiety, in general population; and it could be a viable adjunct 
treatment in combination with pharmacological and psychological management. (Bartley 
et al., 2013; Schuch et al., 2016a; Schuch et al., 2016b). 
 
In the current systematic review, fifteen studies fulfilled the eligibility criteria and included 
in the analysis. In spite of anxiety being one of the most common non-motor symptoms in 
PD (Goldman and Postuma, 2014), only one relevant study (Dashtipour et al., 2015) was 
identified. On the contrary, all the experimental studies focused on depressive levels, but 
in a non-clinically depressed population. Despite the fact that anxiety and depression were 
rarely examined as primary endpoints, the vast majority of selected studies (n= 13) showed 
positive findings in the reduction of depressive symptoms at the end of physical activity 
intervention. These findings are promising, as exercise programmes are less expensive than 
pharmacological and psychological approaches, and have fewer side effects and 
contraindications than pharmacotherapy (Wenger et al., 2014). In turn, six studies revealed 
significant improvements (p< .05) in depression scores at post-intervention. However, 
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there is insufficient evidence to support whether the improvement gained at post-
intervention was sustained in the follow-up period. 
 
Perhaps, the most important finding of this systematic review is the increasing interest of 
RCTs to evaluate psychological morbidities in the field of therapeutic exercise in PD since 
2010.  However, the heterogeneity of interventions in terms of exercise modality and 
exercise parameters, made the comparison between the selected studies difficult. Despite 
the fact that the literature supports that aerobic training is the most antidepressant type 
of exercise (Kvam et al., 2016), a variety types of physical activity were used. Indeed, 
conventional (aerobic, anaerobic, combined exercise), alternative types of physical activity 
(dance, Qigong, Yoga), and prescribed exercise programmes (LSVT BIG, ABC, Feldenkrais, 
Viactive) were applied either to the intervention or the comparison group. In turn, the trials 
utilised different exercise parameters in terms of duration, frequency, intensity, exercise 
format and supervision. Although walking outdoors is a recommended type of exercise in 
depressed populations (Kvam et al., 2016), only one relevant study (Cugusi et al., 2015) was 
identified. This was maybe due to the difficulty of standardising environmental conditions 
(temperature, humidity rates) and the intensity, when exercising outdoors (Perraton et al., 
2010). 
 
Even when only the effective studies were examined (p< .05) (Smania et al., 2010; Nadeau 
et al., 2014; Cugusi et al., 2015; Hashimoto et al., 2015; King et al., 2015; Teixeira-Machado 
et al., 2015), the dissimilarities of training programmes, in conjunction with the limited 
number of RCTs and the methodological flaws; made it difficult to determine the 
superiority of any type of exercise and its parameters on PD anxiety and depression. 
Indeed, five of six effective trials (table 4.2, p. 41) were only of ‘fair’ quality, with a high 
number of methodological flaws, which may lead to several types of bias (section 4.7.3).  
Furthermore, as depression was examined as a secondary outcome, the findings may 
reflect chance. Thus, it was not possible to provide strong and precise recommendations 
for clinical settings. This information is vital to the clinicians who are considering physical 
activity as a treatment of comorbidity depression and anxiety in PD. However, the limited 
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data support that both conventional and alternatives types of physical activity, indoors or 
outdoors training, individualised or group approaches, short and longer periods of exercise 
(four to 24 weeks), with a frequency from one to three times a week, and duration of each 
session no longer than one hour, are associated with significant antidepressant effects at 
post-intervention. The fact that both individualised and group-based programmes 
significantly reduced depression, may support the theory that both biological and 
psychological mechanisms for the reduction of depressive symptoms, work in a complex 
and combined way, apart from the ‘social interaction hypothesis’, which is supported in 
group-based training programmes (Paluska and Schwenk, 2000). 
 
In addition, the studies that reported the drop-out reasons, revealed that physical activity 
is a safe approach without adverse effects for the participants. Indeed, none of the training 
programmes was harmful for the patients, as none injury due to exercise was reported. It 
seems that both conventional and alternative types of therapeutic exercise, community-
based and home-based, group and individualised approaches, highly supervised and non-
supervised programmes are safe. Perhaps a strict screening procedure to assess the ability 
for participation, the design of the protocol and advice by experienced professionals ensure 
the safety of patients mildly or moderately affected by PD to a therapeutic exercise 
programme. 
 
4.7.2. Strengths of included trials 
The major advantage of the included trials was that all of them were RCTs, providing high 
level of evidence, and eliminating selection bias (Evans, 2003). Although, the criterion two 
of the PEDro scale is satisfied even if the precise method of randomisation is not reported, 
it was unclear whether some experimental studies followed quasi-randomised allocation 
procedures for the allocation of participants to the study groups. Furthermore, as the 
sample population consisted of both males and females, there was low risk for gender bias 
(Ramasubbu et al., 2001). Although women are more likely to participate in research 
(Newington and Metcalfe, 2014), the fact that males were more than females in the 
majority of studies, ensures that the sample was representative of the overall population. 
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Similarly, the recruitment of outpatients increases the external validity of the trials, as the 
majority of patients mildly or moderately affected by PD live at their own homes. 
 
Despite the fact that the clinimetric properties of the selected tools to assess anxiety and 
depression were not reported in the articles; the reviewers identified that both reliable and 
validated measurement tools, recommended in PD population, were used for identifying 
depression and screening its severity (Torbey et al., 2015) (see section 8.7.8 for more 
information). However, the self-reported Levine-Pilowsky Depression Questionnaire 
(LPDQ), used in one study (Bridgewater et al., 1996), is considered a valid and reliable tool 
for screening depression in general population (Carr and Smith, 1985), but there is no 
evidence for its clinimetric properties in PD population. Concerning anxiety, the Beck 
Anxiety Inventory (BAI) is a ‘suggested’ tool for anxiety in PD, because basic information 
about its validity and reliability in PD population is missing (Leentjens et al, 2011). However, 
there is not any recommended scale to assess anxiety in PD (Leentjens et al., 2008) (see 
section 8.7.8 for more information). 
 
4.7.3. Methodological flaws and limitations of included trials 
The selected trials appeared several methodological flaws and limitations. The most 
significant limitation is that anxiety and depression were not assessed as primary outcomes 
in the majority of trials. Thus, the exercise intervention may not have been designed to 
alleviate anxiety and depressive symptoms in patients with PD, and the findings may reflect 
chance (Freemantle, 2001). In addition, no information was provided about the 
antidepressant and anxiolytic pharmacological treatment during the study period; and 
whether the subjects were receiving adjunct treatment to depression and anxiety, such as 
CBT. Thus, it is unclear whether other factors, apart from the intervention, influenced the 
anxiety and depression scores up the end of the treatment. These limitations were also 
present even in studies where depression was one of the main outcome measures. 
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 In addition, the exercise protocol was not described thoroughly in 11 articles; and some 
crucial information -such as the number of participants in group-based programmes, the 
environmental conditions of exercise- were missing. Similarly, a large proportion of studies 
insufficiently described the treatment in the CGs. This information is vital to clinicians who 
are considering physical activity as a treatment for comorbidity depression and anxiety in 
PD. 
 
An additional important weakness was that the experimental studies were not focused on 
individuals with clinical levels of anxiety and depression; but in non-anxious and non-
depressed populations.  None of the included studies reported a confirmed clinical 
diagnosis of anxiety or depression using accurate diagnostic criteria for mental disorders, 
such as the DSM and ICD criteria; or clinical levels of anxiety and depression, using relevant 
rating scales with cut-off scores. The effectiveness of training programmes in anxiety and 
depressive scores could differ, if only PD patients with diagnosed anxiety and depressive 
disorders were included in the studies (Wu et al., 2017). 
 
With respect to the study design, four of 15 trials were pilot studies (Schmitz-Hubsch et al., 
2006; Modugno et al., 2010; Rios Romenets et al., 2015; Sharma et al., 2015). Although 
pilot studies provide valuable data regarding feasibility and clinical effectiveness, the use 
of a small sample could lead to instability of the outcomes, making it harder to generalise 
to the whole population, affecting the external validity. Furthermore, it is quite likely that 
the method could be modified after the pilot work, in order to reach the objectives of the 
larger main study (Leon et al., 2011). Apart from the pilot studies, the majority of the 
included studies had been conducted on relatively small samples, without sample size 
calculations. Due to the small group size, there are increased possibilities for type I error9; 
and caution is needed for the generalisation of results (Faber and Fonseca, 2014).  
 
                                                             
9 The rejection of a true null hypothesis 
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In addition, in some studies the PEDro criteria two to nine were not fulfilled. Hence, the 
trials were highly susceptible to bias. In particular, the lack of allocation concealment 
increased the possibilities for selection bias (Altman and Schulz, 2001). The imbalance 
between groups in baseline scores of depression may have influenced the outcomes and 
weakened the trial's credibility (Roberts and Torgerson, 1999). Lack or inadequate reported 
blinding procedure, may have led to performance bias. As the participants were not blinded 
to the group allocation, the effect of the treatment could be due to placebo or Hawthorne 
effect10. Unblinded therapists could have also affected the results, due to therapists' 
enthusiasm or lack of enthusiasm for the treatment or control conditions. However, 
because of the nature of the exercise interventions, participants could never be blinded to 
the intervention, and neither the therapists; and therefore a score of eight out of ten could 
be considered a maximum score in these trials (Perraton et al., 2010). There were also high 
possibilities for assessor bias, as the criterion seven was not fulfilled in the selected studies, 
which used clinician-rated scales to assess depression (Day and Altman, 2000). Although 
the selected self-reported tools were both valid and reliable in PD population, there is 
danger for response bias; as the findings were based on subjects’ answers, which may be 
inaccurate. The high loss to follow-up in nine included trials may have led to attrition bias, 
affecting studies’ validity, because patients lost to follow-up often have a different 
prognosis than those who complete the study (Dettori, 2011). Lastly, an intention-to-treat 
analysis was not performed in 11 trials; hence, clinical effectiveness may have been 
overestimated (Hollis and Campbell, 1999). 
 
Ιn some studies, there were also serious limitations in the presentation of results for 
anxiety and depression, probably because they were tested as secondary outcomes. 
Indeed, some studies lacked information about the results at post-intervention or at follow-
up; few presented the results for the whole sample, and not  for each group separately; 
others did not report whether the improvements were significant or not, as probably the 
non-significant differences are less reported in the articles. In some cases, there were no 
within- and between-group comparisons for the measures of anxiety and depression. 
Hence, these studies may have omitted or modified outcomes, leading to outcome 
                                                             
10 Modification in subjects' behaviour, because they know they are being observed 
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reporting bias. In addition, the effect size was not reported –in all the selected trials- to 
assess the important of findings (Pallant, 2016). Lastly, the majority of trials did not report 
the mean scores before and after treatment; preventing the reviewers to detect whether 
there were any clinically significant changes within the groups, based on the minimal 
clinically important difference (MCID).  
 
Even in studies with significant results at post-intervention, there was lack of the 
interpretation of findings. The possible mechanisms of exercise -biological and 
psychological- which may have contributed to these results were not reported. This may 
partly be explained by the fact that anxiety and depression were examined as secondary 
outcomes. Only two studies (Smania et al., 2010; Hashimoto et al., 2015), which found 
significant improvements in depression scores at post-intervention, interpreted their 
results. It was hypothesised that the social interaction with peers may have contributed to 
the reduction of depressive symptoms. In addition, Smania et al. (2010) suggested that the 
improvement in depression symptoms resulted from the increased confidence in balance 
related to daily-life activities, and the decrease in the number of falls. 
 
4.7.4. Comparison with previous reviews 
The results of the current review were consistent with previous systematic reviews and 
meta-analyses (Goodwin et al., 2008; Adamson et al., 2015; Lamotte et al., 2015; McNeely 
et al., 2015; Cusso et al., 2016) on the effects of exercise on anxiety and depressive 
symptoms in PD population. The above mentioned reviews indicated that conventional and 
alternative types of physical activity may reduce depressive levels; however, the majority 
of the included experimental studies did not reveal significant effects.  Regarding anxiety, 
only the review by Cusso et al. (2016) included one relevant RCT, which examined the 
effectiveness of an occupational therapy programme in PD. Furthermore, no data was 
provided about the methodological quality of the selected trials using a valid critical 
appraisal tool. In addition, our review found more relevant experimental studies than the 
previous reviews, published in the same time period, indicating possible publication bias in 
the previous reviews. 
Chapter 4: Systematic review 
57 
 
However, before the submission of the current thesis, a relevant systematic review (Wu et 
al., 2017) was published in 2017. The review by Wu et al. (2017), which included nine 
studies, found that physical activity interventions have the potential to lessen depressive 
symptoms, even if they were assessed as secondary outcomes. Both conventional and 
alternative types of physical activity (e.g. Tai Chi and Yoga) were effective, particularly the 
implementation of aerobic exercise. On the contrary, it is unsure whether exercise had any 
effect on anxiety. 
 
The results of the present review were in line with those by Wu et al. (2017), which appears 
several limitations. In particular, it included both studies of experimental and quasi-
experimental design, having higher possibilities for selection bias (Torgerson, 2003). The 
literature search was limited from 2006 to 2017; hence, it did not indicate any changes over 
the years (Glasziou et al, 2001). In addition, in some included studies, the physical activity 
intervention was combined with an additional treatment; thus, it was not possible to know 
how each component contributed to results. The methodological quality of the selected 
studies was assessed by the modified Jadad scale. Despite the fact that the Jadad scale and 
its modified version, are two simple appraisal tools for clinical trials, and the most widely 
used worldwide; they have received negative criticism in the field of physiotherapy and 
exercise. As this scale was not originally developed for physiotherapy studies; it focuses 
only on randomisation, blinding, and dropouts to evaluate methodological quality of 
primary research; rather than concealed allocation and treatment adherence, which are 
important issues in physiotherapy (Olivo et al., 2008). Therefore, the Jadad scale provides 
a less comprehensive measure of methodological quality than the PEDro scale (Bhogal et 
al., 2005); and does not distinguish studies of ‘low’ quality from those of ‘high’ quality. In 
addition the scale has only been validated in the field of pain (Olivo et al., 2008). 
 
4.7.5. Strengths of the current review 
The current systematic review was unique, because it was the first that focused solely on 
the effects of therapeutic exercise on anxiety and depression in patients with PD. A 
systematic manner was followed, as proposed by the PRISMA statement, for the selection 
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and critical appraisal of relevant studies (Hoffmann et al., 2013). This procedure, in 
conjunction with the previous experience of both reviewers in systematic reviews; ensured 
that many sources of bias, arising from the way a review is conducted, were kept  to a  
minimum (Aveyard, 2007). In addition, the PEDro scale provided a comprehensive measure 
of methodological quality of the physiotherapy literature. Apart from the blinding 
component; it assessed the methodological quality of studies based on other important 
criteria; such as concealed allocation, intention-to-treat analysis, and adequacy of follow-
up (Olivo et al., 2008).  Lastly, the review provided useful information about the safety of 
exercise on this population, which should be considered in the clinical setting. 
 
4.7.6. Limitations of the current review 
The current review was not free of limitations. Firstly, the decision to include articles 
written only in the English language, and to not locate and obtain relevant studies in the 
‘grey literature’, may have led to publication and language bias (Chalmers and Altman, 
1995). This decision was driven by the need to deliver the review on time, and to not 
increase the financial cost in case of translations. Regarding, the language of publication, 
there is empirical evidence that trials with statistically significant results are more likely to 
be published in English than in non-English language journals (Egger et al., 1997). However, 
the initial search identified only one relevant trial written in Portuguese (Christofoletti et 
al., 2012).  
 
Similarly, studies with positive results are more likely to be published; while unpublished 
literature and ‘grey literature’ are more likely to include negative outcomes. These sources 
may be difficult to be identified when not indexed in electronic databases (Banks, 2004). 
Hence, possible eligible trials with non-significant or negative results may have not been 
included in this review. In addition, despite the extensive literature search, the reviewers 
may have not succeeded in identifying all the relevant experimental studies, leading to 
publication bias (Chalmers and Altman, 1995). Lastly, the reviewers were not blinded to 
studies’ author(s), place of publication or results during the eligibility assessment, the data 
extraction procedure and the quality assessment of the selected trials. Unblinded 
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reviewers may introduce bias into systematic reviews, as they may produce significantly 
higher scores in the included trials, compared to blinded assessors (Jadad et al., 1996). 
 
4.7.7. Proposals for future research 
Since this review cannot make any firm conclusions of the effectiveness of exercise for PD 
patients with comorbid anxiety and depression, and as there is an increasing interest in the 
field of evidence-based practice; there is need for future research in this area. Future 
studies should examine anxiety and depression as primary outcomes. It is advisable for 
future research to use rigorous scientific methodology through adequate samples following 
power calculations, concealed allocation, satisfactory randomisation procedures, adequate 
blinding, between groups comparisons and report of measures of variability. The use of 
clinician-administrated rating scales for the measurement of anxiety and depression may 
satisfy the assessors’ blinding to the participants’ group allocation. In addition, factors that 
may affect the scores of depression and anxiety at the end of the treatment should be 
excluded (e.g. CBT) or kept stable (e.g. antidepressant medication) through the whole study 
period. A rigorous methodology will eliminate the risk of bias, and both the internal and 
external validity of the studies will be higher.  
 
To answer the question whether exercise is effective on improving anxiety and depression 
scores in patients with PD, future studies should focus on populations with clinical levels of 
anxiety and depression. The detection of anxiety and depressive disorders could be 
achieved either using the ICD and DSM criteria, the ‘gold standard’ for the diagnosis of 
mental disorders (Jacob, 2006); or recommended rating scales for this purpose (Torbey et 
al., 2015). 
 
In addition, the design of the exercise protocols should be focused on the primary 
objectives of the study; and incorporate elements from previous experimental studies, 
reviews, clinical guidelines and recommendations for PD population and depressed or 
anxious population. Both conventional and alternative types of physical activity, indoors 
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and outdoors training could be tested. In PD, there is an increasing interest in the role of 
alternative exercise programmes. It is believed that they fill the gap left by conventional 
exercises, which does not always directly target enjoyment and social participation. In the 
general population, evidence supports that alternative forms of exercise are associated 
with higher adherence and continuation of these activities after the end of the intervention 
period (Alves da Rocha et al., 2015). 
 
The comparison of at least two different training programmes would detect the type of 
exercise and the parameters that produce the largest antidepressant and anxiolytic effects 
in PD, determining the optimal dose of exercise. Evidence is also needed for the 
effectiveness of exercise when compared to other treatments, such as CBT; or combined 
approaches, such as exercise and CBT. Therefore, the healthcare system will be able to 
offer to the patients the best treatment and choice with the minimum cost. 
 
The majority of studies are focused to explore statistically significant differences using 
appropriate statistical tests. However, there is more to research than just obtaining 
statistical significance. Thus, it is recommended to calculate the effect size in order to 
assess the importance of findings (Pallant, 2016), and confidence intervals to describe the 
precisions (Moher et al., 2010). In addition, researchers should explore whether there are 
clinically significant differences between the groups and changes within the groups. Lastly, 
patients’ satisfaction could be explored to detect whether there are subjective 
improvements on mood due to intervention (Al-Abri and Al-Balushi, 2014; Porter, 2008). 
 
Future studies should also examine both the short- and longer-term effects of physical 
activity interventions. They should also report data on adverse events, as this information 
is important in clinical populations where safety is an important consideration. Finally, 
assuming that exercise is beneficial for reducing anxiety and depressive symptoms, possible 
mechanisms of action may be of interest. 
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4.8. Conclusion 
To our knowledge, this review is the first to assess the evidence about the effectiveness of 
exercise interventions in anxiety and depressive symptoms in PD. The role of physical 
activity in this area has received little, but increasing attention over the years within 
existing literature. To date, it is not possible to determine exactly how effective physical 
activity is in reducing anxiety and depressive symptoms in clinical and non-clinical anxious 
and depressive populations with PD, and whether the effects persist after the end of the 
intervention period. In addition, only one RCT has assessed the anxiety scores so far. Due 
to the small number, heterogeneity and limitations of studies with significant results; it was 
not possible to provide relevant recommendations to clinician physiotherapists. Hence, 
future experimental studies with a rigorous methodology should fill the gap in the 
literature. However, it is encouraging that physical activity is safe for this population; as no 
injury was reported due to exercise, and none left the intervention, because it was harmful 
or boring.   
 
4.9. Summary of Chapter 4 
 The aim of the present systematic review was to assess the effects of physical activity 
on anxiety and depression levels in PD population. 
 The review was conducted according to the PRISMA statement, and the PEDro scale 
was used to assess the methodological quality of selected trials. 
 11 electronic databases were searched to identify relevant articles. 
 15 RCTs fulfilled the eligibility criteria and included in the analysis. All the studies 
assessed depression, and only one anxiety. 
  The selected trials scored between three and six, with a mean score of 4.64. 
 Although there is some evidence that exercise could reduce PD depression, it is not 
possible to draw firm conclusions and provide recommendations; due to the 
methodological flaws of studies and heterogeneity among the exercise parameters. 
 Despite the fact that only six trials outlined reasons for drop-out; therapeutic exercise 
programmes seem to be safe in this population. 
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 Future experimental studies with rigorous methodology should focus on the 
effectiveness of exercise on PD patients with clinical levels of anxiety and depression. 
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5.1. Introduction 
The survey aimed to identify the impacts of PD on everyday activities and emotional status 
in patients with PD in Greece. The answers of participants would be considered for the 
design of the group-based therapeutic exercise and educational programme of the present 
RCT, in order to meet their needs. A mixed mode survey was conducted using online and 
paper questionnaires. Initially, an online survey was designed. However, due to low 
response rate, it was decided to deliver additional paper questionnaires to reach the 
required sample size.   
 
5.2. Study aim and design 
5.2.1. Aim of the study 
The aim of the survey was to detect and list the impacts of PD on everyday activities and 
emotional status in patients with PD in Greece. The record of these data, in combination 
with the socio-demographic characteristics and the health status of the patients; would 
provide an in depth understanding of the target population, and the most prevalent 
responses would be considered for the design of the group-based therapeutic exercise and 
educational programme of the current thesis. 
 
5.2.2. Research questions 
Based on the study’s aim, the research questions were formulated as follows: 
1. “What are the most prevalent restricted ADLs in Greek PD population?” 
2. “What are the most common emotional disturbances in Greek citizens with PD?” 
 
5.2.3. Research objectives 
The objectives of the survey were listed as follows: 
a) The design of a disease specific questionnaire to record the socio-demographic 
characteristics, health status, physical and mental health in Greek PD population. 
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b) To record personal beliefs about their experience living with PD. This information may 
support further the need for the design of a rehabilitation programme in PD. 
 
5.2.4. Research design 
A survey was considered the appropriate research design, because it is a method of 
gathering information from a sample, without comparing different groups (Iarossi, 2006). 
Surveys do not infer cause-and-effect by manipulating variables. They are designed to 
describe or explain phenomena, and provide an early understanding about clinical 
conditions or situations, without making judgment (de Leeuw et al., 2008; Salaria, 2012). 
Thus, they are recommended in healthcare studies to begin a research in a new area, and 
assess the health status of communities (Grimes and Schulz, 2002). Regarding the type of 
survey, a questionnaire was selected to gather the relevant information, as it is cheaper 
and quicker than interviews (Iarossi, 2006; Rea and Parker, 2014).  
 
5.3. The research team 
5.3.1. Members and responsibilities 
Eight professionals participated in the current project, which were recruited from the 
HPDA, apart from the translator and the physiotherapist who participated in the qualitative 
analysis. All of them were healthcare professionals, volunteers of the HPDA, with previous 
experience in PD. Their duties are reported in table 5.1 (p. 66).  
 
5.3.2. Training of volunteers 
One training session with all the professionals was performed to inform them about the 
purpose of the study and their responsibilities. The standard operating procedure (SOP) for 
the online survey, including the link for the online questionnaire, was sent to them by e-
mail. An updated SOP and the paper-based questionnaire were also sent for the paper 
survey. In addition, the volunteer (nurse), who participated in the paper survey, was 
present during the first meeting of the principal researcher with the respondents, to have 
a general overview about the whole process. 
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Table 5.1. Professionals’ duties. 
Qualification Duties Number of 
professionals 
Principal Researcher 
(PhD student) 
Design of the study, delivery of paper surveys, data analysis 1 
Psychologist  Consignment invitation and reminder e-mails to the members of the 
HPDA for the online survey 
 Post announcements on the official webpage and Facebook page of 
the HPDA for the online and paper survey. 
1 
Nurse Delivery of the paper questionnaire to respondents, in case of principal 
researcher’s absence. 
1 
Neurologist  Selection of items for the questionnaire. 1 
Physiotherapists  2 
Translator Translation of the questionnaire from Greek to English 1 
Physiotherapist Qualitative analysis 1 
 
Abbreviations. HPDA: Hellenic Parkinson’s disease Association. 
 
5.4. Participants 
5.4.1. Eligibility criteria 
The respondents were included whether the following criteria were met: 
1. Individuals with PD, members of the HPDA and residents of Greece; irrespectively of 
their gender, nationality, age, disease duration and stage; or carers of PD patients (e.g. 
caregivers, relatives).  
2. Respondents able to read and write in Greek, as the self-administrated questionnaire 
was written in the Greek language. 
3. Adequate vision and hearing (hearing only for the paper questionnaire) –with or 
without special equipment-, in order to be able to complete the questionnaire and 
communicate with the researcher, if needed (Iarossi, 2006). 
 
Respondents were excluded if: 
1. They were unable to provide consent, due to cognitive impairment or other cause 
(Iarossi, 2006). 
2. The patients were diagnosed with parkinsonism or other extrapyramidal syndrome, 
because the RCT would include just population with idiopathic PD. 
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5.4.2. Sample size determination  
The sample size was determined by the equation proposed by Hicks (2009): 
 
N = Py Pn / (standard error)2, 
 
where Py and Pn are the expected answers to questions, and N is the required number of 
participants.  As there was no expectation of how the respondents would respond to 
questions, and the direction of responses was completely unknown; a 50/50 split was 
assumed. Therefore, both Py and Pn were equal 0.5. The usual acceptable sampling error in 
research is 5% or 0.05. To obtain the standard error in the above equation using a 5% error 
limit and 95% confidence, 0.05 was divided by 1.96, which is equal to 0.025 (Hicks, 2009). 
Thus, entering the values in the formula yields: 
 
N = 0.5 X 0.5 / 0.0252 → N = 384.16 ≈ 384 
 
Therefore, a total of 384 people were defined as the required sample. As the initial survey 
was online, and the average response rate in web surveys is 34 % (Shih and Fan, 2008); the 
invitation had to be sent -via e-mail- to at least 1130 individuals.  
 
5.4.3 Recruitment of participants 
The respondents were recruited from the HPDA. On October 2013, the HPDA had 1254 
enrolled members and about 1500 followers on facebook. The enrolled members were: PD 
patients, caregivers or relatives of PD patients, and individuals who wanted to get informed 
about PD and the actions of the organisation. The HPDA contacts its members only through 
e-mails, as the online enrollment with the HPDA does not require a telephone number and 
a home address. The analytical recruitment process is provided in Sections 5.8.3 and 5.8.4.  
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5.5. Design of the questionnaire 
The previous relevant literature and similar questionnaires found on the internet, were 
consulted for the design of the current questionnaire (Boynton and Greenhalgh, 2004). At 
each step, the strengths and weaknesses of relevant experimental studies and 
recommendations were weighted against each other to reach a final decision, which would 
be the best for the purpose of the current survey. As both an online and a paper-based 
questionnaire were designed for the current survey; this section analyses the design of 
both types of questionnaires. 
 
5.5.1. Mode of administration 
A self-administrated questionnaire was preferred instead of a questionnaire completed by 
the interviewer. In self-administrated questionnaires, there is more privacy and time to 
complete the questionnaire (McDonald, 2012); and the respondents may recheck their 
answers before the final submission (Jenn, 2006). In addition, they may decrease the non-
response percentage in sensitive questions (Krumpal, 2013). As a main disadvantage of self-
administrated questionnaires is that the researcher is usually unaware if the questionnaire 
was filled in by the respondent (Rattray and Jones, 2007); in the current survey the 
individual who completed the questionnaire had to select whether he/she was a PD patient 
or a carer of a PD patient. 
 
5.5.2. Method of delivery 
There are three main methods for the delivery of the questionnaires to the target 
population: phone-, paper- and internet-based surveys (de Leeuw et al., 2008). A phone-
based method was immediately declined, as the HPDA has not the telephone numbers of 
its members. An internet-based method was preferred instead of a paper-based survey. 
Internet questionnaires may reach very large audiences in different areas of the country 
inexpensively. They provide a wide range of time until the deadline for the questionnaires’ 
submission (Deutskens et al., 2004; de Leeuw et al., 2008). They are associated with relative 
rapid replies, as the average response time is 5.59 days (Ilieva et al., 2002). Furthermore, 
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even the senior population in Western countries is familiar with the use of internet, and 
there is a relative high level of computer literacy (Rea and Parker, 2014). Finally, the HPDA 
has a list with all the e-mails of its members. Between the two forms of internet based-
survey; a web (online) survey was preferred, instead of an e-mail survey. Online surveys, 
sending people a link to a web page containing a questionnaire, which is filled in online, are 
generally quicker, easier to complete and submit than e-mail surveys (Wright, 2005).  
 
Paper questionnaires was the ‘plan B’ to continue the survey, in case of low response rates 
of the internet survey (plan A). Although paper questionnaires are associated with higher 
cost (e.g. printing the forms), they have higher response rates than the internet surveys 
(Yetter and Capaccioli, 2010). Between the different forms of paper-based surveys, a mail 
(post) survey was declined for several reasons. The mail survey is associated with higher 
cost, including a stamped, pre-addressed return envelope; and the average response time 
is long (12.21 days) (Ilieva et al., 2002). In addition, the HPDA does not have the home 
addresses of its members. Hence, a face-to-face method was selected for the delivery of 
the paper questionnaires, in venues offered by the HPDA (section 5.8.1). 
 
5.5.3. Questionnaire length  
The researcher attempted to design a relevant short internet questionnaire, completed in 
less than 30 minutes (Deutskens et al., 2004; Marcus et al., 2007). In determining 
questionnaire’s ideal length, previous studies considered the time it takes an average 
respondent to complete the questionnaire, rather than the number of questions included. 
Although some studies concluded that the questionnaire length is not associated with the 
response rates (Cook et al., 2000; McCambridge et al., 2011); other trials showed that 
shorter internet based questionnaires (15 to 30 minutes to be completed) may increase 
response rates than longer versions (Deutskens et al., 2004; Marcus et al., 2007). Lastly, 
long questionnaires may be responsible for fatigue of respondents and errors arising from 
inattention, and incomplete answers (Converse and Presser, 1986). 
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Similarly, shorter versions of paper questionnaires are generally associated with higher 
response rates and full-completed questionnaires. However, there is no agreement among 
the studies about the definitions of ‘long’ and ‘short’ questionnaires regarding the number 
of items or paper pages. Short questionnaires may vary between one and six pages, 
whereas long between two and 36. In addition, the items may differ in complexity (Rattray 
and Jones, 2007; Rolstad et al., 2011). 
 
5.5.4. Questionnaire’s title and instructions 
The title was relevant to the questionnaire’s context. It was not formulated as question; as 
it is unsure whether a question-title attracts or repels the respondents (de Leeuw et al., 
2008).  The instructions for the completion of the questionnaire were as simple as possible. 
Complex routing instructions may reduce motivation and lead to inaccurate answers or 
indiscriminate box ticking when there are closed questions (Schaeffer and Dykema, 2011). 
 
5.5.5. Formulation of questions 
Selection of items 
A standardised procedure was followed for the selection of items (Boynton and 
Greenhalgh, 2004). Firstly, validated disease specific instruments for PD and emotional 
well-being, and relevant literature (articles, books, handbooks for PD published by national 
and international organisations) were collected and read carefully. Secondly, a draft outline 
with items grouped into categories was written by the researcher. Thirdly, the selected 
items were discussed with the supervisory team, and healthcare professionals working in 
Greece. Although the consultation of patients is an important concept for the construction 
of a questionnaire in many countries (Bressee, 2014), this is not the case in Greece. Indeed, 
the HPDA refused the communication of the researcher with its members for the selection 
of items for the current questionnaire.  Instead, the consultation of a neurologist 
specialised in PD and two physiotherapists with experience in PD, was proposed. Fourthly, 
based on the recommendations of professionals, the items of the final version were 
selected (Boynton and Greenhalgh, 2004). 
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Order of questions 
The questionnaire followed a "funnel technique" by placing easier questions first, based on 
the subjective opinion of the principal researcher; and general questions before specific 
questions (Williams, 2003). This procedure may increase respondents’ confidence; and 
they are less likely to quit the questionnaire, compared with questionnaires that difficult 
items are placed earlier (Williams, 2003; Holtgraves, 2004). The selected items, were also 
grouped into themes to facilitate the questionnaire’s completion, to increase response 
rates due to questionnaire’s enhanced internal consistency (Lam et al., 2002), and facilitate 
the analysis section (Anderson, 1998).  
 
Despite the fact that the “funnel technique” supports the placement of the socio-
demographic questions at the end of the questionnaire, to avoid negative feelings about 
the provision of personal information that may impact the answering behaviour or 
participation (Zikmund and Babin, 2012); in the current questionnaire, socio-demographic 
items and questions related to PD and health status were placed in section A (Background 
information).  In addition, the patient’s name was asked in order to ensure that just one 
questionnaire was completed for each patient. To avoid respondents’ negative reactions, 
the invitation letter explained the aim of the current survey, and guaranteed the protection 
of personal information (Boynton et al., 2004).  
 
Question length 
The question length was kept as short as possible in one sentence, as questions with more 
than 20 words may be associated with greater comprehension difficulty (Schaeffer and 
Dykema, 2011). Although it is supported that sensitive questions may include more than 
one sentence and more words, because short sensitive questions can be perceived as 
abrupt and threatening (Boynton and Greenhalgh, 2004); in this survey the sensitive 
questions of the Section A were short, as the invitation letter guaranteed confidentially and 
anonymity to persuade respondents to answer all the items. 
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Wording and phrasing 
Familiar phrases, everyday terms and words were preferred; which do not have nuances, 
alternative or even opposite meanings to respondents. Similarly, medical terms were used 
as little as possible, because their overuse may be a reason for respondents to quit the 
questionnaire (Bradburn et al., 2004). Grammatical complexities were kept to a minimum, 
because they may increase the number of blank or socially desirable responses (Boynton 
et al., 2004). In addition, simple language is a crucial element in senior and less educated 
population, as these individuals may have greater difficulties with comprehension of survey 
questions (Holbrook et al., 2006).  
 
Questions were formulated in active rather than passive voice to increase the respondents’ 
comprehension (Bell, 2005; Lietz, 2010).  Negatively worded questions were also excluded, 
because they have been found to take longer to process and there are increased 
possibilities for respondents to make mistakes (Lietz, 2010). There were also brief 
explanations for some questions into a parenthesis to ensure that they were understood 
by the respondents (Mullen and Daniels, 2009). 
 
Question format 
The survey’s questions were formatted mainly for closed-ended responses, with definitive 
answers. However, few questions of section A and the question at the end of the 
questionnaire were open-ended, with no fixed answers. Closed questions were preferred, 
because: they are usually completed in few seconds; they are associated with higher 
response rates; they facilitate the data analysis, as their answers can be transformed into 
numerical values (Brace 2013). They may also be more suitable, because many PD patients 
face writing difficulties. The closed-ended questions of sections B to E were memory 
questions about motor function and emotional well-being. As the recall of events or 
behaviours may be difficult to being answered (Bell, 2005), the memory questions of the 
current project were referred to the immediate past (previous week). Furthermore, only 
basic ADLs were asked, as this information may have been committed to memory (Jack and 
Clarke, 1998). 
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The open-ended question at the end of the survey about ‘additional comments’, allowed 
respondents whose feelings and thoughts were aroused by the previous questions, to 
express themselves in their own way, and provide more information about their experience 
of being living with PD. Thus, unexpected findings could be detected (O'Cathain and 
Thomas, 2004).  
 
5.5.6. Formulation of responses 
The response options of the closed questions of section A, were categorical, as they were 
related to the sociodemographic characteristics and health related status of PD patients. 
The number of response choices varied among the questions in order to exhaust the entire 
range of answers. As in some questions the range of responses may have been larger than 
the identified, open-ended items were added (image 5.1, p. 74) (Moule and Goodman, 
2009).  
 
The provided possible answers of closed questions in sections B-E were given using a five-
point verbal rating scale. More response options were excluded, because when long 
response scales (at least seven options) are used, the respondents may not be able to 
distinguish alternatives between the answer options of each question. On the contrary, 
respondents can more reliably report their subjective states using response scales between 
five and seven points (Iarossi, 2006). Adverbs were selected as possible responses. As the 
adverbs are vague quantifiers and might be interpreted differently by the respondents 
(Bell, 2005); numeric reference points for a specified time period were given for each 
adverb into a parenthesis (images 5.2, p. 76; and 5.3, p. 79). (Baker, 2003; Bradburn et al., 
2004).  
 
It was decided to have a ‘leave it blank’ option’ instead of a ‘don’t know’ response for those 
who were uncertain for their answer or were not willing to response for personal reasons 
(Lam et al., 2002). Although there is some controversy in the literature whether providing 
a ‘don’t know’ option is reasonable, it seems that their absence does not significantly affect 
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the response rates, compared with ‘leave it blank’ option (Poe et al., 1988). Additionally, in 
questionnaires with a ‘don’t know’ option, even some participants who initially are sure 
about their response, finally they may prefer to choose the ‘don’t know’ option (Gilljam 
and Granberg, 1993). Lastly, questionnaires with ‘leave it blank’ option are slightly shorter 
and are completed in less time (Poe et al., 1988). 
 
What is your primary mean of transportation, except getting around on foot? 
 
 
 
 
 
 
 
If you have ticked other, please specify: …………………………… 
 
Image 5.1. Example of a question of Section A (paper-based questionnaire). 
 
 
5.5.7. Questionnaire’s structure 
The questionnaire’s title was placed on the top of the questionnaire, and below the 
instructions for its completion (Boynton et al., 2004; Marshall, 2005). The questionnaire 
was not anonymous in order to ensure that there was just one completed questionnaire 
for each patient. The questionnaire’s items were grouped into five sections, as seen in table 
5.2 (p. 75). An opened question for additional comments and a thank-you statement were 
included at the end (Bradbrum et al., 2004). Section A included socio-demographic items, 
items related to PD and general health status. The items of sections B to D assessed the 
restrictions in daily life, due to the motor symptoms of PD. Lastly, section E was related to 
the emotional well-being. 
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Table 5.2. Sections of questionnaire and number of included items. 
Section number Section title Number of included items 
A Background information 16 
B Walking 12 
C Transfers and sitting  6 
D Hand activities 8 
E Emotional well-being 9 
                                       Total number of items:      51 
 
 
5.5.8. Questionnaire layout (online questionnaire)  
Special attention was given to the questionnaire’s visual appearance to attract the 
potential respondents and facilitate the completion process. The general rule suggesting 
‘simple in appearance, but sophisticated questionnaires’ was followed (Marshall, 2005).  
The Google Forms, which is a part of the Google Drive suite, was selected for the building 
of the online questionnaire. It is a free survey tool, suitable for the design of simple 
questionnaires in academic and research field (Smallwood, 2015). The ‘required login’ 
option was not ticked in order to access the questionnaire individuals without a google 
account (Fan and Yan, 2010). The questionnaire was available at the link:  
 
http://docs.google.com/forms/d/1JYku5P_ItJGvGwVTriSBVCQ0A-
HAh0iTptYTive2Rbo/viewform  
 
The form background was in white colour, and the internet page background in dark cyan. 
Concerning the text, the questionnaire’s title was written in blue colour, the word 
“required” for the two required questions in red, and the rest text in black. Bold and capital 
letters were used, similarly to the paper questionnaire. The ‘Times New Roman’ typeface 
for the whole survey was selected. In addition, ‘extra-large’ font size and ‘centre align’ were 
ticked for the survey’s title; and ‘large’ font size and ‘left align’ for the rest parts of the 
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survey. The asterisk symbol identified the required items for completion (consent form, 
and if the respondent was a PD patient or carer). 
 
With respect to the design of the sections and items, the numbering was similar to the 
paper questionnaire (section 5.5.9). Depending on the question’s type, the appropriate 
options were selected. Analytically, these were: ‘date’ for the questionnaire’s completion 
date, ‘multiple choice’ for the closed questions, ‘text’ for the open questions required a 
short answer, and ‘paragraph text’ for the open questions required a relative long answer. 
The Google Forms programme automatically designed the visual appearance of questions 
and their responses. The appearance of closed questions of sections B to E is presented in 
image 5.2. 
 
 
04…. Had difficulty turning in a forward position? 
 
            ○ never (0 days a week) 
            ○ occasionally (1-2 days a week) 
            ○ sometimes (3-4 days a week) 
            ○ often (5-6 days a week) 
            ○ always (7 days a week) 
 
Image 5.2.  Question B.04 of the online survey. 
 
It was also decided to include multiple items per screen (online page). Although, there are 
no significant differences in the total completion time between multiple and single items 
per screen for internet surveys; the number of missed questions is significantly higher in 
single items per screen (Couper et al., 2001). The contents per screen of the current online 
questionnaire are presented in table 5.3 (p. 77). 
 
Lastly, buttons and a progress bar were incorporated to help respondents navigate through 
the questionnaire. The “back” and “continue” button allowed respondents to move 
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backward and forward within the questionnaire. The voluntary completion of the questions 
(except the required items on the first page) did not require respondents to answer the 
questions of each page before moving on to the next one. The progress bar was an easy 
way to let the respondents know where they were in the questionnaire. At the end of the 
questionnaire there was the “submit” button for the online submission (Smallwood, 2015). 
 
Table 5.3. Contents per screen for the online questionnaire. 
Number of screen Contents 
1 Consent form, instructions for the questionnaire’s completion; patient’s name; date 
2 Section A (Background information)  
3 Section B (Walking)  
4 Section C (Transfers and sitting)  
5 Section D (Hand activities)  
6 Section E (Emotional well-being)  
7 Open-ended question for additional comments; thank-you statement 
 
 
5.5.9. Questionnaire layout (paper questionnaire)  
Regarding the paper questionnaire, a booklet format was preferred, which was stapled in 
two places along the fold in the manner of a magazine, for two reasons. Firstly, it is easier 
to complete it compared with questionnaires stapled on the corner, and secondly it was 
longer than four pages (Anderson, 1998). Although, it was printed on both sides of the 
paper, the booklet format minimises the possibilities of missing the reverse pages 
(McDonald, 2012). The questionnaire was printed on A4 sheets, as respondents generally 
find A4 sheets easier to handle than A3 sheets (McColl, 1994), and are associated with 
higher response rates than smaller sized papers. However, a cover page was not added, as 
it does not significantly increase the response rate (de Rada, 2005). The questionnaire was 
printed on white-coloured paper, because it is an acceptable colour for questionnaires.  
Black ink was used to contrast sufficiently from the white paper, so that the questionnaire 
could be read easily (Bradburm et al., 2004).  Only the logo of the HPDA was allowed to add 
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on the first page of the questionnaire. It was printed in colour to increase attraction and 
add prestige (Anderson, 1998). 
 
The ‘Times New Roman’ typeface was selected; font size 16 for the title of the 
questionnaire, and 14 for the rest parts of the questionnaire; and 1.15 line spacing. These 
parameters are recommended for the elderly population, due to visual impairments 
(Williams, 2003). Bold and capital letters -in some parts- were used to draw attention and 
ensure emphasis; instead of italics and underlying words or phrases, which make reading 
more difficult. However, the overuse of capital letters was avoided, and lower cases were 
preferred, which are easier to read. The numbering of pages (Arabic numbering), sections 
and items decreased the possibilities of missing a question. The numbering of questions 
and sections also facilitated the analysis process (Iarossi, 2006). 
 
Regarding the overall design, the questions were put into boxes to be more attractive 
(Marshall, 2005); and none of the questions were split over two pages, as this may cause 
confusion (Murray, 1999). With respect to section A, a tick box was placed on the left of 
the response option to be more attractive; whereas the possible answers were placed in 
one column (image 5.1, p. 74), to minimise the danger of missing the answers of the second 
column (Moule and Goodman, 2009).The provided space for the short opened questions 
or the open ended items of closed questions was a single or two lines (image 5.1, p. 74) 
(Edwards, 2010). Regarding sections B to E, a matrix table questionnaire was designed 
(image 5.3, p. 79). This format is a convenient way to collect multiple responses, if the 
response options are the same and all the questions are under the same topic. (Dillman, 
2007). Although there is no strong evidence about the placement of answers (Lietz, 2010), 
frequency adverbs of lower numerical values were placed on the left. Lastly, a big box was 
used for the response of the last open question. Lines are not recommended in relatively 
long answers, as they make the questionnaires look more crowded and have not any useful 
function (Edwards, 2010). The Greek and English version of the paper questionnaire are in 
supplements 1 and 2 respectively. 
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Due to Parkinson’s disease, how often 
during the last week have you…. 
Never 
(0 days a 
week) 
Occasionally 
(1-2 days a 
week) 
Sometimes 
(3-4 days a 
week) 
Often 
(5-6 days a 
week) 
Always 
(7 days a 
week) 
01 Had difficulty taking the first 
step when you begin 
walking? 
     
02 Taken smaller steps when 
walking, which get faster as 
you walk? 
     
 
Image 5.3. Matrix table questionnaire (paper-based questionnaire). 
 
 
5.5.10. Translation of the questionnaire 
A special characteristic of this survey was that the PhD studies were taken place in the 
United Kingdom; whereas the research was conducted in Greece. Firstly, the questionnaire 
was designed in Greek with the assistance of healthcare professionals working in Greece 
(section 5.5.5). Greek was the native language of the researcher and the language of the 
target population. However, the questionnaire had to be translated in English in order to 
be presented to the supervisory team of the University. As the original version of the 
questionnaire was written in the language of the target population; the steps 
recommended by the World Health Organisation (WHO) to achieve different language 
versions of the English instrument, were not followed (Behling and Law, 2000). Instead an 
official translator, with previous experience in the translation of healthcare documents, 
was seeked for the translation of the questionnaire from Greek to English, in order to avoid 
errors in conceptual translation. It should be pointed out that the Greek version of the 
questionnaire was written in demotic (δημοτική) Greek, a form of Greek language spoken 
in everyday life in Greece; and is understandable by all the Greeks, irrespectively of their 
local dialect. 
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5.6. Ethical consideration 
5.6.1. Ethical approval  
Ethical approval for the entire study was granted by the Manchester Metropolitan 
University Research Ethics Committee; and the Scientific Committee of the HPDA 
“Epikouros-kinisi” on 25th May 2011, protocol number 12/2011 (Appendices 5.1 and 5.2). 
An additional ethical approval for the survey was obtained from the HPDA on 1st October 
2013 (appendix 5.3). 
 
5.6.2. Informed consent 
The subjects were informed about the true nature of the survey (Boynton et al., 2013). The 
goals of the survey and the components of the study’s procedure were conveyed in their 
totality to the respondents through the invitation e-mail for the online survey (Appendices 
5.4-5.5), and the invitation sheets for the paper survey (Appendices 5.6-5.7). 
 
 Although a signed consent form is not generally required for survey studies; it was decided 
to include a consent form, as the questionnaire was not anonymous (Iarossi, 2006). 
Consent was obtained voluntarily, without pressure, inducements or influence. The 
consent form indicated that the respondents had understood all the information relevant 
to the study nature and its purpose (Moule and Goodman, 2009).  In the paper survey, 
there was a space to sign at the bottom of the information sheet (Appendices 5.6 and 5.7). 
In the online survey the respondents had to tick the ‘I agree’ option, which was a required 
field, before the completion of the online questionnaire (image 5.4, p. 81). An electronic 
signature was not asked, as the respondents may have not been familiar with it. Lastly, no 
incentives were promised to them for their participation. 
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Consent form for the questionnaire 
 
Before the completion of the questionnaire, be sure that you have read the invitation e-mail sent to you; 
and tick the follow box, if you agree to participate in the study.  
 
  ○ I accept 
 
Image 5.4. Consent form for the online survey. 
 
5.6.3. Confidentiality 
Confidentiality was kept at all times. Data gathered on paper were kept on a locked cabinet 
in researcher’s house. All paper data were not moved outside the researcher’s house. An 
access password, known only to the researcher, protected the information stored on a 
computer. The backup external memory of electronic data was also password protected, 
and locked into the cabinet. No one had access to the online questionnaires beyond two 
members of the research team (psychologist, nurse) and the president of the HPDA. The 
completed paper questionnaires were put into closed envelopes by the respondents, 
before returning back to researcher. Participants’ records were only seen or discussed only 
by authorised personnel relevant to the study, after the permission of the researcher. 
Confidentially was also kept by presenting statistical tabulations by broad enough 
categories, so that individual respondents could not be singled out. Finally, at the end of 
the study, all data gathered on paper were destroyed using a paper shredder; whereas all 
data kept on the computer and external memory were deleted from the recycle bin of the 
computer. 
 
5.6.5. Anonymity 
Participants’ names remained anonymous during and after the completion of the study. 
The names did not appear in any documentation. Each participant had a special code and 
the name in the questionnaire was replaced by this code. The same code was also used for 
the data analysis. The participants were not identified by name or other defining 
characteristics at any point in the study. Instead of the name, the personal code was used 
for each participant. In addition, it was prohibited to the members of the research team to 
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give the respondents’ names and the completed paper-based questionnaires to anyone 
outside the research team and the president of the HPDA. 
 
5.6.6. Harm 
There was no risk for harm, due to the study’s nature (survey). In addition, the answering 
of any item on the questionnaire was voluntary; and there were not unethical questions. 
 
5.6.7. Rights of participants 
The participants had the right to quit the study before submitting the questionnaire. They 
could also being informed about the results of the study, if they wished. 
 
5.7. Pretesting and pilot work  
Before the main survey, a pretesting was performed for the online survey, and a pilot work 
for both the online and paper questionnaire. The pretesting was performed on 17th August 
2013; the pilot work for the online questionnaire between 20th August and 20th September 
2013, and the pilot work for the paper survey on 18th November 2013. 
 
5.7.1. Pretesting (online questionnaire) 
Pretesting is an unofficial, unscientific and very simple way to find errors before delivering 
the self-administrated questionnaires for the pilot work (Holdbrook, 2006). Once the 
supervisory team of the University agreed that the questionnaire could be delivered to the 
target population; four adults, free of PD, accessed the online Greek version to check the 
spelling, grammar and layout, and complete the questionnaire (Boynton, 2004). Their 
feedback was positive, no changes were proposed, and the questionnaire was delivered for 
the pilot work. 
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5.7.2. Pilot work (online questionnaire) 
Aim and objectives 
The general aim of the pilot work - both for the online and paper questionnaire- was to test 
the questionnaire as a whole under real survey conditions, before the main study (de 
Leeuw et al., 2008).  
 
The objectives of the current pilot work were listed as follows: 
 To get informed about the estimated response rate of the questionnaires, and the time 
of questionnaire’s completion (de Leeuw et al., 2008). 
 To determine whether it was necessary to remove some items or any flaws, which had 
caused confusion to respondents or led to high number of non-response answers 
(Marshall, 2005). 
 To determine whether additional items, relevant to the study’s aim, would be added 
(Presser et al., 2004). 
 To determine whether the questionnaire’s layout was suitable for the target 
population, and the questionnaire easy to complete it. 
 To collect information on how respondents may answer in general and specific 
questions (Boynton, 2004). 
 To develop pre-codes for open-ended questions (de Leeuw et al., 2008). 
 To check or analyse whether the data produce usable results (Marshall, 2005).  
 
Implementation of the pilot work 
The whole procedure was similar to the main survey (Marshall, 2005). The volunteer 
(psychologist) sent the questionnaire randomly to 30 individuals, members of the HPDA. 
This ensured that the respondents were representatives of the study’s sample, with similar 
socio-demographic characteristics (Marshall, 2005). However, they were some differences 
between the pilot work and the main study, which are listed below: 
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 At the end of the online survey, there was a ‘feedback questionnaire’ (Appendix 5.8) 
with items relevant to the aims of the pilot work. The items’ completion was voluntary 
and there was a ‘leave it blank’ option. 
 The invitation e-mail included additional information about the ‘feedback 
questionnaire’. 
 The required time to complete the questionnaire was not reported in the invitation e-
mail, as the completion time would be based on the results of the pilot-work.  
 
Results 
Due to limitation of time and small number of respondents, the data produced by the pilot 
were not analysed using the Statistical Package for the Social Sciences (SPSS), or content 
analysis, as the main survey. However, in order to produce usable results, the answers were 
checked using the ‘summary of responses’ and ‘view responses’ options of the Google 
Forms.  
 
Eight individuals –five men and three women- submitted the pre-final version of the 
questionnaire by 19th September 2013. Thus, the response rate was 26.67%. Six of the 
respondents (75%) were PD patients, whereas the others were carers of PD patients. The 
age -in years- varied from 50 to 81 years, and the disease duration from one to 17 years.  
Each subject answered at least 76% of the items. All the open-ended questions of the 
section A were answered clearly. In total, the number of the non-response questions varied 
from zero to two (up to 33.3%), and it was similar among the survey’s sections. However, 
the open question at the end of the questionnaire, was answered by only two persons. 
 
The respondents’ feedback was positive and the overall survey’s mark was 8.8 out of ten. 
The completion time varied from four to 20 minutes. The instructions were 
understandable, there was no objection to answer any sensitive question, and the online 
survey was well-designed and easy to complete it. All questions and response options were 
considered appropriate and comprehensible by seven subjects. 
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Six individuals reported some activities, which were affected due to PD, and were not 
included in the questionnaire: swimming (n= 1), sexual disturbances (n= 1), face shaving 
(n= 1), dysphagia (n= 2), constipation (n= 2), hypotension (n= 1), speech disturbances (n= 
1).  However, five answers were not related to the motor function or emotional status, and 
were considered not relevant to the objectives of the current study. It was decided not to 
add ‘swimming’ and ‘face shaving’ to the final version of the questionnaire; because the 
main study was not conducted during the summer period, and face shaving is related just 
to males. 
 
Modifications for the main survey 
The pre-final version of the questionnaire was not subjected to any modifications, and it 
was considered the final version of the questionnaire. In addition, the final version of the 
e-mail invitation included the estimated time of completion, based on the answers of the 
pilot work. Lastly, the number of individuals, in which the online invitation would sent, 
recalculated; due to the lower response rate (26.67%) than those reported in the literature 
(34%) (Shih and Fan, 2008). Hence, the invitation had to be sent to at least 1440 subjects, 
instead of 1130 (section 5.4.2). 
 
5.7.3. Pilot work (paper questionnaire) 
Two PD patients completed the paper questionnaire at the neurological medical office of 
the president of the HPDA. As the online pre-final version piloted successfully, it was 
decided not to include further respondents for the current pilot work. The implementation 
of the pilot work did not differ from the procedure followed in the main study. No 
reconstructions were made to the final version of the questionnaire, as the participants’ 
feedback was positive.  
 
5.8. Implementation of the main survey 
5.8.1. Location and study’s calendar 
After the questionnaire was piloted, it was administrated to the target population (Murray, 
1999). The delivery, completion and collection of questionnaires were conducted from 
October 2013 to May 2014. Specifically, the online questionnaires were completed from 
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2nd October 2013 to 12th February 2014, whereas the paper questionnaires from 21st 
November 2013 to 22nd May 2014. 
 
The paper survey was conducted at the offices of Parkinson Care (address: 121 Spetson 
Street, Kypseli, 113 63, Athens), on Mondays and Thursdays from 16:00 to 20:00; and the 
neurological medical office of the president of the HPDA (address: 127 Galatsiou Avenue, 
Galatsi, 111 46, Athens), on Fridays from 14:30 to 16:30, during the operating days and 
hours for PD patients-members of the HPDA. These facilities are offered free to the HPDA, 
the aforementioned days and hours, to provide free services to its members. 
 
5.8.2. Online survey 
The first step of the online survey was to send an invitation e-mail (Appendices 5.4 and 5.5) 
to the target population. The aim of the invitation was to gain the respondents’ 
cooperation, and feel confident to answer the questions and express their views openly. In 
addition, the surveys that include invitation letter are associated with increased response 
rates (Iarossi, 2006; Bernd et al., 2007). The recalculation of the target population to which 
the invitation had to be sent, following the pilot work, exceeded the total number of 
individuals enrolled with the HPDA. Thus, it was decided to send the online invitation to all 
the members of the HPDA, except those whom the invitation for the pilot study was sent. 
It was also decided that the invitation e-mails would be sent, based on the way that the 
members of the HPDA appear on the organisation’s list; that is, according to the 
chronological order of enrolment with the organisation, from the newest to the oldest. As 
the principal researcher was not allowed to have access to the database with all the 
personal information of the members of the HPDA; one volunteer (psychologist), who had 
access to the database, sent the online invitations. The time of the survey’s conduction, the 
HPDA did not have a newsletter service. Hence, the invitations had to be sent to each 
member separately. The official e-mail of the HPDA was used, to avoid spam issues, and for 
prestige. In addition, the internet users may be distrustful to click on a provided link, when 
no previous relation with the sender exists (de Leeuw et al., 2008). Based on the volunteer’s 
availability, it was decided to send 200 online invitations per month, except holiday periods 
(e.g. Christmas) to avoid higher non response rates (Iarossi, 2006). The principal researcher 
Chapter 5: Survey-methodology 
87 
 
had immediate access to the completed questionnaires. Thus, he was able to check the 
answers and be aware of the response rates. 
 
In the meanwhile an announcement relevant to the study, without including the survey’s 
link, was posted on the official webpage (http://www.parkinsonportal.gr/epikouros.php) 
and facebook page (https://www.facebook.com/Parkinson.EPIKOYROS.kinesis/?fref=ts) of 
the HPDA. The aim of the announcement was to inform members of the HPDA, who did 
not check their e-mails. 
 
Two reminder (follow-up) e-mails were sent to the potential respondents to get informed 
about deadline of submission and the uniform resource locator (URL) to access the 
questionnaire, in order to maximise the response rates. No further reminder e-mails were 
sent, as there is evidence that they do not increase the response rates, and repeated 
follow-ups may be considered as spam (Bell, 2005; Iarossi, 2006). The volunteer sent the 
reminder e-mails to the whole sample, because the Google Form does not provide to the 
researchers the e-mail address of respondents (Marshall, 2005). As there is not a general 
rule about the time of sending the reminder e-mails (Deutskens et al., 2004), and based on 
the average response rates for the online surveys (5.59 days) (Ilieva et al., 2002); it was 
decided to send the first and second reminder one and three weeks respectively after the 
date the invitation e-mail was sent. The same dates, a reminder announcement on the 
official website and facebook page of the HPDA was posted. 
 
The first 200 invitation e-mails were sent from 2nd to 4th October 2013. However, there was 
one failure e-mail (invalid e-mail address). Despite the follow-up e-mails, the response rate 
was very low (14.5%); lower than the pilot work (26.67%). In addition the availability of the 
volunteer was limited for the next months. As hence, on 10th November, it was decided to 
stop the online survey, and conduct a paper survey as an alternative. The flowchart with 
the number of respondents for the online survey is seen in figure 6.1 (p. 94).  
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5.8.3. Paper survey 
The members of the HPDA were informed about the paper survey through monthly 
announcements on the official webpage and the Facebook page of the HPDA, and through 
direct contact of principal researcher or volunteer (nurse) with PD patients or their carers. 
The contact through e-mail was rejected, because it was proved ineffective for the online 
survey. 
 
The survey was conducted with personal delivery of questionnaires to PD patients or their 
caregivers. Firstly, the purpose of the study was explained briefly, and the information 
sheet (Appendices 5.6 and 5.7) was given to those expressed interest to participate. After 
reading it, they were asked to sign the consent form (Appendices 5.6 and 5.7), if they were 
willing to complete the questionnaire; and the paper questionnaire, inside an opened 
envelope, and a pen were given to them. Furthermore, any question related to the study 
was answered. The link for the online survey (printed online invitation) was given to 
respondents that were willing to participate in the study, but were unable to complete the 
paper questionnaire that time. However, only one individual completed the online survey 
since 21st November 2013. 
 
The rooms were equipped with a table and a chair to complete the self-administrated 
questionnaire. The furniture was placed in a quiet corner of the room, away from other 
people; to eliminate bias arising from lack of privacy, and interaction of being in the same 
place with other individuals (Boynton et al., 2004). In case of inability a PD patient to 
complete the questionnaire, a person who accompanied him/her could provide assistance. 
In case of an absence of a person accompanied the patient, the principal researcher or 
nurse did not assist the respondent to complete the survey, to avoid interviewer bias (Bell, 
2005). 
 
Two to three minutes after the start of questionnaire’s completion, the respondent was 
asked if everything was understood, and whether the required item on the first page had 
been completed. Further guidance was provided, if needed, during the whole completion 
of the questionnaire. The researcher was careful while giving explanations; to avoid: 
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inflections of the voice, facial expressions and gestures, as they may influence responses 
(Boynton et al., 2004). The completed questionnaires were returned back to the researcher 
into a sealed envelope, to protect the privacy of their answers from other persons being in 
the same room (Iarossi, 2006); and was thanked for the participation. 
 
The procedure for the collection of completed questionnaires was relatively slow. On 22nd 
May 2014, after receiving 200 completed online and paper surveys, it was decided to stop 
the study and proceed to the analysis. 197 individuals were asked to complete the paper 
survey; however, 27 refused. Although, they were not asked about the reason(s) for 
refusal; some claimed restriction of time or “the study has nothing to offer to me”. The 
flowchart with the number of respondents for the paper survey is seen in figure 6.2 (p. 96). 
 
5.9. Data analysis 
Before the data analysis, the coding of survey questionnaires was performed. Each 
questionnaire had a unique serial number, which was a combination of upper-case letters 
and numbers (e.g. O21, P148). The letter ‘O’ was selected for the online questionnaires and 
‘P’ for the paper questionnaires. 
 
Only completed questionnaires were included in the analysis; whereas uncompleted 
questionnaires were excluded. A questionnaire was considered completed if at least the 
half items of the whole questionnaire, and one item from each section had been answered; 
as this may provide the most important information for the patient (Iarossi, 2006). Both 
quantitative (descriptive statistics) and qualitative techniques were selected for the 
analysis and interpretation of data, based on the research aim and objectives (Sections 
5.2.1 and 5.2.3). 
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5.9.1. Quantitative analysis 
The responses of closed questions of sections A-E, and the short open-ended questions of 
section A were transformed into quantitative data. The data were entered to the ‘Variable 
View’ of SPSS, and all the variables were defined (named and coded) (Pallant, 2016). Their 
analysis was performed using the SPSS version 22.0. The level of statistical significance 
(alpha level) was set at α < .05. (Sim and Wright, 2000; Hicks, 2009). With respect to the 
missing data of the questionnaire, it was decided to not being replaced with the mean. This 
option is not recommended, as it can severely distort the results of the analysis (Pallant, 
2016).  
 
Two types of analysis were performed: one for the whole sample, and one sub-group 
analysis between males and females (only for the items of Section A). The aim of analysis 
for the whole sample was to detect: the socio-demographic characteristics of PD 
population, their health-related status, and the most frequent mobility and emotional 
disturbances. Thus, descriptive statistics were obtained for the categorical and continuous 
variables of the questionnaire. ‘Summary’ statistics; such as minimum, maximum, range, 
mean, median and standard deviation (SD) were provided for the continuous variables; 
whereas number of answers and proportions for the categorical variables (Hicks, 2009; 
Pallant, 2016). The aim of subgroup analysis was to identify any significant difference 
between males and females with respect to their socio-demographic characteristics and 
health status (Section A). For this purpose Chi-square tests for independence were applied 
to explore the relationship between two categorical variables (Hicks, 2009; Pallant, 2016). 
 
5.9.2. Qualitative analysis 
The comments of respondents at the end of the questionnaire and few items of section A 
were analysed using qualitative analysis. Among the several analysis methods in qualitative 
research, the thematic analysis -a form of content analysis- was selected; because it is 
defined as a systematic approach to categorise data for the purpose of classification, 
summarisation and tabulation. It is also a qualitative descriptive approach, suitable for 
researchers who wish to employ a relatively low level of interpretation; describing a 
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phenomenon in a conceptual form. In addition, by using content analysis, it is possible to 
analyse data qualitatively, and at the same time quantify the data. Moreover, thematic 
analysis is recommended when the approach is inductive11 (Krippendorff, 2013; Vaismoradi 
et al., 2013). Thus, the thematic analysis would assist the researcher to create themes, 
summarise and categorise the beliefs of respondents about their experiences living with 
PD. 
 
In the current study, an official translator was consulted for the conceptual translation of 
some phrases from the Greek to the English language. The material was analysed in its 
entirety. A manifest anaylisis was followed, as the analysis focused on what was actually 
written by the respondents, rather than what the researcher believed (Bengtsson, 2016). 
 
The process of data analysis according to Elo and Kyngäs (2008) was followed. Firstly, during 
the “preparation” phase, the responses were read several times to get familiarised and the 
initial ideas for the categorisation of data were noted down. Secondly, during the 
“organising” phase, based on the available data, categories and subcategories were 
identified. The themes were checked carefully to avoid any overlap. Words and phrases of 
the categories were coded and counted (quantitative content analysis). However, some 
statements of interest, based on the researcher’s view, were presented in words 
(qualitative analysis); to provide further information to the readers. In addition, the 
irrelevant data were deleted. This process was performed with caution to avoid the losing 
of important information for the analysis. Finally, in the third step the results were 
reported, as seen in section 6.3. 
 
To increase validity, Investigator triangulation was followed; involving two investigators 
that performed the analysis separately: the PhD student and a Greek physiotherapist with 
previous experience in qualitative analysis. Then, their results were compared; 
disagreements, regarding the categories and subcategories, were solved by discussion; and 
                                                             
11  No hypothesis is tested 
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the more appropriate way for the presentation of the results was decided (Bengtsson, 
2016). 
 
5.10. Summary of Chapter 5 
 A mixed mode survey, including an online and a paper questionnaire, was conducted 
to detect the restrictions in ADLs and emotional disturbances among Greek population 
suffering from PD. 
 The most prevalent answers would be considered for the design of the group exercise 
and education programme of the current thesis (RCT). 
 The respondents could be either patients with PD or carers of persons with PD. 
 The design of the questionnaire aimed to achieve increased response rates, receive 
accurate responses, and facilitate its completion and analysis. 
 Before the main survey, a pretesting and a pilot work were conducted to identify any 
errors. 
 Although, based on the sample size determination, the required sample had to be 384 
individuals; the study stopped when 200 questionnaires were received, due to low 
response rates and slow process. 
 Both quantitative and qualitative techniques were used for the data analysis, as the 
questionnaire consisted of both close-ended and open-ended questions.  
 Only completed questionnaires were included in the analysis. A questionnaire was 
considered completed if at least the half items of the whole questionnaire, and one 
item from each section had been answered. 
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CHAPTER 6 
SURVEY - RESULTS 
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6.1. Introduction 
The current Chapter refers to the combined results for the online and paper survey.  The 
Chapter is divided into two main parts: the findings of Sections A-E, where quantitative 
approached were applied; and the findings of the last open-ended question, were 
qualitative analysis was performed. 
 
6.2. Number of respondents 
Overall 200 questionnaires were collected (30 online and 170 paper questionnaires), 
whereas 192 were considered completed and included in the analysis section (28 online 
and 164 paper-based). The check of patients’ names revealed that just one questionnaire 
was completed for each patient. The flowchart with the number of respondents for the 
online survey is seen in figure 6.1 (p. 95), whereas the flowchart for the paper survey in 
figure 6.2 (p. 96).  
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Figure 6.1. Flowchart of the number of respondents for the online survey. 
 
The invitation e-mail was sent 
to 200 individuals 
 
1 failure sending 
 
 
 199 individuals received the 
invitation e-mail 
 
29 questionnaires were 
submitted online 
 
28 online questionnaires 
included in the analysis 
(Response rate = 14.5%) 
 
2 questionnaires 
were excluded: 
 
 Non suffering 
from PD (n= 1) 
 Questionnaire 
less than 50% 
completed       
(n= 1) 
 
 
 
1 more questionnaire 
was submitted online 
later (February 2014) 
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Figure 6.2. Flowchart of the number of respondents for the paper survey. 
 
 
6.3. Part one: quantitative results 
6.3.1. Section A  
Socio-demographic characteristics 
The socio-demographic characteristics of PD patients for the whole population, and for 
males and females; are presented in table 6.1 (p. 98). As seen in the table, the number of 
questionnaires completed by PD patients (n= 97) and carers (n= 95) was almost equal. 
Although the reasons that almost half questionnaires were completed by carers of persons 
197 individuals were asked to 
complete the paper 
questionnaire 
 
27 individuals 
refused to complete 
the questionnaire 
 
 
 170 individuals completed the 
questionnaire 
 
164 paper questionnaires 
were included in the analysis 
(Response rate= 86.3%) 
6 questionnaires 
were excluded: 
 
 Non suffering 
from PD (n= 3) 
 Questionnaire 
less than 50% 
completed       
(n= 3) 
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with PD was not explored; it is believed that writing difficulties due to the disease, cognitive 
impairments, inability to read and write, and low level of computer literacy may have 
prevented patients to complete either the online or paper survey. 
 
The findings indicated that the PD patients were almost Greeks (96.9%). All the participants 
were able to speak Greek; however, five reported Greek as not their native language. Males 
(55.2%) were more than females (44.8%). Despite the fact that the mean age of patients 
was 68.31 years, and the retirement age in Greece when the survey was conducted was 65 
years; only 13.6% of patients were currently working, either in the public (n= 10) or in the 
private (n= 16) domain. Seven people reported the reason that were unable to work: six of 
them due to problems arising from PD; and one due to mobility restrictions related to aging. 
A further analysis showed that 18 individuals up to 64 years were retired, whereas only two 
individuals more than 65 years were still working.  
 
Regarding the place of residence, the respondents were counted based on their 
administrative and regional units (Section 2.4). The majority were from the mainland (n= 
172, 91.5%), and only 16 (8.5%) were islanders. The survey population was from 26 regional 
units and from 11 administrative units. The vast majority (68.2%) was living in Attica 
(Athens Metropolitan Area). Specifically, the three most reported regional units were: 
Attica (n= 131); Thessaloniki (n= 8) and Euboea (n= 7). In addition, the distribution of survey 
population in administrative units was listed as: Attica (n= 131), Central Greece (n= 13), 
Peloponnese (n= 12), Central Macedonia (n= 10), Western Greece (n= 7), South Aegean (n= 
5), North Aegean (n= 3), Epirus (n= 3), Thessaly (n= 2), Eastern Macedonia-Thrace (n= 1), 
and Crete (n= 1). On the contrary, there were no respondents from Western Macedonia 
and Ionian Islands.  
 
The primary mean of transportation was car (76.6%). However, as the RCT was decided to 
hold in Athens; it seems important to repot the primary means of transportation for the 
Athenians, which were listed as follows: car (n= 96, 73.3%), metro (n= 17, 13%), bus 12 (n= 
12, 9.2%), taxi (n= 5, 3.8%), and tram (n= 1, 0.8%). 
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Table 6.1. Socio-demographic characteristics for the whole sample, males and females. 
Variables All 
(n= 192 ) 
Male 
(n= 106 ) 
Female 
(n= 86) 
P value 
Survey respondents PD patient 
PD caregiver 
97 (50.5 %) 
95 (49.5 %) 
51 (48.1 %) 
55 (51.9 %) 
46 (53.5 %) 
40 (46.5 %) 
p = .551 
χ2 = 3.55 
 
Age category             
(in years) 
40-49 
50-59 
60-69 
70-79 
80+ 
8   (4.2 %) 
37 (19.3 %) 
50 (24.5 %) 
69 (35.9 %) 
28 (14.6 %) 
7   (6.6 %) 
21 (19.8 %) 
26 (27.9 %) 
38 (35.8 %) 
14 (13.2 %) 
1   (1.2 %) 
16 (18.6 %) 
24 (26 %) 
31 (36 %) 
14 (16.3 %) 
p = .416 
χ2 = 3.92 
 
 
Nationality 
Greek 
Greek-Cypriot 
Albanian 
Russian 
Ukrainian 
Nigerian 
186 (96.9 %) 
1     (0.5 %) 
2     (1.1 %) 
1     (0.5 %) 
1     (0.5 %) 
1     (0.5 %) 
102 (96.2 %) 
1     (0.9 %) 
1     (0.9 %) 
1     (0.9 %) 
0     (0 %) 
1     (0.9 %) 
84 (97.6 %) 
0   (0 %) 
1   (1.2 %) 
0   (0 %) 
1   (1.2 %) 
0   (0 %) 
p =  .876 
χ2 = .02 
 
 
Native language 
Greek 
Albanian 
Russian 
Ukrainian 
Igbo 
187 (97.4 %) 
2     (1 %) 
1     (0.5 %) 
1     (0.5 %) 
1     (0.5 %) 
103 (97.2 %) 
1     (0.9 %) 
1     (0.9 %) 
0     (0 %) 
1     (0.9 %) 
84 (97.6 %) 
1   (1.1 %) 
0   (0 %) 
1   (1.1 %) 
0   (0 %) 
p = .827 
χ2 = .04 
 
 
Educational level 
 
Primary 
Secondary 
Tertiary* 
No school 
Ν/Α 
48 (25 %) 
77 (40.1 %) 
65 (33.8 %) 
0   (0 %) 
2   (1 %) 
23 (21.7 %) 
41 (38.7 %) 
41 (38.7 %) 
0   (0 %) 
1   (0.9 %) 
25 (29.1 %) 
36 (41.9 %) 
24 (27.9 %) 
0   (0 %) 
1   (1.1 %) 
p = .049 
χ2 = 7.84 
 
 
 
Employment status 
Employed for wages 
Self-employed 
Retired  
Household  
Out of work and looking 
for work 
Out of work but not 
looking for work 
Unable to work 
Ν/Α 
17   (8.9 %) 
9     (4.7 %) 
127 (66.1 %) 
21   (10.9 %) 
 
4     (2.1 %) 
 
7     (3.6 %) 
4     (2.1 %) 
3     (1.6 %) 
11 (10.4 %) 
7   (6.7 %) 
79 (74.5 %) 
2   (1.9 %) 
 
1   (0.9 %) 
 
2   (1.9 %) 
2   (1.9 %) 
2   (1.9 %) 
6   (7 %) 
2   (2.3 %) 
48 (55.8 %) 
19 (22.1 %) 
 
3   (3.5 %) 
 
5   (5.8 %) 
2   (2.3 %) 
1   (1.1 %) 
p = .000 
χ2 = 26.21 
 
 
Marital status 
Married  
Separated  
Widowed  
Single  
In a relationship  
N/A 
117 (60.9 %) 
25   (13 %) 
34   (17.7 %) 
11   (5.7 %) 
2     (1 %) 
3     (1.6 %) 
69 (65.1 %) 
15 (14.2 %) 
10 (9.4 %) 
9   (8.5 %) 
0   (0 %) 
3   (2.8 %) 
48 (55.8 %) 
10 (11.6 %) 
24 (27.9 %) 
2   (2.3 %) 
2   (2.3 %) 
0   (0 %) 
p = .004 
χ2 = 15.58 
 
 
Residence 
City  
Village  
N/A 
150 (78.1 %) 
39   (20.3 %) 
3     (1.6 %) 
82 (77.4 %) 
22 (20.8 %) 
2   (1.8 %) 
68 (79.1 %) 
17 (19.8 %) 
1   (1.1 %) 
p = .989 
χ2 = .000 
 
Prefecture 
Attiki 
Thessaloniki 
Other 
N/A 
131 (68.2 %) 
8     (4.2 %) 
49   (25.5 %) 
4     (2.1 %) 
72 (67.9 %) 
7   (6.6 %) 
25 (23.6 %) 
2   (1.9 %) 
59 (68.6 %) 
1   (1.1 %) 
24 (27.9 %) 
2   (2.3 %) 
p = .155 
χ2 = 3.72 
 
 
Primary mean of 
transportation 
Car  
Metro  
Bus  
Taxi  
Tram 
147 (76.6 %) 
17   (8.9 %) 
21   (10.9 %) 
6     (3.1 %) 
1     (0.5 %) 
83 (78.3 %) 
8   (7.5 %) 
12 (11.3 %) 
2   (1.9 %) 
1   (0.9 %) 
64 (74.4 %) 
9   (10.5 %) 
9   (10.5 %) 
4   (4.7 %) 
0   (0 %) 
p = .635 
χ2 = 2.55 
 
* University, College, higher technical school. 
Abbreviations. n: number of respondents; N/A: no answer; PD: Parkinson’s disease 
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Health status 
The results of patients’ health status are summarised in table 6.2. The median duration of 
PD (since PD diagnosis) was four years. Almost all the patients (97.2%) were under 
antiparkinsonian pharmacological treatment. The reason(s) that 2.3% or patients were not 
receiving treatment, was not investigated. Despite the antiparkinsonian medication, only 
28.7% of patients reported significant improvement on PD symptoms. In addition, 92.7% 
of respondents reported at least one additional comorbidity or previous surgery, classified 
in six categories. The most common reported comorbidities of each category are presented 
in table 6.3 (p. 100). Regarding previous surgeries, only four patients reported deep brain 
stimulation (DBS) due to PD. 
 
Table 6.2. Health status for the whole sample, males and females.  
Variables All 
(n= 192 ) 
Male 
(n= 106 ) 
Female 
(n= 86) 
P value 
 
Years since PD 
diagnosis 
0-11 months 
1-4 years 
5-9 years 
10-19 years 
20+ years 
N/A 
24 (12.5 %) 
76 (39.6 %) 
54 (28.1 %) 
33 (17.2%) 
2   (1 %) 
3   (1.6 %) 
11 (10.4 %) 
43 (40.6 %) 
32 (30.2 %) 
16 (15.1 %) 
1   (0.9 %) 
3   (2.8 %) 
13 (15.1 %) 
33 (38.4 %) 
22 (25.6 %) 
17 (20 %) 
1   (1.2 %) 
0   (0 %) 
p = .763 
χ2 = 1.85 
 
PD medication 
Yes 
No 
N/A 
188 (97.9 %) 
2     (1 %) 
2     (1 %) 
104 (98.1 %) 
0     (0 %) 
2     (1.9 %) 
84 (97.7 %) 
1   (1.1 %) 
1   (1.1 %) 
p = .919 
χ2 = .01 
 
Improvement of 
symptoms due to PD 
medication * 
Significant 
Moderate 
Little 
No improvement 
N/A 
54 (28.7%) 
48 (25.5 %) 
67 (35.7%) 
16 (8.5 %) 
3   (1.6 %) 
35 (33.7%) 
23 (22.1 %) 
38 (36.5%) 
7   (6.7 %) 
1   (0.9 %) 
19 (22.6%) 
25 (29.8 %) 
29 (34.6%) 
9   (10.7 %) 
2   (2.4 %) 
p = .527 
χ2 = 4.16 
Additional medical 
conditions /diseases 
Yes 
No  
N/A 
178 (92.7 %) 
7     (3.6 %) 
7     (3.6 %) 
96 (90.6 %) 
4   (3.8 %) 
6   (5.7 %) 
82 (95.3 %) 
3   (3.5 %) 
1   (1.1 %) 
p = 1.00 
χ2 = .00 
 
Sub-categories of 
comorbidities*  ** 
Cardiovascular disease 
Respiratory disease 
Musculoskeletal disease 
Other neurological 
disease  
Other chronic disease 
Previous surgeries 
 
68   (38.2 %) 
7     (3.9 %) 
104 (58.4 %) 
 
4     (2.2 %) 
101 (52.6 %) 
148 (83.1 %) 
43 (44.8 %) 
5   (5.2 %) 
61 (63.5 %) 
 
1   (1 %) 
56 (58.3 %) 
77 (80 %) 
25 (30.5 %) 
2   (2.4 %) 
43 (52.4 %) 
 
3   (3.7 %) 
45 (54.9 %) 
71 (86.6 %) 
 
 
 
* completed only by the respondents who answered ‘yes’ to the previous question 
 **some patients reported comorbidities of two or more categories 
Abbreviations. n: number of respondents; N/A: no answer; PD: Parkinson’s disease. 
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Table 6.3. Most common reported comorbidities for the whole sample. 
Sub-categories of 
comorbidities 
Most common comorbidities 
 
Cardiovascular 
conditions  
 hypertension (n= 47) 
 cardiac arrhythmia (n= 11) 
 coronary artery disease (n= 7). 
Respiratory 
conditions 
 chronic obstructive pulmonary disease (n= 4) 
 bronchial asthma (n= 2) 
 sleep apnoea (n= 1). 
Musculoskeletal 
and rheumatoid 
conditions 
 low back pain (n= 42) 
 osteoporosis (n= 31) 
 osteoarthritis (n= 25)  
 pain in specific body areas (n= 14) (no information about any specific medical diagnosis) 
Neurological 
conditions 
 stroke (n= 2)  
 dementia (n= 2) 
Other medical 
conditions 
 high levels of low density lipoprotein (n= 38) 
 diabetes mellitus type II (n= 16) 
 hypothyroidism (n= 9). 
Previous surgeries  hernia surgery (n= 16) 
 joint replacement (n= 12) 
  hysterectomy (n= 10) 
 
Abbreviations. n: number of respondents. 
 
Gender differences 
As seen in table 6.1 (p. 98) and 6.2 (p. 99) significant gender differences were reported only 
for some socio-demographic characteristics, whereas the health status did not differ 
between the genders. In particular, Chi square tests for independence indicated significant 
association between the gender of PD patient and: education level [χ2 (3, n= 190) = 7.84, 
p= .049], employment status [χ2 (6, n= 189) = 26.21, p= .000], and marital status [χ2 (4, n= 
189) = 15.85, p= .004]. Specifically, the proportion of males (66.1%) was much higher in 
‘tertiary education’; ‘employed for wages’ (64.7%), ‘self-employed’ (77.8%), ‘retired’ 
(62.5%); and ‘singles’ (81.8%). On the contrary the proportion of females was much higher 
in ‘household occupation’ (90%); ‘widowed’ (70.6%); and ‘in relationship’ (100%). 
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6.3.2. Section B, C, D and E  
Descriptive statistics summarised respondents’ answers to all the items of section B-E, as 
seen in table 6.4 (pp. 101-102). The horizontal axis includes the questions; whereas the 
vertical the five response options, as written in the questionnaire. Three extra columns 
were added on the right: one entitled ‘N/A’ to sum the number of no answered questions, 
one ‘5-7 days a week’ to sum up the responses that were at least five days a week 
(responses: ‘often’, and ‘always’), and one ‘0-2 times a week’ to sum up the responses that 
were up to twice a week (responses: ‘never’ and ‘occasionally’). Thus, the two last columns 
revealed the restrictions of mobility and emotional disturbances that appear almost daily 
(at least five days a week) or rarely (up to two days a week). 
 
Table 6.4.Responses to questions of sections B, C, D and E. 
Item Question 
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Due to PD, how often during the 
last week have you…. 
B.01 Had difficulty taking the first step 
when you begin walking? 
42 44 47 30 22 07 52 86 
B.02 Taken smaller steps when 
walking, which get faster as you 
walk? 
45 45 44 30 14 14 44 90 
B.03 Stopped suddenly while walking 
without any specific reason? 
78 39 32 15 8 20 23 117 
B.04 Had difficulty turning in a 
forward position? 
51 36 40 31 17 17 48 87 
B.05 Had difficulty remaining upright 
when walking? 
60 34 36 24 27 11 51 94 
B.06 Noticed no swinging of the arms 
during walking? 
51 38 43 24 17 19 41 89 
B.07 Had a fear of falling during 
walking? 
38 38 34 35 37 10 72 76 
B.08 Had difficulty walking upstairs? 63 36 27 15 35 16 50 99 
B.09 Had difficulty walking down 
stairs? 
67 32 23 18 34 18 52 99 
B.10 Felt stiffness in your legs when 
walking? 
67 38 21 28 16 22 44 105 
B.11 Had difficulty walking on a 
slippery (e.g. wet) or an uneven 
(e.g. rocky ground) surface? 
39 42 38 25 33 15 58 81 
B.12 Had difficulty in deep breathing 
while walking? 
68 48 33 17 11 15 28 116 
C.01 Had difficulty standing up from a 
chair? 
44 36 39 35 30 8 65 80 
C.02 Had difficulty sitting down on a 
chair? 
 
66 38 36 21 19 12 40 104 
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Item Question 
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Due to PD, how often during the 
last week have you…. 
C.03 Had difficulty getting into a bed? 61 26 36 34 22 13 56 87 
C.04 Had difficulty getting out of a 
bed? 
40 35 33 43 29 12 72 75 
C.05 Had difficulty rolling to each side 
in bed? 
44 36 34 35 31 12 66 80 
C.06 Had tendency to lean to one side 
when sitting? 
69 24 29 22 31 17 53 93 
D.01 Had difficulty writing a sentence 
on a paper? 
46 39 41 31 19 16 50 85 
D.02 Had difficulty turning the page of 
a book? 
80 41 33 12 11 15 23 121 
D.03 Had difficulty getting dressed or 
undressed yourself? 
54 27 46 31 23 11 54 81 
D.04 Had difficulty taking a bath or 
shower yourself? 
66 38 29 17 26 16 43 104 
D.05 Had difficulty brushing your 
teeth? 
87 35 24 20 9 17 29 122 
D.06 Had difficulty cutting up your 
food? 
60 39 34 27 19 13 46 99 
D.07 Had difficulty reaching something 
above your head? 
59 33 31 25 30 14 55 92 
D.08 Had difficulty reaching something 
on the ground? 
42 25 37 38 28 22 66 67 
E.01 Felt unable to experience 
pleasure? 
33 49 43 39 8 20 47 82 
E.02 Thought that things will never 
improve? 
25 38 48 40 24 17 64 63 
E.03 Felt angry for apparently minor 
reasons? 
60 43 35 30 4 20 34 69 
E.04 Felt isolated and lonely? 57 45 27 27 13 23 40 67 
E.05 Felt embarrassed due to having 
Parkinson’s disease? 
87 21 23 20 17 24 37 60 
E.06 Felt loss of interesting about 
what is happening around you or 
in doing things? 
59 51 25 20 13 24 33 58 
E.07 Had problems with your 
concentration (e.g. when 
watching TV)?  
67 40 30 23 6 26 29 59 
E.08 Felt loss of memory? 68 44 26 22 7 25 29 55 
E.09 Experienced sleep problems 
(problems in falling asleep or 
frequent awakenings during the 
night)? 
33 35 43 30 32 19 62 
 
 
105 
 
Abbreviations. B: walking; C: transfers; D: hand activities; E: emotional well-being; N/Α: no answer; 
PD: Parkinson’s disease. 
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Table 6.4 (pp. 101-102) showed that all the activities and emotions that were included in 
the questionnaire, were affected in some way due to PD. The number of responses of each 
item of the column ‘5-7 days a week’ ranged from 23 (12% of respondents) (items B.03 and 
D.02) to 72 (37.5%) (items C.04 and B.07). Analytically, the responses ‘5-7 days a week’ in 
section B ranged from 23 (12%) (item B.03) to 72 (37.5%) (item B.07); in section C from 40 
(20.8%) (item C.02) to 72 (37.5%) (item C.04);  in section D from 23 (12%) (item D.02) to 66 
(34.4%) (item D.08); and in section E from 29 (15%) (items E.07 and E.08) to 64 (33.3%) 
(item E.02).  The most ticked items of each section (B-E) for the columns ‘5-7 days a week’ 
and ‘0-2 days a week’ are shown in table 6.5, representing the most and less prevalent 
disability of each section respectively. 
 
Table 6.5. The most ticked items of each section for the columns ‘5-7 days a week’ and ‘0-2 days a 
week’. 
Section 5-7 days a week 
 
0-2 days a week 
Code 
 
Question No of 
responses 
Code Question No of 
responses 
B B.07 …had a fear of falling during 
walking?  
 
72 B.03 …stopped suddenly while 
walking without any 
specific reason?  
117 
C C.04 …had difficulty getting out 
of bed?  
72 C.06 …had difficulty sitting 
down on a chair? 
104 
D D.08 …had difficulty reaching 
something on the ground?  
66 D.05 …had difficulty brushing 
your teeth?  
122 
E E.02 …thought that things will 
never improve?  
64 E.08 …felt loss of memory?  112 
 
Abbreviations. B: walking; C: transfers; D: hand activities; E: emotional well-being; No: number. 
 
In addition, the ten most common reported restrictions in mobility and emotional 
disturbances at least five days a week, are reported in table 6.6 (p. 104). As see in the table, 
four of them were from Section C, related to transfers, and two of each from the rest 
sections. 
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Table 6.6. The ten most common reported restrictions in mobility and emotional disturbances at 
least five days a week.  
Code Question No of responses Proportion (%) 
B.07 Had a fear of falling during walking? 72 37.5% 
C.04 Had difficulty getting out of a bed? 72 37.5% 
C.05 Had difficulty rolling to each side in bed? 66 34.3% 
D.08 Had difficulty reaching something on the ground? 66 34.3% 
C.01 Had difficulty standing up from a chair? 65 33.9% 
E.02 Thought that things will never improve? 64 33.3% 
E.09 Experienced sleep problems (problems in falling asleep 
or frequent awakenings during the night)? 
62 32.3% 
B.11 Had difficulty walking on a slippery (e.g. wet) or an 
uneven (e.g. rocky ground) surface? 
58 30,2% 
C.03 Had difficulty getting into a bed? 56 29.2% 
D.07 Had difficulty reaching something above your head? 55 28.6% 
 
Abbreviations. B: walking; C: transfers; D: hand activities; E: emotional well-being; No: number. 
 
 
6.4. Qualitative analysis 
Thirty two respondents, 11 PD patients and 21 caregivers, provided additional comments 
at the end of the questionnaire. The comments were coded and grouped into four main 
categories (motor symptoms and disabilities, non-motor symptoms, medication and 
beliefs); and in turn, into further subcategories. All the main categories and their 
subcategories are presented in table 6.7 (p. 105). The subcategories of ‘motor symptoms’ 
were related to sections B to D of the survey, to enrich the answers of those sections. In 
addition, although PD is considered a movement disorder, the comments of six 
respondents were referred only to the non-motor symptoms of the disease. 
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Table 6.7. Categories and subcategories of the qualitative analysis.  
Categories Subcategories 
Motor symptoms and disabilities Walking 
Transfers 
Hand activities 
Additional motor symptoms  
Non-motor symptoms Mood disturbances 
Sleep disturbances 
Cognitive impairment  
Additional non-motor symptoms 
Medication  
Beliefs Beliefs about the disease 
Survey’s criticism 
 
 
6.4.1. Motor symptoms and disabilities 
Walking 
Eleven respondents reported gait disturbances. Difficulty in first steps and poor balance 
were the major reported signs. Specifically, difficulty initiating the first steps was the most 
reported walking feature (n= 5). It was more noticed after sitting for a long time (n= 3), and 
when getting out of the bed (n= 1).  During the first steps, the stride length was reduced, 
and the walking velocity was slow (n= 2). 
 
Five individuals reported postural instability. It was described as “…the major daily 
difficulty” (P72), and as a feeling that “…somebody pushes me to fall down” (P17). In 
addition, two individuals stated frequent indoor falls due to impaired balance. Fear of 
falling (FOF) was reported by four patients. In particular, one individual had reduced the 
outdoor activities when raining, and one needed assistance in order to take a shower. 
Other activities with increased risk for falling included: walking downstairs (n= 1), and when 
going to the church (n= 1). Lastly, two patients were using a walking stick due to FOF. 
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The following walking disturbances were reported by one individual each: tremor in the 
hand while walking; leg rigidity; disability in walking sideways; and fatigue after walking for 
a while.  However, one patient in spite of the minor gait impairments, she was trying to 
walk as much as possible: “…On June 2013, I visited Mystras12  with some friends. I was 
walking on the hills for two hours while raining, with only two stops to rest.” (O21). 
 
Transfers 
Five respondents added more comments relevant to the items of Section C (transfers). Two 
patients reported that they had difficulties standing up from a chair, only when the height 
of the chair was low (n= 1) or only during the morning hours (n= 1). Furthermore, there 
were bed transfers difficulties only when getting out of the bed in the morning (n= 2) or 
rolling to each side due to hip pain (n= 1). One individual was not able to get out of the car 
by herself. Thus, she reduced all her social activities due to the avoidance of going out of 
her house. Lastly, one patient noticed that the progression of the disease worsened his 
transfers: “I have gradually decreased my activities. I feel my legs heavy and my trunk stiff. 
I cannot stand up from a chair. I need help.” (O9). 
 
Hand activities 
Only five respondents provided extra information on questions of section D (hand 
activities).  The reported disabilities, and the number of responses are presented in table 
6.8 (p. 107). It seems that the restrictions on hand activities affect patients’ psychology and 
decrease their indepedence. One female stated about her father: “My father is 
disappointed. Parkinson destroyed his calligraphy. His letters are not readable…He is unable 
to get dressed most days and feed himself. My mum helps him daily.” (P139). The possible 
causes of disability in hand activities were not reported; apart from one respondent, who 
stated that he was unable to shave himself due to hand tremor. On the contrary, one 
female reported that the hand disability had been reduced since using special living aids 
for PD population (ergonomic cutlery set: knife, fork and spoon). 
                                                             
12  Fortified medieval town situated on Mount Taygetos, Peloponnese 
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Table 6.8. Disabilities related to hand activities and number of responses. 
Disabilities related to hand activities Number of responses 
Dressing (wearing socks) 2 
Dressing (tying shoes’ laces) 1 
Facial shaving 1 
Micrographia13 1 
Shower 1 
 
 
Additional motor symptoms 
Three respondents stated more general motor-symptoms (primary motor symptoms of PD) 
that cannot be included into the previous subcategories: dystonia (n= 2), tremor (n= 1), 
bradykinesia (n= 1).  These symptoms are also considered disturbing either by the patient 
or the carer: “The tremor in the hand and leg are among the worst symptoms.  I can hardly 
relax.” (O17); “My husband makes unexpected movements while sitting or sleeping…He 
kicks and throws punches…I ‘m afraid of my safety.” (P87). One PD patient noticed relapse 
of the motor-symptoms during the night; before going to bed. 
 
6.4.2. Non-motor symptoms 
The respondents reported non-motor symptoms related to all the categories, as proposed 
by van Laar and Jain (2004) and Pandya et al. (2008) (sensory, autonomic, cognitive-
behavioural, sleep disorders). 
 
Mood disturbances 
Mood disturbances were the most reported non-motor symptom of PD (n= 10). Three 
patients reported depressive symptoms, whereas two were clinically diagnosed with 
depression. Loss of interest (n= 1), thought that things will never improve (n= 1), low self-
esteem (n= 1), were the reported signs of depression. In three cases, depressive symptoms 
were combined with hallucinations. One caregiver stated visual hallucinations: “My father 
                                                             
13 Abnormally small handwriting or handwriting that becomes progressively smaller 
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sees friends and relatives from the past, robots and strange creatures in the house and 
garden.’’ (P139). 
 
Five patients suffered from anxiety signs. None of them reported any diagnosed anxiety 
disorder. One caregiver reported general phobia and high levels of stress, whereas in two 
individuals high levels of stress were associated with tremor. A patient reported symptoms 
of social anxiety disorder; as he was avoiding social situations, due to feelings of 
embarrassment about PD. Three patients expressed concerns about their future. It seems 
that the ongoing financial crisis of the country contributed to their high anxiety levels. They 
were worried whether they would be able to pay for a caregiver (n= 1), buy their PD 
medication (n= 2), and cover the healthcare services (n= 1). One PD patient wrote: “My 
income has been reduced. Taxies are rising up. PD is a disease for rich people. Healthcare 
services and medication are so expensive! I cannot afford to pay them.” (P83). 
 
Finally, two respondents reported mood fluctuations during the day, and one caregiver 
abilities self-overestimation. He/She wrote: “My father has reduced his mobility due to PD. 
However, he believes that he is able to take the metro and go for a walk in the city centre. 
He often wants to drive his car…..He doesn’t understand the severity of his symptoms.” (O3). 
 
Sleep disturbances 
Sleep disturbance seemed to be a serious problem among the respondents. Six individuals 
reported sleep disturbances as follows: intense and sudden movements during sleep (n= 
3); insomnia (n= 2), vivid dreams and nightmares (n= 2), difficulties falling asleep (n= 2), 
early morning awakening (n= 1), and excessive daytime sleepiness (n= 1). A carer wrote:  “I 
cannot sleep during the night….sometimes his movement are so intense! He often speaks 
loudly while sleeping.” (P48). Lastly, one patient wrote: “One of my major problems, since I 
was diagnosed with PD, is insomnia. Sleeping pills help me to sleep; otherwise I may fall 
asleep on the daytime while sitting on a sofa.” (P17). 
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Cognitive impairment  
Cognitive deficits were a major complaint of PD caregivers (n= 4). According to them, two 
PD patients had been diagnosed with dementia. Additional reported impairments were: 
short-term memory loss (n= 2), slowed thinking (n= 1), inability to remember to take their 
PD medication (n= 2), confusion in remembering names (n= 1), poor vocabulary (n= 1), 
difficulty in finding the right word into a sentence (n= 1). Due to cognitive impairments 
some patients were at risk: “My dad forgets to take his medication.  He usually does not 
remember how to use the tap and open a window. My mother looks at him 24 hours a day.” 
(P155). 
 
Additional non-motor symptoms 
Eleven respondents reported additional non-motor symptoms that could not be included 
in the previous categories. These symptoms are presented in table 6.9 (p. 110). Hypophonia 
seems to be a disabling symptom that affects the communication of patients: “I speak in a 
low voice……the others do not understand what I say, and they ask me to repeat it.” (P112). 
 
6.4.3. Medication 
Four people recorded their experience about PD medication, and the improvement or not 
of the symptoms. In one case, the symptoms were improved significantly: “I had all the 
symptoms that are written in the questionnaire. Hopefully due to medication my mobility 
has changed. I have a great improvement.” (O13). On the contrary in two cases there was 
a little improvement some days of the week: “My father is living with PD the last 23 years. 
The medication does not often work. Several days he is not able to start walking.” (P155); 
“I have increased my medication to six Stalevo pills….somedays I feel good, some others 
no.” (O9). One female reported the side effects of medication: “Drug treatment caused me 
gambling. Ι was addicted. I was going to Mont-Parnes14 to play…..I lost a lot of money….My 
family took the keys of my car……I spoke to my doctor after some months……He changed 
my medication…’’ (P126). 
                                                             
14 Casino on the Mount Parnitha, Attica (Athens). 
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Table 6.9. Additional reported non-motor symptoms. 
Sensory symptoms 
(N=6) 
Autonomic symptoms 
(n= 2) 
Speech disturbances 
(n= 2) 
Additional symptoms 
(n= 2)  
Pain (n= 3): 
 low back pain (n= 1) 
 coat hanger pain 
(n=1) 
 headaches (n= 1). 
 cramps*** 
Sialorrhea15 *   (n= 1) Hypophonia (n= 2) Fatigue (n= 2) 
Sweating (n= 1)** Imprecise articulation 
(n= 1) 
 
Sexual dysfunction  
(n= 1) 
  
   
Hyposmia16 (n= 1)    
Impaired sense of taste 
(n= 1) 
   
Peripheral sensory defect: 
burning sensation in the 
hand (n= 1)**** 
   
Abbreviations. n: number of respondents. 
*especially when lying on the bed 
**while sitting or lying on the bed 
***usually while sleeping  
****it was described as “rubbing a sandpaper on the skin” 
 
 
6.4.4. Beliefs 
Beliefs about Parkinson’s disease 
Two respondents -one PD patient and one carer- expressed desperation feelings about the 
disease. One patient described his life as “…hell” (P83) due to PD. Α carer’s text was of 
particular interest: “…because Parkinson's is an everyday and slow death, not only for the 
sufferer, but also for the family; I beg you, as specialists, to find the treatment of the disease. 
It will be our redemption.” (P155). On the contrary two patients were more positive about 
their future. One individual expressed her determination by writing “…I will not give it up” 
(O21); whereas another stated: “Congratulations to you against the insidious disease. I wish 
we became healthy. Things will get better.” (P112). 
 
                                                             
15 Excessive drooling 
16 Impaired sense of smell 
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Survey’s criticism 
Two individuals commented negatively on the survey’s design. They noticed that all the 
questions were referred to the frequency, and not to the degree of difficulty: “The question 
D.01 is about writing difficulties. How it is possible to have difficulties only 1-2 days a week 
and the rest days no? My answer would be that my handwriting has changed. This activity 
is quite difficult for me and is getting worse.” (P5). Furthermore, another patient believed 
that it would be better to split the questions for the on- and off-state of the disease. Hence, 
the answers would differ: “I ‘m getting dressed easily during the on-state, but I have 
difficulties to dress myself at the off-state.” (P17). 
 
6.5. Summary of Chapter 6 
 192 questionnaires were totally included in the analysis section. 
 Almost half of the respondents were carers of PD patients. 
 With respect to the socio-demographic characteristics, the majority of patients were 
males (55.2%), Greeks (96.9%), were living in Attica (Athens Metropolitan Area) 
(68.2%), were retired (66.1%), and their mean age was 68.31 years. 
 Regarding the health status: the median duration of PD since diagnosis was four years, 
97.2% were under antiparkinsonian medication, only 28.7% reported significant 
improvement of PD symptoms due to pharmacological treatment, and 92.7% reported 
comorbidities.  
 All motor sections (walking, transfers, hand activities) and emotional well-being were 
affected in some way due to PD. 
 The most prevalent reported disabilities (at least five times a week) were: FOF, getting 
out of bed, rolling to each side of the bed, reaching something on the floor, standing up 
from a chair. 
 The most common emotional disturbance was that “things will never improve”. 
 Only 32 respondents answered the last open-ended question at the end of the 
questionnaire. Their answers were coded into four categories: motor symptoms, non-
motor symptoms, medication and beliefs. 
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 The answers of the open-ended question revealed that the respondents recognised 
that PD is characterised by both motor and non-motor symptoms. They also stated that 
FOF provokes further disability and reduces social activities; they expressed concerns 
about their future due to the ongoing financial Greek crisis; and believed that the 
antiparkinsonian medication has side effects and is not always effective in controlling 
the motor symptoms. 
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7.1. Main findings – summary of key results 
Everyday activities of people living with PD are particularly challenging, and they also face 
a variety of emotional disturbances. As far it is known, no study has been found to detect 
the level of mobility, and emotional status in Greek population with PD. Thus, the current 
mixed mode survey was conducted. The level of mobility was assessed using items relevant 
to basic ADLs, whereas the socio-demographic profile and health status of patients were 
also recorded. This was an important source of information, as it provided an in depth 
understanding of the target population, in order to design the intervention of the present 
RCT. 
 
Overall 192 questionnaires, completed by patients with PD or their carers, were included 
in the analysis section. The results demonstrated restrictions both in physical function and 
emotional well-being. FOF (item B.07) and ‘difficulties in getting out of bed’ (item C.04) 
were the chief complaints. Four out of ten most prevalent restrictions were related to 
transfers (items C.01, C.03, C.04, C.05), two to walking (items B.07, B.11), two to hands 
activities (items, D.07, D.08), and two to emotional well-being (items E.02, E.09). However, 
it is noticeable that the two most affected hand activities (items, D.07, D.08) require a high 
level of static balance, and may indicate balance impairments. 
 
The open-ended question at the end of the instrument revealed that the patients and their 
carers recognised that PD has both motor and non-motor symptoms, which impact their 
life. Some individuals did not notice any significant improvement of cardinal symptoms, 
due to antiparkinsonian medication, whereas they reported side effects of medication. 
Some of respondents were pessimist about their future, expressing feelings of desperation. 
Lastly, they expressed concerns whether would be able to afford the high cost for the 
management of the disease, due to the ongoing debt crisis. 
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7.2. Interpretation of findings 
7.2.1. Socio-demographic characteristics 
In the current survey, the proportion of males (55.2%) was slightly greater than females 
(44.8%). These results are in accordance (males 57%, females 43%) with a study conducted 
in Greece (Konitsiotis et al., 2014), and findings from other studies supporting that men are 
more likely to be diagnosed with PD worldwide (de Lau and Breteler, 2006; Wirdefeldt et 
al., 2011). The less prevalence of PD in females could be explained by the higher initial 
striatal DA levels in women, and the protective role of oestrogens against nigrostriatal 
degeneration (Miller and Gronin-Golomb, 2010). On the contrary, males may be most 
exposed to environmental factors (e.g. toxins) that are associated with the onset and 
development of PD (Antony et al., 2013). However, as females are typically less likely to 
refuse a survey invitation than males (de Leeuw et al., 2008), the proportion of male 
population affected by PD could be even higher. 
 
The mean age (SD) of PD patients was 68.31 (± 10.39) years, range 42-88. Similar findings 
(mean age: 70.4 years) in Greece were also reported by Konitsiotis et al. (2014). In the 
present study, only 4.2% of patients were between 40 and 49 years. This is also supported 
in the literature, as the prevalence rate of PD increases steadily with age, being extremely 
rare in those under the age of 50 years (Pringsheim et al., 2014; Elbaz et al., 2016). The 
increasing prevalence of PD with age may be associated with age-related changes in the 
neurotransmitter system. In particular, it has been reported decline in DA synthesis in many 
brain areas due to aging, which may speed up the onset of motor symptomatology of PD 
in senior population (Desai et al., 2010).  
 
In addition, the vast majority of patients with PD had Greek nationality (96.9%). The 
number of patients with non-Greek nationality was expected to be higher; because 
according to the official last population census in 2011, 8.3% of the population in Greece 
were immigrants (Hellenic Statistical Authority, 2014a). However, Greece has become a 
final destination for immigrants since the 1990s (Antonopoulos and Winterdyk, 2006), and 
around 90% of them are younger than 60 years (Hellenic Statistical Authority, 2014b); 
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whereas PD affects mainly individuals over 60 years (Elbaz et al., 2016). Furthermore, the 
proportion of immigrants, which were able to read and write in Greek in order to complete 
the current questionnaire, was unknown. Lastly, similarly to other countries; it may be 
under debate whether ethnic minorities and immigrants (especially undocumented 
immigrants) in Greece have limited access to the healthcare system facilities (Wirdefeldt et 
al., 2011), preventing them to complete the current questionnaire through the HPDA. 
 
Regarding the place of residence, 78.1% of patients were living in urban areas. This is in line 
with the Hellenic Statistical Authority, as the urban population in the country was 76.6% in 
2011 (Hellenic Statistical Authority, 2014a). However, residents of two administrative 
regions (Ionian Islands and Western Macedonia), representing 4.47% of the country’s 
population, did not complete the questionnaire. In addition, the questionnaire was 
completed only by one individual each living in Crete and in Eastern Macedonia- Thrace, 
which represent 11.42% of Greece’s population (Hellenic Statistical Authority, 2014a). 
Despite the fact that the paper survey was conducted in Athens Metropolitan Area, 43 of 
164 questionnaires were referred to patients living in other administrative regions. This 
may be explained by the fact that Greek citizens living in small cities or rural areas visit the 
two large cities (Athens, Thessaloniki) of the country at least once a year for personal issues, 
such as medical reasons. Indeed, some patients that participated in the paper survey, 
reported verbally to the researcher that they were in Athens to visit their neurologist- PD 
specialist. In addition, a significant proportion of retired individuals in Greece share their 
time between their main residence in urban areas and their secondary residence in the 
countryside, which is usually their place of origin.  
 
With respect to the employment status, the majority of patients (66.1%) were retired, 
whereas only a small proportion was unable to work due to PD (2.1%). The retirement age 
for both genders in Greece was 65 years up to 2013, 66 in 2014, and 67 since 2017. 
However, in the current study, 18 individuals younger than 65 were retired. This may partly 
be explained by the fact that in the past some categories of citizens enjoyed early 
retirement. Indeed, the retirement age for women was 62 years; whereas for the “heavy 
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and unhealthy jobs” (βαρέα και ανθυγιεινά επαγγέλματα), as being characterised by the 
Greek Constitution, 57 years. Furthermore, individuals with overall disability rate at least 
67% could apply for early retirement. Lastly, it was unknown whether the participants of 
the current survey were fully or partially retired.  
 
7.2.2. Health status 
Despite the fact that only patients with PD were included in the study, it was impossible to 
know whether the respondents gave an accurate response about the disease. As there was 
not any clinical examination to confirm the diagnosis of PD; there is danger that the sample 
may have included participants suffering from other forms of Parkinsonism, apart from PD; 
such as progressive supranuclear palsy, multiple system atrophy and essential tremor. 
Based on empirical knowledge, in Greece some individuals with other causes of tremor, 
often mistakenly state that they suffer from PD. The fact that 97.9% of the sample received 
L-dopa medication, is an indication of PD. However, improvement of symptoms due to 
dopaminergic medication is also seen in multiple system atrophy (Jankovic, 2008). Lastly, it 
is unsure whether newly diagnosed patients (up to three months) were suffering from PD, 
as the negative response to dopaminergic medication is an exclusion criterion for PD (NICE, 
2006).   
 
With respect to antiparkinsonian medication, a significant proportion (65.3%) of 
respondents admitted that the symptoms did not significantly improved due to 
antiparkinsonian medication.  The reasons for this response may be multifactorial. Firstly, 
the answer is totally subjective, based on the respondent’s opinion. Secondly, evidence 
supports that in patients at advanced stages, the medication is not always effective; maybe 
due to motor fluctuations (Pedrosa and Timmermann, 2013). Another issue of 
antiparkinsonian drugs are the side effects of medication, some of them being serious (Rao 
et al., 2006). Indeed, one patient reported the development of pathological gambling, 
which may have been a side effect of DA agonists (Alonso Cánovas et al., 2014).  
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The results revealed that the vast majority of patients (92.7%) were also suffering from 
additional comorbidities, apart from PD.  A direct comparison with the findings of the study 
by Konitsiotis et al. (2014), which was held in Greece, was not feasible; as only the most 
prevalent comorbidities were reported in their study. The increased number of 
comorbidities in the present survey, may be explained by the fact that PD is more prevalent 
in third age (over 60 years), which is linked with aging-associated disorders (Elbaz et al., 
2016). 
 
Despite the fact that anxiety and depression are considered among the most prevalent non-
motor symptoms in PD; only three individuals reported -at item A.16 (additional medical 
conditions) or the open-ended question at the end of the questionnaire- depression as 
comorbidity, and none anxiety. This proportion is below the mean prevalence of depression 
in PD (Perrin et al., 2017). However, at the end of the questionnaire ten respondents stated 
mood disturbances due to PD. It is unknown whether the respondents did not report any 
mental disorder due to stigma arising from their diagnosis, or an existing mental disorder 
has not been recognised yet (Section 3.6.4).  
 
In addition, none of the respondents stated how depression was clinically diagnosed. This 
may be explained by the fact that the survey did not include any relevant item. Although 
the DSM and ICD criteria are considered the gold standards for the diagnosis of mental 
disorders (Jacob, 2006), empirical knowledge supports that this is not the case in Greece. 
The diagnosis of anxiety and depressive disorders is often performed by medical doctors 
(such as pathologists and neurologists), who prescribe medication for their management, 
rather than experienced psychologists and psychiatrists.  
 
7.2.3. Motor restrictions 
All the respondents stated impacts of PD on ADLs (sections B-D); which indicate that the 
disability arising from the disease is evident and well recognised, by the patients or their 
carers, even in the first stages of the disease. However, it was not possible to detect the 
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section (B, C, D) that was more affected, as the distribution of responses seems to not differ 
significantly between the three sections. 
 
Walking 
190 individuals (99% of respondents) reported at least one gait disturbance at section B, 
due to PD, whereas only two newly diagnosed patients did not experience any difficulty. 
This is in line with the gait analysis study by Kang et al. (2005), which revealed that 87% of 
patients with PD had gait impairments, even from the first stages of the disease. Although 
both FOG and festination signs were reported, it seems that the main concern of patients 
was by far the FOF (item B.07). The aetiology of increased FOF in PD may be multifactorial. 
FOF is aggravated by the symptoms of the disease (i.e. postural instability, gait 
disturbances), restrictions in ADLs (i.e. transfers), previous falls, aging, increased levels of 
anxiety and depression. In turn, FOF may provoke further disability, as the patients usually 
restrict further their ADLs to avoid a fall, and may have significant impacts on QoL (Rahman 
et al., 2011). Indeed, one patient wrote that her ADLs were reduced due to FOF, whereas 
two patients were using a walking stick to avoid a fall.  
 
Walking on a slippery or uneven surface (B.11) was the second most common reported 
disability, indicating balance impairments. The maintenance of balance under these 
conditions is extremely difficult; because there is little or no friction, and often redirections 
of the body centre of mass compared to smooth terrain. In order to maintain the upright 
position and avoid a fall, there are increases in the variability of step width and length, and 
high energy expenditure due to the co-activation of muscles (Voloshina et al., 2013).  
 
Disabilities related to FOG (items B.01, B.03, B.04), festination (items B.02, B.06), and 
rigidity (items B.05, B.10), which may lead to postural instabilities, were also reported. In 
turn, postural instability seems to be the major intrinsic factor leading to falls, along with 
the severity of the disease and ageing (Pandya et al., 2008). Indeed, in the current survey, 
two individuals stated frequent indoor falls due to impaired balance.  
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On the contrary, only 28 patients experienced difficulties in deep breathing while walking 
(item B.12) at least five days a week.  In PD, flexed posture, due to rigidity, may decrease 
the strength of the diaphragm and the secondary inspiratory muscles of the upper thorax 
(Baille et al., 2016). In addition, bradykinesia may lead to difficulties in performing relative 
fast and repetitive thoracic movements (Kolesnikova, 2006). These factors may cause a 
restrictive disorder, usually in the moderate and advanced stages of the disease (H&Y stage 
three to five). However, as the patients restrict their daily activities -due to the motor 
symptoms of the disease-, they rarely notice respiratory impairments and report them to 
their physician (Baille et al., 2016). 
 
Transfers 
The findings of Section C revealed that transfer activities from/to chair and bed were 
affected to some extent due to PD. However, 12 respondents ‘never’ had any transfer 
difficulty. Transfers are complex movements, involving several joints, which are carried out 
in a sequence. Although restrictions in transfers may start even from the first stages of the 
disease, they become more apparent as the disease progresses. Although the exact 
mechanism of transfer disability remains unknown; it seems that muscle weakness, 
decreased ROM, and postural deformities due to rigidity may play a role (Keus et al., 2007). 
Biomechanical analysis in patients with early PD revealed that, in order to facilitate rising 
from seated position, they performed small movements of the trunk in the sagittal plane 
with higher velocity, to develop greater forward momentum, allowing them to stand up 
(Nikfekr et al., 2002).  
 
Based on the answers of respondents, ‘standing up from a chair’ (item C.01) and ‘getting 
out of a bed’ (item C.04) were more affected than ‘sitting down on a chair’ (item C.02) and 
‘getting into a bed’ (item C.03); probably because these movements are against gravity, 
and may require more patients’ effort. With respect to the item C.05 (rolling to each side 
on bed), high-friction bed sheets and clothing (i.e. cotton sheets) may make the rolling 
movements more difficult. In addition, during the night and early morning hours the 
medication is reduced making the movements more difficult. Lastly –although it is not 
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considered a transfer activity-, 106 patients experienced ‘tendency to lean to one side 
when sitting’ (item C.06). This is an indicator of ‘Pisa syndrome’, which may affect balance 
and lead to falls (Heisters, 2011).   
 
Hand activities 
178 respondents stated impaired hand activities (section D). Reaching activities (items D.07 
and D.08) were the most common reported disabilities of Section D. These activities require 
a satisfactory level of balance, as the base of support is reduced and the body centre of 
mass is usually beyond the base of support. Despite the fact that difficulties in writing and 
micrographia are among the early signs of PD (Jankovic, 2008), 46 individuals were free of 
writing difficulties (item D.01). Perhaps, patients with writing or typing difficulties were not 
able to complete the questionnaire. 
 
The causes of hand restrictions in PD may be due to the principal motor symptoms of the 
disease (bradykinesia and rigidity). Despite the fact that one patient reported tremor as the 
source of disability; tremor in PD has no correlation with disability, as it is usually at rest 
and stops when performing voluntary movements (Muslimović et al., 2008; Shulman, 
2010). In addition, it was unknown whether special equipment was used by patients to 
improve fine motor skills (items D.03, D.05 and D.06), and to avoid a fall while taking a 
shower (item D.04); or whether assistance was provided by another person. Only one 
respondent stated that assistance was required to take a shower due to FOF, and another 
that special equipment was used for eating. 
 
7.2.4. Non-motor symptoms 
Emotional health  
Mood disturbances due to PD were reported by almost all the respondents at section E, 
apart from two individuals. In addition, they were the most common reported non-motor 
symptoms at the open-ended question at the end of the instrument. This is not surprising 
considering the high prevalence of anxiety and depressive disorders in PD (Perrin et al., 
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2017). However, it seems that the emotional well-being of patients has been also affected 
by the ongoing debt Greek crisis. An interesting fact is that the number of non-answered 
items in section E was much higher than the other sections of the questionnaire (A-D). 
Indeed, the average number of non-responses for each item of section E was 22, whereas 
in the other sections varied from 12.3 (Section C) to 15.5 (Section D). Evidence supports 
that higher non-response rate is usually seen in the items that are placed at the end of the 
questionnaire (Galesic and Bosnjak, 2009). Furthermore, some questions related to the 
emotional well-being may have been considered embarrassing or particularly sensitive by 
the respondents; and hence, they were not answered (Fan and Yan, 2010). 
 
The answers revealed that generally the frequency of depressive symptoms (items E.01, 
E.02, E.04, E.06) was higher than anxiety symptoms (items E.03, E.05, E.07). The less 
reported item of section E was E.05. In particular, 87 patients were free of embarrassment 
due to PD, which is linked with social anxiety disorder (SAD). Hence, the respondents may 
have not restricted their social activities, due to the lack of stigma arising from the signs of 
the disease (Chiong-Rivero et al., 2011). However, based on their statements at the end of 
the questionnaire, social restriction has arisen, due to FOF and impaired mobility. Despite 
the fact that the questionnaire included only items relevant to general anxiety disorder 
(GAD) and SAD, which are more prevalent in PD (Broen et al., 2016); one patient reported 
symptoms of phobia at the end of the questionnaire, indicating that almost all the anxiety 
disorders could be present in PD. Lastly, one patient experienced tremor while walking. 
This may indicate anxiety. Although the exact mechanism is not known, empirical evidence 
supports that anxiety disorders seem to exacerbate PD tremor, especially during the off-
period (Heisters, 2011).   
 
In addition, 99 and 140 patients experienced ‘loss of memory’ (item E.08) and sleep 
disturbances (item E.09) respectively. Loss of memory is an indicator of cognitive deficits. 
Both cognitive impairments and sleep disturbances are linked with anxiety and depression 
(Pachana et al., 2013). Specifically, depression has been identified as a risk factor for 
dementia, maybe due to similar biological mechanisms for their onset (i.e. damages in 
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common brain areas). On the contrary, depression could also be a reaction or a 
psychological response to the diagnosis of cognitive impairment (Muliyala and Varghese, 
2010). Although sleep disorders and cognitive deficits are highly prevalent in mental 
disorders; their causes in PD are numerous, including the neurodegeneration process itself, 
which can disrupt the networks regulating the sleep–wake and affect brain regions involved 
in cognition (i.e. prefrontal cortex and limbic system). Additional factors for sleep 
disturbances in PD include: pain, nocturia17, dystonia, bradykinesia, difficulty turning on 
bed, reactions to medications, and vivid dreaming (Pachana et al., 2013). Thus, it is not 
possible to support that items E.08 and E.09 are solely linked with anxiety and depression. 
 
It was also reported at the end of the questionnaire that three patients suffered from 
hallucinations, which is a sign of psychosis. However, the source of psychosis in PD is 
complicated; and not just a symptom of severe depression or schizophrenia. It may also be 
a natural outcome of the disease, due to increase of serotonergic activity and, greater Lewy 
body presence in the amygdala and cortical area; and a side effect of antiparkinsonian 
medication and DBS. There is also an association between sleep disturbances in PD and 
hallucinations, because sleep disturbances may lead to altered dream phenomena, which 
later lead to daytime hallucinations and delusions (Zahodne and Fernandez, 2008). 
 
Additional non-motor symptoms 
Despite the fact that it is supported in the literature that the non-motor symptoms of PD 
are often under-recognised and poorly treated (Goldman and Postuma, 2014); some 
patients apart from emotional disturbances (Section E), reported sensory and autonomic 
symptoms, speech disturbances, cognitive deficits and sleep disturbances. Nowadays, it 
seems that the patients and their families are more well-informed about PD. In Greece, 
apart from internet which offers access to specialised international websites about PD; it 
seems that the actions of the two PD organisations (Section 2.7) may have played a role. 
Indeed, their webpages and booklets provided in the Greek language, and the organisation 
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of symposiums may have improved the knowledge of Greek citizens about the disease and 
its management options.  
 
7.2.5. Beliefs  
Only four respondents expressed their beliefs about the disease. This prevents the export 
of strong conclusions about the beliefs of Greek patients living with PD and their carers 
about the disease. The findings were controversial; with two participants being optimists, 
and two pessimists about their future. The sociocultural model supports that the beliefs in 
chronic illness may be influenced by cultural and social determinants. These may include: 
education, income, access to healthcare, previous experiences, stigma arising from the 
disease, response to treatment, support from the family, and knowledge about the disease 
(Chin and Noor, 2014).  Indeed, in the current study one patient who described his daily life 
as “hell” (P83) due to PD; stated previously that it was hard for him to afford the cost of 
treatment, as his income had been reduced. It seems that the ongoing Greek crisis, 
characterised by cuts in health domain and reductions in citizens’ income, has affected the 
levels of optimism of patients and their caregivers. In turn, evidence in PD supports that 
illness beliefs are important predictors on psychological outcomes and physical functioning 
(Simpson et al., 2013), and they may affect treatment compliance (Chin and Noor, 2014).   
 
7.3. Comparison with previous studies 
The findings of the present survey are partly in line with those of previous studies 
supporting that PD is characterised by impaired physical functioning, loss of independence 
and emotional consequences (de Boer et al., 1996; Brod et al., 1998; Findley, 1999; Chiong-
Rivero et al., 2011; Konitsiotis et al. 2014; Uebelacker et al., 2014). The combined results 
of these studies indicated that the chief complaints of patients and their caregivers were: 
difficulties in manual motor skills (writing, dressing, bathing, grooming), transfers (getting 
up from a chair, getting out of bed, turning around on bed) walking (turning while walking), 
balance impairments, anxiety and depressive symptoms (e.g. low self-esteem, feeling 
embarrassed due to PD, being afraid of possible disease progression, very sensitive-easily 
driven to tears), sleep disturbances, difficulties with concentration, fatigue and dysarthria.  
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However, a direct comparison between the findings of the current survey with those trials 
is hard to be done, due to the different methods used to assess the restrictions. Although 
their aim was to identify the demographic characteristics and assess the emotional and 
physical health, based on the symptoms of the disease and some basic ADLs; different 
measurement tools were selected. The researchers did not assess the frequency of 
disabilities, apart from Findley (1999). Brod et al. (1998) used Parkinson’s Problem Schedule 
Questionnaire to detect the motor disability and they built a questionnaire to assess the 
emotional status through a semi-structure interview. In the study by Chiong-Rivero et al. 
(2011), participants were asked to answer open-ended questions about their physical 
functioning. In one trial (Konitsiotis et al. 2014), patients were requested to classify the 
severity of tremor, bradykinesia and gait disturbances using a five-point scale. Uebelacker 
et al. (2014) asked the participants to report the two more bothersome problems due to 
PD. Lastly, de Boer et al. (1996) did not report the selected questionnaire to assess physical 
and mental health. Surprisingly, none of the studies with a self-designed questionnaire or 
interview provided a link to access the tool; and only the most troublesome 
symptoms/restrictions were reported in the results section (de Boer et al., 1996; Brod et 
al., 1998; Findley, 1999; Chiong-Rivero et al., 2011; Konitsiotis et al. 2014; Uebelacker et 
al., 2014). Similarly to the present survey, only in the study by Chiong-Rivero et al. (2011) 
the respondent could be either PD sufferers or carers of PD patients. 
 
The literature search identified only one trial (Konitsiotis et al. 2014), conducted in Greece 
to record the clinical characteristics of 986 outpatients suffering from PD all over the 
country. Based on patients’ responses the most troublesome symptom was gait 
disturbances, followed by bradykinesia. A direct comparison between the results of 
Konitsiotis et al. (2014) and those of the present study was not feasible, as concerning the 
physical function, our study assessed specific ADLS and not just the symptoms of the 
disease. Contrary to the present trial, the sample in the trial by Konitsiotis et al. (2014) may 
be representative of the Greek PD population, because it consisted of outpatient PD 
population from all the administrative regions of the country, increasing its external 
validity. 
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7.4. Methodological issues- strengths and limitations 
7.4.1. Strengths of the current study 
After the interpretation of the study’s findings, several strengths must be acknowledged. 
The instrument was designed to be suitable for use in patients with PD living in Greece, and 
facilitate the completion and analysis process. Thus, special emphasis was given to the 
language and the formulation of questions and answers. Close-ended questions were 
preferred to facilitate: the completion of the questionnaire by PD patients, who may 
experience difficulties in writing even from the first stages of the disease; and the analysis 
using quantitative approaches. The socio-demographic questions of section A were 
consistent with the landscape of Greece (Iarossi, 2006). In order to exclude individuals not 
suffering from idiopathic PD, terms that are usually written in medical diagnoses in Greece 
were preferred (Parkinsonism, extrapyramidal syndrome).  The evidence-based design and 
the rigorous methodology aimed to achieve increased response rates, more accurate 
responses, and decreased blank responses. The conduction of a pilot work aimed to identify 
errors in the design of the instrument, and in the whole methodology. The fact that the 
respondent could be either a PD patient or a carer enabled to include in the survey’s sample 
patients, who were not able to complete the questionnaire for a variety of reasons; such 
as disability in writing, and inadequate computer skills. Lastly, the overcoverage bias was 
avoided by checking the patients’ name to identify whether they appeared twice. 
 
7.4.2. Limitations of the current study 
High non-response rates (online survey) 
The whole survey design aimed to keep bias at minimum. Nevertheless, the study was not 
free of limitations. Τhe major limitation was that the online survey produced lower 
response rates than expected.  The high non-response rate may have led to non-response 
bias, because it is unsure whether the vast majority of people who did not respond would 
have responded in the same way as those who did. In turn, the non-response bias may have 
affected the external validity of the study (Brace, 2013). 
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Non-response may occurred for a variety of reasons. The most influential psychological 
theories, which could be combined and explain the low response rate in surveys are: the 
social exchange theory, the social psychological approach, and the leverage–saliency 
theory. Some individuals may do not trust the surveys (social exchange theory). In some 
surveys, respondents are not motivated enough to make the participation decision (social 
psychological approach). Lastly, the potential participants judge all the aspects before 
taking the final decision to complete or not a questionnaire (leverage–saliency theory) (Fan 
and Yan, 2010). 
 
Regarding the present online survey; the instrument’s design, the delivery process, the 
potential respondents’ attitude and skills, and difficulties in internet acces, may partly 
explain the low response rates. In particular, the length of the questionnaire may had been 
long for the target population suffering from a chronic disease, producing fatigue and 
contributing in increasing public resistance (Brace, 2013). Although the anonymity and the 
personalisation of invitations and reminders are significant predictors of response rates in 
online surveys (Fan and Yan, 2010); in the current study, the questionnaire was non-
anonymous to check for double-responses, and the invitation and reminder letters were 
not personalised. Moreover, some items of the questionnaire (i.e. section E -emotional 
well-being-) may have been considered sensitive by the respondents; triggering 
embarrassment, stress or pain (Brace, 2013).  
 
In addition, the members of the HPDA are not solely patients with PD; hence the invitation 
was also sent to individuals free of PD. Some individuals may have also died or been very 
disabled to answer the questionnaire. The high non-response could have been also caused: 
by incorrect e-mail addresses; by rare e-mail check; by the recipient’s email system judging 
the e-mail to be spam, and therefore not delivering it; or by the recipient judging the email 
to be spam and not opening it. Some individuals may have had minimal computer skills to 
complete the online questionnaire (de Leeuw et al, 2008). In some cases they may have 
been difficulties with internet connection (something common in rural areas of Greece) or 
computer access; resulting in a biased sample, and less response rate (Fan and Yan, 2010).  
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Additional limitations 
Additional limitations may have been arisen due to the methodology of the present survey; 
or they may simply reflect the limitations of the selected mode of administration and 
method of delivery and approach for the data analysis. Firstly, there was lack of statistical 
power for the main study and the sub-group analysis, which prevented the drawing of 
strong results and conclusions (Mayer et al., 2015). With respect to the main study, it was 
decided to stop the survey when 200 completed questionnaires were collected. Thus, the 
margin error was 7% instead of 5%, and the confidence 84% instead of 95%. Regarding sub-
group analysis for males-females, the sample size was calculated only for the primary aim 
of the study. A sample size determination is required in order to perform a sub-group 
analysis. Otherwise, the results may not be valid, due to small sample size (Moher et al., 
2010). 
 
Coverage bias may have been arisen, because it was impossible to include the entire 
population of PD patients living in Greece (Tourngeau et al., 2000). In light of the relatively 
small sample size, and the fact that the paper survey was conducted just in Athens; the 
sample population may have not been representative of the target population. In addition, 
the convenience sampling was followed, as the most easily accessible people for the 
sampling frame were selected (Hicks, 2009). Indeed, there were no representatives from 
two administrative regions of the country, whereas it seems that the questionnaire did not 
reach the ethnic minorities and immigrants living in Greece. In addition, PD patients not 
being members of the HPDA, had zero change of being included in the sample. Hence, 
caution is needed for the generalisation of the results. 
 
There were also some additional limitations in the design of the questionnaire. Firstly, PD 
patients were not consulted for the selection of items. Nevertheless, in the pilot work, 
patients’ responses relevant to daily activities that had been affected due to PD and were 
not included in the questionnaire, were evaluated. Secondly, with respect to anxiety 
disorders; Section E consisted only of items relevant to GAD and SAD, whereas items 
relevant to other types of anxiety disorders (e.g. panic disorder) were not included. 
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Although in Section E there was an attempt to avoid items relevant to anxiety and 
depression that may overlap with other core symptoms of PD, this was not always possible. 
Indeed, difficulties with concentration (item E.07) in PD indicate either anxiety or cognitive 
impairments, such as dementia (Caballol et al., 2007). Loss of memory (item E.08) in PD is 
also associated with sleep disturbances; whereas depression, cognitive impairment, and 
side effects of DA agonists and L-dopa may be the cause of sleep disturbances (item E.09) 
(Goldman, and Postuma, 2014). In addition, the items of sections B-E assessed just the 
frequency of restrictions, and not their severity. The questions were also not split for the 
on- and off-state of medication, in order to keep the questionnaire simple and facilitate the 
data analysis. This was criticised by some patients, which reported difficulties in performing 
some activities only during the off-state of medication.  
 
Despite the advantages of self-reported instruments, there are concerns about the 
findings, which depend completely almost on accuracy of individuals’ answers (Tourngeau 
et al., 2000), increasing the possibilities for response and measurement bias (de Leeuw et 
al., 2008). Cognition, emotional well-being and environmental factors may have affected 
the accuracy of answers. Regarding environmental factors, patients living with a carer may 
have reported lower levels of disability (sections B-D), because they could not recognise 
that they were dependent on others. On the contrary, patients living alone may have 
overestimated their level of disability, as there was not another individual to provide 
assistance in case of emergency (e.g. fall) (Shulman et al., 2010). Despite the fact that in 
sections B-E the respondents were not forced to report events that had happened too long 
ago, some may have had difficulties remembering exact dates, reporting events that took 
place before the specified reference period. Thus, there is danger for telescoping bias, a 
category of recall bias (Tournageau et al., 2000). In addition, in surveys some respondents 
have the tendency to give social desirable answers instead of reporting the truth, especially 
in sensitive topics; producing social desirability bias (Cook and Campbell, 1979).  
 
Furthermore, it is unclear whether the responses of carers could have led to response bias, 
as those carers who hold particularly strong views on the health status of patients are more 
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likely to respond. In addition, it is unsure that the carers, who completed the 
questionnaires, were objective about the level of patients' disability and emotional status; 
hence, they may have underestimated or overestimated their health status (Greenwood et 
al., 2010). This is of particular interest in the Greek society, as the carers usually are the 
husband/wife and the children of the patients, which may spend few hours with him/her. 
Lastly, as the current study was a mixed-mode survey, it was unclear which mode of 
questionnaire was associated with more accurate answers. It is supported in the literature 
that it is unclear whether the questions are answered differently online compared to more 
traditional methods, such as self-administrated paper based questionnaires (Iarossi, 2006). 
 
An interesting fact was that only 32 οf 192 respondents completed the open-ended item 
at the end of the questionnaire; whereas only 11 of them were PD sufferers. The low 
response rate of this question may be related to the fact that the completion of long open-
ended questions demands literacy and a relative high level of active command of a 
language. Hence, respodents in order to avoid grammatical inhibited the freedom of 
expression, or did not answer the current question (Bradburm et al., 2004). In addition, 
respondents were likely to be unwilling to take the time to answer this question (Choi and 
Pak, 2005). The writing or typing difficulties, embarrassment arising from micrographia (for 
the paper survey), and the fatigue induced by the length of the questionnaire may explain 
the low completion rate of the last question among the patients with PD (Choi and Pak, 
2005). 
 
The fact that the survey could be completed either by patients or carers is not free of 
limitations. In healthcare surveys, there is the tendency carers to complete the 
questionnaires of more disabled patients, if this is permitted (Moule and Goodman, 2009). 
In addition, in the current survey, the carers responded to the items of the questionnaire 
based on their own perspective, which may have been different from that of patients. As 
the conduction of the present survey aimed to design a group-based therapeutic exercise 
and educational programme, based on the most prevalent responses; the findings may 
have deviated, if only patients with PD completed the questionnaire, because they may 
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have been less disabled than those who have had the questionnaire completed by their 
carers. This is of particular interest, as PD patients with severe clinically disability (four to 
five H&Y stages) and factors that restricted their participation in the exercise programme 
(e.g. dementia) were excluded from the RCT (sections 8.5.2 and 8.5.3). However, the 
survey’s analysis did not explore whether they were any systematic differences in the 
responses that patients and carers gave. As this was not one of the study’s objective, there 
was not probably sufficient statistical power to perform a sub-group analysis. 
 
Lastly, the qualitative analysis, which was used for the last question, has received criticism, 
due to the challenges it faces compared to the quantitative analysis. Despite the fact that 
qualitative analysis is recommended for the detection and interpretation of personal 
beliefs, thoughts and ideas; all qualitative approaches lack the scientific credibility 
associated with traditionally accepted quantitative methods. Human mistakes are more 
common in qualitative studies, arising by errors in the understanding of the text and 
researcher bias. In particular, misrepresentations are possible when the respondents are 
unable to express themselves in the writing text; whereas researcher bias may be 
developed by the limited experience and viewpoints of researcher (Bengtsson, 2016).  
 
7.5. Proposals for future studies  
The results and limitations of the present study should be taken into account for the 
implementation of future studies. Firstly, there is need for a large, nationwide, 
representative study to detect the sociodemographic characteristics, the restrictions in 
daily life and emotional well-being, and beliefs in PD population in Greece. Apart from the 
HPDA; potential respondents could be recruited from the Northern Greece Parkinson's 
Disease Association, neurologists, clinics and hospitals from all the regional units of the 
country. This procedure may assist to reach PD sufferers, ethnic minorities and immigrants 
living in the whole country.  
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Special emphasis should be given in the design of the questionnaire. A shorter 
questionnaire may increase the response rates; whereas the consultation of patients for 
the construction of the instrument will be important for the selection of the most relevant 
items. In addition, future studies, apart from the frequency, could assess the severity of 
restrictions in daily life, both during the on- and off-state of medication. As the complaints 
of patients related to disability tend to be more frequent and severe with the progression 
of the disease, future studies could investigate any changes as the disease progresses. 
 
The descriptive design of the current study enabled the acquirement of many information, 
which may be useful for future research in this field. Future studies could explore in depth 
the relationships between some socio-demographic variables (e.g. age) and health status 
(e.g. severity of PD, years since PD diagnosis) with restrictions in daily life and mental 
health, which was beyond the aim of this survey. Regarding the marital status, it would be 
interesting to assess the quality of the relationship. For instance, whether patients in 
satisfying marriages experience less emotional disturbances than patients in troubles 
marriages. Lastly, future surveys with sufficient statistical power, completed either by 
patients with PD or carers, could explore possible differences in their answers, and how 
these could have implications on the results. 
 
The plethora of motor restrictions, emotional disturbances, additional reported non-motor 
symptoms, ineffective antiparkinsonian medication, impacts –including falls and social 
impacts- and the negative beliefs and worries about the future of patients with PD in 
Greece (based on the findings of the present survey); indicate the need for the design of 
treatment strategies and care management beyond the control of motor symptomatology 
of the disease.  Complementary treatments, such as therapeutic exercise, in conjunction 
with medication or multidisciplinary programmes may be effective to improve the motor 
and non-motor symptoms of the disease, and the QoL of patients and their carers. In 
Greece, the design of an evidence-based low-cost group therapeutic exercise programme, 
instead of individualised programmes, may be of particular importance for this purpose; 
due to the cuts in the public health services, including physiotherapy, and the reduced 
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income of residents. In addition special educational programmes could improve the 
patients’ knowledge about PD and propose ways to overcome the daily difficulties arising 
from the symptoms of the disease. The need for the design of similar programmes in other 
countries is also supported by the findings of one study; where PD patients suggested 
programmes that include physical activity and education, which may help them to cope 
with the restrictions in emotional and motor domain due to PD (Uebelacker et al., 2014). 
 
Lastly, in a time when more emphasis is placed on rehabilitation, such a tool –especially 
sections B to E- is probably needed to adequately assess the rehabilitation needs of those 
affected by PD and to evaluate the results of rehabilitation interventions. Measures of 
disability in ADLs and emotional well-being may be much more meaningful for the patient, 
and thus for clinical decision making, than traditional tools that are widely used by 
healthcare professionals (van Brakel et al., 2012). 
 
7.6. Conclusions 
To our knowledge, this was a unique study, because it was the first that recorded the 
restrictions in ADLs and emotional disturbances due to PD, and the socio-demographic and 
health profile of patients with PD living in Greece. While an attempt was made to minimise 
bias and collect the most accurate data from respondents; there were several limitations, 
and the results should be interpreted with caution. The study revealed that the disease 
does not only affect physical function and patients’ ability to have an active role in the 
society; but it also affects mental health and provokes negative thoughts, both for the 
patients and their carers. The reported daily challenges and emotional disturbances 
highlight the need to improve the provided services in this population; and they should be 
fully considered in the design of treatment strategies and care management, such as 
physiotherapy, which generally focus on controlling the motor symptoms of the disease.  
Thus, the most prevalent answers of the current survey were considered for the design of 
the community-based exercise and educational programme of the RCT. 
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7.7. Summary of Chapter 7 
 The anthropometric characteristics (gender, age) of patients with PD living in Greece 
were in line with the results of previous studies. 
 The ethnic background and place of residence of patients were not in accordance with 
the data of the Hellenic Statistical Authority for the overall population of the country, 
indicating coverage bias. 
 The most prevalent reported motor disabilities revealed balance impairments and 
increased risk for falls. 
 The patients may have not noticed respiratory impairments due to the restriction of 
their ADLs. 
 Although only few patients stated anxiety and depressive disorders as comorbidities, 
the vast majority reported symptoms of anxiety and depression in a weekly basis. 
 A direct comparison between the present and previous relevant studies was not 
feasible, due to limited provided data and differences in methodology.  
 The results should be interpreted with caution due to several limitations; such as 
coverage bias, non-response bias and lack of statistical power. 
 Despite the limitations, the results indicate the need for the design of treatment 
strategies and care management for the control of motor and non-motor 
symptomatology, and education of both patients with PD living in Greece and their 
carers about the disease. 
 The most prevalent answers of the current survey were considered for the design of 
the community-based exercise and educational programme of the RCT. 
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8.1. Introduction 
The present systematic review (Chapter four) revealed that the role of therapeutic exercise 
on depression in PD population, has received little attention; and it is not possible to draw 
firm conclusions about its effectiveness. To address this gap in the literature, the current 
RCT was designed; based on the Greek landscape, without the use of expensive and 
sophisticated equipment. The results of the present survey (Chapter seven) were 
considered for the design of an individualised and a group training protocol, and an 
educational programme by the author of the thesis. Some respondents of the survey also 
participated in the RCT, if the eligibility criteria were met. The steps as proposed by the 
(Consolidated Standards Of Reporting Trials) CONSORT statement were followed for 
reporting the present RCT (Moher et al., 2010). 
 
8.2. Study aim, objectives and design 
8.2.1. Aim of the study 
The primary aim of the study was to develop and evaluate, over both the short and longer 
term, a community-based group exercise and educational programme to improve 
depressive levels in individuals with mild to moderate PD and comorbid depression. The 
subsidiary aim was to consider the effectiveness of this programme on anxiety levels, QoL, 
balance, FOF, functional mobility, walking endurance (exercise tolerance) and respiratory 
function. 
 
8.2.2. Research questions 
The research questions were formulated as follows: 
1. “What are the short and longer term effects of a community-based eight-week group 
exercise and educational programme in individuals with mild to moderate PD and 
comorbid depression; compared to controls who followed an unsupervised, 
individualised home-based exercise programme?” 
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2. “Is an eight-week community-based ‘group exercise and educational programme’ 
effective in improving the psychological and functional status, QoL and respiratory 
function of individuals with mild to moderate PD and comorbid depression?”  
 
8.2.3. Objectives of the study 
The objectives of the study were: 
1. To develop a community-based group and educational programme, and a booklet for 
unsupervised, individualised home-based exercise programme. 
2. To study the relationships between the level of depression and anxiety; and several 
anthropometric characteristics, health status, and outcome measures of the study at: 
baseline; and at post-intervention and follow-up, if significant improvements in 
depressive and anxiety levels were detected. 
3. To assess the effectiveness of a community-based group exercise and educational 
programme on psychological and functional (mobility) status, QoL, and respiratory 
function at post-intervention.  
4. To determine whether the outcomes were maintained at the end of the three-month 
follow-up period. 
5. To record the number and circumstances of falls and fall-related injuries during the 
whole study period, and identify the major predictors of falls. 
6. To study the effectiveness of the community-based group exercise programme in terms 
of participants’ satisfaction, using a questionnaire survey. 
7. To study the  attendance with the group exercise and educational, and home-based 
exercise programme  
 
8.2.4. Hypotheses 
Based on the literature evidence, this study predicts better outcomes in the IG (community-
based group exercise and educational programme) compared to the CG (unsupervised, 
individualised home-based exercise programme); and hence sets one-tailed hypothesis. 
The experimental (or alternative) hypothesis (Ha) for this study was that the IG would 
receive a significant effect in any of the assessed outcomes over time, compared to the CG. 
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The corresponding null hypothesis (Ho) was that there would be no statistically significant 
differences in any of the assessed outcomes over time between the two study groups. 
 
8.2.5. Study design 
This was an experimental study, as it dealt with the phenomenon of ‘cause and effect’ and 
the independent variables (intervention of the IG and CG) were manipulated to study their 
effects on the dependent variables (outcome measures) (Thomas et al., 2005). A parallel 
RCT was undertaken. The RCTs provide a high level of evidence, and low level of selection 
bias, due to randomisation. The parallel design facilitates the comparison between the 
study groups, to identify the superiority of an intervention (Evans, 2003). 
 
The study included two groups: the IG and the CG. The participants of the IG received a 
community-based group exercise and educational programme of eight weeks (≈ 2 months). 
In the same period, the members of the CG participated in an unsupervised, individualised 
home-based exercise programme. During the three-month (≈ 13 weeks) follow-up period, 
all the participants followed an individualised home-based exercise programme. Three 
assessments were undertaken, as reported in section 8.6.1. The design of the RCT is 
represented in figure 8.1. 
 
IG           O1         X1         O2         X2         O3          
CG          O1         X2         O2         X2         O3 
 
Abbreviations. CG: comparison group; IG: intervention group; O1: baseline assessment; O2: post-
intervention assessment; O3: follow-up assessment; X1: ‘group exercise and educational’ 
intervention; X2: ‘individualised home-based exercise’ intervention. 
 
Figure 8.1. Representation of the RCT design. 
 
The current study was not blinded. In practice, it is difficult to blind therapists delivering 
the intervention or participants in rehabilitation studies (Wang and Bakhai, 2006). The 
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assessors of this study were also unblinded, because the chief investigator (PhD student) 
was the main assessor for the clinical tests. Furthermore, in trials in which key outcomes 
are self-reported, the assessor is considered to be blind only if the subject was blind to 
group allocation (Page, 2012a). In the current study, the questionnaires were completed 
by the participants. 
 
8.3. Location and venues 
8.3.1. Selection of regional unit in Greece 
The researcher with the co-operation of the HPDA decided to conduct the study in Athens 
Metropolitan Area for several reasons.  Firstly, as the 40% of the Greek population lives in 
Athens, it would be easier to recruit participants for the current study; and the total cost 
would be reduced compared with a study carried out in multiple cities. Athens also has the 
largest mass transit system of the country, giving the participants’ access to the venues for 
the group exercise and educational programme, screening for inclusion and assessments. 
Furthermore, the HPDA could not offer volunteers for the research team to other regional 
units of the country, apart from Attica. Lastly, in Athens there are many facilities to conduct 
the study; such as hospitals and universities.  
 
8.3.2. Identifying venues 
The next step was to identify venues in Athens Metropolitan Area. The researcher, with the 
guidance of the HPDA, asked for permission to conduct the study in four pubic hospitals 
(251 Aviation General Hospital, 401 General Military Hospital, General Hospital 
‘Evangelismos’ and University Hospital ‘Attikon’) between October 2013 and February 
2014. Three hospitals (401 General Military Hospital, General Hospital ‘Evangelismos’ and 
University Hospital ‘Attikon’) denied immediately access to their facilities, due to logistical 
reasons. An Ethics Application Form was submitted only to the 251 Aviation General 
Hospital in October 2013. However, two months later (December 2013) the Rehabilitation 
Department of the hospital rejected the application for logistical reasons. 
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The plan B was to use public venues, which were offered to the HPDA by eight 
municipalities of Athens Metropolitan Area, to provide free services to patients with PD 
and their caregivers, since September 2014. Firstly, the availability of these venues was 
checked for the total length of the study.  Secondly, the venues were screened by the 
researcher in November 2014, to ensure they met all the required features for the 
participants’ safety, and performance of the exercises, as described in the training protocol 
(section 8.8) (Keus et al., 2004); and all the criteria of the Article 4 (Law 2725/1999) of the 
‘Hellenic General Specifications for the authorisation of a fitness centre’ (Appendix 8.1) 
(Government Newspaper of the Hellenic Republic, 2006).  Thirdly, additional issues, based 
on the experience and knowledge of the chief investigator were examined: free parking 
facilities around the buildings, suitable access to the buildings and venues for disabled 
individuals (e.g. special ramps in case of stairs, elevator), safe access to the toilets. venues 
equipped with air condition and heating system, without furniture or equipment that could 
minimise the provided exercise surface, and at least seven stable chairs into the venue with 
a stable back-rest -without armrests and casters- to perform the group training. 
 
Based on the above criteria, the facilities in three municipalities (Athens, Piraeus, Filadelfia-
Nea Halkidona) were declined. Hence, it was decided to conduct the study in five 
municipalities (Argyroupoli-Elliniko, Galatsi, Ilioupoli, Paleo Faliro and Peristeri), which met 
the standards to conduct the training and the assessments. The municipalities covered the 
south (Argyroupoli-Elliniko, Ilioupoli and Paleo-Faliro), central (Galatsi), and west (Peristeri) 
sections of Athens Urban Area. The geographical location of the selected municipalities on 
the map of Athens Urban Area is presented on image 8.1 (p. 141), whereas the addresses 
of the venues in table 8.1 (p. 141). 
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Image 8.1. Geographical location of the selected municipalities in Athens Urban Area (1 is the 
Municipality of Athens). 3: Ilioupoli; 7: Galatsi; 22: Argyroupoli-Elliniko; 26: Paleo Faliro; 32: Peristeri 
(adopted from Wikipedia). 
 
 
Table 8.1. The addresses of venues where the study was conducted. 
Municipality Building  Address Venue Floor 
Argyroupoli-
Elliniko 
1st KAPI of 
Argyroupoli 
27 Alexioupoleos Str, 
Argyroupoli, PC 164 52 
Physiotherapy 
gym class 
1st floor 
Galatsi 1st KAPI of Gaslatsi 20 Orfeos Str, Galatsi, PC 
111 46 
Physiotherapy 
gym class 
1st floor 
Ilioupoli Town Hall of 
Ilioupoli 
114 Sofokli Venizelou Av., 
Ilioupoli, PC 163 42 
Ex- immigrant hall Ground 
floor 
Paleo Faliro 1st KAPI of Paleo 
Faliro 
43Pandrosou Str, Paleo 
Faliro, PC 175 64  
Physiotherapy 
gym class 
Ground 
floor 
Peristeri KYVE of Peristeri 1 Ethnarhou Makariou Av., 
Peristeri, PC 121 31 
Ex- municipal 
health centre 
Ground 
floor 
 
Acronyms. KAPI: Open Protection Centres for the Elderly; KYVE: Municipal Conference and Multi-
Venue Centre; PC: postal code. 
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8.3.3. Environmental conditions 
During the exercise and the assessments, the environmental conditions (humidity and air 
temperature range) were kept stable. The training in PD population should be avoided in 
extreme temperatures (Gallo and Garber, 2011).  Exercise in warm weather may cause 
exhaustion, due to dehydration and increased body’s temperature; whereas exercise in 
cold weather may increase muscle tone and exacerbate the motor symptoms, as a 
response of hypothalamus to produce more heat and increase metabolism (LeMura and 
Von Duvillard, 2004; Sakellari et al., 2005). As the search of the literature did not reveal 
more specific recommendations for PD, the recommendations by Kleisouras (1997) for 
adults were followed. A temperature and humidity metre (A-10T UNI-T) ensured that the 
humidity levels were kept between 40% and 60%; and air temperature between 20 and 24 
Celsius degrees (Kleisouras, 1997). 
 
8.4. The research team 
8.4.1. Members and responsibilities 
The main team consisted of 17 professionals: the chief investigator (PhD student) and 16 
volunteers. Their responsibilities during the study are presented in table 8.2 (p. 143). The 
chief investigator was the coordinator of the whole study. In January 2015, the assistant 
physiotherapists were recruited from ‘Parkinson Care’, a company of primary health care 
for patients with PD based on Athens (Section 5.8.1); whereas the rest volunteers from the 
HPDA or social networks. The assistant physiotherapists were employees of ‘Parkinson 
Care’ and members of the ‘Panhellenic Physical Therapy Association’, in order to have the 
right to provide physiotherapy services. The chief investigator had some experience in 
exercise classes and previous teaching experience, and all the members of the research 
team (apart from the translator) had experience working with PD population. Lastly, the 
educational programme was conducted by a team of multidisciplinary professionals having 
previous lecturing experience in symposiums for PD population. 
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Table 8.2.  Members of the research team and study’s responsibilities 
Profession Study’s responsibilities Number of 
volunteers 
Source of 
recruitment 
Chief 
Investigator 
(PhD student) 
Design of the intervention, delivery of brochures and 
posters, screening for inclusion, participants’ 
assessments, instructor of the group exercise 
programme, educational programme (lecturer), data 
analysis 
1 None 
Assistant 
physiotherapists 
Screening for inclusion, participants’ assessments, 
assistance to the group exercise * 
6 PC 
Nurse Delivery of brochures and posters 1  
 
HPDA 
 
Secretary, 
psychologist  
PD patients’ record, participants’ randomisation and 
contact 
2 
Neurologist Screening for inclusion, educational programme 
(lecturer) 
1 
Dietician Educational programme (lecturer) 1 
Psychologist  Educational programme (lecturer) 1 
Physiotherapists Advice for the selection of exercises 2 
Physiotheapist  Qualitative analysis 1 Social 
networks Translator Translation of completed FQs and SQs form Greek to 
English 
1 
 
* one of the assistant physiotherapists also participated in the pilot work 
Acronyms. HPDA: Hellenic Parkinson’s disease Association; FQs: Falls Questionnaires; PC: Parkinson 
Care; PD: Parkinson’s disease; SQ: Satisfaction Questionnaires. 
 
8.4.2. Training of volunteers 
A meeting was performed with the professionals involved in the RCT, to inform them about 
the aims of the study and their responsibilities. The SOP for the study was sent to them by 
e-mail, providing information for the study’s methodology. Two additional 90-minute 
training sessions were conducted with the assistant  physiotherapists, to improve their 
knowledge on the outcome measures, and the community exercise in PD. Training also 
involved formal practice and discussion; and hard copies of the grouped training protocol, 
participants’ booklets and assessment forms were given to them.  
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8.5. Participants 
8.5.1. Recruitment of participants 
The subjects were recruited from the HPDA, and the municipalities where the study was 
undertaken, through the ways proposed by Berger et al. (2009) (internet, printed 
announcements, media). Specifically, the HPDA sent a newsletter via e-mail to its enrolled 
members, in February 2015, to inform them about the study. In addition, relevant monthly 
announcements were posted on the official HPDA website and facebook page from 
February 2015 to May 2015. In order to reach PD patients that were not enrolled with the 
HPDA, brochures (appendix 8.2) and posters (appendix 8.3) were delivered to some public 
buildings and local pharmacies of the municipalities where the study was conducted, 
between February and March 2015. Both the posters and brochures aimed to inform PD 
patients about the free services offered by the HPDA to the municipalities, and hence, 
about the current study. Lastly, a relevant advertisement (poster- appendix 8.3) was 
included in the local newspaper of the municipality of Peristeri. 
 
The PD individuals who expressed interest in participating in the study had to contact via 
telephone, and enroll with the HPDA, if they were not already enrolled members. The 
study’s aim was explained to them; basic demographic and PD-related characteristics (i.e. 
name, municipality of residence, confirmed PD diagnosis), contact details, and their 
municipality of preference for the study were recorded.  
 
8.5.2 Inclusion criteria 
The inclusion criteria were as follows: 
1. Confirmed diagnosis of idiopathic PD as defined by the UK PDS Brain Bank criteria (NICE, 
2006).  
2. Both male and female population, because PD affects both genders (Ahlskog, 2009); 
members of the HPDA. 
3. PD patients with mild to moderate clinical disability level (one to three H&Y stages), 
with or without walking aid. This criterion ensured that the participants would be able 
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to complete safely the proposed exercise programme, reducing the risk of falls and fall-
related injuries (Keus et al., 2004). 
4. Score of at least 24 on the Mini-Mental State Examination (MMSE), which guarantees 
adequate cognitive ability of individuals to participate in the exercise programme, and 
complete self-report questionnaires (Folstein et al., 1975). 
5. PD patients with comorbid depression; a score at least eight as measured by the 
Hospital Anxiety and Depression Rating Scale- Depression (HADS-D) (Bjelland et al., 
2002). 
6. Stable dose of antiparkinsonian medication at least four weeks prior the start of the 
programme, and up to the end of the study. Dose and type of medication should remain 
the same in order to minimise its effects on the study’s results (Hackney and Earhart, 
2010). 
7. Patients under antidepressant medication or not. The antidepressant medication 
should have started at least five weeks prior the start of the study, as it usually takes 
three to four weeks to respond to the treatment (Harmer et al., 2009); and the 
medication must have been kept at the same dosage through the entire study’s period. 
8. Patients available for the entire period of the study. 
9. Ability to read, write, understand instructions and follow commands in Greek. 
10. No previous participation in a therapeutic exercise training programme for PD and/or 
depression, to avoid prior training effect (Shulman et al., 2013). 
 
8.5.3. Exclusion criteria 
Individuals were excluded if: 
1. They suffered from secondary PD, or received neurosurgery for PD–such as DBS-, to 
maintain the internal validity of the study with a more homogenous sample. 
2. They had visual or hearing deficits that would eliminate their participation to the study. 
3. They were receiving adjunct treatment for depression, such as CBT, as it would be 
unclear what intervention had an effect on the patient. 
4. They suffered from an acute illness or chronic disorder, or received drugs, which could 
interfere with their safety during testing or training procedures or restrict exercise 
(Frontera et al., 2006). 
Chapter 8: RCT-methodology 
146 
 
8.5.4. Sample size determination 
Although the current project was a Phase I study, which does not require any sample size 
calculation (Charan and Biswas, 2013), the sample size was determined by the equation 
proposed by Noordzij et al. (2010) for RCTs in healthcare: 
 
n= 2 [(α + b)2 σ2] / (μ1 – μ2), 
 
where ‘n’ is the sample size in each of the groups, ‘α’  the conventional multiplier for alpha 
level of significance 0.05 (5%), ‘b’ the conventional multiplier for statistical power 0.80 
(80%), ‘σ’ the population variance (SD), and ‘μ1 – μ2’ the difference the investigator wishes 
to detect between the study groups (absolute effect size). The power should be a minimum 
of 80% and the significance level not greater than 5% (Hicks, 2009). When alpha is chosen 
at 0.05 (5%), the value should be entered in the formula for ‘α’ is 1.96. Similarly, when 
power is chosen at 0.80 (80%), the value should be entered in the formula for ‘b’ is 0.8416 
(Noordzij et al., 2010). Previous trials with therapeutic exercise in chronic diseases, where 
the HADS-D was the primary outcome measure, suggest that the data would be distributed 
with a SD of 2.7 (Bateman et al., 2001; Ridsdale et al., 2004; Arnardottir et al., 2006; Aydin 
et al., 2008; Bircan et al., 2008; Brittle et al., 2009; Jolly et al., 2009; Chien et al., 2011; 
Mitgaard et al., 2011; Murtenazi et al., 2011; Tsuchihashi-Mataya et al., 2013). For the 
current study, the researcher considered a difference in HADS-D of 4 between the study 
groups (μ1 – μ2) as clinically relevant (Wang et al., 2009). Thus, entering the values in the 
formula, 28 patients per group were needed to answer the research question. As the 
researcher anticipated a 20% drop-out rate (Hicks, 2009), the initial sample should be 35 
individuals per group. As the study had two equal groups (Noordzij et al., 2010), 70 PD 
patients were required. 
 
8.5.5. Screening for inclusion 
One week before the screening for inclusion, the potential participants (n= 169) were 
informed by the volunteers (secretary, psychologist) about their meeting with the research 
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team.  They were asked over the phone, if they were available for the whole study period, 
their transport options at the selected venues, their current mobility level (e.g. walking aid, 
wheelchair), and if they suffered from dementia. These questions provided a first 
screening. People unable to commit to the study or who were more disabled than the 
inclusion criteria, were not invited to the main screening assessment to the selected 
venues. At this stage, 18 patients with PD were not invited for screening: seven had severe 
mobility restrictions, two were not available for the total study period, two expressed 
transportation difficulties, three expressed no interest to participate in the study, and the 
telephone communication was not possible with four individuals. Hence, 151 potential 
participants were invited for screening. For this purpose, they were required to bring a 
confirmed diagnosis of PD, their national health booklet, the medicines they received, a 
pair of glasses, and their walking aid (if any); and get dressed in sportswear. Lastly, they 
were asked if they had any further questions relevant to the current study.  
 
The screening for assessment was done by three healthcare professionals: the chief 
investigator, the neurologist and an assistant physiotherapist. The following tools were 
used for this purpose: the United Kingdom Parkinson’ disease Society (UK PDS) Brain Bank 
Criteria (Marsili et al., 2018), Unified Parkinson’s Disease Rating Scale (UPDRS) (Movement 
Disorder Society Task Force on Rating Scales for Parkinson’s Disease, 2003), modified H&Y 
scale (Hoehn and Yahr, 1967), Schwab and England Activities of Daily Living (SEADL) scale 
(Sampaio et al., 2012), MMSE (Folstein et al., 1975), general health questionnaire (GHQ), 
Snijders and Bloem FOG Test (Snijders et al., 2012), and Hospital Anxiety and Depression 
Rating Scale (HADS) (Zigmond and Snaith, 1983) (sections 8.7.1-8.7.8).  
 
Concerning the screening procedure, firstly, the assistant physiotherapist completed the 
MMSE. Secondly, the HADS was completed by the patient and returned to the assistant 
physiotherapist. The MMSE and HADS-D scores were calculated immediately. Then, the 
neurologist confirmed the PD diagnosis using the UK PDS Brain Bank criteria; and 
completed the UPDRS, modified H&Y scale, and SEADL scale. Lastly, the potential 
participants who met the criteria for PD were sent to the chief investigator. The GHQ was 
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completed and the Snijders and Bloem FOG test was performed. At the end of the day, the 
chief investigator and the neurologist read carefully the GHQ, and decided whether the 
individuals met the study’s eligibility criteria. In case of doubt for their health, a medical 
clearance was requested ensuring them to participate in the study. Following screening, 70 
individuals were eligible to take part in the study, and 81 were excluded. The reasons of 
exclusion are presented in table 8.3. 
 
Table 8.3. Reasons of exclusion during the screening procedure. 
Reason of exclusion Number of 
excluded 
individuals (n= 81) 
HADS-D score < 8 38 
MMSE score < 24 9 
Essential (idiopathic) tremor 5 
DBS surgery 4 
Not present in the screening assessment  3 
Not able to attend the hours and days of the IG 3 
Refuse to participate 3 
No availability for the whole study period 3 
Not stable PD medication 3 
Severe low back pain 2 
Knee inflammation 2 
Transportation difficulties 1 
4 H&Y stage  1 
Recent bypass surgery 1 
Recent stroke 1 
Severe COPD 1 
Diplopia (double-vision) 1 
 
Acronyms. COPD: chronic obstructive pulmonary disease; DBS: deep brain stimulation; H&Y: Hoehn 
and Yahr; HADS-D: Hospital and Anxiety Rating Scale-depression subscale; IG: intervention group; 
MMSE: Mini Mental State Examination; PD: Parkinson’s disease 
 
 
8.5.6. Consent form   
Before the main assessment for screening, the assistant physiotherapist informed once 
more the potential participants about the study and its aims, and answered promptly and 
honestly any relevant questions. The ‘Participant Information Sheet’ (Appendix 8.4-8.5) 
and the ‘Informed Consent Form’ (Appendix 8.6-8.7) were given to them. They were 
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requested to read carefully the ‘Participant Information Sheet’. This procedure ensured 
that the subjects had an adequate understudying of the research study nature, purpose 
and implications (Sim and Wright, 2000). The people who met the eligibility criteria and 
wanted to participate in the study, had to bring the signed form to the first session of the 
baseline assessment. Hence, they had at least three working days to decide about their 
participation in the study. 
 
8.5.7. Randomisation procedure 
Once the screening procedure was completed, the randomisation was performed by a 
volunteer (psychologist), in order to give each subject an equal chance of being in either 
the IG or the CG (Sim and Wright, 2000). The random allocation was achieved with a 
computer programme through the website www.randomization.com, which is very simple 
and easy to implement (Suresh, 2011) in 1:1 ratio. Five randomisation procedures were 
performed, one for each municipality. Firstly, on a blank paper the names of participants 
were written alphabetically (by surname). At the left of each name, there was written an 
increasing Arabic number for each participant. Then, the third generator of the software 
was selected for the randomization, because it generates a random permutation of 
integers, and it is particularly useful for selecting a sample without replacement. The 
software randomly provided two equal columns with Arabic numbers corresponding to 
participants’ names. The first column was for the IG, and the second for the CG. 
 
The allocation was concealed, because the volunteer, who performed the randomisation 
procedure, was not involved in the ‘exercise and educational’ programme or the 
assessments. The members of the research team, who participated in these fields, were 
unware about the randomisation process. The randomisation assignments were kept in 
opaque, sealed envelopes and unsealed by the researcher after the end of pre-intervention 
assessment. Similarly, the participants were informed of their allocation in telephone 
contact by the two volunteers (secretary, psychologist) before the commencement of the 
intervention, after the end of the baseline assessment.  
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8.5.8. Meeting with the participants 
Once the baseline assessment was completed and the subjects were informed of their 
allocation to the study groups, two one-hour meetings were held in the study venue of 
each municipality: one for the IG, and one for the CG. The subjects were informed about 
the time and date of their group meeting by telephone by the professional volunteers. The 
members of the IG were provided with the ‘Group exercise booklet’ (section 7.10.1), and 
the CG with the ‘Individualised home-based exercise booklet’ (section 7.10.2). The chief 
investigator explained how to complete the walking diary, falls diary (FD) and falls 
questionnaire (FQ); and perform the home-based individualised exercise. They were also 
asked to bring back the completed booklets at the post-intervention assessment. Lastly, it 
was explained to the members of the CG that if the results of the IG would be significant, 
the same group exercise and educational programme would be offered to them, after the 
data analysis. This may minimise the drop-out rate in the CG (Berger et al., 2009). 
 
8.6. Assessment protocol 
8.6.1. Introduction to the assessment protocol 
Three assessments were undertaken: the pre-intervention (baseline) assessment, prior the 
start of the intervention, to ensure that the baseline characteristics between the study 
groups were similar; the post-intervention assessment, at the end of the eight-week 
intervention period, to determine the short-term effectiveness of the intervention; and the 
follow-up assessment, three months after the end of the intervention, to record the longer 
term effectiveness of the programme. A three-month follow-up period was selected, 
because evidence suggests that short exercise programmes in PD (lasting from four to 12 
weeks) have beneficial effects on mobility, which continue for at least three months after 
the treatment completion (Mak et al., 2017). However, the systematic review of this thesis 
(Chapter 4) did not reveal any relevant data for depression in PD. 
 
The outcome measures of the present RCT, what they measure, and the objective of the 
study they are related are presented in table 8.4 (p. 151). The rationale for the selection of 
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these tools is analysed in section 8.7. The ‘Satisfaction Questionnaire’ (SQ) was given only 
to the members of the IG at the end of the intervention period. The HADS-D was the 
primary outcome measure of effectiveness, whereas the rest tools were the secondary 
outcome measures of the study. 
 
Table 8.4.  Measurement tools, what they measure and related study’s objectives. 
Measurement tool What it measures Objectives of the study 
Hospital Anxiety and Depression 
Scale- Depression (HADS-D) 
subscale 
Depression levels 2, 3, 4 
Hospital Anxiety and Depression 
Scale- Anxiety (HADS-A) subscale 
Anxiety levels 2, 3, 4 
Parkinson’s Disease Questionnaire 
39 (PDQ-39) 
Quality of life 2, 3, 4 
Timed Up and Go (TUG) test Functional mobility 2, 3, 4 
Berg Balance Scale (BBS) Balance 2, 3, 4 
Falls Efficacy Scale International 
(FES-I) 
Fear of falling 2, 3, 4  
2-minute walk test (2MWT) Gait endurance  2, 3, 4 
Spirometry  Lung function 2, 3, 4 
Falls diary (FD) Number of falls 5 
Falls questionnaire (FQ) Circumstances of falls and fall-related 
injuries 
5 
Satisfaction questionnaire (SQ) Participants’ satisfaction for the 
exercise and educational programme 
6 
Attendance form (AF)- group 
programme, Attendance form (AF)- 
individualised programme 
Adherence to the programme 7 
 
 
8.6.2. Characteristics of the assessment protocol 
The conditions during and between the assessments were stable in order to not influence 
the outcome (Keus et al., 2013). All the assessments were held in the selected venues of 
the municipalities; apart from the 2-minute walk test (2MWT), which was performed in a 
corridor of the buildings -where the assessment was performed-, due to its long walking 
path (12 metres). Both the temperature and the humidity levels remained stable, as 
described in section 8.3.3. In addition, the same equipment (e.g. chair) was used for all the 
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clinical tests. The participants were tested by the chief investigator and the assistant 
physiotherapists. All participants were given at least a five-minute recovery period 
between different clinical tests to decrease fatigue (Dibble et al., 2008). The majority of 
self-administrated tools [HADS, Parkinson’s Disease Questionnaire 39 (PDQ-39), Falls 
Efficacy Scale International (FES-I)] were completed by the patients during the 
assessments; apart from the FD, FQ and SQ, which were completed at their homes. They 
were strongly encouraged to respond honestly to all the questions and seek clarification 
from the assistant physiotherapist if something was unclear. The completed questionnaires 
were collected by the assistant physiotherapist.  The assistant physiotherapist also checked 
if all the items of the HADS, PDQ-39 and FES-I were fully completed and if only one answer 
was selected in each item. Lastly, the two attendance forms (AFs) (AF-group programme, 
AF-individualised programme) were completed by the chief investigator, secretary and 
psychologist. 
 
Each assessment was completed in two sessions, lasting approximately 60 minutes each. 
Between the two sessions there was a break of one to two working days, based on the 
number of subjects in each municipality. The HADS, BBS, FES-I and TUG were completed in 
the first session; whereas the PDQ-39, 2MWT and spirometry in the second session. As 
some items in the PDQ-39 resemble items in the HADS, these questionnaires were not filled 
out in the same session; to avoid participants looking back at their previous responses, and 
to complete the questionnaires honestly (Marinus et al., 2002a). Regarding the baseline 
assessment, the HADS was completed during the screening assessment, which was held 
one week prior the baseline assessment; whereas the FD was completed in the second 
session. The SQ was completed voluntarily by the members of the IG, and submitted either 
in the first or second session of the post-intervention assessment. 
 
All the assessments of each participant were carried out at similar times of the day and 
during the ‘on-state’ to minimise the effects of motor fluctuations, and for safety reasons 
(Keus et al., 2013). Thus, subjects were asked to take their L-dopa dose about one hour 
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prior the assessment to ensure that they were at their best ‘on-state’ (Protas et al., 2005). 
They were always dressed in sportswear to perform the clinical tests (Keus et al., 2013).  
 
8.7. Screening and assessment tools 
The selection of the screening and assessment tools was consistent with the aims and the 
objectives of the study. A systematic approach was followed to select the appropriate tools. 
The selection process included four steps. Firstly, disease-specific instruments were 
preferred instead of generic instruments, as they reflect better the special characteristics 
of the disease and the effectiveness of intervention (Guyatt et al., 1986). Although there 
are generic instruments ‘recommended’18 for PD population, they lack specificity, and they 
seem more helpful in studies including populations suffering from different diseases to 
allow comparisons (Martinez-Martin et al., 2011). Secondly, ‘recommended’ instead of 
‘suggested/reasonable’19 tools were selected, based on the reports of the EPDA (Keus et 
al., 2013) and Parkinson Evidence Database to Guide Effectiveness (PEDGE) (Kegelmeyer et 
al., no date). Thirdly, the clinimetric properties –reliability, validity, responsiveness, 
sensitivity- of the measurement tools were examined, to select tools that meet the desired 
characteristics for the current study (Loretz, 2005). Lastly, as the project was conducted in 
Greece, the selected tools should have been translated in the Greek language, and their 
clinimetric properties should have been examined in the Greek population. Special 
attention was given to the visual appearance of the self-administrated scales, and the 
procedure that is described in the paper questionnaire of the survey (section 5.5.9) was 
followed to design the assessment forms.  
 
The selected screening and assessment tools for the current study have been already 
reported in Sections 8.5.5 and 8.6.1 respectively. Only the HADS was used both as screening 
and assessment tool. Sections 8.7.1-8.7.17 provide evidence for the selection of these 
instruments. 
                                                             
18 Tools with high clinimetric properties and clinical utility, that have been used in clinical studies in PD 
population. 
19 Tools with reasonable clinimetric properties and clinical utility, that have been used in clinical studies in PD 
population. 
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8.7.1. Hospital anxiety and depression rating scale (HADS) 
In the current study, the HADS was used as a screening tool for identifying depression and 
anxiety, and as assessment tool to evaluate the treatment response (Zigmond and Snaith, 
1983). The description of the HADS, and the Greek and English version of the scale are 
presented in appendices 8.8-8.10. 
 
Rationale for screening depression  
Although a structured interview, based on the DSM or ICD criteria, is considered the gold 
standard for the diagnosis of mental disorders, this is not always practical (Jacob, 2006). 
The clinical interview may require a long time for the correct diagnosis, expert staff to 
administer the interview, and it may be expensive (Nordgaard et al., 2012). Thus, this plan 
was declined for the current study. The second option was the use of rating scales, 
completed either by the patient or by a clinician. Williams et al. (2012) stated that almost 
all the rating scales are appropriate tools to identify depression in PD, when an optimum 
cut-off score demonstrates high sensitivity and specificity. However both of them are not 
official diagnostic tools for depression, and they cannot replace the need for a clinical 
diagnosis (Jacob, 2006). 
 
With respect to the clinician-rated scales, both the HAM-D and MADRS are recommended 
tools for identifying depression in PD and screening its severity (Nordgaard et al., 2012; 
Torbey et al., 2015). However, they should be administrated by experienced staff to 
complete the items through interviews, and their completion time is longer than the self-
report rating scales (Schrag et al., 2007; Williams et al., 2012). Due to the inability to find 
relevant professionals, and the unawareness of the chief investigator to complete these 
clinician-rated scales, the HAM-D and MADRS were also declined. In addition, despite the 
fact that the literature search identified Greek versions of these scales; no study was found 
to examine their clinimetric properties. The ‘mentation, behaviour and mood’ part of the 
UPDRS assesses the general emotional well-being in PD. However, the UPDRS is not a 
recommended tool to diagnose depression or measure its severity; due to limited face, 
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content and construct validity, and test-retest reliability (Schrag et al., 2007; Torbey et al., 
2015). 
 
On the contrary, the self-report questionnaires do not require experienced staff and are 
completed by the patient (Schrag et al., 2007). Although many self-report scales have been 
validated in PD, few studies have assessed the comparative validity of rating scales in PD 
(Schrag et al., 2007; Williams et al., 2012; Torbey et al., 2015). The most common proposed 
scales for the detection of PD depression are: the Beck Depression Inventory (BDI), the 
Geriatric Depression Scale (GDS) (Williams et al., 2012; Torbey et al., 2015), and the Zung-
Self Rating Depression Scale (SDS) (Schrag et al., 2007). These scales have strong 
psychometric properties for depression screening (Schrag et al., 2007; Williams et al., 
2012), apart from the SDS, as further evidence is needed to establish its validity (Schrag et 
al., 2007).  Although the GDS is suitable for senior PD population, further research is needed 
for younger patients (Schrag et al., 2007). Furthermore, only the short-form of the GDS has 
been translated and validated in the Greek language (Fountoulakis et al., 1999). Lastly, 
there are concerns about the number of somatic items that are included in the BDI and 
SDS, which may make difficult to differentiate between the depressive symptoms and the 
motor symptoms of PD, limiting their use as a screening tool for depression. (Schrag et al., 
2007; Williams et al., 2012).  
 
There is some evidence to support the use of the HADS to identify depression and measure 
its severity in the current study.  Despite the fact that the HADS was originally designed to 
be used with hospital populations, it has been found to perform well with non-hospital 
groups (Snaith, 2003). Both the Hospital Anxiety and Depression Scale- Anxiety (HADS-A) 
and HADS-D subscales seem suitable for screening anxiety and depression in a non-
psychiatric medical population, because they lack somatic items (Zigmond and Snaith, 
1983). Thus, the HADS subscales could be used to monitor changes in PD anxiety and 
depression, irrespectively the progress and the severity of motor symptoms (Leentjens et 
al., 2008).  
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Although there is limited evidence so far, experimental studies support that the HADS-D 
has acceptable properties for detecting depression in: cardiac patients (Stafford et al., 
2007); multiple sclerosis (Watson et al., 2014); and PD (Mondolo et al., 2006). The HADS-D 
subscale has also been found to assess well the severity of depression among healthy and 
non-healthy populations, such as diabetes and coronary heart disease (Bjelland et al., 
2002). However, in PD-free population evidence suggests that the HADS-D is equal to 
Patient Health Questionnaire 9 (PHQ-9) to identify only mild and moderate depression, 
whereas the PHQ-9 seems superior to identify severe depression (Hansson et al., 2008). 
This may be linked to the fact that the HADS-D excludes most of the somatic symptoms, 
which may be present in severe depression (Schrag et al., 2007). As the majority of PD 
patients suffer from mild to moderate depression (Marsh, 2013), and the HADS has been 
translated and validated in the Greek language (Mystakidou et al., 2004; Michopoulos et 
al., 2007); it was decided to use just the HADS-D as an instrument for identifying and 
measuring the severity of depression in this study. 
 
Rationale for screening anxiety 
There are no ‘recommended’ anxiety scales for PD, but only ‘suggested’, as: basic 
information about validity and reliability in PD population is missing (Leentjens et al., 2011),  
they focus only on the symptoms of GAD and panic disorder, and they were not designed 
to identify specific anxiety disorders (Leentjens et al., 2008). However, the GAD is the most 
prevalent anxiety disorder in PD (Broen et al, 2016). The ‘suggested’ self-reported scales 
for anxiety in PD include: the BAI, State-Trait Anxiety Inventory (STAI), HADS-A subscale 
(Leentjens et al., 2008), Geriatrics Anxiety Inventory, and Parkinson Anxiety Scale 
(Leentjens et al., 2014). To our knowledge, only the STAI and the HADS-A have been 
translated and validated in the Greek language (Mystakidou et al., 2004; Fountoulakis et 
al., 2006; Mystakidou et al., 2009). Neither scale was found superior with respect to its 
validity and reliability (Leentjens et al., 2008). Between the 40-item STAI and seven-item 
HADS-A, the HADS-A was selected, because it is shorter and quicker to complete it. 
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Clinimetric properties 
Meta-analytic evidence indicates that the HADS is a valid and reliable tool for screening 
anxiety and depression in the general population. The test-retest reliability of the whole 
scale is good to excellent, whereas the concurrent validity is satisfactory. The internal 
consistency of the HADS-A is excellent, and of the HADS-D varies from adequate to 
excellent (Herrmann, 1997; Bjelland et al., 2002). However, the face validity of both 
subscales is moderate (Leentjens et al., 2008; Torbey et al., 2015). This is related to the fact 
that the HADS-D does exclude some items of severe depression –having ceiling effects-, 
such as psychotic features and suicide thoughts. Thus, the HADS-D subscale may be non-
sensitive for severe depression, but further research is needed (Torbey et al., 2015). 
Similarly, the items of the HADS-A do not reflect defined anxiety symptoms according to 
the DSM criteria (Leentjens et al., 2008). 
 
Regarding PD, the scale is also valid, reliable and responsive for use in PD (Rodriguez-
Biazquez et al., 2009). It appears to have good test-retest reliability, and satisfactory 
internal consistency (Leentjens et al., 2001; Marinus et al., 2002a; Rodriguez-Biazquez et 
al., 2009). The absence of any information about the criterion validity of the scale, keeps 
the HADS-A as a ‘suggested’ scale to screen anxiety in PD population. The two subscales 
(HADS-D, HADS-A) have no floor or ceiling effects (Marinus et al., 2002a; Rodrigues-
Biazquez et al., 2009), except only one ceiling effect for item eight (‘slowing down’) 
(Rodrigues-Biazquez et al., 2009). This may be explained by the fact that this item overlaps 
major motor symptoms of PD (Schrag et al., 2007).  The literature search did not reveal the 
minimal clinically important difference (MCID) for the HADS and its subscales in PD or other 
neurological disorders. However, the established MCID value for HADS-D and HADS-A in 
inpatient population with chronic obstructive pulmonary disease (COPD) is equal to 1.5 
(Puhan et al., 2008). 
 
Strengths and limitations 
Apart from the data that were reported previously, the HADS and its subscales appear to 
have additional strengths and limitations. The HADS is a low-cost tool that captures 
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information on both depression and anxiety, whereas the majority of mood scales focus on 
one particular aspect of mood (Snaith, 2003). The results are easy to interpret with higher 
scores on each individual scale or the entire scale indicating greater anxiety, depression or 
general psychological distress (Johnston et al., 1995; Roberts et al., 2001). The completion 
time of the scale is short, varying from two to five minutes.  
 
On the contrary, the HADS-D addresses less DSM criteria for depression than other rating 
scales, such as the HAM-D and the BDI (Shumway et al., 2004; Williams et al., 2012). The 
HADS-D emphasises in anhedonia20 rather than sadness (Schrag et al., 2007), and some 
non-somatic symptoms (cognitive symptoms, guilty, suicidal thoughts) are not recorded. 
Regarding anxiety, the HADS-A was developed as a brief measure of generalised symptoms 
of anxiety and fear, and not for detecting specific anxiety disorders based on the DSM 
criteria (Leentjens et al., 2008). However, the study by Terluin et al. (2009) proposed cut-
off points for GAD and panic disorder in a distressed population. 
 
 Cut-off points 
A score at least eight for either the HADS-A or HADS-D was suggested to indicate anxiety 
and depression; and at least 11 for the clinical anxiety and depression (Zigmond and Snaith, 
1983). The review by Bjelland et al. (2002), based on the results of previews studies in 
somatic diseases with comorbid depression or anxiety, also suggests a cut-off score of eight 
for both subscales for optimal balance between sensitivity21 and specificity22 of about 0.80. 
Regarding PD, further research is needed for the best cut-off score distinguishing depressed 
and non-depressed patients (Torbey et al., 2015). Thus, in the current study, based on the 
suggestions of Bjelland et al. (2002) for chronic diseases, a cut-off of eight out of 21 in each 
subscale was selected. 
 
                                                             
20 Loss of pleasure, interest 
21 True positive rate 
22 True negative rate 
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Greek version 
The Greek version of the HADS has not been validated in PD population yet. However, the 
administration of the scale to patients with advanced cancer and general hospital 
population (inpatients and outpatients), indicated adequate to high internal consistency, 
test-retest reliability and concurrent validity (Mystakidou et al., 2004; Michopoulos et al., 
2007).  
 
8.7.2. UK PDS Brain Bank criteria 
Although the potential participants were required to provide written medical clearance 
from their neurologist to certify them as idiopathic PD sufferers; the neurologist examined 
the participants to ensure the disease. The examination was based on the UK PDS Brain 
Bank Criteria (Appendix 8.11). These are the most widely accepted clinical criteria for PD 
diagnosis (Massano and Bhatia, 2012), recommended by the National Institute for Clinical 
Excellence (NICE) guidelines (National Collaborating Centre for Chronic Conditions, 2006). 
The diagnostic accuracy rate using these criteria is 82.7% (Rizzo et al., 2016). 
 
8.7.3. Unified Parkinson’s Disease Rating Scale (UPDRS) 
The UPDRS (officially known as UPDRS version 3.0) was used to assess the PD impairment 
and disability at baseline (Sampaio et al., 2012). It is a multidimensional instrument, and 
measures both the motor and non-motor features of the disease (Ebersbach et al., 2006). 
Although its reliability has been examined more than its validity, it is the ‘gold standard’ for 
the assessment of PD, and the most frequently applied instrument in clinical setting and 
research (Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease, 
2003; Ebersbach et al, 2006). It is also an easy-to-use instrument, its completion time is 
between 20 and 30 minutes, and the coverage of motor symptoms is comprehensive 
(Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease, 2003). 
 
On the contrary, the tool does not provide a sufficient measurement of some non-motor 
symptoms of PD (e.g. depression), whereas some prevalent non-motor symptoms -such as 
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anxiety, fatigue and sexual dysfunction- are not covered (Ebersbach et al., 2006).  In 
addition, as the instructions for raters are inadequate, special training is needed (Goetz, 
2006). Lastly, the Part IV of the scale has been criticised negatively. In particular, the five-
point option of some items and the dichotomous rating of others, make the overall 
quantitative analysis difficult; because the first assess the severity of disability and the 
others are related with the presence or absence of some signs (Sampaio et al., 2012). Thus, 
a new advanced scale was developed in 2007 by the Movement Disorder Society (MDS), 
entitled MDS-UPDRS. The four parts of the MDS-UPDRS appear adequate to excellent 
internal consistency, and excellent concurrent validity, when compared to the UPDRS 
(Goetz et al., 2008). 
 
Both versions of the UPDRS have been officially translated in the Greek language 
(International Parkinson and Movement Disorder Society, no date). However, there is no 
study that examined the validity and reliability of the Greek version so far. Between the 
two versions, the neurologist selected the UPDRS (version 3.0), as he was experienced and 
trained on this version of the scale. The UPDRS scale and its description are found in 
appendices 8.12 – 8.14. 
 
8.7.4. Modified Hoehn and Yahr (H&Y) Scale 
Τhe most widely and universally accepted staging system for overall functional disability in 
PD is the H&Y scale (original version) (Hoehn and Yahr, 1967), and its modified version, the 
Modified H&Y scale. The H&Y scale has been used extensively in many studies in PD 
population (Goetz et al, 2004), and it accompanies the UPDRS. It is a ‘recommended’ scale 
by the MDS Task Force on PD (Sampaio et al., 2012), and the PEDGE (Kegelmeyer et al., no 
date). The scale is simple and easily applied by specialists and non-specialists, and it is 
related to the whole disease spectrum (Goetz et al., 2004; Sampaio et al., 2012). However, 
the scale is limited by its focus on bilateral or unilateral involvement, and on balance 
impairments, whereas other motor or non-motor signs are unassessed. In addition, the 
categorisation relies highly on rater’s subjectivity; without identifying the aetiology of 
impairment (Goetz et al., 2004).  
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With respect to the clinimetric properties of the scale, few studies have explored the 
clinimetric aspects of the H&Y scale, indicating high internal consistency and interrater 
reliability (Ginanneschi et al., 1988; Ginanneschi et al., 1991; Goetz et al., 2004); whereas 
no clinimetric data are available for the Modified H&Y scale (Goetz et al., 2004). Lastly, 
there is not official translation of any H&Y scale in the Greek language; however, they are 
found easily in the ‘grey literature’. Between the two versions of the H&Y scale; the 
Modified H&Y scale was selected by the neurologist, as it has wider acceptance in Greece 
and it is used by him on a daily basis. The Modified H&Y scale and its description are found 
in appendices 8.15-8.17. 
 
8.7.5. Schwab and England Activities of Daily Living (SEADL) Scale 
The SEADL scale, which accompanies the UPDRS (Sampaio et al., 2012), was used to assess 
the individual's ability to function in ADLs. It is a simple scale, quick to complete it, and no 
training is required for its administration (McRae et al., 2002). The SEADL scale has 
adequate test-retest reliability (Dal Bello-Haas et al., 2011), and interrater reliability 
between physicians, patients and caregivers (McRae et al., 2002). However, it does not 
examine the ADLs separately, and there may be some overlap, because the categories are 
broad (Shulman et al., 2010). Lastly, the scale is not validated in the Greek language. The 
SEADL scale and its description are found in appendices 8.18-8.20. 
 
8.7.6. Mini Mental State Examination (MMSE) 
The MMSE was used to ensure that participants were of adequate cognitive function to 
participate in the study (Folstein et al., 1975). Although the Scale for Outcomes of PD-
Cognition, and the PD-Cognitive Rating Scale are ‘recommended’ scales to assess cognitive 
impairment in PD (Kulisevsky and Pagonabarraga, 2009), no data concerning their 
translation in the Greek language were found. The Montreal Cognitive Assessment (MoCA) 
also seems sensitive instrument for this purpose (Hoops et al, 2009). However, its Greek 
version was validated, in general population and parkinsonian individuals with dementia, 
in 2016 (Konstantopoulos et al., 2016); after the completion of the current study. 
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The MMSE is considered the ’gold standard’ screening instrument for the detection of 
cognitive impairment. It assesses the short-term memory (Sampaio et al., 2012), which is 
required for the participation in an exercise programme. Its clinical utility is good, because 
it does not require any special equipment or training for administration, and the 
completion time of the test is between five and ten minutes (Loue and Sajatovic, 2008). 
The Greek version of MMSE seems to be valid and reliable (Fountoulakis et al., 2000). 
 
On the other side, the MMSE is less sensitive than MoCA for the detection of mild cognitive 
impairment in PD (Hoops et al., 2009). The MMSE also demonstrates floor effects in 
populations with severe cognitive impairment, and ceiling effects in populations with mild 
cognitive impairment (Wind et al., 1997). In addition, its score is not a diagnostic tool for 
dementia (Sampaio et al, 2012). The total score can be influenced by socio-demographic 
characteristics; such as age, and education level (Tombaugh and McIntyre, 1992). As the 
MMSE relies heavily on verbal response, reading and writing; patients with hearing and 
visual impairments, communication disorders, and low communication level on the test’s 
language, may perform poorly (Wind et al., 1997). 
 
The selected cut-off point for the current study was 23/24. Potential participants with score 
23 or below were excluded. This was in accordance with the cut-off points proposed by 
Fountoulakis et al (2000) in Greek population, and with previous similar studies on 
therapeutic exercise in PD.  The MMSE and its description are presented in appendices 
8.21-8.23. 
 
8.7.7. General health questionnaire (GHQ) 
The GHQ (Appendices 8.24 and 8.25), designed by the researcher, was a screening tool to 
identify whether the potential participants met the study’s inclusion criteria; and if there 
were any additional contraindications or limitations for their participation in the study, 
apart from those that were detected using the UK PDS Brain Bank Criteria, MMSE, and 
HADS-D. In addition, basic anthropometric and socio-demographic data, and the health 
Chapter 8: RCT-methodology 
163 
 
status were recorded. The questionnaire was completed by the researcher by asking 
relevant questions; and by performing simple clinical examinations: measurement of 
height and weight, and calculation of the body mass index (BMI) (appendix 8.26). The parts 
of the GHQ are presented in table 8.5. 
 
Table 8.5. The parts of the GHQ. 
Parts of the questionnaire Number of items 
A. Background information 9 
B. Anthropometric characteristics 6 
C. Medical history of PD 10 
D.  Medical background 15 
E. Family’s medical history 6 
F. Approval/refusal. 2 
 
 
8.7.8. Snijders and Bloem Freezing Of Gait (FOG) Test 
In the current study, an instrument had to be selected to define freezer and non-freezer 
population, and assess the severity of FOG. The current ‘gold standard’ for clinical 
evaluation of FOG is the determination of the number of FOG episodes from video by 
independent raters (Morris et al., 2013). However, this method was rejected, because it is 
time consuming and costly. Although the self-administrated questionnaires that assess the 
severity and frequency of FOG episodes (Freezing of Gait Questionnaire and the New 
Freezing of Gait Questionnaire) are considered valid and reliable tools (Giladi et al., 2009; 
Nieuwboer et al., 2009), they do not utilise clinimetric tools to distinguish freezing and non-
freezing population (Shine et al., 2012). In addition, they have not been translated in the 
Greek language so far. Hence, they were also rejected. The UPDRS scale contains one 
question about FOG (item 2.10) (Goetz et al., 2008); however, this instrument is not a 
validated methods to detect FOG (Sampaio et al., 2012). 
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The Snijders and Bloem FOG test is a clinical test, recommended by the EPDA (Keus et al., 
2013), to detect freezers patients with PD. It is completed in a short time, usually less than 
ten minutes (Snijders et al., 2012). Turning around ‘on a spot’ appears to be the strongest 
provoking factor of FOG compared to other factors, such as walking through narrow 
passages (Snijders et al., 2008). According to the results of the study by Snijders et al. 
(2012), rapid full turns defined 84% of freezes in a subjective off period, before taking their 
medication; and rapid full turns dual task 96%. The specificity was significantly higher 
compared with other motor examinations such as half turns, wider turns and walking 
through narrow passages. It was hypothesised that narrow, high speed turns may provoke 
more often FOG, due to temporal and spatial conditions (Snijders et al., 2012). As a minority 
of PD patients appear FOG episodes during the ‘on-state’, it is recommended to perform 
the test during the ‘on-state’ and ‘off-state’ (Snijders et al., 2012).  However, the test 
requires adequate clinical experience to distinguish differences between festination and 
FOG (Snijders et al., 2008).  
 
Based on the above data, in the current study only the Snijders and Bloem FOG test was 
selected to detect freezing PD population, whereas the severity and frequency of FOG 
episode was not assessed. However, as the assessment took place only during the ‘on-
state’; the test was not performed during the ‘off-state’. The description of the Snijders and 
Bloem FOG test and the relevant forms are in appendices 8.27-8.29. 
 
8.7.9. Parkinson’s Disease Questionnaire 39 (PDQ-39) 
The ‘recommended’ PD specific instruments to assess QoL include: the Parkinson’s Impact 
Scale (PIMS), the Scales for Outcomes in Parkinson's Disease–Psychosocial (SCOPA-PS), the 
Parkinson’s Disease Quality of Life Questionnaire (PDQL), the PDQ-39, and the Parkinson’s 
Disease Questionnaire 8 (PDQ-8) (Marinus et al., 2002b; Martinez-Martin et al., 2011). 
However, the PIMS, SCOPA-PS and PDQL are not available in the Greek language; hence, 
they were rejected. Furthermore, the PIMS does not contain items on cardinal motor 
features, cognition and social stigma (Sampaio et al., 2012). The SCOPA-S is focused on 
psychosocial adjustment rather than in QoL, and lacks physical and mental health domains 
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(Martinez-Martin et al., 2011). The PDQL has a frame time of three months (Sampaio et al., 
2012), which is not suitable for the current two-month intervention period; and is less 
precise than the PDQ-39 (Martinez-Martin et al., 2007).  
 
Both the PDQ-8 and PDQ-39 have been translated and validated in the Greek language 
(Katsarou et al., 2001). Although the PDQ-8 (the short version of PDQ-39) has a very high 
correlation with the PDQ-39, it reaches lower reliability and validity than the PDQ-39 
(Martinez-Martin et al., 2011). Therefore, the PDQ-39 was selected for the current study to 
assess the QoL. The description of the PDQ-39, and the Greek and English versions of the 
scale are provided in appendices 8.30-8.32. 
 
The PDQ-39 is probably the most appropriate QoL instrument in PD, because its clinimetric 
properties are better than those of the previous reported scales, and it has been used in a 
large number of studies (Marinus et al., 2002b; Martinez-Martin et al., 2011). The English 
version of the scale demonstrated acceptable internal consistency and high test-retest 
reliability (Marinus et al., 2002b; Tan et al., 2004). In addition, the construct validity is well-
established. The instrument appears to have no floor or ceiling effect (Marinus et al., 
2002b). The calculated MCID value for the PDQ-39 summary index (SI) is 4.2 (Horvath et al., 
2017).The PDQ-39 is also a low-cost tool, and its completion time is between 15 and 20 
minutes (Keus et al., 2013). It does not need special training to calculate the total score and 
the score of each subscale; and it adequately covers physical, mental, and social domains 
(Martinez-Martin et al., 2011). The Greek version was found to have a high test-retest 
reliability, and internal consistency in patients with mild to moderate PD. The total score 
was also correlated well with the motor features of the disease and depression levels 
(Katsarou et al., 2001).  
 
The PDQ-39 is not completely free of limitations. It assesses the frequency of some items, 
and not the impact or the intensity of the disease on patients’ lives. As it assesses long 
periods of time (one month), a long-term memory is required (Martinez-Martin et al., 
2011). The content validity is satisfactory, as it lacks items addressing some areas; such as 
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sleep, sexual function and transfers (Martinez-Martin et al., 2011). Lastly, the reliability of 
the social support subscale (test-retest and internal consistency) is inadequate (Marinus et 
al., 2002b). 
 
8.7.10. Berg Balance Scale (BBS) 
The literature search identified two balance scales that are widely used in PD studies to 
assess balance: the Berg Balance Scale (BBS), and the Mini-Balance Evaluation Systems Test 
(Mini-BESTest). The Mini-BESTest assesses functional activities through different balance 
control systems, including dynamic gait. However, its clinimetric properties in PD 
population and the validation of the Greek version were established recently (Benka Wallen 
et al., 2016; Lampropoulou et al., 2016), after the completion of the current study. Thus, it 
was rejected, and the BBS was selected. 
 
The BBS was developed to assess functional balance, without including walking activities 
(Berg, 1998); and it is reportedly used by the 71% of surveyed British neurorehabilitation 
physiotherapists (Yoward et al., 2008). Its clinical utility is high, because the test is simple 
and cheap to perform with minimal training required, and quick to complete it (15-20 
minutes) (Berg et al., 1989). The EPDA proposes the BBS to assess stationary balance in PD 
patients (Keus et al., 2013). However, the PEDGE does only ‘highly recommend’ the 
instrument at H&Y stages two and three, as the functional balance is usually unaffected in 
the early stages of the disease (H&Y stage one) (Kegelmeyer et al., no date).  
 
The clinimetric properties of the BBS are well established in PD population. Specifically, the 
scale appeared to have excellent test-retest reliability (Lim et al., 2005; Steffen and Seney, 
2008), interrater reliability (Leddy et al., 2011), and internal consistency (Steffen and Seney, 
2008). In addition, the criterion validity of the BBS is well established. There is excellent 
correlation with: the TUG test, and the UPDRS total score, indicating good validity for the 
disease severity (Kokko et al., 1997; Brusse et al., 2005). The Greek version of the scale in 
healthy older individuals appeared to have high internal consistency and interrater 
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reliability (Chatzitheodorou et al., 2006). The description of the BBS, and the Greek and 
English version of the scale are in appendices 8.33-8.35. 
 
The reported limitations of the BBS in PD are related to the ceiling and floor effects (Leddy 
et al., 2011), the cut-off points, and the non-established MCID value in PD. The ceiling 
effects may arise, as the BBS does not assess dual task activities and freezing (however item 
11 –turn 3600- may result in freezing) (Keus et al., 2013). Furthermore, patients in H&Y 
stage four are usually reliant on assistive devices, and so would likely exhibit floor effects 
(Leddy et al., 2011).  
 
The cut-off points of the test usually indicate the risk of falling. Generally, a score of zero 
to 20 indicates a high risk of falling, 21 to 40 a medium risk, and 41 to 56 a low risk (Keus et 
al., 2013). In geriatric population, scores below 36 points are associated with at least one 
fall during the last six-month period (Shumway-Cook et al., 1997). However, the literature 
search did not identify any relevant study in PD population to discriminate fallers and non-
fallers; but it seems that lower scores are associated with greater risk of falls (Dibble et al., 
2008). Lastly, the MCID for improvement in balance, as measured by the BBS, was not 
found in patients with PD; but it is three points in inpatient and outpatient population 
suffering from multiple sclerosis (MS) (Gervasoni et al., 2017). 
 
8.7.11. Timed Up and Go (TUG) test 
The EPDA recommends the TUG test and Modified Parkinson Activity Scale (M-PAS) as the 
most appropriate tools to assess functional mobility in PD. Although  the M-PAS appears to 
have high clinimetric properties (Keus et al., 2009a); it was declined as there was no Greek 
version of the scale, and the required equipment (i.e. bed, pillow, sheet and blanket) was 
not available in the venues, where the assessment was performed. Thus, the TUG test was 
selected, which is recommended by the PEDGE at one to three H&Y stages (Kegelmeyer et 
al., no date). The description of the test and the completion forms are presented in 
appendices 8.36-8.38.  
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The TUG is a test, originally designed for use in the elderly population (Podsiadlo and 
Richardson, 1991). It is a measure of functional mobility to evaluate transfers, gait and 
dynamic balance, and to predict future falls (Keus et al., 2013). Thus, the test performance 
requires both muscle strength and balance. Subjects who are able to complete the test in 
less than 20 seconds, have been shown to be independent in ADLs and walk at speeds that 
are sufficient for community mobility.  Those subjects requiring greater than 30 seconds to 
complete the test, tend to be more dependent in ADLs and often require gait aids 
(Podsiadlo and Richardson, 1991). Poor TUG performance (more time to complete the test) 
in PD has been associated with poor muscle strength, poor balance, slow gait speed, FOG 
and physical inactivity (Bennie et al., 2003). The test does not require special equipment, 
or a high level of assessor skill; it takes about five minutes to be performed (Podsiadlo and 
Richardson, 1991); and it is reportedly used by the 53% of the British physiotherapists 
working in the neurological field (Yoward et al., 2008). 
 
The TUG test has reasonable psychometric properties in the general elderly population 
(Steffen and Seney, 2008), and in PD. With respect to PD, the test-retest reliability and 
interrater reliability during the ‘on-state’ and the ‘off-state’ were found high, even when 
the physiotherapy assessors had different levels of experience (Steffen and Seney, 2008; 
Huang et al., 2011). The significant correlation between the BBS and TUG test, supports the 
validity of TUG as a balance test (Bennie et al, 2003). Lastly, the TUG performance seems 
to be associated with previous falls in PD, and the test may distinguish PD population 
between fallers and non-fallers (Balash et al., 2005), using a cut-off score of 11.5 seconds 
(Nocera et al., 2013).  
 
Nevertheless, it is doubtful whether the TUG test can predict future falls in general 
population. The reviews of Barry et al. (2014) and Schoene et al. (2013) concluded that 
although the TUG performance is associated with previous falls, the diagnostic accuracy of 
the TUG test to predict falls in the general population is limited. This may be explained by 
the fact that the cause of falls in elderly population is multifactorial. The TUG test reflects 
on strength and balance; and not on additional intrinsic and extrinsic factors that may be 
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associated with falling, such as poor vision, drugs taken (Rossat et al., 2010). Thus, cut-off 
points are not recommend to predict falls (Beauchet et al., 2011). Lastly, the author was 
not aware of the MCID value for the TUG in PD; however, Gautschi et al. (2017) found that 
it was 3.4 points in patients with degenerative disc disease. 
 
8.7.12. Falls Efficacy Scale International (FES-I)  
FOF is a remarkably common fear in PD (Rahman et al., 2011). Due to the absence of 
specific-disease instruments to assess FOF in PD, a generic self-reported instrument was 
preferred for this purpose. The literature search identified six relevant scales: the Activities-
specific Balance Confidence Scale (ABCS), Tinetti Falls Efficacy Scale (FES), FES-I, short 
version of FES-I, Survey of Activities and Fear of Falling in the Elderly (SAFFE), and mini 
SAFFE version (Sampaio et al., 2012). Although the FES is considered useful in assessing FOF 
in elderly communities, it seems to have ceiling effects in PD (Thomas et al., 2010). The 
comparison of rest scales (FES-I, ABCS, SAFFE and mini SAFFE) assessing FOF in PD 
population, showed that all of them had high internal consistency and acceptable test-
retest reliability. However, only the FES-I showed high test-retest reliability (Jonasson et 
al., 2014). Furthermore, to our knowledge, the FES-I and its short version are the only of 
the above FOF scales translated and validated in Greek population (Billis et al., 2011). In 
addition, the FES-I is the only FOF scale suggested by the EPDA in PD patients, and it allows 
a better insight understanding of the FOF than its short version (Keus et al., 2013). Thus, 
the FES-I was selected for the current study. The description of the scale, and the Greek 
and English version are in appendices 8.39-8.41. 
 
The scale also is free of cost, easily completed in less than 15 minutes, and does not need 
any special training of assessors (Sampaio et al., 2012). A cut-off of 23 points discriminates 
between low and high fall concern (Delbaere et al., 2010). The Greek version showed 
excellent test-retest reliability and internal consistency, good discriminant validity, and no 
floor of ceiling effects in third age population (Billis et al., 2011). Although the study of 
Jonasson et al. (2014) verifies the high psychometric properties of the test in PD population, 
more research is needed to establish its validity and reliability. Thus, the EPDA mentions 
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that the test should be used and interpreted with caution, due to inadequate knowledge 
of its psychometric properties in PD population (Keus et al., 2013).  Although, the MCID for 
the FES-I in PD was unknown, when the current RCT was conducted; the estimated value 
in geriatric population (70-90 years) is 3.5 seconds (Delbaere et al., 2010). 
 
8.7.13. Falls diary (FD) and Falls Questionnaire (FQ)  
A FD (appendices 8.43-8.44) and a FQ (appendices 8.45-8.46) were used to record falls’ 
number and their characteristics. These tools are advised by the EPDA, as they may provide 
physiotherapists with essential information about the frequency and circumstances of 
falling, and help them to set the goals for the design of the rehabilitation programme (Keus 
et al., 2013). The FD included a fall definition to facilitate its completion, adopted by the 
Prevention of Falls Network Europe: “Fall is a sudden, unexpected event that results in 
coming to rest unintentionally on the ground or at some other lower level” (Lamb et al., 
2005: 1620). The FQ was a short, structured, self-completed instrument, designed by the 
researcher. Its design was based on previous relevant questionnaires in PD population 
(Keus et al., 2004; Morris et al., 2011; Keus et al., 2013). The questions were relevant to the 
falls’ circumstances and their consequences. The estimated completion time of the FQ was 
between three and five minutes, based on the pilot study. The description for the 
completion of both instruments is in Appendix 8.42. 
 
8.7.14. Two Minute Walk Test (2MWT) 
Exercise tolerance can be assessed by either maximal or submaximal exercise tests. In the 
current study, a submaximal test was preferred for the following reasons: the mean age of 
PD patients was over 60 years, fatigue is one of the most prevalent non-motor symptoms 
among PD population, and the ADLs are submaximal activities (Noonan and Dean, 2000). 
Furthermore, walking is one of the most common activities, which may be carried out by 
all ambulatory persons (Light et al., 1997). The 6 Minute Walk Test (6MWT) is a submaximal 
measurement of endurance, which assesses walking distance over six minutes (ATS, 2002). 
The test is the ‘gold standard’ to assess exercise tolerance in healthy populations and in 
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chronic diseases (ATS, 2002), and it is recommended by the EPDA in PD (Keus et al., 2013). 
Hence, the 6MWT was initially selected for the purpose of the current study. 
 
Although the 6MWT was initially selected; after the end of the pilot study (section 8.12), it 
was decided to use an alternative submaximal walking test to assess the exercise tolerance. 
Furthermore, the performance of 6MWT in a single visit may exhaust the patients with PD, 
reducing their capacity for further evaluation during the same assessment session (Light et 
al., 1997). Thus, the 2MWT, a shorter version of the 6MWT, was selected. The 2MWT was 
firstly suggested in PD population by Light et al. (1997), and it is recommended by the 
PEDGE in PD patients with H&Y stage one to three (Kegelmeyer et al., no date). With 
minimal cost, training, and length of test (five minutes or less for one trial), the 2MWT is 
feasible in both research and clinical domains (Light et al., 1997). Although it is less used 
than the 6MWT, the literature search identified previous rehabilitation studies in PD (Ellis 
et al., 2008; White et al., 2009), which used the 2MWT to assess exercise tolerance.  
 
The 2MWT has three major limitations: the psychometric properties of the test have not 
been examined in patients with PD;,the normative values for the 2-minute walking distance 
(2MWD) are not well established, and the description of the test is not clearly reported. 
 
Despite the fact that the 2MWT is a recommended test in PD (Kegelmeyer et al., no date); 
the psychometric properties of the test in PD have not been established so far.  However, 
they are established in the healthy population and other neurological diseases; such as 
multiple sclerosis and stroke. The test is both valid and reliable in these populations (Kossak 
and Smith, 2005; Gijbels et al., 2010; Hiengkaew et al., 2012). The excellent correlation of 
distances covered in 2MWT and 6MWT, indicates high construct validity, and that the 
2MWT is an alternative to the 6MWT as a measure of walking distance among patients with 
neuromuscular diseases (Gijbels et al., 2010). However, the systematic review by Pin (2014) 
concluded that more studies are needed to support that its validity and reliability. 
Concerning the MCID for the 2MWD, it was found 5.5. metres in people with COPD 
undergoing pulmonary rehabilitation (Johnston et al., 2017). 
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An additional limitation of the 2MWT is that the normative values for the 2MWD are not 
well established; and the available evidence is provided by the study of Bohannon et al. 
(2015) in an adult population (age: 18-85 years). Specifically, the 2MWD ranged from 64.6 
to 300.8 metres, with a mean of 180.9 metres. The mean 2MWD was found 184.9 metres 
for men and 176 metres for women (Bohannon et al., 2015).  
 
Lastly, there is not a standardised protocol for the 2MWT. However, previous experimental 
studies reported that they adopted the American Thoracic Society (ATS) guidelines for the 
6MWT (ATS, 2002). Although Pin (2014) proposed a protocol for the test; this was not 
strictly followed the ATS guidelines for the 6MWT (ATS, 2002), as there was absence of 
verbal instructions during the test.  The description of the protocol that was used in the 
current study, and all the relevant forms are presented in appendices 8.47-8.51. 
 
8.7.15. Spirometry 
Spirometry is the ‘gold standard’ test, which was selected to evaluate the pulmonary 
function. Spirometry measures the volume of air that the patient is able to move from or 
to the lungs (Ranu et al., 2011; García-Río et al., 2013). As a ‘gold standard’ test, its 
clinimetric properties are well established (McCarthy et al., 1975). Despite the fact that the 
MCID values have not been calculated  in PD yet, based on the literature search; the MCID 
values for the forced vital capacity (FVC) and forced expiratory volume in the first second 
(FEV1) are 3% in respiratory disorders (Kafaja et al., 2017) and 5% in COPD respectively 
(Jones et al., 2014). Apart from the diagnosis of respiratory diseases, spirometry is a 
valuable tool for the evaluation of rehabilitation programmes (García-Río et al., 2013). 
However, it is a valid tool only when used by trained staff (Burton et al., 2015). The chief 
investigator of the current study was trained, and had previous experience using the 
spirometre in a clinical setting. A hand-held spirometre (MIR Spirobank Usb) was selected, 
because it is portable. The standardisation guidelines of the ATS and the European 
Respiratory Society were followed (Miller et al, 2005; García-Río et al., 2013), as reported 
in Appendix 8.52. 
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8.7.16. Satisfaction Questionnaire (SQ) 
Patient satisfaction is an important and commonly used indicator for measuring the quality 
in health care; and it provides useful information for the improvement of healthcare 
services. (Prakash, 2010). Questionnaires that assess patients’ satisfaction distinguish the 
treatment delivery and treatment effect (George and Hirsh, 2005). Thus, a SQ (Appendices 
8.53-8.54), designed by the researcher, aimed to record the beliefs of the subjects about 
the group exercise programme, irrespectively from the outcome measures. The SQ was 
anonymous to let them express their beliefs openly; and its completion was optional, in 
order to avoid social desirable answers. 
 
8.7.17. Attendance forms (AFs) 
Two AFs were designed to record the adherence of participants with the group-based 
exercise and educational programme (AF-group programme, Appendix 8.55) and the 
home-based individualised programme (AF-individualised programme, Appendix 8.56). 
The placing of a tick mark stated that the participant was present in each group-based 
exercise and educational class or followed the home-based individualised exercise 
programme on a weekly basis. The AF-group programme was being completed by the chief 
investigator, before the start of each group class; and the AF-individualised programme by 
the secretary, psychologist or chief investigator, through weekly telephone contact with 
each participant to confirm the adherence to the weekly home-based training programme. 
 
8.8. Design of the group exercise programme 
8.8.1. Parameters of the exercise programme 
Special consideration was given by the author for the design of the exercise programme in 
order to capture the objectives of the study. Before the selection of specific exercises for 
the training protocol of the IG, basic features related to the training had to be defined. As 
the sample population was patients with PD suffering from depression, it was sensible to 
consider and combine the recommendations of organisations and results from previous 
effective studies in PD and depressed population, where possible. These features are 
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presented briefly in table 8.6. (p. 175), whereas the definition of some exercise terms are 
presented in the Glossary (p. xxix). The rationale behind the selected environmental 
conditions (temperature and humidity) is reported in section 8.3.3. With regards to 
outdoor exercise, the participants were advised to avoid exercise in extreme conditions 
(e.g. hot and cold weather, rainy days). 
 
Indoor versus outdoor exercise 
Although the EPDA proposes both indoors and outdoors exercise for PD population (Keus 
et al., 2013); the training was carried out indoors, apart from the aerobic exercise 
component, to ensure participants’ safety and comfort. Indoors exercise also offers stable 
environmental conditions, eliminating the external factors that may affect the study’s 
results (Hackney and Earhat, 2010). Moreover, there is limited evidence for outdoor 
training in PD and depression; even for outdoor walking, which is considered a promising 
effective approach in reducing depressive symptoms (Ranjbar et al., 2015). Lastly, the 
weather in Athens is unpredictable during winter, and dry and hot during summer. 
 
Group versus individual exercise 
A group exercise was preferred instead of individualised training. A group training protocol 
is recommended in PD populations with a disease severity from mild to moderate (1-3 H&Y 
stage) (Keus et al., 2007); to improve physical capacity, emotional well-being, and 
encourage socialisation (Keus et al., 2004). The social aspect may improve subjective 
feelings of well-being, and compliance with therapy might be increased (Ravenek and 
Schneider, 2009).  Similarly, in a clinically depressed population, group exercise may 
improve depressive symptoms, due to peer support and encouragement (Rethorst et al., 
2009). Although this was a research study and the participation was costless, group training 
is considered cheaper for the trainee compared to personal training (Porter, 2008). 
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Table 8.6. Parameters of the exercise programme. 
Parameters Parameters of the current study Source(s) for the parameters  
Indoor versus 
outdoor exercise 
Indoor (the aerobic component –walking- 
was performed either indoors or outdoors) 
Keus et al., 2013 
Environmental 
conditions                   
(for indoor exercise) 
Humidity levels: 40%-60% ;                          
air temperature: 200 – 240 C                                                              
Kleisouras, 1997 
Group versus 
individual training 
Group exercise (the aerobic training was 
individualised) 
Keus et al., 2004; Keus et al., 2007; 
Ravenek and Schneider, 2009; 
Rethorst et al, 2009 
Group size  5  to 6 participants Allen et al., 2012 
Supervised versus 
unsupervised 
training 
Supervised (apart from the aerobic 
component -walking-) 
Conn, 2010; Gallo and Garber, 
2011; Allen et al., 2012; Stubbs et 
al., 2016 
Instructions during 
exercise 
As simple as possible Keus et al., 2004 
Total length of the 
exercise programme 
8 weeks Baatile et al., 2000; Scandalis et al., 
2001; Protas et al, 2005; Cakit et al., 
2007; Ravindran et al., 2009; 
Rethorst et al., 2009; Perraton et 
al., 2010; Smania et al., 2010; Keus 
et al., 2013; Volpe et al., 2014; 
Stubbs et al., 2016 
Session duration 60 minutes (plus a 5-minute break) Reuter and Engelhardt, 2002; 
Ravindran et al., 2009; Rethorst et 
al., 2009; Keus et al., 2013; Silveira 
et al., 2013 
Exercise frequency Twice a week (recommended frequency of 
aerobic exercise –walking-: 5 times a week) 
Nelson et al., 2007; CPG, 2008; 
Gallo and Garber, 2011; Keus et al., 
2013 
Time of training Morning or evening hours, during the ‘on’ 
phase of PD medication 
Keus et al., 2013 
Exercise intensity Progressive, up to moderate Craft and Perna, 2004; NHFA, 2007; 
Ravindran et al., 2009; Perraton et 
al., 2010; Gallo and Garber, 2011; 
Keus et al., 2013; Shu et al., 2014; 
Cruickshank et al., 2015 
Exercise position Sitting and standing Keus et al., 2013 
Types of exercise ROM, respiratory, muscle strengthening, 
co-ordination, balance, gait, stretching and 
aerobic –walking- 
Craft and Perna, 2004; Keus et al., 
2007; Rethorst et al., 2009; Strohle, 
2009; Gallo and Garber, 2011; Keus 
et al., 2013; King and Horak, 2009 
Warm-up exercises ROM and respiratory (diaphragmatic 
breathing) exercises 
Sakellari et al., 2005; Goodwin et 
al., 2011; Volpe et al., 2014 
Exercises of the 
dynamic phase 
Respiratory (except diaphragmatic 
breathing), muscle strengthening, co-
ordination, balance, gait exercises 
Sakellari et al., 2005; Volpe et al., 
2014 
Cool-down exercises Stretching Hough et al., 2009; Goodwin et al., 
2011; Page 2012b 
Outdoor 
individualised 
exercise 
Aerobic training (walking) PSC, 2003; CPG, 2008; Robetson et 
al., 2012; Keus et al., 2013; Ranjbar 
et al., 2015 
 
Abbreviations. ROM: range of movement. 
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Group size 
Although the EPDA (Keus et al, 2013) advises a maximum number of eight patients per 
group; in the current study, each exercise group consisted of five to six individuals, because 
small training groups – up to six individuals- seem to improve the adherence of participants 
(Allen et al., 2012). 
 
Supervised versus unsupervised exercise 
A supervised, instead of an unsupervised, training was preferred; because reviews in PD 
concluded  that exercise programmes under physiotherapist supervision were more 
effective at improving, mobility, psychological well-being and QoL compared with self-
supervised home programmes (Conn, 2010; Allen et al., 2012). In addition, supervision may 
be necessary in patients with PD with more balance impairments (3-4 H&Y stage) (Gallo 
and Garber, 2011). Lastly, supervised training programmes are associated with high 
adherence and small percentages of drop-out in participants with mild to moderate PD 
(Allen et al., 2012), and mild to moderate depression (Stubbs et al., 2016). In the current 
study, each exercise class was supervised by the chief investigator and an assistant 
physiotherapist (section 8.4.1). Exercise classes were led by the principal investigator giving 
instructions to participants how to perform the exercises; whereas the assistant 
physiotherapist was present to provide technical and individual support to patients, when 
necessary, for the correct exercise performance. 
 
Instructions during exercise 
The instructions, which were given by the chief investigator, were as simple as possible. 
Further instructions during the performance of an activity or movement could lead to a 
dual task, which may affect balance and increase freezing episodes. Hence, there are more 
falls possibilities (Keus et al., 2004). 
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Total length of the training period 
As a vulnerable group of patients who were also suffering with a co-morbidity participated 
in the study, it would be logical and ethical to keep the programme as short as has shown 
to improve both the primary and the secondary outcome measures. In PD, the EPDA 
recommends a treatment period of at least eight weeks to improve physical capacity (Keus 
et al., 2013). This length period is also supported by relevant experimental studies of 
medium to high quality to significantly improve: balance and FOF (Cakit et al., 2007; Volpe 
et al., 2014), muscle strength (Scandalis et al., 2001), cardiorespiratory fitness (Baatile et 
al., 2000; Volpe et al., 2014), functional mobility (Protas et al., 2005; Cakit et al., 2007), gait 
parameters (Protas et al., 2005; Volpe et al., 2014), QoL (Baatile et al., 2000; Volpe et al., 
2014), and reduce the total number of falls (Protas et al., 2005; Volpe et al., 2014). Even a 
seven-week exercise programme was found effective in reducing depression symptoms in 
PD (Smania et al., 2010). 
 
Regarding a depressed population, several lengths of exercise intervention have been 
shown to be effective in reducing depressive symptoms. The Canadian Network for Mood 
and Anxiety Treatments (CANMAT) recommends exercise programmes between eight and 
20 weeks (Ravindran et al., 2009). One meta-analysis of RCTs showed that programmes 
with duration between four and nine weeks were more effective compared with 
interventions lasting 10 to 16 weeks; however, 18 of 20 studies with a duration up to nine 
weeks included just aerobic exercise (Rethorst et al., 2009). The review by Perraton et al. 
(2010) revealed that the majority of effective experimental studies in improving depression 
had a duration of eight weeks. Finally, long exercise programmes with a total length 
duration more than three months are associated with higher dropout rates than 
programmes of shorter duration (Stubbs et al., 2016). Based on the above information in 
PD and depression, it was decided that the total length of the exercise programme would 
be eight weeks. 
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Session duration 
The session duration was approximately 60 minutes, plus a five-minute break for rest and 
socialisation. This was in accordance with the recommendations of the EPDA in mild to 
moderate PD (Keus et al., 2013), and CANMAT for clinical levels of depression (Ravindran 
et al., 2009). Furthermore, session durations over than one hour are not recommended in 
PD to avoid fatigue symptoms (Reuter and Engelhardt, 2002). Lastly, the meta-analyses by 
Rethorst et al. (2009) and Silveira et al. (2013) concluded that exercise bouts between 45 
and 60 minutes are more effective in clinically depressed population, compared with 
sessions of longer or shorter duration. 
 
Exercise frequency 
The group exercise frequency was twice a week, plus 150 minutes walking a week (five 
times on a weekly basis). The weekly frequency was in accordance with the exercise 
recommendations, which propose therapeutic exercise at least twice a week in PD (Gallo 
and Garber, 2011; Keus et al., 2013), and in individuals with mild to moderate depression 
(CPG, 2008). In addition, with regard to the elderly population and patients with chronic 
diseases aged between 50 and 64 years, the American College of Sports Medicine and the 
American Heart Association (AHA) propose muscle-strengthening, stretching and balance 
exercise twice a week, whereas aerobic exercise five times on a weekly basis (Nelson et al., 
2007). A low frequency of exercise (two to three times a week) is also associated with 
decreased dropout rates and increased adherence to the programme (Keus et al., 2013). 
There was a rest at least one day between the group exercise sessions, because the 
strengthening exercises should not include the same muscles on consecutive days; the 
muscles need a day to rest before training again (ACSM, 2009).  
 
Time of exercise 
Special attention was given to the training time; to perform the exercise during the ‘on-
state’, when the parkinsonian symptoms are well controlled, and the individual’s motor 
function is at its best (Keus et al., 2013). Although the EPDA advises that the patients should 
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take their L-dopa medication one hour before exercise (Keus et al., 2013), the time of 
receiving the antiparkinsonian medication may differ among the trainees of an exercise 
group.  Thus, the potential participants during the screening assessment were informed 
about the exercise timetable in each municipality, and they were asked if during this period 
of the day were experiencing less parkinsonian kinetic symptoms. In addition, the exercise 
class was held at the same time each day -morning or evening hours- to avoid the diurnal 
fluctuations of the disease itself (Dereli and Yaliman, 2010). 
 
Exercise intensity 
With respect to PD, the EPDA proposes either moderate [3.5-6 Metabolic Equivalent of 
Task (METS)] or vigorous activity (more than 6 METS) based on the fitness levels of each 
individual. Moderate activity is needed when walking on a flat surface (4.5-6.5 km/h) or 
doing general exercise at home; whereas vigorous intensity when doing jogging or 
participating in competitive sports, such as soccer. During moderate activities, individuals 
breathe harder than normal, and there is an increased heart rate; however they can carry 
out a conversation. In vigorous activities there is more increased heart and breath rate, and 
the normal conversation is difficult or not possible (Keus et al., 2013). The review by Shu et 
al. (2014) concluded that moderate intensity (50%-70% HRmax) of aerobic exercise is 
effective in improving gait and cardiorespiratory parameters. Progressive anaerobic 
training with initial levels of 30-40% 1-repetition maximum (1-RM), being increased to 60% 
or 70% 1-RM, and from one to three sets of eight repetitions, seems to be effective in 
improving muscle strength (Cruickshank et al., 2015). Lastly, Gallo and Garber (2011) 
recommend a moderate intensity between 40% and 50% of 1-RM for depressed PD 
patients.  
 
The CANMAT and the National Physical Guidelines for Australians recommend moderate 
intensity exercise in depressed population (NHFA, 2007; Ravindran et al., 2009). However, 
they do not define what moderate intensity is, and ways to measure it. Craft and Perna 
(2004) and Perraton et al. (2010) recommend a moderate intensity aerobic exercise (60% -
80% of HRmax) to reduce levels of depression. A more dynamic intensity may be a deterrent 
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to continue the programme, and is associated with higher drop-out rate (Craft and Perna, 
2004). Less evidence is available on anaerobic training in a depressed population. The high 
quality RCT of Singh et al. (2005) indicated that although both high (80% 1-RM) and low 
intensity (20% 1-RM) resistance training improved muscle strengthening, the results were 
greater in high intensity group. 
 
In the current study, based on the above information in PD and depression, and having the 
knowledge that fatigue is a prevalent non-motor symptom of PD (Keus et al., 2013), and PD 
and depressed individuals are less physically active than their peers (NHFA, 2007; Keus 
2013); it was decided to follow a progressive moderate intensity. As there was no available 
equipment to measure exercise intensity, a subjective scale was used for aerobic training 
(walking) (section 8.8.2), and patients were taught to recognise the signs to stop the 
exercise. 
 
Exercise position 
The exercises were performed in standing and sitting. The seated position was selected, 
because of the reduced danger of falling (Keus et al., 2013). During exercises in standing, 
to ensure safety, participants were required to stand behind the back of the chair (Sakellari 
et al., 2005). Although exercises in lying position are recommended in PD population (PAI, 
no date; PNZ, no date; Webber and Ramaswamy, no date; PSC, 2003; Cianci, 2014); they 
were not included in the present study, due to the shortage of beds and exercise mats.  
 
Types of exercise 
The selection of the types of exercise was related to the aims and objectives of the study. 
In patients with mild to moderate PD, the treatment goals of physiotherapy are: the 
prevention of inactivity, FOF and falls; and the preserving or improving physical capacity 
(Keus et al., 2007; King and Horak, 2009). Thus, an exercise programme may include 
aerobic, muscle strength, joint mobility, respiratory, balance and gait (Keus et al., 2007; 
Keus et al., 2013), and co-ordination exercises (Gallo and Garber, 2011). Although the 
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majority of previous experimental studies focused on the effectiveness of aerobic exercise 
in depression, it seems that both aerobic and anaerobic activities seem beneficial for the 
relief of mild to moderate depressive symptoms (Craft and Perna, 2004; Ströhle, 2009). 
Thus, Rethorst et al. (2009) supported that a regimen of aerobic and non-aerobic training 
may be more effective than aerobic exercise and resistance exercise itself. Hence, in this 
study a multimodal intervention was designed; including both aerobic and anaerobic types 
of exercise, which are listed as follows: ROM, respiratory, strengthening, co-ordination, 
balance, gait, stretching, and aerobic exercises.  
 
Parts of each exercise bout  
Each exercise bout consisted of three parts (Keus et al., 2013):  
 A five to ten-minute warm-up period; including ROM exercises, plus deep 
diaphragmatic breathing (Goodwin et al., 2011; Volpe et al., 2014). The exercises were 
simple, involving only one part of the body; and in a seated position, due to the low risk 
for falls. Their low intensity aimed to prepare the musculoskeletal and cardiovascular 
system to respond better to the dynamic state of the rehabilitation programme 
(Sakellari et al., 2005). 
 A 40 to 45-minute dynamic part, which involved more complex exercises of higher 
intensity: respiratory, strength, co-ordination, and balance and gait training (Sakellari 
et al., 2005; Volpe et al., 2014). 
 A five to ten-minute cool down period, consisting of static stretches (Goodwin et al., 
2011). The stretches were placed just in the cool-down period, as there is no evidence 
to support that stretches in warm-up prevent from muscle injuries; and static stretching 
as part of warm-up, is associated with reduced muscle strength (Page, 2012b), or with 
reduced performance in sports (Hough et al., 2009). 
 
Special exercise considerations in Parkinson’s disease 
There are three exercise considerations for the design of an exercise programme in PD. 
Firstly, due to the imbalance between the agonist muscles that contribute to opening 
movements (i.e. extensors) and antagonist muscles that facilitate closing movements (i.e. 
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flexors) (Gallo and Garber, 2011); it is recommended to include a strong focus on 
strengthening on extended muscles of the body, and stretching on the shortened muscles 
to promote an erect posture (Tambosco et al., 2014). Secondly, the use of cues, which are 
external stimuli or generated by the patient; may facilitate movements, improve gait 
parameters (e.g. speed, stride length, cadence) while walking (Spaulding et al., 2013), and 
minimise freezing episodes (Keus et al., 2007). Thirdly, the use of cognitive movement 
strategies (CMS), in which a complex movement is transformed to a number of simple 
movement elements that are performed in a defined sequence; may improve the 
performance of complex and simultaneous activities, such as transfers (Keus et al., 2007). 
 
All the above considerations were applied in the current exercise protocol, apart from the 
CMS; due to time restrictions of each exercise bout and total length of the training period. 
However, both the educational programme (section 8.9), and the ‘individualised home-
based exercise booklet’ (section 8.10.2) informed the participants about the role of CMS to 
improve transfers, giving relevant examples. With respect to cues, both visual and auditory 
cues were selected. The visual cues were looking and following the instructor’s movements, 
and stripes placed on the floor; whereas the auditory cues were the verbal instructions for 
the performance of exercises. 
 
8.8.2. The exercises of the training protocol 
The next step was the selection of specific exercises for the training protocol. The exercises 
were adopted or modified from effective experimental studies, guidelines and exercise 
booklets for PD and depression. Furthermore, some exercises were based on the 
knowledge and previous experience of the chief investigator, who had already designed 
exercise booklets for PD and for the prevention of falls in senior population. Lastly, the 
advice of two experienced physiotherapists in PD was asked.  
 
The training protocol was mainly focused on lower limbs once a week, whereas the second 
weekly session was mainly on upper limbs exercises. The training protocol included only 
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low-cost, non-sophisticated and portable equipment; such as ankle weights and elastic 
bands for strengthening exercises.  Each exercise bout started with exercise in seated 
position to ensure participants’ safety. Similarly, exercises in upright position started at the 
third week of training. All the types of exercise were performed during the whole training 
period, apart from the gait exercises which started at the third week. The full standard 
protocol can be found in supplement 3, whereas the majority of exercises are presented 
with images in the ‘Individualised home-based exercise booklet (supplement 6-7). 
Alternative exercises were proposed for patients with difficulties in performing the 
prescribed exercises, or using a walking aid, for safety and practical reasons. Special 
emphasis was given to the correct erected position during the exercise performance. Thus, 
in the first session the patients were taught to sit down or stand up appropriately, and 
correct their posture during the exercise bout, if needed. 
 
Range of movement (ROM) exercises 
The low intensity ROM exercises aimed to improve or maintain the ROM of joints; and 
hence, the performance of functional activities (Sakellari et al., 2005). The ROM exercises 
were performed in the whole available ROM of each movement in a seated position. The 
speed of movement was moderate (one to two seconds to cover the whole available ROM), 
and ten repetitions of each movement were performed (O’ Brien, 1998). They included 
exercises for the upper and lower limbs, and the trunk. Emphasis was given to the 
movements of joints that tend to be reduced in PD; such as trunk rotation and neck 
extension (van de Kolk and King, 2013). All the exercises are presented in table 8.7 (p. 184). 
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Table 8.7. Brief description of the ROM exercises. 
No Exercise Exercise position Progression 
01 Chin tucks  
 
Sitting 
 
 
None 
02 Cervical spine (neck) rotation (left-right) 
03 Cervical spine (neck) flexion-extension 
04 Cervical spine (neck) lateral flexion (left-right) 
05 Lumbar and thoracic spine (trunk) rotation (left-
right) 
06 Scapula adduction 
07 Shoulder circles (backwards direction) 
08 Shoulder flexion-extension 
09 Elbow flexion-extension 
10 Finger abduction 
11 Hip abduction-adduction 
12 Knee flexion-extension 
13 Ankle dorsiflexion-plantarflexion  
 
 
Respiratory exercises 
Concerning respiratory exercises, emphasis was given to inspiratory training; because 
56.7% of PD patients develop a restrictive obstructive disease, whereas less present an 
obstructive or mixed pattern (Baille et al., 2016). Inspiratory muscle strength training and 
deep inspiration breath are recommended to improve pulmonary function (Köseoglu and 
Tomruk, 2001; Keus et al., 2013), whereas diaphragmatic breathing helps to adopt a normal 
pattern of breathing (Cianci, 2014).  Based on these recommendations, the respiratory 
training included three exercises, which are presented in table 8.8. 
 
Table 8.8. Brief description of the respiratory exercises. 
No Exercise Exercise position Progression 
01 Diaphragmatic breathing  
        Sitting 
  
None 
02 Breathing-enhanced upper 
extremity exercises (horizontal 
abduction of shoulders) 
Week 2-4: end-inspiratory hold 
Week 5-8: sniff and  end-inspiratory 
hold 
03 IMT using a Threshold IMT device Increase of work load (2 cm H2O 
every week) 
 
Acronyms and abbreviations. H2O: water; IMT: inspiratory muscle training. 
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The inspiratory muscle training (IMT) was performed using a 
Threshold IMT device (image 8.2). The analytical description 
of the respiratory exercises is presented in appendix 8.57. 
 
 
 
 
Muscle strengthening exercises 
The muscle strengthening was focused on the weak and elongated muscles, resulted from 
rigidity, to improve functional ability; and all the muscle groups of the lower limbs, which 
may be weak due to sedentary lifestyle, to improve balance and prevent from falls (King 
and Horak, 2009; David et al., 2012). A resistive programme of the lower limbs may also 
have effects on gait parameters; such as stride length and velocity (Hass et al., 2012). Thus, 
in the current study, in accordance to the National Parkinson Foundation (NPF) (Cianci, 
2014), the muscle strengthening exercises included the following muscle groups of the 
trunk, and the upper and lower limbs: shoulder flexors, extensors and abductors; scapula 
elevators and abductors; lumbar extensors; hip extensors, flexors, abductors, and 
adductors; knee extensors and flexors; and ankle plantarflexors. 
 
A progressive resistance training protocol was designed, because it has been shown to 
improve muscle strength in mild to moderate PD (Lima et al., 2013); and it is also proposed 
by the EPDA (Keus et al., 2013). The parameters of strengthening exercises were adopted 
from disease-specific recommendations and relevant previous studies in PD, and guidelines 
in the overall population and chronic diseases. 
 
Image 8.2. IMT training using 
a Threshold IMT device. 
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As it was reported in Section 8.8.1, the exercise intensity was moderate; however, there 
was no special stable equipment to measure 1-RM, and perform the resistive training. 
Hence, portable equipment was used as resistance against the movement. However, the 
most effective type of equipment for strength training in patients with PD is not known yet 
(Tambosco et al., 2014). Thus, elastic bands (Thera-bands) (Keus et al., 2013), free weights 
(plastic water bottles) (PSC, 2003), and ankle weights (Gallo and Garber, 2011) were 
selected as external resistance. Lastly, patient’s body weight acted as resistance for the 
closed chain exercises of the lower limbs (Gallo and Garber, 2011). The initial resistance 
and the progression of exercises was based on previous experimental studies in mild to 
moderate PD, and relevant recommendations (PSC, 2003; Goodwin et al., 2011; Morris et 
al., 2011; McGinley et al, 2012). Specifically, the progression of exercises was achieved by: 
adjusting the number of repetitions; increasing the resistance (Goodwin et al., 2011; Morris 
et al., 2011; McGinley et al., 2012); and reducing hand support, while performing an 
exercise behind a chair. The following portable equipment was used to increase the 
resistance: bottle waters of 0.5, 0.75 and 1 littre, adjustable ankle weights with eight iron 
weights of 0.25 kilos each,  and 1.5 metre length red, green and blue Thera-bands, with a 
resistance at 100%  elongation 1.7, 2.1 and 2.6 kilos respectively (APTA, 2012).  
 
Multi-joint and larger muscle group exercises preceded single-joint and smaller muscle-
group exercises (ACSM, 2009; Keus et al., 2013).Thus, the sequence of the exercises for the 
lower limbs was from the central to peripheral joints. Isotonic (concentric and eccentric) 
muscle contractions were preferred instead of isometric exercises (ACSM, 2009), as it 
seems that isometric exercises strengthen the muscles in a particular part of the joint angle 
(Kleisouras, 1997). One to two sets of eight to 15 repetitions were performed for each 
muscle group (Keus et al., 2013). The rest period between the sets was one minute, which 
is the minimum rest recommended by Kleisouras (1997) for moderate intensity (40%-60% 
RM). Participants were encouraged to move through the full available ROM, and the 
exercise speed was two seconds for the whole movement (ACSM, 2009). Tables 8.9 (p. 187) 
and 8.10 (p. 188) provide a brief description of strengthening exercises and their 
progression levels respectively, whereas a strengthening exercise can be seen in image 8.3 
(p. 187). 
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Image 8.3. Hip abduction using elastic bands. 
 
 
 
Table 8.9. Brief description of the strengthening exercises. 
No Exercise Exercise position Exercise resistance 
01 Shoulder flexion Sitting  Bottle of water 
02 Shoulder extension 
(hyperextension) 
Sitting  Bottle of water 
03 Shoulder abduction Sitting  Bottle of water 
04 Scapula elevation Sitting  Bottle of water 
05 Scapula adduction Sitting  Elastic band 
06 Lumbar extension Sitting  Body weight and ankle weight on the 
chest 
07 Hip extension Standing Ankle weight 
08 Hip abduction Sitting  Elastic band  
09A Knee extension  Sitting  Ankle weight 
*Hold a bottle of water above knees for isometric contraction of 
hip adductors 
09B Knee extension  Standing  Body weight 
*Hold a bottle of water above knees for isometric contraction of 
hip adductors 
10A Ankle plantarflexion Sitting  Elastic band 
10B Ankle plantarflexion Standing  Body weight 
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Table 8.10. Progression levels of strengthening exercises. 
No Exercise Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 
01 Shoulder flexion 1 set   
10 rep. 
bottle 
0.5 L 
1 set   
12 rep. 
bottle 
0.5 L 
2 sets 
10 rep. 
bottle 
0.5 L 
2 sets 
12 rep.  
bottle 
0.5 L 
2 sets   
8 rep.  
bottle 
0.75 L 
2 sets 
10 rep.  
bottle 
0.75 L 
2 sets   
8 rep.  
bottle   
1 L 
2 sets 
10 rep.  
bottle 
1L 
02 Shoulder extension 
(hyperextension) 
03 Shoulder abduction 
04 Scapula elevation 
05 Scapula adduction 1 set   
10 rep. 
elastic 
band 
red 
1 set   
12 rep. 
elastic 
band 
red 
2 sets 
10 rep.  
elastic 
band 
red 
2 sets 
12 rep.  
elastic 
band 
red 
2 sets   
8 rep.  
elastic 
band 
green 
2 sets 
10 rep.  
elastic 
band 
green 
2 sets   
8 rep.  
elastic 
band 
blue 
2 sets 
10 rep.  
elastic 
band 
blue 
06 Lumbar extension 1 set   
10 rep. 
 
1 set   
15 rep. 
 
2 sets 
10 rep.  
2 sets 
15 rep.  
2 sets 
10 rep.  
ankle 
weight 
1 kg 
2 sets 
15 rep. 
ankle 
weight 
1 kg 
2 sets 
10 rep. 
ankle 
weight 
1.5 kg 
2 sets 
15 rep. 
ankle 
weight 
1.5 kg 
*The ankle weight was hold with both 
arms in from of the chest 
07 Hip extension   
 
2 sets 
10 rep.  
ankle 
weight 
0.75 kg 
2 sets 
12 rep.  
ankle 
weight 
0.75 kg 
2 sets   
8 rep.  
ankle 
weight 
1 kg 
2 sets 
10 rep.  
ankle 
weight 
1 kg 
2 sets   
8 rep.  
ankle 
weight 
1.5 kg 
2 sets 
10 rep.  
ankle 
weight 
1.5 kg 
*Progressive reduced of hand support 
08 Hip abduction 1 set   
10 rep. 
elastic 
band 
red 
1 set   
12 rep. 
elastic 
band 
red 
2 sets 
10 rep.  
elastic 
band 
red 
2 sets 
12 rep.  
elastic 
band 
red 
2 sets   
8 rep.  
elastic 
band 
green 
2 sets 
10 rep.  
elastic 
band 
green 
2 sets   
8 rep.  
elastic 
band 
blue 
2 sets 
10 rep.  
elastic 
band 
blue 
09A Knee extension  1 set   
10 rep.  
ankle 
weight 
0.75 kg 
1 set   
12 rep.  
ankle 
weight 
0.75 kg 
      
09B Knee extension    1 set   
10 rep. 
1 set   
12 rep. 
2 sets   
8 rep. 
2 sets 
10 rep. 
2 sets 
12rep. 
2 sets 
15 rep. 
*Progressive reduced of hand support 
10A Ankle 
plantarflexion 
1 set   
10 rep. 
elastic 
band 
red 
1 set   
12 rep. 
elastic 
band 
red 
      
10B Ankle 
plantarflexion 
  1 set   
10 rep. 
1 set   
12 rep. 
2 sets   
8 rep. 
2 sets 
10 rep. 
2 sets 
12rep. 
2 sets 
15 rep. 
*Progressive reduced of hand support 
 
Abbreviations. kg: kilograms; L: littre; rep.: repetitions.  
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Co-ordination exercises 
The aim of co-ordination exercises was to improve the synchronisation of movements 
between the two sides of the body. In PD, one side is more affected than the other, and 
kinetic symptoms (e.g. bradykinesia) are more obvious in one side of the body (Djaldetti et 
al., 2006). As a result, it is difficult for patients to sychronise movements between the left 
and right part of their body, and ADLs are hampered (Huang et al., 2012). Co-ordination 
exercises of the upper and lower limbs were selected in the current training protocol, 
lasting for one to two minutes each. Similarly to the CMS, before the initiation of the 
exercise, patients were recommended to plan and mentally visualise the movement. Then, 
they had to sychronise their movements with the verbal instructions provided by the chief 
investigator. A brief description of the co-ordination exercises is provided in the table 8.11. 
As seen in the table, the progression was mainly achieved by increasing movements’ speed. 
 
Table 8.11. Brief description of the co-ordination exercises. 
No Exercise Exercise 
position 
Progression Weeks that the 
exercise was 
performed 
01 Finger exercises between the 
thumb and the other fingers 
separately in both directions 
sitting 1.One hand → both 
hands at the same 
time 
2.↑speed  
3. holding a straw 
1-8 
02 Plantarflexion / dorsiflexion 
alternately  
sitting ↑ speed 1-3 
03 Hand touch the same side knee 
three times 
sitting ↑ speed 1-3 
04 Hand touch the opposite site 
knee  
sitting ↑ speed 4-6 
05 Arm swinging in opposite 
directions 
sitting ↑ speed 4 
06 Marching on the spot with arm 
swing 
sitting ↑ speed 5-6 
07 Marching on the spot without 
arm swing 
standing ↑ speed 5-6 
08 Marching on the spot with arm 
swing 
standing ↑ speed 7-8 
 
Symbols. ↑: increase; →: to. 
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Balance exercises 
Balance training aimed to improve balance and minimise the number of falls (Cianci, 2014; 
Keus et al., 2013).  Their combination with other training modalities including in the current 
protocol, such as strength and gait training, may be more effective in reducing the falls 
number (Van der Kolk and King, 2013). The balance activities of the training protocol and 
their levels of progression are described in table 8.12. The duration of each exercise was 
between one and two minutes. During balance training in the seated position, participants 
were taught not to rest their back on the chair. The progression of exercises was achieved 
by reducing: the base of support, hand support, and visual input. External forces to 
maintain balance through anticipatory adjustments were not used, as they seem 
insufficient in the PD population (Ward and Robertson, 2003). This is probably, because 
balance impairments in PD are not only caused by extrinsic factors, but mainly by intrinsic 
factors related to the symptoms of the disease (Sakellari et al., 2005). Lastly, group balance 
exercises (ball games) were preferred (Kronhed et al., 2001), instead of independent 
reaching exercises (Morris et al., 2011); as group ball exercises seem more enjoyable, and 
promote cooperation and socialisation between the trainees (Kronhed et al., 2001). 
 
Table 8.12. Brief description of the balance exercises. 
No Exercise Exercise position Progression Weeks that the 
exercise was 
performed 
01 Shoulder flexion in 900 
and opposite hip flexed 
Sitting position Eyes open → eyes closed 1-2 
02 One hip flexed Sitting position 1.Both shoulders 
abducted in 900 → arms 
hold opposite shoulder 
2. Eyes open → eyes 
closed 
1-2 
03 Group ball exercises* Sitting and 
standing position 
Sitting → standing 
position 
1-8 
04 Stepping in all directions 
(forwards, backwards, 
side steps) 
Standing position 1.Eyes open → eyes 
closed 
2.↓ hand support 
3-6 
05 Single limb standing  Standing position ↓ hand support 7-8 
 
* throwing and catching balls in different directions. 
Symbols. ↓: reduce; →: to. 
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Gait exercises 
The aim of gait exercises was the improvement of the qualitative characteristics of walking 
(e.g. stride length, arm swinging, heel first), and re-education of additional accompanying 
kinetic problems (FOG, body posture) (Sakellari et al., 2005). Cues were applied to increase 
the patients’ attention, and facilitate automatic movement and movement initiation (Keus 
et al., 2004). However, it is unknown whether all the PD patients benefit from the use of 
cues, and the characteristics of PD patients that benefit more (Keus et al., 2013).  Visual 
and auditory cues were selected for the gait protocol; because evidence supports their 
effects on improving gait parameters, FOG episodes and number of falls (Lim et al., 2005; 
Muñoz-Hellín et al., 2013).  
 
Regarding visual cues, as there is not enough evidence to draw strong conclusions about 
the preferred type of visual stimuli (Muñoz-Hellín et al., 2013), lines on the ground were 
used in the present study. These are stable marks, which assist patients to focus on their 
gait pattern, while participating in a group exercise programme (Ward and Robertson, 
2003). The recommendations by Sakellari et al. (2005) were followed for the design of the 
visual cues. The path length for walking forwards was six metres long, and it was well 
visually defined. In each exercise room, there were two to three walking paths, allowing at 
least two participants to exercise in the same time. Transverse lines, 2.5 cm wide, were 
placed on the floor. The colour of the lines was in contrast with that on the floor. It has 
been proved that these characteristics have influence on PD population (Sakellari et al., 
2005).  The transverse lines were placed 50 centimetres apart, as the average stride length 
in early PD usually varies from 46 to 76 centimetres (Webster, 1968). The minimum normal 
stride length was selected to allow all the participants to walk with confidence, regardless 
their somatometric characteristics and the stage of the disease. 
 
With respect to auditory cues, verbal instructions were used instead of a metronome. 
Although there is a sufficient number of high quality studies to support the use of the 
metronome to improve gait parameters, such as gait velocity and stride length (Spaulding 
et al., 2013); it was declined after the pilot work (see Section 8.12). On the contrary, it is 
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not possible to draw firm conclusions about the effectiveness of verbal instructions in PD 
population; due to the limited number of relevant studies of low quality, which have 
assessed the effectiveness of verbal instructions after the end of a single exercise bout (Fok 
et al., 2011). However, due to metronome’s rejection; verbal instructions were applied on 
gait activities around a chair, backwards and forwards walking. The verbal instructions were 
kept simple ('take big steps, 'swing arms when walking', ‘heel first’) in order to not confuse 
the patients. 
 
With regard to the forward walking, the verbal instructions were added the sixth week. The 
combination of visual and auditory cues may lead to dual task activities (Sakellari et al., 
2005), which should be avoided in the early stages of training (Keus et al., 2013), because 
they may be associated with higher risk of falls and FOG episodes (Keus et al., 2004). On 
the contrary, more recent published research indicates that walking under dual task 
conditions in PD may lead to larger steps and gait velocity (Brauer and Morris, 2010). 
 
In addition, attentional and proprioceptive strategies were selected to facilitate the 
movement and improve the qualitative characteristics of gait pattern. In attentional 
strategies, the participants had to think about the whole performance of movement (e.g. 
upright position of the head, erected body posture, arm swing, heel first, big steps) in 
advance (Keus et al., 2013). Special emphasis was given to the upright position of the head, 
as much as possible. Patients were asked to look straight at a fixed body while walking. The 
upright positioning of the head may activate the proprioceptors in the neck, contributing 
to the normal body posture (Sakellari et al., 2005). Proprioceptive strategies were used at 
the initiation of walking, as they may assist freezers to overcome FOG episodes and initiate 
the movement. Proprioceptive strategies included: rocking from left to right, marching on 
the spot and one step backwards (King and Horak, 2009; Brauer et al., 2011). In addition, 
during forwards walking, participants were asked: to walk across the path, to turn in ‘clock’ 
(on the spot) pattern, to avoid FOG, and to continue back (Almeida and Bhatt, 2012). 
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The gait training included six activities (table 8.13), two of them in freezing-provoking 
situations. The participants were focused on qualitative aspects of walking performance 
(Sakellari et al., 2005). At the end of training, the physiotherapists were giving feedback to 
patients, to try to improve all the gait aspects in the following session (Keus et al., 2013). 
Participants using a walking stick, were instructed to perform these exercises with their 
equipment, which acts as an horizontal visual cue at foot level (Rubinstein et al., 2002). The 
total duration of gait training was between six and ten minutes. 
 
Table 8.13. Brief description of gait exercises. 
No  Exercise Description Progression Weeks that the 
exercise was 
performed 
01 Walking forwards in 
the walking path 
Visual cues on the floor Add verbal 
instructions (‘arm 
swing’, ‘heel first’) 
3-8 
02 Walking backwards  Verbal instructions  (‘big 
steps’) 
None  5-6 
03 Walking on a 
coloured line 
sideways 
Visual cues on the floor Add verbal 
instructions  (‘big 
steps’) 
7-8 
04 Walking around a 
chair in ‘arc’ pattern 
Walking forwards. Verbal 
instructions  (‘big steps’) 
None  3-4 
05 Sudden starts and 
stops while walking 
forwards* 
Walking in the walking 
path. Verbal instructions 
for stop and start (‘stop’. 
‘start’) 
None  5-6 
06 Moving in eight 
figures around two 
chairs* 
Walking forwards. Verbal 
instructions  (‘big steps’) 
Reduce distance 
between chairs 
(1.50m, 1.20m.) 
7-8 
 
* activities in freezing-provoking situations 
 
 
Stretching exercises 
The general aim of stretching exercises was the restoration of the entire ROM and the 
characteristic flexed posture, usually adopted by PD patients (Sakellari et al., 2005). 
However, it is unclear whether the increase in ROM is caused by the increased length of 
the muscles, or by the increased tolerance of subjects to stretching (Knudson, 2006). In the 
current study, the stretching exercises focused on the shortened muscles, due to rigidity, 
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as proposed by the NPF (table 8.14) (Cianci, 2014). Static active and passive (using 
assistance provided by the gravity and body’s weight) self-stretches were preferred. Static 
stretches are performed easily; they are safe, as there is no high risk for injury; and are 
recommended in mild to moderate PD (Gallo and Garber, 2011; Page, 2012b). In addition, 
self-stretches allow participants to control the end-feel of the stretch (Page, 2012b). The 
movement speed from the initial to the final position was relatively slow; as it seems that 
a slow velocity does not activate the myotatic reflex, caused by the rapid muscle length, 
and the rapid muscle contraction is avoided (Kleisouras, 1997). In the general population, 
evidence indicates that the greatest change in ROM with a static stretch occurs when the 
final position is held between 15 and 30 seconds (Page, 2012b). This duration is similar to 
the recommendations in PD population, ranging from 10 to 30 seconds (Gallo and Garber 
2011; Cianci 2014). As Gallo and Garber (2011) recommend 60 seconds of total stretching 
time for each stretching exercise, in the current study, it was decided to perform two 
stretches of 30 seconds each. Patients were advised to feel the stretch like a gentle pull, do 
not stretch to the point of pain to prevent injuries, and remain motionless while holding 
the stretch (Cianci, 2014). 
 
Table 8.14. Brief description of the stretching exercises. 
No Muscle stretching Position Description Weeks that the 
exercise was 
performed  
01 Pectorals and flexor 
muscles of the trunk 
Seated Extension of the trunk, horizontal 
abduction of both arms, 
extension of cervical spine 
1-8 
02A Biceps brachii Seated Extension of both elbows and 
shoulders 
1-2 
02B Biceps brachii Upright On the wall. Extension of elbow 
and shoulder 
3-8 
03 Wrist flexors Seated Wrist extension of both hands 1-8 
04 Hamstrings Seated Knee extension and flexion of the 
trunk, if possible 
1-8 
05A Calves Seated Knee extension and ankle 
dorsiflexion with the use of an 
elastic band 
1-2 
05B Calves Upright  On the wall. Knee extension and 
ankle dorsiflexion 
3-8 
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Aerobic exercise (walking) 
Aerobic exercise is a suggested component of training programmes in PD and the clinically 
depressed population to improve cardiorespiratory fitness and emotional well-being (CPG 
2008; Keus et al., 2013). Although there is more evidence to support the effectiveness of 
treadmill training to improve gait parameters and cardiorespiratory fitness in PD 
population (Keus et al., 2013; van de Kolk and King, 2013); the exercise venues were not 
equipped with treadmills, stationary bicycles or elliptical trainers. Walking is an alternative 
form of physical activity that has the potential to improve aerobic capacity and alleviate 
depression (Robetson et al., 2012); and it is recommended by international organisations 
in healthy adults and chronic diseases (Cianci 2004; Nelson et al., 2007), in PD (PSC, 2003; 
Keus et al., 2013), and depression (CPG, 2008). Waking has the advantages of being an 
enjoyable and free mode of exercise, with minimal risk of adverse effects; and easily 
undertaken by most people (Stokes, 2004). When taken outdoors, an attractive natural 
environment may decrease levels of stress (Robetson et al., 2012). Hence, individualised, 
outdoors or indoors, non-supervised walking was selected as the mode of aerobic training 
in the current study. 
 
The participants were instructed to walk outdoors or indoors (e.g. mall) at least 150 
minutes per week (Nelson et al., 2007; Cianci, 2014). The recommended frequency and 
duration was 30 minutes a day, five times a week. The exercise intensity was moderate (40-
60% HRmax); and patients were advised to walk at a comfortable self-selected pace, with a 
preferred intensity between five and six on a ten-point Borg scale (Nelson et al., 2007; Keus 
et al., 2013). The patients could rest for a few minutes or reduce their walking speed in case 
of fatigue. It was also recommended, for safety reasons, to be accompanied by another 
person. Participants with low levels of physical activity, could split the daily walking time 
into smaller segments; and gradually increase the duration of the walking bout, and walking 
speed (Cianci, 2014; Craft and Perna, 2004). 
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8.9. Design of the group educational programme 
The aim of the group educational programme was to improve the patients’ knowledge 
about PD and ways to overcome the daily difficulties arising from the symptoms of the 
disease. The educational programme was designed by the author of the present thesis in 
co-operation with the lecturers, who delivered the sessions. The whole design was based 
on relevant recommendations in PD (Keus et al., 2004), and previous experimental studies 
in PD (Guo et al., 2009). 
 
The programme composed of eight sessions lasting approximately 30 minutes, which were 
scheduled once a week, after the end of the exercise bout. The lectures included 
background information about PD, pharmacological and non-pharmacological 
management (e.g. surgical operation, dietician and psychological advice, physiotherapy-
therapeutic exercise), advice on ADLs, and education about falls. The titles of the lectures 
and their content are presented in table 8.15 (p. 197). The education sessions were 
delivered by relevant experienced professionals for prestige reasons, to provide accurate 
information, and able to response to the participants’ questions.  The educational 
programme was delivered with the use of PowerPoint presentations, through a PowerPoint 
projector. The recommendations by Finkelstein and Samsonov (2008) were followed for 
the design of PowerPoint presentations to facilitate the lecture and attract learners. The 
PowerPoint presentations are presented in supplements 8-9. The language of lectures was 
as simple as possible, in order the patients to understand simple medical terms, especially 
relevant to the pathophysiology and symptomatology of the disease. Some lectures were 
designed as an interactive dialogue, rather than a traditional lecture. Patients were also 
encouraged to share their own experiences and beliefs. Thus, the lectures, promoted the 
communication, and socialisation between the participants (Brox et al., 2008; Guo et al., 
2009). 
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Table 8.15. The lectures of the group educational programme.  
No Title of lecture Content of lecture Lecturer’s 
occupation 
01 Understanding PD (I)  Pathophysiology of PD 
 Symptoms of PD 
 
Neurologist 02 Understanding PD (II)  PD diagnosis 
 PD pharmacological management 
 Surgical operation in PD 
03 Diet in PD  Importance of diet in PD 
 The role of dieticians in PD 
 General advice about diet in PD 
Dietician 
04 Psychology in PD  The psychology of PD patients 
 The role of psychologists in PD 
 General advice about psychological disturbances 
in PD 
Psychologist 
05 Physiotherapy in PD’  Aims of physiotherapy in PD 
 Types of exercises in PD 
 
 
Physiotherapist*  
06 Transfers in PD’  Advice to improve transfers 
 Walking aids in PD 
07 Advice in ADLs  Advice to improve the performance of ADLs 
08 Keep active  Additional healthcare professionals for the 
management of PD 
 Alternative exercises in PD 
 Falls in PD 
 
*chief investigator 
 
8.10 Design of the study’s booklets 
Two booklets were designed for the present study by the author, and delivered to 
participants, entitled:  ‘Group exercise booklet’, ‘Individualised home-based exercise 
booklet’. 
 
8.10.1. Group exercise booklet 
The ‘Group exercise booklet’ (supplements 4-5) provided the subjects of the IG information 
about: the exercise venue, the timetable of the exercise and educational sessions, their 
duties during the intervention period, indications for termination of exercise, walking and 
falls. A two-month walking diary was included in the ‘Walking’ part, and a two-month FD 
and FQs in the ‘Falls’ part. The participants were requested to complete the FD and the FQ, 
if a fall occurred. Furthermore, they had to fill out the walking diary indicating the days and 
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the duration they walked. The walking diary was used as a feedback to check their walking 
activity, and their weekly progress. As the IG consisted of six groups, six versions of the 
booklet were printed. 
 
8.10.2. Individualised home-based exercise booklet 
The aim of the ‘Individualised home-based exercise booklet’ (supplements 6-7) was to 
provide the patients with a variety of exercises and adequate instructions to perform the 
training programme on their own at home. The rationale for the selection of exercises did 
not differ from those reported in the group exercise programme (section 8.8). The home-
based exercises were grouped in six categories. However, in contrast to the group-based 
exercise programme; the booklet did not include gait exercises at home for safety reasons, 
as the training was unsupervised. Instead of it, there was advice for indoor walking. Before 
the presentation of exercises, advice about the appropriate erect posture was provided. 
The proposed exercises were performed either in seated or upright position, except from 
one (code: B4), which was done in lying position. 
 
Apart from the proposed exercises, the booklet contained: background information about 
PD, using short questions and answers; advice about training at home, and transfers; and 
a ‘Walking’ and ‘Falls’ part, as described in the ‘Group exercise booklet’ (section 8.10.1), 
including a walking diary, a FD, and FQs. The instructions for the exercises, transfers and 
indoor walking were accompanied by appropriate images to facilitate the performance of 
movements. A healthy male adult was preferred as a model for the pictures of the booklet, 
as he was able to perform all the movements in an appropriate way. Before the photo 
shooting, the aim of the study and the booklet was explained to him.  He had 24 hours to 
decide his participation or not; and signed on a consent form (Appendices 8.58-8.59). His 
facial characteristics were covered to protect his anonymity. 
 
Regarding the training programme; subjects were instructed to exercise four times a week, 
for 30 to 45 minutes in each session. If this was not possible, shorter sessions could be 
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combined, to make up a total of 30-45 minutes exercise each day (Sakellari et al., 2005).  
They were taught one day to exercise their upper limbs, and the following the lower limbs; 
following the instructions that were provided through the booklet. In each session, 
participants had to select exercises from all the exercise categories, and complete the 
exercise diary. The diary was used to document the type and duration of exercise 
performed. At the end of the intervention and follow-up period, the diary was checked by 
the research team to ensure that the participants were exercised regularly. Lastly, similar 
to the group exercise, participants were instructed to walk at least 2.5 hours on a weekly 
basis (section 8.8.2), and complete the walking diary, FD and FQ (section 8.10.1). Two 
versions of the booklet were printed: one for the members of the CG including a five-month 
walking diary; and one for the IC with a three-month walking diary. 
 
8.11. Ethical consideration 
The ethical principles of the RCT did not differ significantly from those of survey (Section 
5.6). The current subchapter provides additional information relevant to the current RCT. 
All procedures followed during the study were in accordance with the Hellenic National 
Standards of Physiotherapeutic Ethics (PPTA, 2007) and the ethical principles for medical 
research, as presented by the World Medical Association in the Helsinki Declaration (WMA, 
2008). 
 
Apart from the ethical approval for the entire study (section 5.6.1); an additional approval 
was granted by the HPDA (Appendix 8.60) on 2nd February 2015 to conduct the current 
step; in order to protect the rights, safety, dignity and well-being of those who participated 
in the study. The nature and the purpose of the study were explained to participants before 
the initiation of the study; and the study’s information sheet (appendices 8.4-8.5), which 
was given to them, provided an overview for the whole study. They had the right to 
withdraw at any time of the study, access their personal information, and get informed 
about the results of the study. A consent form was signed by all the participants, before 
the start of the intervention (Appendices 8.6-8.7); and by the model used for the photo 
shoot (Appendices 8.58-8.59). 
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Anonymity of the participants (Section 5.6.4), as well as confidentiality (Section 5.6.3) of 
their personal information were ensured; whereas it was prohibited to the participants and 
the research team, to report to third people the names of patients that participated in the 
study. Only two volunteers (psychologist and secretary) and the president of the HPDA had 
access to the database of participants with their contact details and other personal 
information. Even the researcher was unware about the contact details of participants and 
had no access to this database. The RCT guaranteed justice, and exploitation was avoided. 
In particular, all the participants were treated fairly and equally through the whole study, 
as standardised intervention and assessment protocols were followed. No member of the 
research team accepted financial reward or other gifts from the participants, and was not 
paid by them for medical and allied health care. 
 
The study possessed no risk for participants and the topic of the research was not sensitive. 
The whole study design was suitable for the target population and minimised the harm risk. 
Both the assistant physiotherapists and the participants, before the start of the 
intervention, were informed about safety considerations indications for stopping exercise, 
adopted by the American College of Sports Medicine (ACSM, 2014) (Appendix 8.61).  All the 
healthcare professionals had the knowledge and experience to provide acute care in case 
of an emergency. In case of health issues during the study period, the participants were 
taught to inform the research team. The programme allowed a maximum number of 
absences, that it could be used for health issues to prevent participants for any harm. They 
were also advised to stop any exercise and rest for a while, if they were unable to perform 
it, due to fatigue. Lastly, as none of the participants was paid to take part in the study, they 
did not feel obligated to take part, even if they were not certain.   
 
8.12. Pilot study 
An initial study was conducted two months before commencing classes. Its length was 
three weeks, lasting from 19th January 2015 to 6th February 2015.  
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8.12.1. Aim of the pilot study 
The purpose of conducting a pilot study is to examine the feasibility of an approach that is 
intended to be used in a larger scale study (Leon et al., 2011). The specific objectives of the 
current pilot work were: 
 To ensure whether the screening and assessment tools were suitable for the study 
population. 
 To test the feasibility of exercises and their parameters (e.g. sets and repetitions) 
included in the group exercise programme and the individualized home-based exercise 
programme. 
 To test whether the instructions and pictures of the booklet were adequate and 
understandable. 
 To ensure whether the most disabled would be able to complete the programme.  
 To estimate the completion time of the assessments and exercise sessions. 
 To receive feedback for the final design of all the components of the proposed RCT. 
 
 
8.12.2. Design of the pilot study 
Only the exercises of both study groups were piloted, and not the entire intervention, due 
to restricted time. Thus, the pilot study was a modified small-scale version of the research 
study. Specifically: 
 It was a non-RCT. 
 The intervention period lasted only two weeks. Hence, the group training was not 
progressive, as designated for the main study; however all the exercises were tested. 
 Clinical depression, as detected by the HADS-D, was not an inclusion criterion. 
 The SQ was not included in the assessments. 
 The educational sessions, follow-up assessment and result analysis were not 
performed.  
 
Hence, the IG participated in a two-week group exercise programme; whereas the CG in a 
two-week individualised home-based exercise programme. The pilot work (IG training and 
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assessments) carried out at the offices of ‘Parkinson Care’, as there was an empty room 
suitable for the group exercise programme and the assessments. Τhe research team 
included three healthcare professionals: the chief investigator, an assistant physiotherapist 
and a neurologist. All of them were also involved in the main study. 
 
8.12.3. Participants 
The subjects were recruited from the patients list of the neurologist, who participated in 
the study. Six patients with PD participated in the pilot work; four in the IG, and two in the 
CG. All of them were under stable antiparkinsonian medication. With respect to the IG, it 
was decided to select at least one individual from each PD stage, using the H&Y scale, in 
order to see how patients with different levels of PD severity react to the training 
programme. The major demographic characteristics and the health status of participants 
are presented in table 8.16 (p. 203). Only three participants were identified with clinical 
depression using the HADS-D subscale; and only one was clinically diagnosed with 
depression, before the onset of PD.  
 
The patients were informed about the aim of the study and signed the relevant consent 
form (Appendix 8.6 and 8.7). None of them participated in the main study, due to possible 
training effects. However, they were able to participate in the group exercise programmes 
at the end of the study, offered to the members of the CG. When the intervention was 
completed, a semi-structured interview was performed by the chief investigator; and the 
participants expressed their opinion about the group training and the study’s booklets. The 
basic questions of the interview are presented in Appendix 8.62. 
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Table 8.16. Demographic characteristics and health status of participants. 
Code Group Gender Age         
(in 
years) 
H&Y 
stage 
Years since 
PD 
diagnosis 
Freezing  Independent 
walking 
HADS-D at 
baseline 
Clinical 
diagnosis of 
depression 
01 IG M 60 1 1 NF Y 8 N 
02 IG F 58 2 3 NF Y 5 N 
03 IG M 71 3 9 NF Y 10 Y 
04 IG M 68 3 7 FR Y 11 N 
05 CG M 62 1.5 1 NF Y 4 N 
06 CG F 70 3 8 NF Y 2 N 
 
Acronyms and abbreviations. CG: comparison group; F: female; FR: freezer; H&&: Hoehn and Yahr; 
IG: intervention group; M: male; N: no; NF: non-freezer; Y: yes.  
 
 
8.12.4. Modifications in the study protocol 
Feedback of participants was generally positive about study’s design. However, regarding 
the measurement tools, it was decided to select the 2MWT instead of 6MWT to assess the 
exercise tolerance. The 6MWT exhausted the patients, especially on three H&Y stage. In 
addition, its long duration, in combination with the other measurement tools exceeded an 
hour. 
 
With respect to the group exercise programme, the followed modifications were made, 
based on participants’ comments and chief investigator’s judgment: 
 The use of metronome as an auditory cue in gait exercises was rejected, because it was 
not considered practical for the current study. As the walking exercises took place 
simultaneously for all the participants; there was inability of participants to synchronise 
their steps with metronome’s sound; probably due to different disability level. Thus, 
verbal instructions were preferred. 
  Due to limited time of each exercise bout and total length of the intervention, it was 
decided to exclude facial exercises, and functional exercises (e.g. writing), from the 
training protocol; as other types of exercise were considered more relevant with the 
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aims and objectives of the study. Furthermore, the duration of some exercises was 
reduced. For instance, two sets of muscle strengthening exercises were preferred 
instead of three. 
 The CMS exercise from sitting to standing was declined, because it was impossible for 
patients with different disease severity to sychronise their movements with the 
researcher’s instructions. Hence, it was decided to inform the patients of the IG about 
the role of the CMS through the educational programme (Section 8.9). 
 Strengthening and stretching exercises to improve the sideways tilting of the trunk 
were not included in the main study; because not all the PD patients had Pisa’s 
syndrome, and some individuals  may have the tendency to lead on the left side, 
whereas others on the right. 
 Alternative strengthening exercises were designed, in case that some participants were 
unable to perform some exercises in upright position, or whether the overhead 
movements were reduced due to another condition (e.g. adhesive capsulitis). 
 
Lastly, the following modifications in the ‘Individualised home-based exercise booklet’ 
were made: 
 Some exercise instructions were re-written in a simpler way in order to be 
understandable by the patients. 
 Strengthening exercises with elastic bands and ankle weights were not included in the 
final version, as they would not be provided to the patients. 
 The ‘near fall’ definition was deleted from the booklet, because it was difficult for some 
patients to distinguish the difference between the ‘fall’ and ‘near fall’ definition. 
 
8.13. Main study 
The current section describes thoroughly the implementation of the main study. However, 
a briefly description of the research design was already reported in the section 8.2.5. 
Following the completion of the pilot study and the modifications in study’s design (section 
8.12), and as the number of potential participants was satisfactory, the main study was 
conducted from March 2015 to March 2016. The study’s flowchart is presented in figure 
8.2 (p. 207). The intervention started after the random allocation of participants to the 
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study groups (Section 8.5.7). During the main study, all the subjects were allowed to 
continue their routine activity, and receive their usual care; which apart from the 
pharmacological treatment, it could be non-pharmacological treatment (e.g. speech 
therapy, occupational therapy, dietary advice). However, they did not undergo any other 
form of physiotherapy-therapeutic exercise and psychotherapy (e.g. CBT), to ensure the 
results were due to the current intervention. 
 
The members of the IG participated in an eight-week (≈2 months) ‘group exercise and 
educational programme’ (sections 8.8 and 8.9). They were also walking independently on 
a weekly basis; and they were required to complete by themselves the walking diary, the 
FD and the FQs, which were found in the ‘Group-exercise booklet’ (section 8.10.1). Their 
duties were reminded on a weekly basis, during the exercise classes. One training and 
educational group was made in each municipality, apart from Argyroupoli-Elliniko, where 
two groups were running, based on the number of participants. The exercise and 
educational classes were held from Monday to Saturday, apart from public holidays. The 
start and end date of the group programmes in each municipality is reported in table 8.17 
(p. 206).  
 
During the three-month (≈13 weeks) follow-up period, the members of the IG 
independently continued their exercises at home and walking activity, using the 
instructions of the ‘Individualised home-based exercise booklet’ (section 8.10.2). This 
booklet was given to them at the last session of the intervention programme, and 
instructions were provided about how to use it. The patients were contacted via telephone, 
once a week, by the chief investigator or the volunteers (secretary, psychologist), to ensure: 
their participation in the fitness programme; the completion of the walking diary, FD and 
FQs; and if their medication remained stable. Telephone calls may also increase the 
adherence of participants to an unsupervised exercise programme, and minimise the drop-
out rate (Ravenek and Schneider, 2009). The telephone number of the HPDA was used for 
this purpose.  The participants had to bring the ‘Group exercise booklet’ and the 
‘Individualised home-based exercise booklet’ at the post-intervention and follow-up 
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assessment respectively. The research team checked whether the individualised 
programme was followed on a regular basis, and received the completed FD and FQs. 
 
The members of the CG participated in a five-month individualised home-based exercise 
programme, based on the booklet ‘Individualised home-based exercise booklet’ (section 
8.10.2). Similarly to the IG, the research team contacted them once a week, and they were 
asked to bring the booklet at the post-intervention and follow-up assessments. 
 
The subjects in the IG and CG had to complete the ‘group exercise and educational 
programme’ and the ‘unsupervised individualised home-base exercise programme’ at least 
85% accuracy. This ensured that all the participants of the IG and CG received the same 
intervention (Hackney and Earhart, 2010). Patients with more absences were excluded 
from the study.  Lastly, it should be stated that the follow-up period in both study groups, 
commenced after the end of post-intervention assessment in each municipality. 
 
Table 8.17. Start and end date of the intervention in each municipality. 
Municipality Start date End date 
Argyroupoli-Elliniko * 16th April 2015 11th June 2015 
Galatsi 7th October 2015 2nd December 2015 
Ilioupoli 21st April 2015 16th June 2015 
Paleo Faliro 16th May 2015 11th July 2015 
Peristeri 1st April 2015 27th May 2015 
 
* two intervention groups 
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Acronyms. CG: comparison group; IG: intervention group. 
Figure 8.2. Study’s flowchart. 
Enrollment with the EPDA to 
participate in the study 
 
Screening for eligibility and         
pre-intervention assessment 
 
Randomisation 
 
IG: 8-week group-exercise and 
educational programme 
sessions 
 
CG : 8-week ndividualized 
home-based exercise 
programme 
 
Post-intervention assessment 
 
IG: 3-month 
individualised home-
based exercise 
programme 
 
CG: 3-month individualised 
home-based exercise 
programme 
 
Follow-up assessment 
 
Data analysis 
 
ENROLLMENT 
 
ALLOCATION 
 
FOLLOW_UP 
 
ANALYSIS 
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8.14. Data analysis 
Before the data analysis, the coding of participants was performed. Τhe participants' codes 
were a combination of capital letters and numbers. The letters indicated the municipality 
in which each patient participated, either in the IG or the CG. Thus, the letters ‘AE’ were 
selected for the municipality of Argyroupoli-Elliniko, ‘GA’ for Galatsi, ‘IL’ for Ilioupoli, ‘PE’ 
for Peristeri, and for ‘PF’ for Paleo Faliro. 
 
Quantitative and qualitative techniques were selected for the analysis and interpretation 
of data, based on the research aim and objectives of the present study. All the data, apart 
from the FQ and SQ, were converted into numerical values and quantitative analysis was 
used. The qualitative analysis followed for the FQ and SQ is described in Section 5.9.2. 
Similarly to survey’s qualitative analysis, two investigators (the PhD student and a 
physiotherapist with previous experience in qualitative analysis) were involved to increase 
validity, and a translator was consulted for the conceptual translation of some phrases from 
the Greek to English language. 
 
With respect to the quantitative analysis, the following outcome measures were examined: 
depression (as measured by the HADS-D), anxiety (as measured by the HADS-A), 
psychological distress (as measured by the HADS), QoL (as measured by the PDQ-39 and its 
domains), functional balance (as measured by the BBS), FOF (as measured by the FES-I), 
functional mobility (as measured by the TUG test), exercise tolerance (as measured by the 
2MWT), and lung function (as measured by spirometry: FVC %, FEV1 %, FEV1/FVC %, IVC 
%). 
 
Quantitative data were analysed using SPSS (version 22.0).  After having defined (named 
and coded) all the variables, descriptive and inferential statistics were selected. Descriptive 
statistics were applied to analyse the socio-demographic features and health status. 
Percentages, means (SD) and median were used for this purpose. Inferential analysis was 
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used to explore differences between different study’s groups or measures, or explore 
relationships between variables. Significance was set at p < .05 (Pallant, 2016). 
 
Normal distribution was assessed by the Shapiro Wilks test (Hicks, 2009). The Shapiro- 
Wilks test was preferred instead of Kolmogorov-Smirnov, because it is the most powerful 
test to assess normality for all sample sizes, especially when the population is less than 
2,000 (Ghasemi and Zahediasl, 2012). Of those variables with normal distribution (p > .05), 
parametric tests were applied. When data were not normally distributed or categorical, 
alternative non-parametric tests were selected (Pallant, 2016).  
 
Three between-group comparisons were performed, to assess differences between the IG 
and CG at: baseline, post-intervention and follow-up. Of those variables with normal 
distribution; comparison between means was performed by independent sample t-tests. 
For the data not normally distributed, the alternative non-parametric Mann-Whitney U test 
was used. When a statistical significant difference was found, the direction of the 
difference was explored by comparing the median values. Lastly, Chi-square tests for 
independence were applied among two categorical variables to explore differences 
between two groups at baseline (Pallant, 2016). 
 
The within-group comparison for the IG and CG was performed by one-way repeated 
measures of One-way Analysis of Variance (ANOVA), when data were normally distributed, 
because there was one group of subjects measured in three different times (baseline, post-
intervention, follow-up). Where the results of ANOVA indicated significance between 
groups (Group effect), post hoc analysis (Bonferroni) was carried out, to find the groups 
that differed significantly. The alternative non-parametric, Friedman test was selected, 
when data were not normally distributed; and the Wilcoxon Signed Rank Test, as post-hoc 
testing, if a statistically significant difference was found somewhere among the three time 
points (Pallant, 2016). 
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With respect to the between- and within-group comparison, the importance of findings 
was calculated using the effect size. The eta squared or partial eta squared was calculated 
for parametric tests. In particular, after performing independent samples t-test the eta 
squared was calculated using the formula: Eta squared= t2/ t2 + (N1+N2- 2); where N1 and 
N2, the number of subjects per group. The effect size for the one-way repeated ANOVA 
was given by the partial eta squared (Pallant, 2016).  These values were interpreted as: 
small (= .01), moderate (= .06), or large (= .14) effect (Cohen, 1988).  The effect size for the 
non-parametric tests (Mann-Whitney U test and Wilcoxon Singed Rank Test) was calculated 
by the formula: r= z/square roots of N; where N, the total number of cases (Pallant, 2016). 
These values were interpreted as: small (r= .10-.29), medium (r= .30-.49), or large (r= .50-
1.00) effect (Cohen, 1988). Apart from the significant difference and the effect size, the 
study aimed to identify clinical differences between the groups and clinical changes within 
the groups, making comparisons between the MCID value for each measurement tool and 
the difference in means for each outcome measure.  
 
Bivariate correlational techniques were also used for the assessment of the relationship 
(strength and direction) among anxiety and depressive levels and the participants’ 
anthropometric characteristics (e.g. age), and features related to PD (e.g. years since PD 
diagnosis); as well as other outcome measures (e.g. FES-I). All these variables were 
continuous or dichotomous. In particular, the relationship between normally distributed 
variables was assessed by Pearson Correlation co-efficient (r); whereas the Spearman 
correlation co-efficient (rs) among the variables, which did not present a normal 
distribution. A co-efficient up to .09 indicated a very small strength of relationship, 
between .10 and .29 a small, from .30 up to .49 a medium, and between .50 and 1.00 a 
large relationship (Pallant, 2016). 
 
Lastly, a logistic regression was used to predict the factors (independent variables) that 
contributed significantly to falls (dependent variables) (Pallant, 2016). Anthropometric data 
(e.g. age) and features related to PD (e.g. years since PD diagnosis) were used as 
independent variables.  
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8.15. Summary of Chapter 8  
 An RCT was designed to investigate the short and longer-term effects of an eight-week, 
multimodal, progressive, supervised, community-based group exercise and education 
class, in people affected with PD and comorbid depression; comparing them to a CG 
following an unsupervised, individualised home-based exercise programme.  
 Depression, as measured by the HADS-D, was the primary aim of the study. 
 The author designed the group-based exercise and educational programme, and the 
two study’s booklets. The whole design was based on the combined recommendations 
of organisations and results of previous effective studies in PD and depressed 
population. 
 Before the implementation of the main study, a pilot work was conducted to examine 
the feasibility of the approach. 
 The main study was held in five municipalities of Athens Metropolitan Area, Greece, 
between March 2015 and March 2016. 
 The subjects were recruited from the HPDA, and the municipalities where the study 
was undertaken, through: internet, printed announcements and media. 
 Based on the sample size determination, 70 patients were participated in the study. 
 During the two-month intervention period, the IG participated in a combined 
community group-bsed exercise and educational programme; whereas the CG in an 
individualised home based exercise programme, based on the instructions of a booklet. 
During the three-month follow-up period, both groups followed the individualised 
home-based training. 
 With respect to the IG, the group-exercise programme was performed indoors, twice a 
week. The programme was progressive, and the duration of each exercise bout was 60 
minutes. It included the following types of exercises: ROM, respiratory, muscle 
strengthening, co-ordination, balance, gait, stretching and walking. Individualised 
walking was performed outdoors, five times a week. The educational programme 
consisted of eight thirty-minute lectures to inform patients about PD and assist them 
to overcome the daily difficulties arising from the symptoms and signs of the disease. 
 The individualised, home-based, unsupervised exercise programme; was held four 
times a week. The duration of each exercise bout was 30-45 minutes. It included: ROM, 
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respiratory, strengthening, co-ordination, balance and stretching exercises; plus 
walking outdoors five times a week. 
 The study assessed: psychological and functional (mobility) status, number and 
circumstances of falls, QoL, respiratory function, and patients’ satisfaction about the 
group exercise programme.  
 Appropriate tools with high clinimetric properties, translated and validated in the Greek 
language, were selected for the screening procedure and the assessments. Four 
additional instruments (GHQ, FD, FQ, SQ) were designed by the chief investigator.  
 The HADS was selected both as a screening tool to detect depression and anxiety, and 
an assessment tool to measure the response to the treatment.   
 Both qualitative and quantitative approaches were applied for the data analysis. The 
effects of the intervention were explored by: statistical and clinical significance, effect 
size, and the subjective view of participants, based on their answers in the SQ. 
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9.1. Introduction 
The current chapter includes the presentation of the results of the RCT, using quantitative 
and qualitative approaches. In the tables, continuous variables are presented as mean 
(±SD), when data were normally distributed; and median in non-normally distributed data. 
With respect to the effect size, the eta or partial eta squared is written for parametric data; 
and the value of r, for non-parametric data. In addition, the categorical variables are 
presented as absolute (number of individuals or falls) and relative frequencies 
(percentages).  
 
9.2. Number of participants, drop-out reasons and attendance rate  
Following screening, 70 patients with PD were eligible to take part in the study. Both groups 
comprised of 35 individuals. During the intervention period seven individuals, three from 
the IG and four from the CG, discontinued the study. During the follow-up period, one more 
subject from the CG abandoned the study. Thus, the drop-out rate for the whole sample, 
for the entire period of study (from the baseline to follow-up), was 13.3%. However, the 
drop-out rate was lower in the IG (8.6%), compared to the CG (14.2%). Finally, 62 
individuals -32 from the IG and 30 from the CG- completed the study and included in the 
analysis. Figure 9.1 (p. 215) presents the patients’ journey through the whole study period. 
 
As seen in figure 9.1 (p. 215), the main drop-out reasons in both groups were not related 
to the training programme itself. However, one participant of the IG at H&Y stage one 
stated that: “I want to quit the programme…the interaction with other patients doesn’t help 
me. Before the start of the class, they discuss about their daily difficulties and the side 
effects of medication…Here, I see people with more serious problems than me…This 
provokes stress to me. I’m thinking of my future…and I’m afraid of it.” (IL07). Regarding the 
CG, one participant discontinued the programme, because he found the exercises of the 
booklet quite difficult to perform them without supervision; whereas a woman at the third 
week of the intervention stated: “I decided to stop the exercise at home. I have not seen 
any improvement yet.” (AE16). 
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Figure 9.1. Patients’ journey through the whole study period 
 
 
Assessed for eligibility (n= 151) 
Excluded (n= 81) 
   Not meeting inclusion criteria (n= 74) 
   Declined to participate (n= 3) 
   Other reasons (n= 4) 
Analysed  (n= 32) 
 Excluded from analysis: 
 Refused (n= 2) 
 Impossible communication 
(n= 1) 
 
Discontinued intervention (n= 0) 
Allocated to intervention (n= 35) 
 Received allocated intervention  
    (n= 32) 
 Did not receive allocated 
intervention :  
 Injury, due to car accident 
(n= 1) 
 Pain, due to knee 
inflammation (n= 1) 
 Psychological reasons, due 
to interaction with other 
patients (n= 1) 
Discontinued intervention: 
 Moved away to another city (n= 1) 
Allocated to comparison (n= 35) 
 Received allocated intervention (n= 31) 
 Did not receive allocated intervention:   
 Difficulties to perform the home-
based exercise programme 
without supervision (n= 1) 
 The home-based exercise 
programme was not beneficial  
(n= 1) 
 Change in antiparkinsonian 
medication (n= 1) 
 Unable to commit time for the 
assessments (n= 1) 
Analysed  (n= 30) 
 Excluded from analysis: 
 Impossible communication       
(n= 2) 
 Transfer difficulties (n= 2) 
 Refused (n= 1) 
 
Allocation 
Analysis 
Follow-Up 
Randomised (n= 70) 
Enrollment 
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Attendance rates were calculated based on the total initial number of participants in each 
study group (n= 35). With respect to the IG, the overall attendance at the exercise classes 
was 83% (465 out of a possible 560 sessions), and at education classes 77% (216 out of 280 
sessions). The attendance rate for the CG, during the two-month intervention period, was 
not calculated, because it was based on subjective data given by the patients to the 
research team through the weekly telephone contacts. 
 
Lastly, there were no missing data for any outcome measure. In cases of an absence at the 
assessments or when the chief investigator deemed it clinically unsafe to perform the 
clinical tests; an additional appointment was arranged as soon as possible. Concerning the 
self-report questionnaires; only the full-completed HADS, PDQ-39 and FES-I were included 
in the analysis in order to not violate the total scores and scores of subsections. Similarly 
to the survey, the FQ was considered completed and included in the analysis, if at least the 
half items had been answered (Iarossi, 2006). 
 
9.3. Socio-demographic characteristics and health status 
9.3.1. Socio-demographic characteristics and features related to Parkinson’s disease 
Table 9.1 (pp. 217-218) indicates that there were no significant differences between the 
two groups in all the socio-demographic characteristics and features related to PD at 
baseline, apart from UPDRS-I subscale (mentation, behavior, and mood) (p = .01, z = - 2.37), 
where the CG had worse scores [5.57 (±2.3)]. All the participants were Caucasians, aged 
between 48 and 89 years old, and males (54.8%) were more than females (45.2%).  
Regarding BMI, 33 patients were classified as overweight (BMI: 25.0-29.9 kg/m2), 12 as 
obese type I (BMI: 30.0-34.9 kg/m2), and six as obese type II (BMI: at least 35 kg/m2). The 
majority of patients (46.8%) attended at least one year of secondary education (high school 
or technical school), and 17 were graduates or attended at least one year of tertiary 
education (University, College or higher technical school). An interesting finding was that 
despite the fact that the retirement age in Greece was 65 years (67 since 2015), 90.3% of 
participants were not working.  
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Concerning PD, its duration since diagnosis ranged between five months and 12 years. The 
total UPDRS score and the UPDRS-III (motor evaluation) score ranged from 16 to 57 and 
from 5 to 26, respectively. In addition, 37.1% of participants were categorised as fallers, 
reporting at least one fall the last two months prior the start of the intervention. Lastly, ten 
patients were using a walking stick, either a simple (n= 8) or tripod walking stick (n= 2), and 
none used a walking frame. 
 
Table 9.1. Socio-demographic characteristics and features related to Parkinson’s disease at baseline 
for the whole sample, IG and CG. 
Variable All 
(n= 62) 
 
Intervention Group 
(n= 32) 
Comparison Group 
(n= 30) 
P value 
Municipality 
of enrollment  
Argyroupoli- Elliniko 
Ilioupoli 
Paleo Faliro 
Peristeri 
Galatsi 
17 (27.4%) 
11 (17.7%) 
11 (17.7%) 
12 (19.4%) 
11 (17.7%) 
9 (28.1%) 
5 (15.6%) 
6 (18.8%) 
6 (18.8%) 
6 (18.8%) 
8 (26.7%) 
6 (20%) 
5 (16.7%) 
6 (20%) 
5 (16.7%) 
p = .99 
χ2 = .24 
Gender Male 
Female 
34 (54.8%) 
28 (45.2%) 
17 (53.1%) 
15 (46.9%) 
17 (56.7%) 
13 (43.3%) 
p = .98 
χ2 = .77 
Nationality Greek 
Albanian 
Ukrainian 
Armenian 
59 (95.2%) 
1   (1.6%) 
1   (1.6%) 
1   (1.6%) 
30 (93.8%) 
1   (3.1%) 
1   (3.1%) 
0   (0%) 
29 (96.7%) 
0   (0%) 
0   (0%) 
1   (3.3%) 
p = .59 
χ2 = .31 
Marital status Married 
Separated 
Windowed 
Single 
In a relationship 
 
42 (67.7%) 
8   (12.9%) 
8   (12.9%) 
2   (3.2%) 
2   (3.2%) 
22 (68.8%) 
4   (12.5%) 
4   (12.5%) 
1   (3.1%) 
1   (3.1%) 
20 (66.7%) 
4   (13.3%) 
4   (13.3%) 
1   (3.3%) 
1   (3.3%) 
p = 1.00 
χ2 = .02 
 
Educational 
level 
Primary 
Secondary 
Tertiary  
 
16 (25.8%) 
29 (46.8%) 
17 (27.4%) 
8   (26%) 
15 (46.9%) 
9   (28.1%) 
8   (26.7%) 
14 (46.7%) 
8   (26.7%) 
p = .98 
χ2 = .14 
Employment 
status 
Retired 
Household 
Employee 
 
46 (74.2%) 
10 (16.1%) 
6   (9.7%) 
25 (78.1%) 
6   (18.8%) 
1   (3.1%) 
21 (70%) 
4   (13.5%) 
5   (16.7%) 
p = .18 
χ2 = .33 
H&Y stage 1 
1.5 
2 
2.5 
3 
9   (14.5%) 
5   (8.1%) 
12 (19.4%) 
10 (16.1%) 
26 (41.9%) 
5   (15.6%) 
2   (6.2%) 
7   (21.9%) 
5   (15.6%) 
13 (40.6%) 
4   (13.3%) 
3   (10%) 
5   (16.7%) 
5   (16.7%) 
13 (43.3%) 
p = .96 
χ2 = .38 
Walking Independent 
Walking aid (stick) 
 
52 (83.9%) 
10 (16.1%) 
25 (78.1%) 
7   (21.9%) 
27 (90%) 
3   (10%) 
p = .35 
χ2 = .85 
Freezing Freezers 
Non freezers 
 
13 (21%) 
49 (79%) 
7   (21.9%) 
25 (78.1%) 
6   (20%) 
24 (80%) 
p = 1.00 
χ2 = .02 
Falls Fallers 
Non fallers 
 
23 (37.1%) 
39 (62.9%) 
12 (37.5%) 
20 (62.5%) 
11 (36.7%) 
19 (63.3%) 
p = 1.00 
χ2 = .00 
SEADL 50% 
60% 
70% 
80% 
90% 
100% 
2   (3.2%) 
10 (16.1%) 
18 (29%) 
19 (30.6%) 
12 (19.4%) 
1   (1.6%) 
2   (6.2%) 
5   (15.6%) 
8   (25%) 
10 (31.2%) 
6   (18.8%) 
1   (3.1%) 
0   (0%) 
5   (16.7%) 
10 (33.3%) 
9   (30%) 
6   (20%) 
0   (0%) 
p = .66 
χ2 =.22 
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Variable All 
(n= 62) 
 
Intervention Group 
(n= 32) 
Comparison Group 
(n= 30) 
P value 
Age in years 
 
70.69 
 (± 8.52) 
70.87  
(±7 .62) 
70.52 
 (± 9.49) 
p = .87 
t = .16 
Height (in centimetres) 
 
166.69  
(± 7.96) 
167.67 
 (± 8.00) 
165.69  
(± 7.92) 
p = .95 
t = .34 
Weight (in kilos) 
 
77.89 
(± 12.98) 
79.05 
 (± 13.14) 
76.69  
(± 12.93) 
p = .48 
t = .69 
BMI  (kg/m2) 
 
28.11  
(± 4.48) 
28.28 
(± 5.03) 
27.94 
 (± 3.91) 
p = .78 
t = .28 
MMSE total score 
 
28 * 28 * 28 * p = .73 
z = -.33 
Years since PD diagnosis 
 
5 * 4.5 * 5.98 
(± 3.2) 
p = .87 
z = -.15 
UPDRS total score  
 
41 * 39.63  
(± 10.87) 
40.00  
(±11.46) 
p = .90 
t = -.12 
UPDRS-I score 
(mentation, behaviour and mood) 
4.64  
(± 2.48) 
3 * 5.57 
(±2.3) 
p = .01 
z = - 2.37 
UPDRS-II score 
(activities of daily living) 
13 * 13.73  
(± 4.41) 
13.55 
(± 4.93) 
p = .88 
t = .14 
UPDRS-III score 
(motor examination) 
19 * 19* 17.48 
(± 4.83) 
p = .36 
z = - .89 
UPDRS-IV score 
(complications of therapy) 
4 * 4 * 4 * p = .84 
z = -.20 
 
* median (for non-parametric data) 
Acronyms. BMI: Body Mass Index; H&Y stage: Hoehn and Yahr stage; MMSE: Mini Mental State 
Examination; n: number of participants; PD: Parkinson’s disease; SEADL: Schwab-England Activities 
of Daily Living; UPDRS: Unified Parkinson’s disease Rating Scale.  
 
 
9.3.2. Co-morbidities 
The mean number of co-morbid conditions per participant was 2.3. Only six individuals 
(9.7%) were free of co-morbidities, whereas 49 (79%) reported at least two comorbidities. 
The number of participants who reported at least one co-morbidity from each category is 
presented in table 9.2 (p. 219), whereas the analytical list of comorbidities and previous 
surgical operations in Appendix 9.1. Chi squares tests for independence revealed no 
significant differences between the IG and CG (p > .05). 
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Table 9.2. Types of co-morbidities in the study population. 
Type of co-morbidities All 
(n= 62) 
Intervention Group 
(n= 32) 
Comparison Group 
(n= 30) 
P value 
Cardiovascular disease 24 (40.6%) 12 (40%) 12 (41.3%) p = 1.00 
χ2 = -.02 
Respiratory disease 2   (3.3%) 1   (3.3%) 1   (3.4%) p = 1.00 
χ2 = -.00 
Musculoskeletal disease 41 (69.4%) 19 (63.3%) 22 (75.8%) p = .37 
χ2 = -.14 
Neurological disease* 2   (3.3%) 1   (3.3%) 1    (3.4%) p = 1.00 
χ2 = -.00 
Other disease ** 29 (49.1%) 15 (50%) 14 (48.2%) p = .79 
χ2 = .61 
 
*neurological disease apart from PD 
**diseases or conditions that could not be included to the previous categories (i.e. hyperlipidemia, 
thyroid disease) 
Abbreviations. n: number of participants. 
 
 
9.3.3. Parkinson’s disease medication 
All participants were receiving antiparkinsonian medication (table 9.3, p. 220). The 
medication was classified into six categories, according to the NICE Guidelines (NICE, 2006).  
Twelve patients were treated with one-drug therapy (19.3%), whereas a two and a three-
drug therapy were administrated to 50 patients (80.7%). An interesting finding was that 
only four patients were not treated with L-dopa, as in these cases a DA agonist was 
combined with a MAO-B inhibitor, a recommended two-drug therapy in PD (Rao et al., 
2006).  In addition, no participants were treated with catechol-O-methyltransferase 
(COMT) inhibitors. However, the drug Stalevo, which was administrated to 19 patients, 
apart from L-dopa, contains two additional active substances: carbidopa and entacapone. 
Entacapone is a COMT inhibitor. 
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Table 9.3. Administrated antiparkinsonian medication to participants. 
Types of  
PD medication 
All 
(n= 62) 
Intervention Group 
(n= 32) 
Comparison Group 
(n= 30) 
P value 
L-dopa 58 (93.5%) 
 
30 (93.7%) 
 
28 (93.3%) 
 
p = 1.00 
χ2 = .94 
DA Agonists 27 (45.7%) 
 
15 (50%) 
 
12 (41.4%) 
 
p = .96 
χ2 = .76 
MAO-B inhibitors 19 (32.2%) 
 
10 (33.3%) 
 
9   (31%) 
 
p = .45 
χ2 = .28 
Amentadine 5   (8.4%) 
 
3   (10%) 
 
2   (6.8%) 
 
p = .50 
χ2 = .17 
Anticholinergics 2   (3.3%) 
 
1   (3.3%) 
 
1   (3.4%) 
 
p = .97 
χ2 = .29 
COMT inhibitors 0   (0%) 0   (0%) 
 
0   (0%)  
 
Abbreviations. COMT: Catechol-O-methyltransferanse; DA: dopamine; L-dopa: levodopa; MAO-B: 
monoamine oxidase-B; n: number of participants; PD: Parkinson’s disease. 
 
 
9.3.4. Depression 
Although, the HADS-D subscale identified all the participants as depressed (HADS-D score 
at least eight) during the screening procedure; only 37.1% of them had been officially 
diagnosed with depression, by a medical doctor or psychologist, either before or after PD 
diagnosis (table 9.4).  
 
Table 9.4. Number of participants with or without official clinical diagnosis of depression.  
Official diagnosis of depression All 
(n= 62) 
Intervention Group 
(n= 32) 
Comparison  Group 
(n= 30) 
P value 
No 
 
39 (62.9%) 19 (59.4%) 20 (66.7%)  
p = .74 
χ2 = -.07 Yes Before PD diagnosis 
 
9   (14.5%) 3   (9.4%) 6   (20%) 
After PD diagnosis 
 
14 (22.6%) 10 (31.2%) 4   (13.3%) 
 
Abbreviations. n: number of participants; PD: Parkinson’s disease. 
 
A further analysis revealed that antidepressant drug therapy was administered to 25 out of 
62 (40.3%) participants. Nineteen of them had been officially diagnosed with depression, 
whereas six not. Despite the fact that four individuals had been diagnosed in the past with 
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depression, they did not receive any relevant pharmacological treatment during the study 
period. On the contrary, although six participants had never been officially diagnosed with 
depression, they were under antidepressant therapy. Table 9.5 provides information 
relevant to the antidepressant medication the participants received, which was grouped 
into five categories (Kupfer, 2005). 17 patients were treated with one drug therapy, 
whereas eight with two-drug therapy.  
 
Table 9.5. Types of antidepressant medication and number of receivers. 
Types of  
antidepressant medication 
All 
(n= 62) 
Intervention Group 
(n= 32) 
Comparison Group 
(n= 30) 
SSRIs 15 9 6 
SNRIs 8 3 5 
TCAs 2 1 1 
MAOIs 1 0 1 
Atypical antidepressants 7 4 3 
 
Abbreviations. MAOIs: Monoamine oxidase inhibitors; n: number of participants; SNRIs: Serotonin-
norepinephrine reuptake inhibitors; SSRIs: Selective serotonin reuptake inhibitors; TCAs: Tricyclic 
antidepressants. 
 
 
An additional interesting fact is that five patients were treated with anxiolytic drugs 
(Benzodiazepine or Benzodiazepine derivatives), and four with antipsychotic drugs 
(Atypical antipsychotic). The majority of them (seven out of nine) were also under 
antidepressant medication. Lastly, four out of five patients that were under anxiolytic 
medication, scored at least eight in the HADS-A subscale at baseline. 
 
9.4. Outcome measures: Between-group comparisons 
9.4.1. Between-group comparison at baseline 
With respect to the outcome measures, the between-group comparison did not reveal any 
significant difference (p > .05) between the IG and CG at baseline (table 9.6, p. 222). As 
seen, the effect sizes were small for all the variables. 
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Table 9.6. Between-group comparison at baseline.  
Outcome measure Intervention group 
Mean (SD) 
Comparison group 
Mean (SD) 
P value Effect size 
 
HADS 
Anxiety 8.88 (± 4.61) 8.23 (± 3.09) p = .52  
t =  .62 
.00 
Depression 10 * 10 *   p = .30  
z = -1.01 
.12 
Total 19 * 18 *   p = .98  
z = -.21 
.00 
 
 
 
 
PDQ-39 
Mobility (%) 44.31 (± 21.51) 
 
35.87 (± 19.28) p = .11  
t =  1.58 
.03 
ADL (%) 37* 
 
35* p = .13  
z = -1.48 
.03 
Emotional 
well-being (%) 
49.81 (± 20.27) 
 
44.87 (± 17.82) p = .31  
t =  1.01 
.01 
Stigma (%) 31 * 22* p = .28 
z =  -1.06 
.13 
Social support (%) 10 * 
 
12 * p = .99 
z =  -.00 
.00 
Cognition (%) 35.18 (± 20.01) 
 
31.33 (± 18.83) p = .41  
t =  .81 
.01 
Communication (%) 25 * 
 
25 * p = .98 
z =  -.02 
.00 
Bodily discomfort (%) 36.72 (± 17.55) 
 
33.90 (± 13.63) p = .48  
t =  .70 
.00 
Summary Index (%) 32* 
 
32* p = .44 
z =  -.76 
.09 
FES-I 37.80 (± 9.44) 
 
35.00 (± 10.91) p = .29  
t = 1.05 
.01 
BBS 46 * 
 
46 * p = .76 
z =  -.30 
.00 
TUG (seconds) 13 * 
 
11.5 * p = .92 
z =  -.99 
.01 
2MWT Walking distance 
(metres) 
85.02 (± 24.77) 
 
82.53 (± 27.72) p = .71  
t = .36 
.00 
 
 
 
Spirometry  
FVC (%) 88* 
 
89* p = .97 
z =  -.03 
.00 
FEV1 (%)  90.57 (± 20.49) 
 
94.45 (± 21.75) p = .48 
t = -.70 
.00 
FEV1 / FVC (%) 94 * 
 
96 * p = .72 
z =  -.34 
.06 
IVC (%) 81.33 (± 17.46) 
 
82.55 (± 16.48) p = .78 
t = -.27 
.00 
 
* median (for non-parametric data) 
Acronyms. 2MWT: two-minute walk test; ADL: activities of daily living; BBS: Berg Balance Scale; FES-
I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first second; FVC: forced 
vital capacity; HADS: Hospital and Anxiety Depression Scale; IVC: inspiratory vital capacity; PDQ-39: 
Parkinson’s disease Questionnaire-39; SD: standard deviation; TUG: Timed Up and Go.  
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9.4.2. Between-group comparison at post-intervention 
There were no significant differences (p > .05) between the study groups for the primary 
(depression) and secondary outcomes at the end of the treatment; apart from the HADS 
total score (p= .03, t= -2.17), where the effect size indicated a moderate effect (eta 
squared= .07)  (table 9.7). For the rest outcomes the effect size was small. 
 
Table 9.7. Between-group comparison at post-intervention.  
Outcome measure Intervention group 
Mean (SD) 
Control group 
Mean (SD) 
P value Effect size 
 
HADS 
Anxiety 6.81 (± 3.42) 8.03 (± 2.79) p = .13  
t =  - 1.53 
.03 
Depression 9 * 9.5 * p = .07  
z = -1.75 
.22 
Total 16.03 (± 4.71) 18.70 (± 4.97) p = .03  
t = -2.17 
.07 
 
 
 
 
PDQ-39 
Mobility (%) 35.47 (± 20.43) 35.30 (± 19.02) p = .97  
t = .03 
.00 
ADL (%) 27 * 29 * p = .52 
z = -.64 
.08 
Emotional 
well-being (%) 
33 * 41 * p = .08  
z = -1.73 
.21 
Stigma (%) 15 * 25 * p = .12  
z = -1.55 
.19 
Social support (%) 16 * 16 * p = .38  
z = -.87 
.06 
Cognition (%) 31.22 (± 17.56) 30.23 (± 15.46) p = .66  
t = .43 
.00 
Communication (%) 16 * 29 * p = .52  
z = -.62 
.07 
Bodily discomfort (%) 50 * 41 * p = .44  
z = -.72 
.07 
Summary index (%) 30.38 (± 11.01) 32.47 (± 10.33) p = .44  
t = -.77 
.00 
FES-I 35.57 (± 9.27) 34.90 (± 10.93) p = .80  
t =  .25 
.00 
BBS 48.72 (± 4.53) 46.53 (± 6.38) p = .12  
t =  1.56 
.03 
TUG (seconds) 10.5 * 11 * p = .25  
z =  -1.13 
.15 
2MWT Walking distance 
(metres) 
92.42 (± 27.24) 81.91 (± 30.37) p = .16  
t = 1.40 
.04 
 
 
Spirometry 
FVC (%) 97.20 (± 25.94) 95.00 (± 19.78) p = .71  
t = .36 
.00 
FEV1 (%)  95.23 (± 23.36) 96.28 (± 22.37) p = .86  
t = -1.75 
.00 
FEV1 / FVC (%) 97 * 97.5 * p = .63 
z = -0.47 
.05 
IVC (%) 
 
83.40 (± 17.50) 80.93 (± 15.29) p = .56  
t = .57 
.00 
* median (for non-parametric data) 
Acronyms. 2MWT: two-minute walk test; ADL: activities of daily living; BBS: Berg Balance Scale; FES-
I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first second; FVC: forced 
vital capacity; HADS: Hospital and Anxiety Depression Scale; IVC: inspiratory vital capacity; PDQ-39: 
Parkinson’s disease Questionnaire-39; SD: standard deviation; TUG: Timed Up and Go.  
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9.4.3. Between-group comparison at follow-up 
The between-group comparison at follow-up did not reveal any significant difference (p > 
.05) in any of the outcome measures between the IG and CG (table 9.8), whereas the effect 
size was small for all the variables. 
 
Table 9.8. Between-group comparison at follow-up.  
Outcome measure Intervention group 
Mean (SD) 
Control group 
Mean (SD) 
P value Effect size 
 
HADS 
Anxiety 7.47 (± 3.53) 8.13 (± 2.63) p = .40  
t =  -.83 
.01 
Depression 9 * 10 * p = .12 
z =  -1.55 
.19 
Total 16 * 18. * p = .23 
z =  -1.18 
.14 
 
 
 
 
PDQ-39 
Mobility (%) 38.66 (± 18.90) 33.83 (± 18.17) p = .31  
t = 1.02 
.00 
ADL (%) 37.16 (± 22.76) 34.37 (± 15.11) p = .57 
t =  .56 
.00 
Emotional well-being 
(%) 
39 * 41 * p = .50  
z =  -.67 
.08 
Stigma (%) 18 * 25 * p = .15 
z =  -1.43 
.18 
Social support (%) 16 * 16 * p = .67  
z =  -.41 
.05 
Cognition (%) 31.53 (± 16.67) 25.50 (± 14.29) p = .13  
t = 1.52 
.03 
Communication (%) 25 * 25 * p = .80  
z =  -.25 
.03 
Bodily discomfort (%) 46.78 (± 19.97) 45.20 (± 12.78) p = .54  
t = .64 
.00 
Summary index (%) 32.31 (± 10.77) 31.50 (± 9.75) p = .75  
t = .31 
.00 
FES-I 35.33 (± 8.35) 34.38 (± 10.44) p = .69  
t = .38 
.00 
BBS 48 * 49 * p = .83  
z =  -.20 
.07 
TUG (seconds) 10.5 * 11 * p = .47 
z =  -.71 
.10 
2MWT Walking distance 
(metres) 
90.20 (± 27.33) 85.98 (± 28.48) p = .56  
t = .58 
.01 
 
 
Spirometry 
FVC (%) 92* 92 * p = .91 
z =  -.10 
.13 
FEV1 (%)  94.90 (± 22.45) 96.86 (± 20.78) p = .72 
t = -.34 
.00 
FEV1 / FVC (%) 
 
98.17 (± 11.32) 100.14 (± 10.25) p = .48  
t = -.70 
.01 
IVC (%) 
 
80.5* 81.5 * p = .71 
z =  -.36 
.04 
 
* median (for non-parametric data) 
Acronyms. 2MWT: two-minute walk test; ADL: activities of daily living; BBS: Berg Balance Scale; FES-
I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first second; FVC: forced 
vital capacity; HADS: Hospital and Anxiety Depression Scale; IVC: inspiratory vital capacity; PDQ-39: 
Parkinson’s disease Questionnaire-39; SD: standard deviation; TUG: Timed Up and Go. 
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9.5. Outcome measures: Within-group comparison  
9.5.1. Within-group comparison: intervention group 
Table 9.9 (p. 226) summarises the within group comparison for the IG between the three 
assessments of the study.  In summary, the group-based exercise and educational 
programme led to many statistically significant improvements, which persisted up to the 
end of the follow-up period, with medium or large effect sizes. In particular, the Friedman 
test and the post-hoc Wilcoxon Singed Rank tests revealed that depression (HADS-D) –the 
primary outcome measure- was statistically significant improved from baseline up to the 
end of the treatment (p= .00), and from baseline to follow-up (p= .00). The magnitude of 
the differences in the means was medium in both cases (t1-t2: r= .40; t1-t3: r= .31). 
Regarding the secondary outcomes, statistically significant improvements (p ≤ .05) 
emerged up to the follow-up period for: anxiety (HADS-A), with a large effect size (partial 
eta squared= .31); psychological distress (HADS), with a large effect size (partial eta 
squared= .34); functional balance (BBS), with a large effect size (t1-t2: r= .61; t1-t3: r= .59); 
functional mobility (TUG test); with a large effect size (t1-t2: r= .58; t1-t3: r= .59); exercise 
tolerance (2MWT), with a large effect size (partial eta squared: .45); forced vital capacity 
(FVC), with a medium effect size (t1-t2: r= .32; t1-t3: r= .34); forced expiratory volume in 
one second (FEV1), with a large effect size (partial eta squared: .26); and inspiratory vital 
capacity (IVC), with a medium effect size (t1-t3: r= .33). QoL (PDQ-39 SI) was statistically 
significant improved up to the end of the treatment, whereas its strength of association 
was medium (t1-t2: r= .33).  With respect to the subscales of PDQ-39, significant differences 
up to the follow-up were identified only in three subscales (mobility, emotional well-being, 
and stigma), whereas the scores of bodily discomfort subscale were worsened.  
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Table 9.9. Within-group comparison for the IG. 
Outcome measure T1 
Mean 
 (SD) 
T2 
Mean 
(SD) 
T3 
Mean 
(SD) 
P value Notes 
 
Effect size 
 
 
HADS 
Anxiety 8.88  
(± 4.61) 
6.81 
(± 3.42) 
7.47 
(± 3.53) 
F = 13.97 
p = .00 
t1-t2: p= .00 
t1-t3: p= .01 
t2-t3: p= .00 
.31 
Depression 10 * 9 * 9 * x2 =  12.06        
p =  .00 
t1-t2: p= .00 
t1-t3: p= .01 
t1-t2: r = .40 
t1-t3: r = .31 
t2-t3: r = .35 
Total 19.34 
(± 5.93) 
16.03 
(± 4.71) 
17.12 
(± 4.81) 
F = 16.52 
p = .00 
t1-t2: p= .00 
t1-t3: p= .00 
t2-t3: p= .00 
.34 
 
 
 
 
PDQ-39 
Mobility (%) 44.31 
(± 21.51) 
35.47 
(± 20.43) 
38.66 
(± 18.90) 
F = 9.83 
p = .00 
t1-t2: p= .00 
t1-t3: p= .00 
.24 
ADL (%) 37 * 27 * 35 * x2 =  9.47        
p =  .00 
t1-t2: p= .00 
 
t1-t2: r = .37 
t1-t3: r = .19 
t2-t3: r = .21 
Emotional well-
being (%) 
49.81 
(± 20.27) 
45.73 
(± 16.19) 
44.37 
(± 16.16) 
F = 16.55 
p = .00 
t1-t2: p= .00 
t1-t3: p= .00 
.34 
Stigma (%) 31 * 15 * 18 * x2 =  16.06          
p =  .00 
t1-t2: p= .00 
t1-t3: p= .01 
t1-t2: r = .40 
t1-t3: r = .40 
t2-t3: r = .18 
Social support 
(%) 
10 * 16 * 16 * x2 =  4.29          
p =  .11 
 t1-t2: r = .19 
t1-t3: r = .13 
t2-t3: r = .21 
Cognition (%) 35.18 
(± 20.01) 
31.22 
(± 17.56) 
31.53 
(± 16.67) 
F = 2.04 
p = .15 
 .06 
Com. (%) 25 * 16 * 25 * x2 =  .19         
p =  .90 
 t1-t2: r = .06 
t1-t3: r = .00 
t2-t3: r = .03 
Bodily 
discomfort (%) 
36.72 
(± 17.55) 
44.70 
(± 15.28) 
46.78 
(± 19.97) 
F = 13.34 
p = .00 
t1-t2: p= .00 
t1-t3: p= .00 
.30 
Summary index 
(%) 
32 * 31.5 * 32 * x2 =  12.20         
p =  .00 
t1-t2: p= .00 
 
t1-t2: r = .33 
t1-t3: r = .25 
t2-t3: r = .25 
FES-I 37.80 
(± 9.44) 
35.57 
(± 9.27) 
35.33 
(± 8.35) 
F = 3.09 
p = .08 
 .09 
BBS 46 * 48.5 * 48 * x2 =  42.27          
p =  .00 
t1-t2: p= .00 
t1-t3: p= .00 
t1-t2: r = .61 
t1-t3: r = .59 
t1-t3: r = .34 
TUG (seconds) 13 * 10.5 * 10.5 * x2 =  42.92        
p =  .00 
t1-t2: p= .00 
t1-t3: p= .00 
t1-t2: r = .58 
t1-t3: r = .59 
t2-t3: r = .33 
2MWT Walking 
distance 
(metres) 
85.02 
(± 24.77) 
92.42 
(± 27.24) 
90.20 
(± 27.33) 
F = 25.64 
p = .00 
t1-t2: p= .00 
t1-t3: p= .00 
 
.45 
 Sp
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o
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FVC (%) 88 * 87.5 * 92 * x2 =  13.02          
p =  .00 
t1-t2: p= .01 
t1-t3: p= .00 
t1-t2: r = .32 
t1-t3: r = .34 
t2-t3: r = .18 
FEV1 (%) 90.57 
(± 20.49) 
95.23 
(± 23.36) 
94.90 
(± 22.45) 
F = 11.17 
p = .00 
t1-t2: p= .00 
t1-t3: p= .00 
.26 
FEV1 / FVC (%) 94 * 97 * 98 * x2 =  1.08          
p =  .58 
 t1-t2: r = .13 
t1-t3: r = .14 
t2-t3: r = .08 
IVC (%)                      80 * 79.5 * 80.5 * x2 =  7.64          
p =  .02 
t1-t3: p= .00 t1-t2: r = .23 
t1-t3: r = .33 
t2-t3: r = .07 
* median (for non-parametric data) 
Abbreviations. 2MWT: two-minute walk test; ADL: activities of daily living; BBS: Berg Balance Scale; 
Com.: communication; FES-I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the 
first second; FVC: forced vital capacity; HADS: Hospital and Anxiety Depression Scale; IVC: 
inspiratory vital capacity; PDQ-39: Parkinson’s disease Questionnaire-39; SD: standard deviation; 
T1: pre-intervention; T2: post-intervention: T3: follow-up; TUG: Timed Up and Go. 
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9.5.2. Within-group comparison: comparison group 
With respect to the CG, no statistically significant differences (p > .05) occurred between 
the three assessments for depression and the majority of secondary outcome measures 
(table 9.10, p. 228). However, the individualised home-based programme improved 
significantly (p ≤ .05) balance (BBS) and functional mobility (TUG test) from baseline to 
follow-up; whereas the strength of association was large (r= .50-1.00). The IVC was 
significantly improved from post-intervention to follow-up (p= .00), and the magnitude of 
the differences in the means was medium (partial eta squared= .12) 
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Table 9.10. Within-group comparison for the CG. 
Outcome measure T1 
Mean     
(SD) 
T2 
Mean 
(SD) 
T3 
Mean   
(SD) 
P value Notes 
 
Effect size 
 
 
HADS 
Anxiety 8.23 
(± 3.09) 
8.03 
(± 2.79) 
8.13 
(± 2.62) 
F = .02 
p = .79 
 .00 
Depression 10 * 9.5 * 10 * x2 = 2.18 
p = .33 
 t1-t2: r = .12 
t1-t3: r = .17 
t2-t3: r = .03 
Total 18 * 17 * 18 * x2 = 2.11 
p = .34 
 t1-t2: r = .15 
t1-t3: r = .17 
t2-t3: r = .03 
 
 
 
 
PDQ-39 
Mobility (%) 35.87 
(± 19.28) 
35.30 
(± 19.02) 
33.83 
(± 18.17) 
F = 1.98 
p = .15 
 .06 
ADL (%) 39.50 
(± 20.35) 
33.83 
(± 17.02) 
34.37 
(± 15.11) 
F = 2.74 
p = .08 
 .08 
Emotional well-
being (%) 
39 * 41 * 41 * x2 = 2.13 
p = .34 
 t1-t2: r = .05 
t1-t3: r = .02 
t2-t3: r = .15 
Stigma (%) 22 * 25 * 25 * x2 = .46 
p = .79 
 t1-t2: r = .04 
t1-t3: r = .02 
t2-t3: r = .11 
Social support 
(%) 
12 * 16 * 16 * x2 = .45 
p = .79 
 t1-t2: r = .01 
t1-t3: r = .02 
t2-t3: r = .02 
Cognition (%) 31.33 
(± 18.83) 
30.23 
(± 15.46) 
25.50 
(± 14.29) 
F = 5.47 
p =  .00 
t1-t3: p= .02 
t2-t3: p= .01 
.15 
Com. (%) 25 * 29 * 25 * x2 = 3.24 
p = .19 
 t1-t2: r = .19 
t1-t3: r = .01 
t2-t3: r = .02 
Bodily 
discomfort (%) 
39 * 41 * 34 * x2 = 13.41 
p = .00 
t1-t2: p = .00 
t1-t3: p = .00 
 
t1-t2: r = .45 
t1-t3: r = .45 
t2-t3: r = .04 
Summary index 
(%) 
31.73 
(± 10.94) 
32.47 
(± 10.33) 
31.50 
(± 9.75) 
F = .71 
p = .45 
 .02 
FES-I 35.00 
(± 10.91) 
34.90 
(± 10.93) 
34.38 
(± 10.44) 
F = .37 
p = .60 
 .01 
BBS 46 * 48 * 49 * x2 = 41.73 
p = .00 
t1-t2: p = .00 
t1-t3: p = .00 
 
t1-t2: r = .58 
t1-t3: r = .59 
t2-t3: r = .07 
TUG (seconds) 11.5 * 11 * 11 * x2 = 30.05 
p = .00 
t1-t2: p = .00 
t1-t3: p = .00 
 
t1-t2: r = .52 
t1-t3: r = .53 
t2-t3: r = .19 
2MWT Walking 
distance 
(metres) 
82.53 
(± 27.72) 
81.91 
(± 30.37) 
85.98 
(± 28.48) 
F = 1.50 
p = .23 
 .04 
Sp
ir
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FVC (%) 93.90 
(± 19.48) 
95.00 
(± 19.78) 
96.30 
(± 18.02) 
F = 2.49 
p = .10 
 .07 
FEV1 (%) 94.45 
(± 21.75) 
96.28 
(± 22.37) 
96.86 
(± 20.78) 
F = 3.81 
p = .51 
 .11 
FEV1 / FVC (%) 96 * 97.5 * 98 * x2 = 1.07 
p = .58 
 t1-t2: r = .09 
t1-t3: r = .10 
t2-t3: r = .09 
IVC (%) 82.55 
(± 16.48) 
80.93 
(± 15.29) 
82.60 
(± 14.89) 
F = 3.94 
p = .03 
t2-t3: p= .00 .12 
* median (for non-parametric data) 
Abbreviations. 2MWT: two-minute walk test; ADL: activities of daily living; BBS: Berg Balance Scale; 
Com.: communication; FES-I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the 
first second; FVC: forced vital capacity; HADS: Hospital and Anxiety Depression Scale; IVC: 
inspiratory vital capacity; PDQ-39: Parkinson’s disease Questionnaire-39; SD: standard deviation; 
T1: pre-intervention; T2: post-intervention: T3: follow-up; TUG: Timed Up and Go. 
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9.6. Score differences and minimum clinically important difference (MCID) 
The score differences of the outcomes -within and between the study groups- from 
baseline to follow-up- were compared with the MCID values for each instrument, to detect 
any clinically significant change within the group or difference between the groups. The 
MCID values for each measurement tool have already been reported in Sections 8.7.1-
8.7.15. However, table 9.11 summarises the MCIDs values for the measurement tools of 
the present study, and the population for which they were calculated. 
 
Table 9.11. MCIDs values for the measurement tools and the population for which they were 
calculated. 
Measurement tool MCID 
value 
Population References for the 
MCID values 
HADS HADS-A 1.5 Chronic obstructive pulmonary disease (inpatients) 
 
Puhan et al., 2008 
HADS-D 1.5 Chronic obstructive pulmonary disease (inpatients) 
 
Puhan et al., 2008 
PDQ-39 PDQ-39 SI (%) 4.2 Parkinson’s disease 
 
Horváth et al., 2017 
BBS 3 Multiple sclerosis (inpatients and outpatients) 
 
Gervasoni et al., 2017 
FES-I 3.5 Geriatric population 
 
Delbaere et al., 2010 
TUG (in seconds) 3.4 Lumbar degenerative disc disease (after surgery) Gautschi et al., 2017 
2MWT 2MWD (in metres) 
 
5.5 Chronic obstructive pulmonary disease Johnston et al., 2017 
Spirometry FVC% (%) 
 
3 Respiratory disorders Kafaja et al., 2017 
FEV1 (%) 
 
5 Chronic obstructive pulmonary disease Jones et al., 2014 
 
Abbreviations. 2MWD: two-minute walking distance; 2MWT: 2-metre walk test; BBS: Berg Balance 
Scale; FES-I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first second; FVC: 
forced vital capacity; HADS: Hospital and Anxiety Depression Scale; HADS-A: Hospital and Anxiety 
Depression Scale-anxiety; HADS-D: Hospital and Anxiety Depression Scale-depression; MCID: 
minimal clinically important difference; PDQ-39: Parkinson’s disease Questionnaire-39; SI: 
summary index; TUG: Timed Up and Go.  
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9.6.1. Between-groups score differences 
Table 9.12 presents the between-group comparison at baseline, post-intervention and 
follow-up. Clinically significant differences between the study groups were detected only 
at post-intervention for the following outcomes: 2MWD (11.56 > 5.5), FVC (%) (4.05 > 3).  
 
Table 9.12. Score differences between the study groups at baseline, post-intervention, follow-up. 
Variables T1: Δ(IG-CG) T2: Δ(IG-CG) T3: Δ(IG-CG) 
HADS-A 0.65 -1.22 -0.66 
HADS-D -0.37 -1.45 -0.87 
PDQ-39 SI (%) 3.33 -2.09 0.81 
BBS -0.03 2.19 1.18 
FES-I 2.67 -0.12 0.39 
TUG                     
(in seconds) 
-1.11 -2.47 -2.13 
2MWD                
(in metres) 
3.07 11.56 * 5.38 
FVC (%) 0.72 4.05 * 1.79 
FEV1 (%) -2.22 0.42 -0.32 
  
* clinically significant changes  
Abbreviations. 2MWT: two-minute walking distance; Δ: difference; BBS: Berg Balance Scale; CG: 
comparison group; FES-I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first 
second; FVC: forced vital capacity; HADS-A: Hospital and Anxiety Depression Scale-anxiety; HADS-
D: Hospital and Anxiety Depression Scale-depression; IG: intervention group; PDQ-39 SI: Parkinson’s 
disease Questionnaire- 39 summary index; T1: pre-intervention; T2: post-intervention: T3: follow-
up; TUG: Timed Up and Go. 
 
 
9.6.2. Within-group score differences 
Table 9.13 (p. 231) shows that within the IG, the following clinically significant changes 
occurred: 
 HADS-A (2.07> 1.5), PDQ-39 summary index (SI) (4.68> 4.2), BBS (4.85> 3), 2MWD 
(7.40> 5.5), and FVC (%) (4.1 >3) from baseline to post-intervention. 
 BBS (3.94> 3), and FVC (3.47> 3) from baseline to follow-up. 
 
On the contrary, no clinically significant changes emerged within the CG from baseline to 
follow-up (table 9.14, p. 223).  
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Table 9.13. Score changes within the IG. 
Variables T1 T2 T3 Δ (Τ2 –Τ1) Δ (Τ3 –Τ1) Δ (Τ3 –Τ2) 
HADS-A 8.88 6.81 7.47 -2.07 * -1.41 0.66 
HADS-D 10.5 9.22 9.66 -1.28 - 0.84 0.44 
PDQ-39 SI (%) 35.06 30.38 32.31 -4.68 * - 2.75 1.93 
BBS 43.87 48.72 47.81 4.85 * 3.94 * -0.91 
FES-I 37.80 35.57 35.33 -2.23 -2.47 -0.24 
TUG                  
(in seconds) 
13.15 11.03 11.32 -2.12 -1.83 0.29 
2MWD             
(in metres) 
85.02 92.42 90.20 7.40 * 5.18 * -2.16 
FVC (%) 94.62 98.72 98.09 4.1 * 3.47 -0.63 
FEV1 (%) 90.57 95.23 94.90 4.66 4.33 -0.33 
 
* clinically significant changes 
Abbreviations. 2MWT: two-minute walking distance; Δ: difference; BBS: Berg Balance Scale; FES-I: 
Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first second; FVC: forced vital 
capacity; HADS-A: Hospital and Anxiety Depression Scale-anxiety; HADS-D: Hospital and Anxiety 
Depression Scale-depression; PDQ-39 SI: Parkinson’s disease Questionnaire- 39 summary index; T1: 
pre-intervention; T2: post-intervention: T3: follow-up; TUG: Timed Up and Go.  
 
 
Table 9.14. Score changes within the CG. 
Variables T1 T2 T3 Δ (Τ2 –Τ1) Δ (Τ3 –Τ1) Δ (Τ3 –Τ2) 
HADS-A 8.23 8.03 8.13 -0.2 -0.1 0.1 
HADS-D 10.87 10.67 10.53 -0.2 -0.34 -0.14 
PDQ-39 SI (%) 31.73 32.47 31.5 0.74 -0.23 -0.97 
BBS 43.9 46.53 46.63 2.63 2.73 0.1 
FES-I 35.27 35.53 34.80 0.26 -0.47 -0.43 
TUG                  
(in seconds) 
14.26 13.5 13.45 -0.76 -0.81 -0.05 
2MWD             
(in metres) 
82.05 81.61 85.63 -0.44 3.58 4.02 
FVC (%) 93.9 94.67 96.3 0.77 2.4 1.64 
FEV1 (%) 93.63 96.17 96.63 2.54 3 0.46 
 
Abbreviations. 2MWT: two-minute walking distance; Δ: difference; BBS: Berg Balance Scale; FES-I: 
Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first second; FVC: forced vital 
capacity; HADS-A: Hospital and Anxiety Depression Scale-anxiety; HADS-D: Hospital and Anxiety 
Depression Scale-depression; PDQ-39 SI: Parkinson’s disease Questionnaire- 39 summary index; T1: 
pre-intervention; T2: post-intervention: T3: follow-up; TUG: Timed Up and Go.  
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9.7. Categorisation of anxiety and depression severity 
Α further within- and between-group analysis for anxiety and depression was carried out. 
The scoring of each sub-scale (HADS-A, HADS-D) for each participant, was replaced by the 
corresponding category (table 9.15), as had been proposed by Zigmond and Snaith (1983) 
(Appendix 8.8). As seen in the table, at baseline none of the participants was identified as 
not depressed in order to meet all the inclusion criteria of the RCT (section 8.5.2). The 
majority of participants (n= 38, 61.3%) were classified as ‘mild depressed’, whereas only 
five subjects (8%) as ‘severe depressed’. At the end of the intervention period, 15.32% of 
subjects in the IG and 13.33% in the CG were free of depression. Regarding anxiety, 28 
subjects (45.1%) were free of anxiety at baseline, whereas 31 (50%) at post-intervention 
and follow-up assessment.  
 
Table 9.15.  Categorisation of anxiety and depression based on the HADS-A and HADS-D scores. 
Categories for anxiety and depression Pre-intervention Post-intervention Follow-up 
IG 
(n= 32) 
CG 
(n= 30) 
IG 
(n= 32) 
CG 
(n= 30) 
IG 
(n= 32) 
CG 
(n= 30) 
Normal 
(0-7) 
A 15 13 18 13 18 13 
D 0 0 5 4 5 1 
Mild 
(8-10) 
A 7 10 10 11 9 10 
D 20 18 23 12 21 17 
Moderate 
(11-14) 
A 5 7 3 6 4 7 
D 9 10 2 10 3 10 
Severe 
(15-21) 
A 5 0 1 0 1 0 
D 3 2 2 4 3 2 
 
Acronyms. A: anxiety; CG: comparison group; D: depression; IG: intervention group; n: number of 
patients. 
 
 
9.8. Correlations of anxiety and depression with other variables 
9.8.1. Correlation of anxiety and depression at baseline (whole sample) 
A correlation analysis was conducted at baseline for the whole sample to explore the 
strength of relationship of anxiety and depression with: the anthropometric characteristics, 
features related to PD and rest outcome measures (table 9.16, p. 234). The results revealed 
a medium correlation between anxiety (as measured by the HADS-A subscale) and 
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depression (as measured the by the HADS-D subscale) (rs = .36, p = .00), with higher levels 
of depression being associated with higher levels of anxiety. 
 
With respect to depression, there was not any strong correlation (r/rs = .50-1.00) between 
the HADS-D subscale and the other examined variables. However, there was a medium 
correlation (r/rs = .30- .49) between depression and: several domains of QoL (PDQ-39 
mobility, PDQ-39 ADL, PDQ-39 emotional well-being, PDQ-39 cognition), PDQ-39 SI score, 
FOF (FES-I), functional mobility (TUG test),  balance (BBS), and exercise tolerance (2MWT). 
In particular, higher levels of depression were associated with: poorer QoL, more FOF to 
perform ADLs, more time to complete the TUG test, lower levels of functional balance, and 
less walking distance covered in two minutes time. Lastly, its correlation with the other 
variables was either small (r/rs = .10-.29) or very small (r/rs = .00-.09). 
 
Concerning anxiety, there was only a strong correlation (r/rs = .50-1.00) between the HADS-
A and PDQ-39 cognition subscale. The tests also indicated medium correlation (r/rs = .30- 
.49) between anxiety and: some subscales of QoL (PDQ-39 mobility, PDQ-39 emotional 
well-being, PDQ-39 bodily discomfort), and QOL (as measured by the PDQ-39 SI). The 
correlation between anxiety and the other variables was either small (r/rs = .10-.29) or very 
small (r/rs = .00-.09). 
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Table 9.16.  Correlation of anxiety and depression with other variables at baseline. 
Variables Anxiety  Depression 
 
Gender rs =  .26 
p = .03 
rs =  .15 
p = .23 
 
Age (in years) 
r = -.08 
p = .95 
rs =  .22 
p = .08 
 
Years since PD diagnosis 
rs = .09 
p = .45 
rs =  -.02 
p = .84 
H&Y stage r = .16 
p = .21 
rs =  .26 
p = .03 
FOG rs = .21 
p = .91 
rs =  -.01 
p = .08 
 
UPDRS 
 
Total 
rs = .06 
p = .63 
rs =  .23 
p = .07 
 
III (motor) 
rs = .08 
p = .53 
rs =  .27 
p =  .03 
 
HADS 
 
Anxiety  
 rs = .36 
p = .00 
  
Depression 
rs = .36 
p = .00 
 
 
 
 
PDQ-39 
 
Mobility 
r = .30 
p = .01 
rs = .35 
p = .00 
 
ADL 
rs =  .21 
p = .10 
rs =  .32 
p = .01 
Emotional well-being rs =  .37 
p = .00 
rs =  .32 
p = .01 
 
Stigma  
rs = .06 
p = .63 
rs =  .18 
p = .15 
 
Social support 
rs = .09 
p = .47 
rs =  .11 
p = .40 
 
Cognition  
r =  .57 * 
p = .00 
rs =  .31 
p = .01 
 
Communication 
rs =  .20 
p = .11 
rs = .22 
p = .08 
Bodily discomfort rs =  .38 
p = .00 
rs = .10 
p = .44 
 
Summary index  
r =  .48 
p = .00 
rs = .45 
p = .00 
 
FES-I 
r = .29 
p = .02 
rs =  .32 
p = .01 
 
BBS 
rs = -.18 
p = .15 
rs = -.47 
p = .00 
 
TUG 
rs =  .13 
p = .32 
rs = .40 
p = .00 
 
2MWT 
Walking distance r = -.13 
p = .32 
rs = -.41 
p = .00 
 
 
Spirometry 
 
FVC % 
rs =  -.23 
p = .07 
rs =  -.06 
p = .63 
 
FEV1  % 
rs =  -.06 
p = .64 
rs =  .02 
p = .84 
 
FEV1 / FVC % 
rs =  .18 
p = .17 
rs = -.06 
p =  .60 
 
IVC %                      
r =  -.22 
p = .08 
rs =  -.08 
p = .50 
* strong relationship  
Acronyms. 2MWT: two-minute walk test; ADL: activities of daily living; BBS: Berg Balance Scale; 
H&Y: Hoehn and Yahr; FES-I: Fall Efficacy Scale-International; FOG: freezing of gait; FEV1: forced 
expiratory volume in the first second; FVC: forced vital capacity; HADS: Hospital and Anxiety 
Depression Scale; IVC: inspiratory vital capacity; PDQ-39: Parkinson’s disease Questionnaire-39; 
TUG: Timed Up and Go. 
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9.8.2. Correlation of depression at post-intervention and follow-up (intervention group) 
As the levels of depression were statistically significant improved in the IG at post-
intervention and follow-up; it was decided to conduct a correlation analysis to explore the 
strength of the linear relationship between depression (as measured by the HADS-D) and 
the secondary outcome measures, using Spearman rho (Table 9.17, p. 236). As seen in the 
table, at post-intervention there was a strong relationship (rs= .50- 1.00) between the 
HADS-D and: HADS, PDQ-39 mobility and FES-I scores; and a medium relationship (rs= .30- 
.49) between the HADS-D and: HADS-A, PDQ-39 emotional well-being, PDQ-39 social 
support, PDQ-39 SI, BBS, FVC, FEV1, and FEV1/FVC. At follow-up, a strong relationship (rs= 
.50- 1.00) was found between HADS-D and: HADS, PDQ-39 mobility, and PDQ-39 emotional 
well-being. Lastly, a medium relationship (rs= .30- .49) was detected between HADS-D and: 
PDQ-39 social support, PDQ-39 SI, FES-I, BBS, and FEV1/FVC scores. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 9:   RCT-results 
236 
 
Table 9.17.  Correlation of depression (HADS-D) with other outcomes at post-intervention and 
follow-up for the IG. 
Variables Post-intervention Follow-up 
 
 
HADS 
 
Anxiety  
rs = .34 
p = .05 
rs = .29 
p = .10 
  
Total 
rs =  .67 * 
p = .00 
rs = .84 * 
p = .00 
 
 
 
PDQ-39 
 
Mobility 
rs =  .58 * 
p = .00 
rs = .50 * 
p = .00 
 
ADL 
rs =  .20 
p = .26 
rs =  .21 
p = .23 
Emotional well-being rs =  .34 
p = .05 
rs =  .55 * 
p = .00 
 
Stigma  
rs =  .03 
p = .85 
rs =  .08 
p = .62 
 
Social support 
rs = .33 
p = .05 
rs =  .35 
p = .04 
 
Cognition  
rs = .25 
p = .15 
rs =  .26 
p = .13 
 
Communication 
rs =  .05 
p = .75 
rs = -.18 
p = .30 
Bodily discomfort rs =  .16 
p = .34 
rs = .21 
p = .23 
 
Summary index  
rs =  .45 
p = .00 
rs = .42 
p = .01 
 
FES-I 
rs =  .52 * 
p = .00 
rs =  .41 
p = .01 
 
BBS 
rs =  -.47 
p = .06 
rs =  -.45 
p = .00 
 
TUG 
rs =  .17 
p = .33 
rs = .23 
p = .19 
 
2MWT 
Walking distance rs =  .23 
p = .20 
rs = -.25 
p = .15 
 
 
Spirometry 
 
FVC % 
rs =  -.35 
p = .06 
rs =  -.23 
p = .20 
 
FEV1  % 
rs =  -.32 
p = .06 
rs =  -.28 
p = .11 
 
FEV1 / FVC % 
rs =  -.37 
p = .03 
rs = -.33 
p =  .06 
 
IVC %                      
rs =  -.09 
p = .60 
rs =  -.06 
p = .73 
 
* strong relationship 
 
Acronyms. 2MWT: two-minute walk test; ADL: activities of daily living; BBS: Berg Balance Scale; FES-
I: Fall Efficacy Scale-International; FEV1: forced expiratory volume in the first second; FVC: forced 
vital capacity; HADS: Hospital and Anxiety Depression Scale; IVC: inspiratory vital capacity; PDQ-39: 
Parkinson’s disease Questionnaire-39; TUG: Timed Up and Go. 
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9.9. Falls 
9.9.1. Number of falls and fallers 
During the five-month study period, a total of 121 falls were reported by 28 participants 
(45.1%); 12 of them being in the IG and 16 in the CG. The majority of falls were recorded in 
the CG (n= 65, 53.7%); compared the IG (n= 55, 46.7%). Nine participants fell once; whereas 
19 were classified as recurrent fallers, reporting at least two falls during the whole study 
period. The majority of fallers (n=18) were at H&Y stage three; whereas one at H&Y stage 
1.5; five at H&Y stage two, and four at H&Y stage 2.5. 
 
9.9.2. Predictors of falls  
With respect to the fallers during the intervention and follow-up period, the logistic 
regression contained one dependent variable (fallers), and seven independent variables, 
related to the demographic characteristics and features of the disease (gender, age, years 
since PD diagnosis, walking aid, UPDRS, H&Y stage, FOG). The full model containing all the 
predictors was statistically significant (χ2 = 16.97, p = .01), indicating that the model was 
able to distinguish between patients who reported and did not report any fall, and correctly 
classified 74.2% of cases. However, only two independent variables made a unique 
statistically significant contribution to the model (p < .05): the UPDRS total score and H&Y 
stage. The strongest predictor of reporting falls was H&Y stage (p < .03). An increase in 
these two independent variables resulted in an increased probability for a fall. 
 
9.9.3. Circumstances of falls 
The circumstances of falls were fully reported in 116 out of 121 cases, and are presented 
in table 9.18 (p. 239). A large proportion of falls (n= 39, 32.2%) occurred in the late night or 
early in the morning (12 am – 9 am). In addition, the majority of falls happened at patient’s 
home/property (n= 69, 57%). Seven occurred indoors, but not in patient’s home; and 44 
outdoors. The living room was the most common location for indoor home/property falls 
and for overall falls (n= 28, 23.1%). Four home/property falls occurred outdoors (balcony, 
garden). The activity during fall was reported in 115 cases. Ambulation (n= 79, 65.3%), 
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standing (n= 27, 22.3%) and transfers (n= 10, 7.2%) activities indicated that the cause of 
falls was related to static or dynamic balance. An interesting fact is that four falls occurred 
at late night, when the patients woke up to go to the toilet. The fall-associated factors were 
reported in 75 falls (61.5%). The number of intrinsic (n= 37) and extrinsic factors (n= 38) 
was almost equal; whereas in four cases the subjects were unable to describe the fall’s 
cause, as they were found suddenly on the floor. Two common extrinsic factors (pavements 
and beach) are related to the landscape of the country. In particular, the subjects reported 
that they lost their balance while walking on a sandy or rocky beach. In addition, the bad 
condition of pavements (i.e. broken pavements), obstacles -especially on narrow 
pavements (i.e. parked cars, trees, stairs leading to front doors)-, and uphill/downhill 
pavements, led to 27 outdoors falls.  
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Table 9.18. Circumstances of falls during the intervention and follow-up period. 
Variables Number of cases 
 
Time 
Morning (5:00 am - 11:59 am) 44 (36.3%) 
Afternoon (12:00 pm – 3:59 pm) 12 (9.9%) 
Evening (4:00 pm – 7:59 pm) 37 (30.6%) 
Night (8:00 pm – 4:59 am) 22 (18.2%) 
Missing 6 (4.9%) 
Location  Indoors 72 (59.5%) 
Outdoors 48 (39.7%) 
Missing 1 (0.8%) 
Location for 
home/property 
Indoors  (n= 65) 
  
Living room  28 (23.1%) 
Bedroom  12 (9.9%) 
Kitchen  8 (6.6%) 
Hallway  5 (4.1%) 
Bathroom  4 (3.3%) 
Stairs  3 (2.5%) 
Warehouse  3 (2.5%) 
Garage  1 (0.8%) 
Non-specified  1 (0.8%) 
Outdoors (n= 4) Balcony  2 (1.6%) 
Garden  2 (1.6%) 
Activity during fall Ambulation (n= 79) Walking  48 (39.7%) 
Turning  12 (9.9%) 
Stairs 7 (5.8%) 
Carrying  9 (7.4%) 
Running  3 (2.5%) 
Standing (n= 27) Bend/reach 23 (19%) 
Shower  2 (1.6%) 
Dressing 1 (0.8%) 
Gardening  1 (0.8%) 
Transfers (n= 10) To/from bed 2 (1.6%) 
To/ from chair/sofa 5 (4.1%) 
To/from car 1 (0.6%) 
Rolling out of bed  1 (0.6%) 
Fall-associated factors Intrinsic (n= 37)  Freezing  19 (15.7%) 
Loss of balance  9 (7.4%) 
Dizziness 4 (3.3%) 
Misjudgment 3 (2.5%) 
Distraction  2 (1.6%) 
Extrinsic (n= 38)  Pavement 27 (23.2%) 
Beach 5 (4.1%) 
Wet floor  3 (2.5%) 
Dark 2 (1.6%) 
Carpet  1 (0.8%) 
Work of medication 
during fall 
Well 36 (29.7%) 
Moderate 53 (43.8%) 
OFF 25 (20.7%) 
 
 
9.9.4. Fall-related injuries 
Of 121 falls, 32 (26.5%) sustained an injurious fall (table 9.19, p 240). Nearly 1/4 of injurious 
falls (n= 9) occurred indoors. In 15 cases, more than one injury was reported. Medical/ 
healthcare assistance was required in 14 cases. In seven cases, the patients sought 
assistance from a local pharmacy. In Greece, it is very common for employees working in 
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pharmacies to provide first aids, in case of minor injuries. The injuries were not serious, 
there was no fracture, and no need for hospitalisation. However, two lacerations required 
sutures. 
 
Table 9.19. Features of injuries during the intervention and follow-up period. 
Variables Number of cases 
Injury due to fall No 89 
Yes 32 
Type of injury Pain  21 
Contusion  16 
Laceration  13 
Ligament lesion (hand finger) 1 
 
Medical /healthcare  
assistance 
No 18 
Hospital 5 
Doctor  2 
Pharmacy 7 
 
 
9.10. Satisfaction questionnaire 
Twenty two participants –ten males and twelve females- of the IG completed the SQ about 
the exercise classes.  However, only in twelve cases all the questions were answered. The 
feedback of participants was positive, indicating subjective improvements in emotional 
well-being and mobility. Although the questions were just designed for the exercise 
programme, few answers provided useful information for the educational programme. The 
emergent themes were related to the questionnaire's items. A synopsis of the answers of 
items one to eight is presented in table 9.20 (p. 241). 
 
 
 
 
 
 
Chapter 9:   RCT-results 
241 
 
Table 9.20. Answers of questions 1-8. 
Question Answers Number of 
answers 
1. How easy/hard was the 
programme? 
Moderate 7 
Easy with some difficulties, tailored in PD 6 
Quite easy 5 
Easy  2 
Difficult  2 
2. Have you noticed any 
positive effects from doing 
the programme?  
Improvements  in gait parameters 7 
Improvements in emotional well-being 5 
Improvements in transfers 4 
More erected posture 4 
General improvements 3 
Social interaction 2 
Improvements in reaching 1 
Improvements in breathing 1 
More knowledge  about PD  1 
No benefits 1 
3. Have you noticed any 
negative effects from doing 
the programme?  
No 17 
4. What did you like more 
about the programme? 
Whole programme 11 
Physiotherapy team 3 
Breathing exercises 2 
Group-based design 2 
Gait training 2 
Ball exercises  1 
Variety of exercises 1 
5. What did you like less 
about the programme? 
Nothing  8 
Exercise venue 4 
Few exercise bouts 2 
No variety of exercises 2 
Ball exercises 1 
Breathing exercises  1 
6. What would you like to 
change in the programme? 
Any ideas to propose? 
No changes 7 
More exercise hours 6 
Exercise venue 4 
Time of exercise (evening instead of morning) 1 
More homogeneous sample: similar age and level of mobility 1 
Warmer indoor exercise environment  1 
7. What motivated you to 
participate to the 
programme? 
To improve functional mobility 7 
Financial reasons 5 
Socialisation- meet other patients with PD 2 
The programme was provided by specialists in PD 2 
Family’s instigation 1 
To improve knowledge about PD 1 
8. What motivated you to 
complete the programme? 
Health improvement related to PD 13 
Physiotherapy’s team attitude 4 
Socialisation 3 
Knowledge about PD 2 
Group-based environment 1 
Variety of exercise modalities 1 
 
Acronyms. PD: Parkinson’s disease. 
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How easy/hard was the programme? 
The participants characterised the exercise programme passable, whereas only two found 
it difficult. Only six individuals gave long answers, describing the programme generally easy 
with some difficulties, tailored in PD population. One female wrote: “I cannot say how much 
easy or difficult the training programme was, as its aim was to exercise PD patients.” 
(GA05). Although, some patients found the programme difficult at the beginning, they did 
not quit: “…Some exercises were difficult, but I didn’t give up!” (AE07); “During the first 
sessions I found the whole programme difficult. I was getting tired easily. Afterwards, the 
fatigue was reduced.” (PE01). 
 
Have you noticed any positive effects from doing the programme?  
Twenty out of 21 participants found the exercise programme beneficial. Although the 
patients were asked to specify the positive effects they noticed, three of them reported 
just “General improvements” (AE18, IL10, PE01). A large proportion (n= 10) noticed 
improvements in functional mobility: transfers and quality aspects of gait. Some beneficial 
effects on mobility were obvious even during the first weeks of exercise: “Many movements 
were improved from the first week.” (IL03). Regarding walking, one respondent noticed 
improvements (increased step length, walking speed and improved balance) both in indoor 
and outdoor walking. An interesting fact was that in many cases the verb ‘learning’ was 
written in the answers. This may indicate that the whole programme helped the patients 
to see the exercise as a learning procedure to manage PD and change their lifestyle: “I 
learned practical exercises that helped my walking and my sitting on a chair.” (GA05); “…I 
learned how to overcome freezing and turn safely.” (PF04); “I learned to stand up properly 
and correct my posture.” (PE01); “I learned how to perform stretches by myself.” (GA03); “I 
learned to use my belly to breathe.” (AE21); and “The exercise and educational sessions 
helped me to learn more about my disease.” (PF12). In addition, five patients reported 
improvements in emotional well-being: “I was feeling better psychologically!” (GA05); 
“Wellness” (PF06). Lastly, two patients pointed out the social interaction of group 
therapeutic exercise programmes between individuals with similar features: “I made new 
friends.” (IL10); “I met other people with Parkinson’s disease.” (IL05). 
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Have you noticed any negative effects from doing the programme?  
None of the trainees found the exercise harmful. Ιndicaticely, one female wrote: “No 
negative effects, just positive!”  (IL10). 
 
What did you like more about the programme? 
With respect to what they liked more about the programme, few patients gave specific 
answers; whereas 11 individuals reported that they enjoyed the whole programme. It 
seems that exercise instructors specialised in PD, polite, and having the knowledge how to 
approach the participants; it was not only appreciated by the patients, but it was also an 
important factor to complete the programme: “Our physiotherapist taught us all the 
exercises in detail. He explained the aim of each exercise and answered all our questions 
relevant to the exercise.” (IL01); “The physiotherapists were polite…they were correcting 
our movements, if they were wrong.” (GA05); “The physiotherapist’s instructions were 
clear…” (PE01).  Similarly, a non-monotonous design, consisting of a variety of exercise 
modalities, both attracted the participants, and motivated them to complete the 
programme. The group-based design also enhanced sociability and reduced isolation: “…I 
was arriving half an hour earlier to discuss with my friends” (PF04); “In group exercise 
programmes you can meet and compare yourself with other patients. You learn many 
things from them…how to address daily problems related to Parkinson’s.” (IL03). 
 
What did you like less about the programme? 
Eight out of 15 patients, who responded this question, found nothing negative for the 
programme: “Everything was perfect!” (PE09). Only five individuals expressed some 
complaints about the design of the training programme. Two wrote that the total training 
hours were not enough, and more exercises could be included into the programme. 
However, in two municipalities there were complaints about the exercise venues, as they 
were considered either small for the current training protocol or dirty. 
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What would you like to change in the programme? Any ideas to propose? 
The participants were generally satisfied: “I would not change anything” (IL10); “The 
programme was effective.” (AE21); “….I was totally satisfied.” (PE09). However, some 
modifications were proposed.  Some of them were related to their responses on question 
five (What thing did you like less about the programme?), about the exercise venue and 
the total training hours (i.e. three exercise bouts a week). One respondent proposed 
outdoors exercise, because: “…the weather in Athens is perfect for training outdoors.” 
(PF05). Lastly, despite that the air temperature in the venues was strictly followed the 
recommendations in the literature, one female would prefer exercise in warmer 
environment, as she was feeling cold. 
 
What motivated you to participate in the programme? 
The reasons, which led the individuals to participate in the study, were not related to the 
primary aim of the study (depression); despite the potential participants were aware of it. 
The main reason was to improve functional mobility (n= 7): ADLs and walking. An 
interesting fact, related to the ongoing financial crisis in Greece, was that five patients 
decided to participate, due to their inability to cover the expenditures of a physiotherapy 
programme. Specifically, one respondent wrote: “PD is the disease of the rich people. Visits 
to doctors, physiotherapists and speech therapists are very expensive. I cannot afford the 
high cost, as my income has been reduced.” (PF12). Two people decided to participate in 
the programme, because it was offered by healthcare professionals with knowledge in PD; 
indicating the need for specialised physiotherapists in PD in Greece. One female wrote that: 
“This study is provided by a doctoral student and healthcare professionals, under the 
supervision of the Greek PD Association. Thus, they are specialised in the management of 
the disease.” (PF06). Another patient wrote: “The programme was provided by 
physiotherapists with knowledge in PD. There are no many physiotherapists and doctors 
specialised in PD (in Greece)….” (AE21). 
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What motivated you to complete the programme? 
Improvements mainly in motor function and emotional well-being motivated patients to 
complete the programme. 13 individuals decided to complete the programme, due to 
improvements in gait (n= 6), ADLs (n= 3), emotional well-being (n= 3), breathing (n= 1). One 
male wrote: “The improvement on my gait, posture and psychology.” (GA09). Additional 
factors were: the physiotherapists’ attitude, and the interaction with other people suffering 
from PD. Lastly, it is believed that previously reported answers in the question “What did 
you like more about the programme?” may provide additional reasons that led the 
individuals to complete the intervention. 
 
Do you have anything else you would like to add? 
Eighteen patients completed the last question providing more information about their 
perception relevant to the exercise programme and their emotional well-being. It is 
remarkable that nobody wrote negative comments, whereas some included a thankful 
statement: “Thank you for the exercise programme. I was lucky I participated” (AE14). Some 
patients described the programme as one of their few pleasures: “Apart from food, the 
programme was my only pleasure.” (AE03); “…I live alone and I feel lonely…I was very happy 
on Wednesdays and Fridays……I made new friends……After the end of the exercise bout, we 
were going out for coffee” (IL05). Four patients with PD expressed their desire, to 
participate in similar programmes in the future: “It would be great if Epikouros-kinisi will 
offer a similar free exercise programme” (PE12); “I want to follow again the exercise 
programme in the autumn” (IL05).  
 
Five patients wrote comments related to their psychological well-being. One woman stated 
the motivation needed when treating depressed population: “Sometimes, due to 
depression, it was difficult to take the decision to get out of my house and go to the exercise 
venue…...I was feeling exhausted for no reason…The programme gave me motivation… 
When I was starting the exercise, I was able to complete the whole session” (PF06).  Two 
patients explained the reason that their psychological well-being was not improved at the 
end of the intervention period. It seems that their family did not support them: ‘My 
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psychology was not improved. My husband does not support me. We do nothing together. 
He pressures me to walk faster. When the tremor starts, he hits my hand.…” (AE13); “My 
psychology is getting worse. I am afraid of my disease. When I walk, I feel that all the people 
watch at me…. My mother always tells me that I am suffering from PD and I ‘m gonna die. 
I feel depressed. I cannot do the activities I did in the past…” (AE21).  Finally two patients 
expressed their concern about the future: “I am worried about the future. I live by myself” 
(IL05); “Although the programme was beneficial, the fear of falling has been increased. I 
am afraid of a future fall, because Mrs X had a fall-related injury.” (PE09). 
 
9.11. Summary of Chapter 9 
 There were no significant differences at baseline between the study groups in all the 
socio-demographic characteristics and health status; apart from the UPDRS-I scores. 
 There were no significant differences between the two groups at baseline, end of 
treatment or follow-up on any outcome measure score, apart from the HADS score at 
post-intervention. 
 The IG demonstrated a statistically significant improvement in depression (HADS-D), 
anxiety (HADS-A), psychological distress (HADS), QoL (PDQ-39) functional balance 
(BBS), functional mobility (TUG), exercise tolerance (2MWT) and lung function (FVC, 
FEV1) scores at the end of the treatment. These improvements, apart from the QoL, 
persisted up to the end of the three-month follow-up period. 
  On the contrary, in the CG, only the BBS and TUG scores were statistically significant 
improved from baseline to post intervention and follow-up.  
 However, the between-group comparison revealed that there were no significant 
differences between the IG and CG at post-intervention and follow-up, apart from the 
HADS total score at post-intervention. 
 The group-based exercise and educational programme also resulted in clinically 
significant changes (based on the MCID values) on HADS-A, PDQ-39 SI, BBS, 2MWD and 
FVC scores at the end of the treatment. However, only the MCID value for PDQ-39 has 
been established in PD. 
 Although the SQ was completed only by 22 participants of the IG; the feedback was 
positive, indicating subjective improvements in emotional well-being and mobility. 
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 The drop-out rate for the entire period of study in both groups was 13.3%, and the 
training protocols were not harmful for the participants. 
 121 falls were recorded during the entire study’s period. The majority of falls occurred 
at patient’s home/property; and they were caused by both intrinsic and extrinsic 
factors. Only ¼ of them caused minor injuries. 
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10.1. Main findings – summary of key results 
The main purpose of the present RCT was to deliver and investigate the short- and longer-
term effects of an eight-week group-based therapeutic exercise and educational 
programme in patients with PD suffering from depression; against a CG, which followed a 
home-based, individualised, unsupervised training. Depression, as measured by the HADS-
D, was the primary endpoint of the study; whereas anxiety, QoL, functional mobility, 
exercise tolerance, balance, FOF, lung function and patients’ satisfaction about the group-
based exercise programme the secondary outcomes. The number of falls and their features 
through the whole study period, were also recorded.  
 
The results of the study, contrary to the researcher’s expectation, demonstrated no 
statistically significant differences (p > .05) between the two study groups for the primary 
and secondary outcomes at the end of the treatment and three-month follow-up period, 
whereas the effect sizes were small (eta squared= 0.01- 0.05; r= .10-.29). A significant 
difference (p= .03) was only detected for the total HADS scores at post-intervention, where 
the improvement was significant higher in the IG, and the magnitude of the difference 
between the groups was medium (eta squared= .07).   
 
However, regarding the within-group comparison; the findings suggest that a supervised 
group-based exercise and educational programme was able to elicit positive responses in 
a relatively short time frame. In particular, the data extraction showed significant 
improvements (p ≤ .05) for the primary and secondary outcomes, with medium and large 
effect sizes (partial eta squared ≥ .06; r ≥ .30), at the end of the treatment.  Only the FES-I, 
FEV1/FVC and IVC scores were not significantly improved (p > .05). The positive findings 
were also supported by the trainees’ feedback in the SQ; who reported subjective 
improvements in emotional well-being, mobility and lung function, due to the training.  
Although after the end of the intervention period, the vast majority of the measured values 
had the tendency to return to the initial levels prior the exercise. the results remained 
statistically significant improved, apart from the PDQ-39 SI scores. Lastly, with respect to 
the CG, no statistically significant results emerged in all the outcomes –apart from the BBS 
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and TUG scores-, as a result of the home-based individualised training. However, the vast 
majority of values appeared to improve from baseline to follow-up. 
 
10.2. Interpretation of findings 
10.2.1. Baseline characteristics 
The study groups were similar at baseline regarding almost all: the anthropometric and 
socio-demographic characteristics; the health status, including the severity of the disease; 
and the key and secondary outcomes.  It seems that the proper randomisation procedure 
and the concealed allocation reduced the possibilities for selection bias, and any difference 
between the two study groups at baseline reflects chance (Moher et al., 2010). The vast 
majority of anthropometric and socio-demographic characteristics, and health status (i.e. 
gender, age, nationality, marital status, education level, years since PD diagnosis, medical 
comorbidities) were consistent with the results of the present survey. Thus, the 
interpretation of these findings is presented in the survey’s discussion (sections 7.2.1 and 
7.2.2). 
 
Anthropometric characteristics 
Concerning the anthropometric characteristics, a finding of particular interest was that the 
mean BMI of participants was 28.11 kg/m2, and the vast majority of subjects (82.2%) were 
overweight and obese. This is in contrast with prior work indicating that the BMI of patients 
with PD is usually normal (18.6-24.9 kg/m2), and less than that of the controls (van de Marck 
et al., 2012). This is may be explained by the fact that PD patients usually lose weight, due 
to the combination of non-motor (i.e. dysphagia, loss of sense of smell and taste), and 
motor symptoms, which may increase energy expenditure (Kashikara, 2006).  Furthermore, 
a nationwide study that was held in Greece revealed that the mean BMI of Greek adults 
was 26.5 kg/m2, and that the BMI of 57.7% of the population was more than 25 kg/m2 
(Kapantais et al., 2012). Surprisingly, in the present study the mean BMI value for the whole 
sample was higher (28.11 kg/m2). However, it is unknown whether the participants lost 
weight since PD diagnosis, as this was not an objective of the current study. In addition, it 
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is doubtful whether the BMI is a strong indicator of body fat, because the equation for the 
calculation of BMI is not able to capture the proportion in fat and fat-free body mass (van 
de Marck et al., 2012). 
 
Health status- Parkinson’s disease 
Despite the increasing recognition of therapeutic exercise in PD management from the 
early stages, in order to educate patients and minimise the future impacts of the disease 
(Keus et al., 2013), the majority of participants (41.9%) were in the middle stage of the 
disease (H&Y stage three). As depression in PD does not correlate with the stage of motor 
deficits (Marsh, 2013), and the majority of patients in Greece start physiotherapy in the 
middle stages of the disease -when the motor symptoms and the impacts of PD are more 
apparent-; this reveals concerns whether Greek population with early PD is well informed 
about the disease, co-morbidity depression, and the role of physiotherapy against the 
disease progression. 
 
Regarding freezers’ proportion, 21% of the overall sample was detected as freezers using 
the Snijders and Bloem FOG Test. This proportion was much lower compared to that of a 
recent study, which classified 54.3% of its sample (H&Y stage one to four) as freezers, based 
on item three of the FOG Questionnaire (Amboni et al., 2015). However, the FOG 
Questionnaire assesses the severity of FOG, and does not utilise clinimetric tools to 
distinguish freezing and non-freezing population (Shine et al., 2012). On the contrary, the 
Snijders and Bloem FOG Test is not a ‘gold standard’ to detect freezers. Furthermore, the 
test was not performed during the ‘off-state’, as it is proposed in the literature (Snijders et 
al., 2012), probably limiting the freezers’ proportion. Only the method of observation could 
reveal the exact number of freezers, which is rarely possible in the clinical setting and 
research field. Thus, the classification of freezers and non-freezers is usually based on self-
reported data (Nieuwboer and Giladi, 2013). 
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Lastly, all the participants were under antiparkinsonian medication. L-dopa was 
administered to the vast majority (93.5%) of patients, as it is the most common used drug 
for the management of motor symptomatology (Heisters, 2011). Despite the fact that 
monotherapy is a recommended pharmacological treatment in the early stages of the 
disease (H&Y stage one to two), and two drug-therapy in the moderate and advanced 
stages (H&Y stage three to five) (NICE, 2006; Rao et al., 2006); one-drug therapy was 
administrated only to 19.3% of the sample. This is quite interesting, as 58.1% of the 
population was classified in the early stages of the disease (H&Y stages 1-2.5) by a specialist 
neurologist in PD. Further investigation was beyond the scope of the current thesis, but 
future studies should examine whether neurologists in Greece have the adequate 
knowledge to assess PD population and treat them with the most effective drugs. 
 
Health status- depression 
Although all the participants were identified as depressed by the HADS-D (HADS-D ≥ 8), 
only 37.1% of them had been officially diagnosed with depression, either before or after 
PD diagnosis. A possible explanation might stem from the fact that depression in PD is often 
under-recognised (section 3.6.4). Moreover, the HADS-D is not a recommended tool for the 
diagnosis of depression in PD. As the estimated rates of depression in PD appear much 
higher when rating scales with cut-off values are used, instead of specific diagnostic criteria 
(Reijnders et al., 2008), some subjects of the sample may have not been suffering from 
MDD. If a cut-off of 11 (indicating clinical depression) instead of eight (borderline for 
depression) (Zigmond and Snaith, 1983), had been selected, the percentage of participants 
with clinical diagnosis of depression may have been higher.  
 
The HADS subscales also revealed that the co-existence of anxiety and depression (HADS-
A ≥ 8 and HADS-D ≥ 8) in 53.2% of the whole sample. This percentage is lower to that 
supported in the literature, varying from 67% to 76%, when the DSM criteria are used (Chen 
and Marsh, 2014). The high co-existence may be explained by the fact that anxiety and 
depression share common pathophysiological mechanisms (Section 3.6.2) (Kano et al., 
2011). However, a direct comparison between present findings and prior work may not be 
Chapter 10: RCT-discussion 
253 
 
feasible, as the HADS subscales are not the ‘gold standards’ for the diagnosis of mental 
disorders. In addition, the HADS-A includes only items relevant to GAD and fear, excluding 
symptoms of other anxiety disorders (Leentjens et al., 2008).  This limitation of the HADS-
A, in combination with the fact that the minimum score on the HADS-D subscale was eight; 
may partly explain the medium positive relationship (rs= .36) of anxiety and depression at 
baseline for the whole sample. 
 
With respect to depression’s treatment, 19 out of 23 patients diagnosed with MDD –either 
by a psychologist or medical doctor- were under antidepressant medication. This 
proportion (82.6%) is much higher in comparison to the evidence supporting that less than 
50% of overall clinically depressed population in PD receive any type of treatment (e.g. 
drugs, CBT) (Aarsland et al., 2011). In addition, 16 out of 25 patients, who received 
antidepressant treatment, were females. However, in PD, women are more likely to receive 
antidepressant regardless of behavioural symptoms, as they are more likely to seek mental 
health treatment than men (Miller and Gronin-Golomb, 2010). With reference to the whole 
sample, 30.6% (19 out of 62) of patients were treated with antidepressant drugs. 
Surprisingly, this percentage is lower compared to the findings of a nationwide study in 
Greece, which revealed that 37.1% of Greek patients with PD were under drug treatment 
for depression (Konitsiotis et al., 2014). 
 
A highly unexpected finding was that six patients, non-diagnosed with MDD, were receiving 
antidepressant drugs. However, it is unsure whether all of them gave accurate responses 
about their mental health. Perhaps, they hidden a clinical diagnosis of depression during 
the screening procedure. Even in nowadays, there is still the stigma of having a mental 
disorder in Greece, especially among senior population, and in rural areas. However, they 
were aware of the purpose of the current investigation through the ‘Patient Information 
Sheet’. In addition, based on empirical knowledge and discussing with two neurologists 
working in Athens; it is quite common for neurologists in Greece to administer to patients 
antidepressant medication when depressive symptoms are recognised, without clinical 
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diagnosis by psychologists, using accurate diagnostic criteria for mental disorders, as 
“….Parkinson and depression usually coexist.”. 
 
Relationship of anxiety and depression with other variables at baseline 
The relationship of anxiety and depression with the anthropometric characteristics, 
features of PD, mobility, QoL and lung function; revealed that mental disorders in PD are a 
complex concept, and a combination of factors may be responsible for the increased levels 
of depression. Indeed, the Pearson Correlation co-efficient detected only one strong 
relationship (r= .50-1.00) between anxiety scores (HADS-A) and cognition, as measured by 
the PDQ-39 cognition subscale; whereas all the other correlations varied from very small 
to medium (r/rs≤ .49). However, caution is needed for the interpretation of the results for 
three reasons. Firstly, all the patients scored at least eight in the HADS-D, based on the 
eligibility criteria. Secondly, the HADS-A contains only items relevant to GAD and panic 
disorder. Thirdly, all the patients were in the first three stages of the disease (H&Y stage 
one to three). 
 
The small and medium correlations of anxiety and depression with H&Y staging, mobility 
and age (Section 9.8.1) may be explained by the fact that depression and anxiety may occur 
at any stage of PD and affect all the ages. High rates of depression at early stages, may 
indicate a reactive depression, due to PD diagnosis; whereas increased rates at advanced 
stages may be associated with the more severe symptoms (e.g. motor fluctuations) and 
impacts of the disease (Marsh, 2013). Similarly, GAD and panic disorder in the first stages 
and younger ages are related to disruptions in the professional domain and financial 
impacts; whereas in later stages, to motor fluctuations, FOG and perceived disability (Nuti 
et al., 2004; Pontone et al., 2009).  The medium correlations between anxiety and 
depression and QoL (as measured by the PDQ-39 SI) (Section 9.8.1) may reflect the fact 
that in spite of QoL being a subjective complex concept, anxiety and depression are among 
the main predictors of diminished QoL in PD (Hanna and Cronin-Colomb, 2012; Den 
Oudsten et al., 2017). However, the relationship of anxiety with QoL in PD has been less 
studied (Hanna and Cronin-Golomb, 2012). Regarding, the PDQ-39 subscales, more 
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evidence is required to support whether the non-motor symptoms of PD –such as cognitive 
impairments or symptoms that cause bodily discomfort- may influence anxiety and 
depression levels (Marsh, 2013; Dissanayaka et al., 2014).  
 
The current results are partly consistent with findings from previous literature in PD. 
Similarly to the present study, Rojo et al. (2003) and Quelhas and Costa (2009) found  small 
and medium correlations between anxiety and depression levels and: H&Y stage, years 
since PD diagnosis, and total UPDRS score. Although the results of two trials support a 
medium correlation between anxiety, depression and overall QoL (Quelhas and Costa, 
2009; Jones et al., 2015); the study by Hanna and Cronin-Golomb (2012) found a strong 
correlation. Concerning the secondary outcomes of the present study related to mobility 
(i.e. BBS, TUG test, 2MWT), no relevant trial was identified. Previous work only examined 
the prevalence of depression in the motor subtypes of PD.  Three studies concluded that 
the highest rates of depression appear with the postural instability-gait disturbances 
subtype (Riedel et al., 2010; Dissanayaka et al., 2011; Djamshidian, and Friedman, 2014), 
whereas van der Hoek et al. (2011) supported that the prevalence of depression is similar 
between the motor subtypes of PD. Lastly, although in the present study the correlation 
between gender and depression was found small (rs= .15); prior work supports that levels 
of depression are more elevated in women (Rojo et al., 2003; Riedel et al., 2010), because 
they are more likely than men to respond positively to the items of self-rated scales of 
depression (Allen-Burge et al., 1994). 
 
10.2.2. Primary outcome-depression 
Contrary to the author’s expectation and the bulk of the literature, depression scores did 
not significantly differ (p > .05) between the two groups at the end of the treatment and 
follow-up, confirming the null hypothesis for the primary outcome measure (Section 8.2.4). 
However, the within-group comparison of both groups revealed that only the treatment of 
the IG was effective (p= .00), and superior to that of the CG to relieve depressive symptoms 
at the end of the treatment. Although the depressives scores in the IG started to increase 
at the end of the intervention, to reach the initial levels prior intervention, the results 
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remained significantly improved (p= .01) form the baseline up to the end of the three-
month follow-up period. The effect sizes in both cases revealed that the magnitude of the 
effect was medium (r= .30- .49). 
 
On the contrary, the MCID for the HADS-D revealed no clinically significant differences 
between and within the study groups. However, the author was not aware of the MCID 
value for the HADS-D in patients with PD or other neurological disorders, such as MS. Thus, 
the MCID in inpatient population with COPD (Puhan etal., 2008) was selected to identify 
any changes in the clinical intervention. The comparison between this MCID value and the 
difference in means may have been inaccurate, because the MCID score is specific to the 
population being studied and is non-transferable across patient populations. In addition, 
even in a specific population,  the lack of a universally accepted methodology to determine 
the MCID score, results in a wide range of MCID values for a single outcome measure 
(Wright et al., 2012). 
 
The statistically significant improvements within the IG are of particular interest, due to the 
time that the current study was conducted in Greece (March 2015-March 2016). Although 
strict eligibility criteria (Sections 8.5.2 and 8.5.3) aimed to minimise the effects of 
pharmacological and non-pharmacological treatment on the study’s’ results, the events 
that occurred that period in the country, which were not part of the intervention, may have 
affected the study outcome, threatening the internal validity of the study (Buckwalter et 
al., 2009). In particular, on 29th June 2015, during the intervention period or the post-
intervention assessment in three municipalities, capital controls were introduced, and a 
referendum took place on 5th July 2015 to decide whether Greece was to accept the bailout 
conditions proposed by Troika. Despite the fact that there was danger that these events 
may have had a serious impact on the emotional well-being of participants, introducing 
bias to study’s results and preventing any improvement in the HADS-D scores, the 
treatment for the IG was proved effective.  
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Based on the above data, it is believed that the systematic design of the intervention plan 
-that aimed to select the appropriate exercise parameters and design an interdisciplinary 
education component- may have been responsible for the significant improvements at 
post-intervention and follow-up. The possible reasons that both components of the 
programme produced antidepressant effects in the IG, are reported and analysed in the 
following paragraphs. However, as the therapeutic exercise classes were combined with 
education, it is not possible to know the extent to which each component contributed to 
the effective outcome of the treatment.  Although the investigation of the underlying 
mechanism, responsible for the significant improvements, was beyond the scope of the 
present thesis; it is believed that both biological and psychological mechanisms, proposed 
in the literature, may have contributed to the antidepressant effects. These mechanisms 
have probably worked in a complex and combined way for the reduction of depressive 
symptoms (Craft and Perna, 2004). 
 
With respect to exercise classes, evidence-based data in PD and depressed population were 
combined for the selection of the appropriate exercise parameters, in order to improve 
both the primary and secondary outcomes of the study. This was a crucial step, as the 
evidence to relieve depression in PD is limited, and is provided mainly by studies that 
assessed depression as a secondary outcome in a non-depressed population.  
 
Firstly, the high supervision in the IG may have produced antidepressant effects.  Although 
a meta-analysis in depressed population, concluded that both supervised and unsupervised 
formats were associated with antidepressant effects, evidence was provided mainly by 
supervised programmes (Schuch et al., 2016a). Supervised programmes may have 
motivational effects in trainees and improve long-term exercise behaviour, when they are 
led by experienced staff (Schuch et al., 2011). Indeed, in the present study, the motivation 
the subjects received by the exercise instructors, was reported in the SQ. It was also cited 
that the exercise instructors explained the aim of all the exercises, which were included in 
the programme, and taught patients to perform them by themselves by giving them 
guidance. 
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The group exercise format may have also provided some mental benefits. According to the 
‘social interaction hypothesis’,  the group-based exercise leads to improved opportunities 
for social interaction between the trainees and pleasure; which, in turn, may have 
beneficial effects on mental health (Ransford, 1982). Thus, Keus et al. (2007) recommend 
a group training protocol in PD population to improve emotional well-being. Enhanced 
sociability leading to new friendships, and reduced isolation due to the group format, were 
also reported by four participants in the SQ. However, recent studies in depressed 
population failed to demonstrate any evidence about the superiority of group programmes 
compared to individualised training. It is believed that other factors, such as the mode of 
exercise and the exercise intensity, may play a more significant role (Wegner et al., 2014). 
 
In addition, it seems that the selected exercise dose may have been adequate in order to 
alleviate depressive symptoms. In particular, two one-hour exercise sessions were 
performed for a total period of eighth weeks, plus 150 minutes of walking per week. These 
are the minimum recommended parameters for exercise in depressed population (CPG, 
2008; Ravindran et al., 2009). The systematic review by Stanton and Reaburn (2014), based 
on effective RCTs in depressed population, proposed the range of exercise dose to manage 
depression in the overall population, and calculated the means for each exercise 
parameter; confirming that both the total length of intervention and exercise frequency of 
the present study were suitable to relieve depression, but below the means (mean 
intervention period: 9.3 weeks; and mean exercise frequency: 3.8 times a week). On the 
contrary, the duration of each exercise session was beyond the normal range (30-40 
minutes). However, this information was derived from studies using solely aerobic exercise 
as intervention. Furthermore, although the mechanism of action is unknown, it seems that 
more training hours and interventions longer than ten weeks, do not display greater 
antidepressant effects (Rethorst et al., 2009). Lastly, the findings about the intensity of 
aerobic and anaerobic exercise are controversial, and it seems that both moderate and high 
intensity (Appendix 4.5) may produce antidepressant effects (Stanton and Reaburn, 2014). 
However, a high intensity was avoided in the present study, as it may produce fatigue, a 
prevalent non-motor symptom of PD (Keus et al., 2013). 
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It is unknown whether the combined aerobic and anaerobic protocol contributed to 
significant improvements in depression scores at the end of the treatment. In depressed 
population, evidence is mainly derived from aerobic training; whereas anaerobic, and 
mixed programmes combining aerobic and anaerobic exercises, have been less studied. In 
addition, resistance training programmes have been briefly described; and major exercise 
parameters –such as the number of repetitions, the length of rest period, and the load of 
resistance- were not reported in the protocol of previous trials in depressed population 
(Kvam et al., 2016). Although there is limited and controversial evidence, it seems that 
resistance training, similarly to aerobic exercise, induces the expression of growth factors, 
such as the brain-derived neurotrophic factor (BDNF) and vascular endothelial growth 
factor (VEGF), promoting neurogenesis in the hippocampus, whose volume is reduced in 
MDD (Phillips, 2017). However, in the current study, relevant blood tests to measure the 
expression of the BDNF or VEGF before and after the intervention, as well as magnetic 
resonance imaging (MRI) for the measurement of brain volumes, were not performed. 
Thus, the underlying biological mechanisms that may have been responsible for the 
antidepressant effects of exercise werenot explored.  
 
Concerning the educational classes, they may have provoked antidepressant effects 
through the education of participants about PD and ways to overcome the daily difficulties 
arising from the symptoms and signs of the disease. Education is a suggested strategy to 
improve the management of depression in primary care (Unützer and Park, 2012). The 
systematic review by Cuijpers et al. (2009) concluded that psychoeducational treatment, 
providing by psychologists and additional professionals, was effective in treating 
depression, producing similar effects as other psychological approaches, such as CBT. 
 
Lastly, the positive influences of exercise in the secondary outcomes of the study, may have 
improved depressive status. Although the pathophysiology of depression in PD is complex, 
it seems that motor restrictions and disability may contribute in a degree to the 
development of mental disorders (Marsh, 2013). Thus, it is possible that the statistically 
significant improvements (p ≤ .05) in the secondary outcomes of mobility, resulted in 
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significant reductions on depression scores at post-intervention. Previous studies, which 
explored the effects of therapeutic exercise in PD, found significant improvements both in 
depression and motor function at the end of the treatment (Nadeau et al., 2010; Smania et 
al., 2010; Cugusi et al., 2015; Hashimoto et al., 2015). Nevertheless, only Smania et al. 
(2010) hypothesised that the improvements on depression may have been due to the 
increased confidence in balance and reduced number of falls. This may be interpreted by 
the ‘self-efficacy theory’, which supports that the ability of the individual to perform an 
exercise programme successfully increases confidence, and is strongly related to changes 
in behaviour (Bandura, 1977).  Similarly, the ‘mastery hypothesis’ supports that the 
performance of a challenging pursuit, such as exercise, may create a sense of indepedence 
and success (Boggiano et al., 1982). 
 
Despite the psychological mechanisms that were reported above, in the IG of the present 
study, the relationship between the HADS-D and BBS scores at post-intervention and 
follow-up were medium (rs = .30-.49), and between HADS-D and TUG and 2MWT scores 
small (rs= .10-.29). However, the tests did not examine the relationship between the 
improvements in depression and mobility. Thus, it cannot be supported that the increased 
sense of self-empowerment produced significant antidepressant effects. In addition,  a tool 
to assess the self-efficacy –such as the Self-Efficacy for Exercise (SEE) Scale or SEE 
Questionnaire- or self-confidence – such as the Activities-specific Balance Confidence Scale 
(ABCS)- before and after treatment was not used. Thus, it was not possible to explore the 
relationship between improved depressive symptoms (as measured by the HADS-D) and 
self-efficacy (as measured by the SEE Scale or Questionnaire) or self-confidence scores (as 
measured by the ABCS), and support or reject the ‘self-efficacy’ theory. This was beyond 
the scope of the current project, and the author was not aware if the SEE Scale, SEE 
Questionnaire and ABCS have been translated and validated in the Greek language. 
   
The failure of the CG to improve depression through the whole study period, probably 
stems from the design of the intervention for the CG. Although the selected dose of 
exercise could relieve depression (Stanton and Reaburn, 2014), and the exercises were 
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similar to that of the IG; it is believed that due to the lack of supervision, the members of 
the CG received less motivation for the performance of the programme. Despite the fact 
they received specific information and guidelines on how to use the booklet and perform 
the exercises by themselves; the selection of specific exercises was based on their own 
judgment, and no further advice was given through the weekly telephone calls. Moreover, 
as the programme was individualised, they were more isolated, and had no benefit from 
social interactions with other participants. However, a SQ, similar to that of the IG was not 
delivered to the members of the CG. Hence, the personal beliefs of the subjects about the 
intervention were not recorded in order to interpreter the less antidepressant effects. 
 
In addition, caution is needed for the results’ interpretation within the CG, based on the 
‘self-efficacy’ or ‘mastery hypothesis’. The study by Smania et al. (2010) revealed that 
significant improvements in depression (as measured by the GDS) were accompanied by 
improvements in self-confidence (as measured by the ABCS) and motor function (as 
measured by the BBS), in PD patients who followed an individualised training programme, 
supporting the ‘self-efficacy’ theory for the antidepressant findings. On the contrary, in the 
present study, despite the fact that some aspects of mobility (BBS, TUG scores) were 
improved significantly at the end of intervention and follow-up, probably they did not lead 
to increased confidence and improvements in the mental domain, similar to that of the IG. 
However, none relevant measurement tool was used to assess the self-efficacy or 
confidence levels at baseline and at the end of the intervention period.  
 
Thereby, based on the lack of supervision and social interaction in the CG; and assuming 
that almost the same exercises were performed in both programmes, and the exercise 
intensity was not well-defined; the ‘reductio ad absurdum’ principle leads to support that 
the significant antidepressant effects in the IG were almost related to the socialisation 
aspects of group-based exercise, and the motivation the participants received by the 
exercise instructors and lecturers. On the contrary there is less evidence to support other 
predominant psychological mechanisms, which could relieve depression; such as the ‘self-
efficacy theory’,  the ‘mastery hypothesis’, and the ‘distraction hypothesis’, which claims 
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that diversion from unpleasant stimuli -due to exercise- may lead to improved mood 
(Paluska and Schwenk, 2000).   
 
With respect to the biological mechanisms, the degree of their interaction with the ‘social 
interaction hypothesis’ to produce antidepressant effects in the IG, is unknown. A 
considerable body of research supports that exercise could relieve depressive symptoms 
through the increased of the synaptic transmission of monoamines (monoamine 
hypothesis), the increased levels of β-endorphins during exercise (endorphin hypothesis), 
the expression of growth factors BDNF and VEGF in several brain areas (neurogenesis 
hypothesis), the reduced activity of the HPA axis and decreased secretion of 
glucocorticoids, and the regulation for the production of inflammatory cytokines that have 
been shown to be dysregulated in depressed people. Concerning the overall depressed 
population, this information is mainly derived from studies utilising aerobic exercise, 
whereas anaerobic training has been less studied. In addition, there is limited evidence for 
the action of these mechanisms under different doses of exercise (e.g. total training period, 
exercise intensity) (Wegner et al., 2014). However, in the present RCT, the lack of 
physiological tests before and after the treatment, did not allow us to explore the precise 
biological mechanisms, responsible for the antidepressant effect in the IG.  
 
The current research not only it demonstrated that depressed patients with PD obtained 
antidepressant benefits in relevant short time from commencing a well-designed, group-
based, supervised exercise, combined with educational classes; but also that the significant 
results did remain up to the end of a three-month follow-up period. This is in contrast with 
the follow-up data in depressed population, which indicate that the effects of exercise 
diminish after the end of the intervention (Kvam et al., 2016). Interestingly, the systematic 
review by Whiteford et al. (2012) concluded that when there is no treatment in the follow-
up period the depressive levels return to their initial values within one year after the end 
of the exercise in 53% of cases. Although the responsible aetiological mechanism for this 
decline is unknown, it seems that the high BDNF synthesis stops after the end of the 
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exercise programme, preventing further improvement in depressive scores (Knaepen et al., 
2010).  
 
Regarding the present study, the follow-up period had a small duration of three months. 
Perhaps if the follow-up period was longer (i.e. one year), the significant improvements in 
depression would not be long-lasting. Indeed, the scores started to increase from the post-
intervention to the follow-up assessment.  In addition, similarly to the study by Hoffman et 
al. (2011), the IG followed a self-reported exercise during the follow-up period, which may 
partly explain the significant results up to the follow-up assessment. Interestingly, during 
the follow-up period, the IG followed the same individualised, unsupervised, home-based 
exercise programme as the CG. So it may be inaccurate to assume that the exercise dose 
was optimum to maintain the effect.  It seems that the group exercise programme that 
preceded, motivated the participants to continue the exercise. In addition, the fact that 
they were taught by the instructors how to perform the exercises correctly, may have 
facilitated them to follow the exercises as being described in the booklet. 
 
Comparison with previous studies 
The findings of the present study on depression scores were partly in congruence with 
those obtained from previous trials in patients with PD. In those trials the intervention was 
either exercise or education; or a combined programme. The main privilege of the present 
study, compared to those, is that it was the first that assessed the effectiveness of an 
exercise programme, combined with education, in PD population with clinical levels of 
depression. However, it should be pointed out that during the writing period of the current 
thesis, one year after the completion of the RCT’s intervention, one study (Sajatovic et al., 
2017) with similar design was published. In addition, only the present project aimed to 
explore both statistical and clinical changes due to intervention, report the effect sizes and 
participants’ satisfaction; apart from two studies (Smania et al. 2010; Sajatovic et al., 2017) 
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The literature search identified only two studies, in which supervised multimodal exercise 
was combined with education; in order to reduce scores of depression in PD, either as a 
primary (Sajatovic et al. 2017) or secondary outcome (Dereli and Yaliman, 2010). Both of 
them revealed significant improvements in depression scores at the end of the 
intervention, whereas their total PEDro score was four (fair quality), indicating that their 
results were believable. However, as only in the trial by Sajatovic et al. (2017) depression 
was assessed as principal outcome, similarly to the present study, its design aimed to 
alleviate depressive symptoms. In addition, the study population was only PD patients 
diagnosed with MDD, using the MADRS (Sajatovic et al. 2017). With respect to the study by 
Dereli and Yaliman (2010), the BDI was selected to assess depression and the subjects could 
be non-clinically depressed at baseline. However, the MADRS is considered superior to the 
self-report questionnaires (e.g. BDI, HADS-D) for screening depression in PD, and is a highly 
recommended tool (Section 8.7.1). 
 
The subjects in the study by Sajatovic et al. (2017) were allocated either to a supervised, 
combined group or self-guided exercise and chronic disease self-management programme; 
which is a behavioural intervention, including educational classes, aiming to reduce the 
negative consequences of chronic somatic diseases. Similarly to the present study, aerobic 
and resistance training were combined; whereas in both groups, three one-hour exercise 
bouts were performed for 12 consecutive weeks. Although the randomisation procedure 
and the clinician-rated MADRS ensured less possibilities for selection and assessor bias 
respectively; the trial lacked an intention-to-treat analysis and between-group 
comparisons of the results at post-intervention and follow-up. Instead, a combined sample 
was included in the data analysis, making impossible to know the group that was favoured 
more due to intervention. However, the results demonstrated significant changes in 
depressive scores from baseline up to the end of the 12-week intervention and 12-week 
follow-up period for the combined group. The benefits were also confirmed by the 
participants’ satisfaction. In contrast to the current project, their study aimed to explore 
the mechanisms that may have been responsible for the relief of depression. Plasma 
analysis revealed that the levels of Interleukin 6 (IL-6) cytokine and BDNF remained stable 
through the whole study period; whereas the quality of sleep -using the Scales for 
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Outcomes in PD-Sleep Scale (SCOPA-S)- and the self-efficacy –as measured by the General 
Self-Efficacy Scale-, improved significantly.  Thereby, contrary to the literature, only the 
psychological mechanisms were proved effective to alleviate depression in PD. 
 
Concerning the study by Dereli and Yaliman (2010), patients were allocated either to a 
physiotherapist-supervised or an unsupervised home group. The exercise programme in 
both groups was performed three times a week for 10 weeks. Although the QoL was the 
primary aim of the study; similarly to our findings, patients in the supervised physiotherapy 
group benefited more, and the underlying mechanisms for the antidepressive effects were 
not explored. In addition, the long-term effects were not assessed. The lack of 
randomisation is one of the basic limitations of the study, as there are increased 
possibilities for selection bias. Lastly, due to the lack of sample size determination, the 
statistic power may have been small; hence, the treatment effect may have been 
overestimated. 
 
Furthermore, one additional trial (Trend et al., 2002) was detected, which investigated the 
short-term effectiveness of intensive multidisciplinary approach for people with PD and 
their carers. The participants attended a day care unit one day per week for six consecutive 
weeks. Each weekly session lasted 5.5 hours. It combined group-based and individualised 
treatment, based on individual needs; and consisted of exercise by a physiotherapist, 
education by a specialist PD nurse, occupational therapy and speech and language therapy. 
Although a direct comparison between the findings of the present RCT with those of the 
study by Trend et al. (2002), may not be feasible, due to the different study design; the 
significant improvements in depression, as measured by the HADS-D in such a short time, 
may indicate that multidisciplinary programmes may encourage greater improvements in 
depressive levels, than combined exercise and education classes. However, clinical levels 
of depression were not among the eligibility criteria, and the study lacked a control or 
comparison arm in order to define the superiority of this approach over other treatment 
or usual care. 
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As already recalled in the present systematic review (Chapter 4); 15 RCTs were identified 
that assessed the effects of therapeutic exercise, as sole intervention, on levels of 
depression in patients with PD (Bridgewater and Sharpe, 1996; Burini et al., 2006; Schmitz-
Hubsch et al., 2006; Modugno et al., 2010; Smania et al., 2010; Shulman et al., 2013; 
Nadeau et al., 2014; Cugusi et al., 2015; Dashtipour et al., 2015; Hashimoto et al., 2015; 
King et al., 2015; Rios Romenets et al., 2015; Schlenstedt et al., 2015; Sharma et al., 2015; 
Teixeira-Machado et al., 2015). Only six out of 15 studies found significant results at the 
end of the intervention (Appendix 4.6) (Smania et al., 2010; Nadeau et al., 2014; Cugusi et 
al., 2015; Hashimoto et al., 2015; King et al., 2015; Teixeira-Marchado et al., 2015). The 
effect size for depression was calculated only in the study by Smania et al. (2010), which 
revealed that the magnitude of the effect was large. Investigation of depression as primary 
measure is limited, apart from two trials, which revealed statistically significant 
improvements on depression at the end of the treatment (Cugusi et al., 2015; Teixeira-
Marchado et al., 2015). Thus, the findings of the rest studies may reflect chance (Smania et 
al., 2010; Nadeau et al., 2014; Hashimoto et al., 2015; King et al., 2015). However, even in 
these studies (Cugusi et al., 2015; Teixeira-Marchado et al., 2015), depression was not the 
only primary outcome measure, as it is proposed by the CONSORT statement (Moher et al., 
2010). 
 
In contrast to the present RCT, none of the aforementioned 15 studies included solely 
patients with clinical levels of depression, using relevant rating scales with cut-off points. 
Hence, the findings of those RCTs with statistically significant results at post-intervention  
(Smania et al., 2010; Nadeau et al., 2014; Cugusi et al., 2015; Hashimoto et al., 2015; King 
et al., 2015; Teixeira-Marchado et al., 2015) are of particular interest; because it seems that 
exercise may reduce depressive symptoms in non-depressed population with PD. However, 
none of these studies aimed to explore the underlying mechanisms that produced 
antidepressant effects by using relevant tools. Only Smania et al. (2010) suggested that the 
‘self-efficacy theory’ may partly explain the reduced levels of depression at the end of the 
treatment. However, as a supervised individualised format was selected by half of the trials 
(Smania et al., 2010; Nadeau et al., 2014; King et al., 2015), it seems that social support was 
not a strong predictor for antidepressant effects in PD patients that have completed the 
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treatment. Limited evidence is available for the longer-term effects of training, because 
only one trial with significant results at post-intervention (Smania et al., 2010) reported a 
follow-up assessment, four weeks after the end of the treatment. Surprisingly, contrary to 
our study and the bulk of the literature in depressed population (Whiteford et al., 2012) 
the improvements were not maintained in such a small timeframe. 
 
Despite the fact the six effective studies (Smania et al., 2010; Nadeau et al., 2014; Cugusi 
et al., 2015; Hashimoto et al., 2015; King et al., 2015; Teixeira-Marchado et al., 2015) did 
not explore the mechanisms for the antidepressant effects, and it is unknown whether the 
design of the intervention aimed to relieve depression; based on the review by Stanton and 
Reaburn (2014), the exercise dose of these studies was optimum to achieve antidepressant 
effects.  A direct comparison between the exercise parameters of our project and those 
trials is complicated; because there was a great variability among their parameters, as seen 
in Appendix 4.6. It is quite interesting that in three trials an individualised format was 
followed (Smania et al., 2010; Nadeau et al., 2014; King et al., 2015); as in the CG of the 
present study, which was not proved effective. Probably, the supervision of the training, in 
contrast to the present study, may have been a strong contributor for the significant 
results. 
 
Lastly, with respect to the educational classes, few studies were identified that assessed 
the effects of education on depression in patients with PD (Macht et al., 2007; Tiihonen et 
al., 2008; Teixeira-Machado et al., 2015). These programmes aimed to improve the 
patients’ knowledge on PD (Teixeira-Machado et al., 2015) or were focused on the socio-
psychological aspects of the disease (Macht et al., 2007; Tiihonen et al., 2008). The RCT by 
Teixeira-Machado et al. (2015) compared the effectiveness of Feldenkrais exercise method 
(IG) with an educational programme (CG). The CG received education lectures once a week, 
for 24 weeks. The programme consisted of instructions to prevent falls, inform about the 
antiparkinsonian medication and manage the ADLs. The studies by Macht et al. (2007) and 
Tiihonen et al. (2008), lacked a comparison or control group; and the Edu-Park programme 
was applied, which was developed specifically for PD. It consisted of eight 90-minutes 
Chapter 10: RCT-discussion 
268 
 
supervised session, which were held once a week. The sessions aimed to inform patients 
about the psychological impacts of the disease and propose ways to manage them. 
 
None of the aforementioned trials (Macht et al., 2007; Tiihonen et al., 2008; Teixeira-
Machado et al., 2015) included participants with clinical levels of depression, depression 
was assessed as a secondary outcome, and the self-rating scales SDS (Macht et al., 2007; 
Tiihonen et al., 2008) and BDI (Teixeira-Machado et al., 2015) were selected to assess the 
effectiveness of the intervention. Despite the fact that the total hours of education were 
more than those in the present study (12 hours in the Edu-Park programme, 4 hours in the 
current project); the depressive scores were not improved at post-intervention. This is in 
contrast with the results of the present study. As in the present study the education was 
combined with exercise, in opposition to previous work, it seems that an education 
programme cannot by itself improve the depressed mood in PD. However, the content of 
educational classes in these trials differed from that of the present study. 
 
10.2.3. Secondary outcomes 
The results indicated no statistically significant changes regarding the secondary outcomes, 
between the two groups at the end of the treatment, apart from the total HADS scores, 
and at follow-up. Hence, the null hypothesis (section 8.2.4) cannot be rejected. This is quite 
interesting, because completing an exercise programme should have influenced more 
these variables in a positive manner, and it was expected that supervised training in a 
specialised exercise facility would have been more beneficial for physiological 
enhancements. However, the within-group comparison for the IG revealed statistically 
significant improvements (p≤ .05) for almost all the secondary outcomes from baseline to 
post-intervention and follow-up, with usually a medium or large effect size (eta squared 
and partial eta squared ≥ .06; r ≥ .30). The results also highlighted that most outcomes had 
the tendency to return to the initial levels, after the end of the treatment. On the contrary, 
the CG did not show any significant improvement over time, apart from the BBS and TUG 
scores. This is quite encouraging, as it seems that an unsupervised, individualised, home-
based programme could promote improvements in balance and functional mobility in a 
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relevant short timeframe. However, the fact that during the intervention period there was 
a more rapid and greater improvement in the outcomes for the participants that were 
allocated to the IG, reveals the superiority of the supervised group training. 
 
It is noticeable that the use of MCIDs values revealed a few clinically significant changes in 
the IG. More precise; the HADS-A, PDQ-39 SI and 2MWD scores were significantly improved 
from baseline to post-intervention; and the BBS and FVC scores from baseline t follow-up. 
As the author was not aware if the MCID values have been calculated in patients with PD, 
apart from the PDQ-39 SI (section 9.6); in the current Section, the interpretation of the 
findings was based solely on the statistical tests, due to the reasons that have already been 
reported in Section 10.2.2.  
 
Special caution is needed for the interpretation of the secondary outcomes. The sample 
size of the study was calculated only for the primary outcome. Hence, the statistical power 
for the secondary measures may have been low, preventing for drawing strong conclusions. 
Any difference may have been produced by chance (Freemantle, 2001). However, it seems 
that the dose of exercise was suitable to produce significant results, especially in the group-
based training programme. This is not surprising, as the design of the exercise protocol 
focused in all the aspects of mild to moderate PD, synthesising relevant evidence-based 
data and recommendations. The fact that in the IG the vast majority of outcomes remained 
significantly improved up to the end of the follow-up period, may be explained by the 
length and the intervention of the follow-up period. In particular, the review by Mak et al. 
(2017) concluded that short exercise programmes in PD (up to 12 weeks) have beneficial 
effects on mobility for at least three months after the end of the treatment. In addition, in 
the present RCT, the subjects of the IG did not receive just usual care during the follow-up 
period, but participated in an unsupervised home-based exercise programme. Although, 
the members of the CG followed the same home-based programme through the whole 
study period (five months), they received less improvements. It seems that the training 
effect of the two-month group programme during the intervention period in the IG, was 
responsible for the significant findings up to the end of the three-month follow-up period. 
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Apart from the possible specific biological mechanisms, which are reported in the following 
sub-sections and may have contributed to the significant effects at mobility, the promotion 
of neuroplasticity23 and neuroprotection24 in PD through exercise may have played a 
significant role for the improvements in mobility (Ahlskog, 2011; Petzinger et al., 2013); but 
it was not explored using relevant clinical tests, because it was beyond the scope of the 
current project. This evidence is derived from neuroimaging studies in human beings and 
animal models studies; which have shown that aerobic, resistance and cueing training may 
have effects on neuroplasticity and neuroprotection. However, the relationship between 
animal studies, where a neurotoxin that destroys the DA neurons is administrated, and PD 
in human beings, whose aetiology is unknown, is open to debate; as it is still unsure 
whether the exercise could have similar effects in specific brain areas. The same doubts 
appear in human studies that examine the neurobiological mechanisms of exercise in PD 
free population, as the action of exercise may differ in an already altered neurological 
system (Ahlskog, 2011). 
 
More precise, and despite the controversial data, Exercise may mitigate the parkinsonian 
deficit by the increase of neurotrophic factors in the SN, such as the BDNF and glial-derived 
neurotrophic factor (GDNF), which regulate survival and activity of DA neurons and are 
reduced in PD. In particular, the increase of these factors has been thought to regulate 
branching and remodeling of axons and dendrites, whose length is reduced in PD. However, 
it is still unsure whether the neuron numbers within the circuit BG-cortex-thalamus could 
be also increased due to exercise (Ahlskog, 2011). In addition, increased blood flow in the 
brain and VEGF levels, whose expression in the SN of PD patients is also diminished, may 
provide angiogenesis, and in turn, facilitate neuroplasticity (Petzinger et al., 2013). Animal 
studies have shown that exercise-induced neuroplasticity may be achieved through the 
increase of DA neurotransmission, by enhancing the release of DA and increasing synaptic 
occupancy (Hirsch et al., 2016). Lastly, although there is no direct evidence for the 
neuroprotective effects of cueing training, it is believed that cues facilitate movements 
bypassing the affected BG, and activating further the premotor and parietal cortex for the 
                                                             
23 The capacity of the nervous system to develop new neuronal connections through life. 
24 The protection of the neuronal loss over time. 
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control of movements (van Wegen et al., 2014). Hence, based on these data, Mak et al. 
(2017) support that the long-term improvements following exercise training in PD 
population, are probably related to neuroplasticity. 
 
Lastly, before the further interpretation of the secondary outcomes, it should be noted that 
regarding the HADS, only the findings of the two subscales (HADS-D and HADS-A) were 
interpreted. It is unsure whether the total HADS score is meaningful, because it is a 
measure of psychological distress among medical patients (Roberts et al., 2001). 
Psychological distress is a general term used by some practitioners to describe unpleasant 
feelings or emotions that impact the level of functioning (Ridner, 2004); it is not a syndrome 
as defined by the DSM or ICD criteria (Phillips, 2009); and individuals with psychological 
distress also experience symptoms of anxiety and depression (Ridner, 2004).  On the 
contrary, anxiety and depression are narrow terms, and are included in the classification of 
mental disorders (Phillips, 2009).  Thus, similarly to the present study, the vast majority of 
trials using the HADS scale have focused solely on its subscales (Roberts et al., 2001). 
 
Anxiety 
The results indicated significant improvements in anxiety, as measured by the HADS-A, only 
in the IG from baseline to post-intervention (p= .00), and from baseline to follow-up (p= 
.01); whereas the magnitude of the relationship was large (partial eta squared= .31). Since 
there has been considerably less research examining the effect of exercise on anxiety in PD 
than depression, these results provide a useful addition to the current body of knowledge. 
In addition, the findings are of particular interest, as the intervention managed to relieve 
anxiety symptoms, despite the events that occurred in Greece during that time, and may 
have biased the results. Moreover, the findings provide evidence that a combined exercise 
and educational programme could decrease anxiety symptoms in an anxious free 
population with PD. Indeed, as anxiety was not one of the inclusion criteria of the present 
study; almost half of the participants were non-anxious at baseline. The current findings 
appear to conflict with previous studies in PD that suggested that therapeutic exercise itself 
(Dashtipour et al., 2015) or when combined with education (Sajatovic et al., 2017) did not 
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produce any anxiolytic effect. However, in both studies the data analysis was performed 
for the whole sample, and not for each study group separately.  
 
A considerable body of research has proposed possible biological and psychological 
mechanisms for the anxiolytic effects of exercise, which are similar to those of depression. 
This is probably because anxiety and depression share common pathophysiological 
mechanisms for their onset and development. However, the mechanisms that connect 
exercise and anxiety are under debate (Wegner et al. 2017), because there is insufficient 
evidence about the anxiolytic effects of exercise in the overall population. Indeed, only 35% 
of experimental studies that have been included in reviews, managed to treat the 
symptoms of anxiety disorders (Bartley et al., 2013; de Souza Moura et al., 2015; Stonerock 
et al., 2015). Concerning the present RCT, it is believed that the mechanisms that produced 
antidepressant effects in the IG, as have been reported in Section 10.2.2, also reduced 
significantly the levels of anxiety. On the contrary, the non-significant improvement of 
depression in the CG may explain the ineffectiveness of the home-based programme to 
relieve anxiety symptoms.  
 
Balance 
A significant increase (p≤ .05) in balance abilities, as measured by the BBS, was observed in 
both groups over time. When comparing the two study groups to each other, effect size 
calculations indicated that no intervention was more effective at improving balance, as the 
effect sizes for the IG and CG were large (r ≥ .50). The findings are in line with prior work 
indicating that different types of physical activity (balance training, dance, Nordic walking) 
could improve significantly functional balance, as measured by the BBS, at the end of the 
treatment (Smania et al., 2010; Cugusi et al., 2015; Hashimoto et al., 2015) and at follow-
up (Smania et al., 2010). Even training programmes with short intervention periods (seven 
weeks) could be effective (Smania et al. 2010). 
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The increased BBS scores may have been related to improvements in muscular strength of 
the leg muscles, and improved postural control.  Evidence supports that the combination 
of balance and resistance training in PD is more effective on improving balance, compared 
with simple balance or resistance training programmes (Yitayeh and Teshome, 2016). In 
addition, balance training seems to be superior to walking on improving balance, because 
it is a more complex and dynamic task (Low et al., 2017). Hence, in the present study, 
probably the combination of muscle strengthening and balance training increased BBS 
scores in both groups. 
 
Biological approaches support that resistance training improves muscle strengthening, due 
to alterations within the muscle cells and motor neurons supplying the muscle fibers. In 
particular, resistance training increases the muscle size, the number of motor units that are 
activated against the resistance, and the frequency of the nerve stimulation. Thus, agonist 
muscles are fully activated, whereas antagonist muscles are more relaxed (Glendinning and 
Enoka, 1994). In healthy individuals, these neural adaptations may take place within the 
first six weeks of training, before hypertrophy is seen (American College of Sports Medicine, 
2009). Although, in an already altered neural system, as is found in PD, adaptations 
required for improvements in strength may be different to those of a healthy population; 
previous research suggests that PD patients commencing exercise, derive favourable 
alterations in muscle strength (Yitayeh and Teshome, 2016). However, in the present RCT, 
due to the shortage of equipment, the muscle strength was not assessed before and after 
the treatment. Lastly, the extent to which the stretches may have contributed to the 
relaxation of antagonist muscles remains unknown. 
 
In addition, the progressive balance training of the present study may have improved 
postural control, through adaptations in neuromuscular control mechanisms.  Balance 
relies on the ability of the peripheral sensory systems to react to the environment; and it 
requires vestibular, visual and proprioceptive feedback to and from the central nervous 
system, where the role of cerebellum is significant. The neuromuscular responses in the 
ankle and hip joints through balance training may decrease postural sway (Ruhe et al., 
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2010). The progression of training from eyes opened to eyes closed conditions blocks the 
visual input; and the postural control relies solely on efferent neuromuscular and 
sensorimotor input, which could be improved with exercise (Low et al., 2017).  Indeed, in 
the present study the education of the upright positioning of the head may have activated 
the proprioceptors in the neck, contributing to the normal body posture (Sakellari et al., 
2005).  In addition, the combination of balance and strength training may have improved 
the neuromuscular control in the ankle and hip joints. 
 
Interestingly, despite the fact that the exercise booklet included less and more simple 
balance and strengthening exercises -for safety reasons-, and due to the shortage of 
relevant equipment; the supervised group-based environment was not proved superior to 
the unsupervised home-based programme to improve functional balance. This finding 
appear to contradict with the results of the systematic review by Lacroix et al. (2017), who 
concluded that supervised training interventions improved muscle strength, balance and 
walking distance to a greater extent than unsupervised programmes; because the 
performance of exercise was more precise in order to receive improvements, and the 
almost higher adherence rates in the supervised programmes resulted in greater exercise 
adaptions. Regarding the current study, possible explanations for the increased muscle 
strength in the CG include: the increased number of exercise sessions per week compared 
to the community-based programme, the clear instructions of the booklet accompanied by 
pictures, and the use of an exercise diary to record the exercise sessions. In addition, a 
privilege of unsupervised home-based programmes, which may have been responsible for 
the positive effects, is that participants were able to exercise at times that are most 
convenient to them. Lastly, it is possible that individuals who agree to participate in a 
research project may be more motivated to participate in all the study groups. 
 
Functional mobility and exercise tolerance 
Functional mobility, as measured by the TUG test, was statistically significant (p ≤ .05) 
improved in both groups over time; suggesting that both exercise programmes were able 
to elicit positive responses in a relatively short time frame. The effect sizes calculations 
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indicated that none programme was more effective at improving TUG scores, as all the 
effect sizes were large (partial eta squares≥ .14; r≥ .50). Regarding, the exercise tolerance, 
as measured by the 2MWT; the treatment favoured only the IG, from baseline to post-
intervention and follow-up (p≤ .05; r≥ .50). 
 
Improvements in the TUG test and 2MWT, indicated increases on walking speed, whereas 
both tests require muscle strength and balance (Podsiadlo and Richardson, 1991; Light et 
al., 1997). Thus, any improvement in the scores, may reflect increases in muscle strength 
and balance. Although the BBS indicated improvements in functional balance, the majority 
of its items assess static balance, whereas walking activities are excluded (Berg, 1988). It is 
unknown whether the gait training with the use of cues, the educational classes or the 
advice in the ‘Individualised home-based exercise booklet’, assisted patients to improve 
gait disturbances (i.e. FOG and festination), resulting in increased walking speeds. A gait 
analysis would have revealed any improvement in gait parameters; such as cadence, 
double support time and arm swing. In addition, as bradykinesia may be dependent on the 
emotional state of patients (Jankovic, 2008); perhaps any reduction in anxiety and 
depressive scores, may have improved the motor symptomatology, increasing the walking 
speed. Regarding the 2MWT, it is a submaximal test that could predict maximal aerobic 
capacity (Light et al., 1997). Based on the findings, it seems that the IG exhibited a greater 
training response due to the respiratory training and/or walking activity. This is quite 
interesting, as walking training was performed by both groups, under the same conditions; 
and therefore, aerobic fitness gains were expected for both groups. However, the intensity 
for the aerobic component was not monitored. 
 
The current results for the group-based supervised programme are also supported by 
research examining functional mobility and exercise tolerance, using the TUG test and the 
2MWT respectively, in the PD setting. In particular, supervised structured and unstructured 
training programmes, varying from seven to 12 weeks, have been proved effective in 
functional mobility at post-intervention (Cugusi et al., 2015; Hashimoto et al., 2015; Rios 
Romenets et al., 2015; Schlenstedt et al., 2015) and one-month follow-up period 
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(Schlenstedt et al., 2015). On the contrary, home-based programmes, either supervised or 
unsupervised, found trivial improvements in TUG scores (King et al., 2015; Rios Romenets 
et al., 2015); indicating that the findings of the present study regarding the CG, are of 
particular interest. Although the 2MWT has been rarely used in PD to assess exercise 
tolerance, one study found significant results following a six-month supervised resistance 
and aerobic training in a facility (Collett et al., 2017).  
 
Fear of falling 
With respect to FOF, the results revealed trivial improvements (p≥ .05) in both groups. The 
finding of the present study is dissimilar with previous research, illustrating that supervised 
exercise programmes up to 12 weeks long, may reduce FOF, as measured by the FES-I (Liao 
et al., 2015; Silva-Batista et al., 2018). However, these studies utilised more complex 
activities (Silva-Batista et al., 2018) or sophisticated equipment (Liao et al., 2015). 
Nevertheless, the results of the present RCT still surprising, because functional balance 
performance (BBS scores), which is important for the safe performance of many activities, 
was significantly improved. Interestingly, the mean BBS scores were over 41 from baseline 
to follow-up, indicating a low risk of falling (Keus et al., 2013); whereas the mean FES-I 
scores were above 23, indicating high fall concern (Delbaere et al., 2010). In addition, the 
mean TUG score at the end of the treatment, was less than 11.5 seconds, demonstrating 
less possibilities for falls in PD (Nocera et al., 2013). In turn, enhanced balance and 
functional mobility could increase confidence, reducing the FOF.  
 
The fact that the FOF was not improved, reflects its complexity in PD. Studies support that 
greater FOF is associated with: the presence of hesitation and freezing, impaired balance, 
increased fall frequency, elevated levels of anxiety and depression, fatigue, middle-stage 
and advanced PD (Rahman et al., 2011; Lindholm et al., 2014), poorer stride length and gait 
speed (Bryant et al., 2011), and the presence of additional co-morbidities -such as 
osteoporosis, which may increase further the FOF- (Lindholm et al., 2014). Despite the fact 
that many of these factors were improved in both groups, the FES-I scores remained stable. 
However, it is unsure whether the community-based and the unsupervised home-based 
Chapter 10: RCT-discussion 
277 
 
environment were suitable for all the patients. Regarding the IG, the interaction with other 
patients may have increased FOF. Indeed, one female, whose balance was statistically and 
clinically significant improved at post-intervention, whereas FOF scores were slightly 
decreased; stated that her FOF was increased during the two-month intervention period, 
because some members of the group experienced falls and fall-related injuries. 
 
Quality of life 
PDQ-39 SI reflected positive statistical responses (p= .00) to the community-based exercise 
and education group from baseline to post-intervention, with a medium effect size (r= .33). 
Nonetheless, that gain was completely reversed in the follow-up period.  The statistically 
significant changes were also confirmed by the clinically significant changes from baseline 
to post-intervention, as the MCID value for the PDQ-39 in PD has been established (Horvath 
et al., 2017).With respect to the home-based group; neither the PDQ-39 SI score, nor the 
subscales’ scores were improved due to the intervention, apart from the cognition and 
bodily discomfort subscales. Prior work showed that neither supervised or unsupervised, 
group or individual, facility or home-based exercise programmes, could improve PDQ-39 SI 
scores and PDQ-39 subscales’ scores (Nadeau et al., 2014; Rios Romenets et al., 2015; 
Schlenstedt et al., 2015).  Interestingly, improvements on mobility did not enhance QoL, 
whereas the non-relief of depressive symptoms in two trials (Rios Romenets et al., 2015; 
Schlenstedt et al., 2015) may have also contributed to insignificant results. Similarly to 
exercise, educational programmes in PD did not manage to detect any change in PDQ-39 
scores, despite the fact that depressive symptoms were relieved (Mach et al., 2007; 
Tiihomen et al., 2008). However, none of the aforementioned studies consulted the MCID 
value to identify any clinical change over time. 
 
QoL is a complex subjective concept (Opara et al., 2012), and is affected by a combination 
of factors. Although the primary motor symptoms, motor fluctuations and falls may affect 
QoL in PD (Rahman et al., 2008); it seems that non-motor symptoms are also strong 
predictors for diminished QoL (Rahman et al., 2008), and may have a greater impact on QoL 
than the motor symptoms (Martinez-Martin and Kurtis, 2012). The more number of non-
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motor features, the more impaired QoL (Barone et al., 2009). Depression is the strongest 
predictive value for poor QoL in PD (Section 3.6.3), whereas additional non-motor 
symptoms (e.g. apathy, anxiety, FOF, and fatigue) are also consistent (Den Oudsten et al., 
2007; Rahman et al., 2008). Lastly, some socio-demographic features (e.g. financial issues, 
unemployment) may impact QoL levels in PD (Den Oudsten et al., 2007). 
 
With respect to the present study, and based on the above data; it could be hypothesised 
that the improvements in depression scores and mobility in the IG, may have been partly 
responsible for the enhanced QoL at the end of the treatment. This may be supported by 
the fact that all the relevant subscales (mobility, ADLs, emotional well-being) were 
improved significantly at post-intervention. It is unknown whether the educational sessions 
contributed to the positive effects of the overall QoL, or stigma and bodily discomfort 
subscales. The benefits on QoL in the IG are of particular interest, due to the events that 
occurred in Greece during the study, which could have affected the outcomes. Regarding 
the CG, the trivial effects of exercise on depression and anxiety, and the lack of an 
educational programme may have been partly responsible for the non-significant results 
on PDQ-39 SI scores. Interestingly, the significant effects of the home-based programme 
on TUG and BBS scores, did not reflect any improvement on PDQ-39 mobility and ADLs 
subscales.  
 
Lung function 
The respiratory training favoured only the IG, as the FEV1 and FVC indices were improved 
(p≤ .05) from baseline to post-intervention and follow-up, and IVC from baseline to follow-
up. The strength of association varied from medium to large (partial eta squared ≥ .06; r≥ 
.30). On the contrary, the training failed to demonstrate any impact on Tiffeneau-Pinelli 
index (FEV1/FVC). Perhaps, the lack of Threshold IMT device in the home-based programme 
was responsible for the insignificant improvements.  
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Despite the fact that PD has respiratory impairments, and a restrictive, obstructive or mixed 
disorder, could affect half patients, usually in H&Y stages three to five (Baille et al., 2016); 
there is limited number of studies that have examined the effects of respiratory muscle 
training to improve muscle strength and lung function. Only the trial by Inzelberg et al. 
(2005) examined the effects of IMT using a POWERbreathe device. Although the training 
was effective on maximal inspiratory mouth pressure (PImax), there were no changes in the 
respiratory volumes and capacities. The effects of IMT have been studied more in MS, a 
neurological disease with pulmonary impairments as well. However, the results on lung 
function were mixed (Reyes et al. 2013); whereas one trial demonstrated improvements 
using breathing-enhanced upper extremity exercises (Mutluay et al., 2007). However, the 
IMT programmes in previous studies were unsupervised. Thus, the positive effects of IMT 
in the IG of the present study, are of particular interest, as it proved that a supervised 
training, with less respiratory exercise dose, could produce more improvements in lung 
function.  However, due to the lack of a maximal inspiratory pressure (MIP) device to 
measure the PImax, the intensity of the training was not prescribed, and progression was 
achieved empirically by increasing the training load of the Threshold IMT device. 
 
Regarding the present findings, there is insufficient evidence to support the mechanism of 
action leading to positive effects on lung function, as the mechanism of ventilatory 
dysfunction in PD is poorly understood, and its aetiology may be multifactorial. IMT may 
lead to respiratory muscle hypertrophy increasing the mobility of the thorax, which may 
have been reduced, due to rigidity and bradykinesia. In turn, the increased mobility of the 
thorax may improve pulmonary ventilation, allowing more efficient gas exchange between 
the lungs and the environment (Azad et al., 2011). On the contrary, it is unknown whether 
respiratory training could improve all the pulmonary volumes and capacities, because the 
respiratory impairments in PD may also have a central aetiology. In particular, the 
neurodegeneration in brainstem, due to PD, could affect both the apneustic and 
pneumotaxic centres, which regulate respiration (Kolesnikova, 2006). 
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Although further investigation is needed, it seems that MDD may be linked with poor lung 
function, as measured by spirometry (Afreen and Ferdousi, 2016). In addition, the study by 
Momtaz et al. (2015) revealed that patients with COPD, who were treated with drugs for 
depression, improved also significantly their spirometric parameters.  As the ‘monoamine 
hypothesis’ supports that physical activity may act as antidepressant medicine (Wegner et 
al., 2014); in the present study, it could be hypothesised that the relief of depressive 
symptoms within the IG, due to exercise, was partly responsible for the improvements in 
lung volumes and capacities. However, further evidence is needed to support this theory. 
 
10.2.4. Satisfaction level 
The qualitative analysis of the SQ aimed to establish the views on therapeutic exercise 
intervention, in individuals with PD that participated in the current study. Patients’ 
feedback is of particular interest in healthcare services, as it can be used to improve 
methods of providing health services to patients (Porter, 2008; Al-Abri and Al-Balushi, 
2014). Regarding previous relevant trials on PD depression, only the effective study by 
Sajatovic et al. (2017) evaluated participants’ satisfaction using a questionnaire with close-
ended questions. The findings indicated that participants were very satisfied with the social 
aspects of group attendance in exercise and educational classes. 
 
The current SQ was completed by 68.75% of patients in the IG. Only the views of those who 
completed the intervention period and agreed to complete the questionnaire were 
obtained. Perhaps, the writing difficulties due to PD, may have prevented some patients 
from completing the open-ended questions of the instrument. The number of completed 
questionnaires may have been higher if the SQ consisted only of close-ended questions. In 
addition, certain individuals may have disliked the structure of the programme and the 
interaction with other people, and found the training ineffective, avoiding to complete the 
questionnaire. These patients may have responded better to individualised programmes, 
because there is usually greater attention from their therapist. Thus, the findings of the SQ 
cannot be generalised, as it is unknown whether the intervention’s environment was 
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suitable for those did not complete the questionnaire or stopped to attend the exercise 
class. 
 
The collection and interpretation of data about patients’ satisfaction revealed that the 
feedback for the exercise was positive, and most of the participants in the training 
commented that they did enjoy the programme.  The positive feedback was accompanied 
with improved mood, as measured by the HADS subscales, confirming that the emotional 
level of patients is usually being linked with their satisfaction level (Sotgiu and Rusconi, 
2013). As patient satisfaction is believed to be a multidimensional concept (Prakash, 2010); 
a variety of factors during the intervention period, contributed to the overall positive 
feedback of participants. Some of the most common reported were: the variety of 
exercises, the courteous attitude of instructors, and the socialising with other sufferers. 
Thus, the whole intervention was non-time consuming.  
 
Not only the feedback was positive during the intervention period, but the vast majority of 
participants cited major beneficial aspects of the programme, apparent even from the first 
week of intervention. Although the majority of positive outcomes from participating in the 
exercise intervention were related to mobility; additional perceived benefits were related 
to emotional well-being, socialisation and learning through exercise.  One participant also 
noticed improvement on lung function. The benefits the participants noticed, were in 
accordance with the quantitative results, which emerged that the intervention had a 
significant effect on mobility and mood. It is also important that the vast majority of 
patients did not find the programme hard to complete it. None noticed any negative 
effects, and minor dissatisfactions were related to the exercise venues. The proposal to add 
more training hours and outdoor activities in the future, revealed more the success and 
acceptance of the community-based programme. 
 
An interesting finding was that despite the fact that the main goal of the current RCT was 
the improvement of depression, and the participants were aware of it, their priority goal 
to participate in the study was the improvement of motor symptoms. However, the 
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majority of patients with PD feel embarrassed about the non-motor symptoms of the 
disease or ignore that they may be related to it, reporting only the motor symptoms to 
healthcare professionals (Kummer and Teixeira, 2009). Lastly, the fact that some patients 
decided to participate due to financial difficulties to cover the physiotherapy cost, proves 
the need for the promotion of low-cost community-based programmes in Greece. 
 
10.2.5. Falls 
To our knowledge, this is the first study to examine the characteristics of falls in patients 
with PD living in Greece. However, all the patients were depressed at baseline, based on 
the HADS-D score; and through the whole five-month reference period, they participated 
in a training programme to improve mood and mobility. During the whole study period 
overall 28 individuals (45.1%) were classified as fallers, and 19 out of 28 (67.8%) as 
recurrent fallers. On the contrary, the findings of the review by Allen et al. (2013), 
synthesising the results of 19 studies, showed that the mean proportion of fallers in PD was 
60.5%, whereas 39% of them were classified as recurrent fallers. In our study, the 
proportion of fallers would probably be greater, if: a longer reference period was selected, 
and if the sample included patients with severe clinical disability level (H&Y stage four) as 
well; because the majority of falls usually occur at the advanced stages of the disease, when 
balance impairment is increased (Kim et al., 2013). Although the presence of depression 
could increase the number of falls and fallers, because it is believed to be a strong 
contributor for falls; its contribution on falls in PD has been little studied so far (Ashburn et 
al., 2001; Allen et al., 2013). In addition, the improvements the subjects received on 
mobility due to the exercise, may partly explain the less proportion of fallers. The more 
improvements on the primary and secondary outcomes, which were noticed in the IG 
compared to the CG over time, may partly explain the higher number of fallers and falls in 
the CG. 
  
Logistic regression revealed that the major predictor of falls was the H&Y stage, following 
by the UPDRS score. The larger the H&Y stage and the UPDRS, the larger possibilities for a 
fall. The vast majority of fallers were in the third H&Y stage. This seems logical, as balance 
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impairment is a manifestation of the late stages of PD (three to five H&Y stages) (Hely et 
al., 2005); and the severity of gait disturbances is associated with the severity of the 
disease, as measured by the UPDRS (Kang et al, 2005). Surprisingly, years since PD 
diagnosis, age of participants, and presence of FOG were not identified strong predictors 
for falls, as supported in the literature (Pandya et al, 2008). 
 
Concerning the circumstances of falling, the majority of falls happened at patient’s 
home/property (57%), indicating that patients with PD and comorbid depression may 
restrict their outdoor activities even from the first stages of the disease. This proportion is 
lower than that reported in the study by Ashburn et al. (2008), which revealed that 80% of 
falls among patients with PD in the United Kingdom (UK) occurred at home. Perhaps, in the 
UK, due to the rainy weather, PD patients restrict further their outdoor activities. A high 
percentage of indoor falls in the present study, occurred at living room (23.1%), because 
patients may spend the majority of their day there. A significant proportion of falls (n= 39, 
32.2%) occurred in the late night or early in the morning (12 am – 9 am), maybe due to the 
under-dosing of antiparkinsonian medication through nighttime hours. An interesting fact 
is that four falls occurred at late night, when the patients woke up to go to the toilet. As 
previously reported, at that time the medication does not work well. Only 29.7% of falls 
were reported during the ‘on-state’ of medication, when motor symptoms are well-
controlled.  
 
Regarding the activity during falling, in 68.10% of cases the individuals were ambulant, and 
the main reported activity that led to indoors and outdoors falls was walking (39.7%). This 
may arise concerns whether the patients were able to recognise their level of mobility 
through the day, or whether the outdoor and house environment in Greece are safe for 
patients with PD. Surprisingly, only 9.9% of falls occurred during turning, which is 
considered a high risk activity for falls; as it requires axial rotation, and is usually 
accompanied by FOG (Ashburn et al., 2008). However, it is believed that the actual 
proportion of falls during turning was higher. In particular, stairs, which accounted for 5.8% 
of falls, usually involve turning. In addition, almost all the respondents did not report the 
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direction of walking prior falling, or did not provide further information to understand the 
exact mechanism of falling. The relevant low percentage of standing falls (22.3%), may be 
explained by the fact that assistance was provided or special equipment was used for some 
activities with high risk of falling, such as dressing and shower.  
 
The results also revealed that both intrinsic and extrinsic factors contributed equally to 
falls. However, indoors falls were caused mainly by intrinsic factors, while outdoor falls by 
extrinsic factors. This finding is in line with a recent study that was held in Serbia (Gazibara 
et al., 2014). Probably, some patients reduce or avoid outdoor activities during the off-state 
of medication. The main intrinsic factors were related to the motor symptoms of the 
disease (freezing, balance impairment); whereas dizziness accounted only for 3.3% of falls, 
indicating orthostatic hypotension, a major non-motor symptom of PD (Barone et al., 
2009), or a side effect of medication. An interesting fact was that the reported reason of 
three falls was personal misjudgment of the level of foot elevation when crossing obstacles. 
However, it is believed that this may also be related with decreased dorsiflexion strength 
to cross the obstacle (Liao et al., 2014). Damaged, narrow and uphill/downhill pavements 
were the most reported extrinsic fall-associated factors, indicating that some 
neighborhoods of Athens are unfriendly for pedestrians, especially for people with 
disability. This may also reveal an additional factor that Greek individuals with disability, 
such as PD patients, may restrict their outdoor activities. Walking over a damaged 
pavement, curb, carpet or wet floor led to tripping. Similarly the study by Gazibara et al. 
(2014) reported that tripping while waking was a dominant cause of falls in Serbian PD 
population. The fact that no outdoor falls were cited while walking on a slippery surface, it 
is mainly related to weather condition in Greece during the summer period. 
 
The reported circumstances of falls in the IG, raised issues whether the educational 
programme managed to educate patients how to overcome gait difficulties and avoid 
falling. However, it is supported that despite the fact that some patients with PD may be 
aware of the factors leading to falls, they feel confident while performing activities with 
high risk of falling (Rahman et al, 2008). Alternatively, some patients may recognise their 
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current mobility limitations, but continue to perform their ADLs independently, as they 
wish to preserve their autonomy. 
 
Based on participants’ answers, 26.5% of the reported falls were injurious. Nearly ¾ of the 
injuries occurred outdoors, and caused mainly by extrinsic factors. The most commonly 
injuries were minor, and specific medical intervention was not required. Only two 
lacerations required sutures, and there were no fractures. The increased BMI of 
participants may have decreased the risk of bone fractures (Bachmann and Trenkwalder, 
2006).  These results are similar to those one that found in Serbia, where the majority of 
injurious falls occurred outdoors (Gazibara et al., 2014); and in contrast with the findings 
that reported in the UK, where 65% of injurious falls happened at home (Ashburn et al., 
2008). It seems that in the UK, apart from the fact that PD patients may restrict their 
outdoor activities due to the weather conditions, there may be less extrinsic factors leading 
to outdoor falls compared to Balkan countries (e.g. less damaged pavements, more flat 
pavements, less outdoor stairs). 
 
10.2.6. Drop-out reasons and attendance rate 
In the present study, the overall drop-out rate, from the baseline up to the follow-up, was 
13.3%. It seems that the strict eligibility criteria, in combination with the screening 
procedure, assisted to select participants suitable for the nature of the study; and 
individuals with comorbidities, which may affect their participation to the programme, 
were excluded. Secondly, the selected venues were easily accessible by public means of 
transportation or personal automobiles. The individuals who expressed interest to 
participate in the study, were placed in municipalities closed to their place of residence to 
ensure fast access to the selected venues.  The community-based and home-based 
programmes were not monotonous, including a variety of exercises to keep the interest of 
trainees. It is also believed that the free-of-charge-participation was an additional 
important factor to complete the programme, as due to the ongoing debt crisis some 
patients were unable to cover their healthcare expenditures. 
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Concerning the CG, the high attendance was also achieved by: telephone calls to ensure 
their participation to the training (Ravenek and Schneider, 2009), and the offer of the group 
exercise and educational programme, if the results would have been significant (Berger et 
al., 2009). However, the lower drop-out rate in the IG could be explained by the: systematic 
selection of the exercise dose to achieve high attendance (section 8.8.1), the interactive 
nature of the educational lectures, the highly exercise supervision by professionals with 
expertise in PD, the motivation provided by the healthcare providers, the facility-based 
environment (Allen et al., 2012; Stubbs et al., 2016), and the socialisation aspects of the 
group attendance.  
 
The most important finding was that the exercise intervention did not cause a detrimental 
effect on patients; providing further evidence to the current knowledge of the present 
systematic review (Section 4.6.2), that therapeutic exercise is safe in this population, if the 
programme is organised by experienced healthcare professionals, and a careful assessment 
ensures the ability for participation. It is of particular interest that none of the individuals 
left the programme or made absences due to an injury during training, or because the 
programme was exhausting or boring. More interestingly, a further investigation of 
individuals who left the IG and CG from baseline to post-intervention, revealed that the 
mean HADS-D score was 10.8 and 12.4 for the IG and CG respectively at baseline, indicating 
that more severe levels of depression in unsupervised programmes may likely result in a 
higher drop-out rate. However, further research is needed to confirm this finding. 
 
10.3. Methodological issues- strengths and limitations  
10.3.1. Strengths of the current study 
The strengths of the present study should be recognised. The RCT was unique in a number 
of areas. It was the first to: establish the impact of a therapeutic exercise programme 
combined with education on depression to those affected with PD, include only individuals 
with elevated levels of depression, use a self-report tool to detect participants’ satisfaction 
about the exercise programme. With reference to Greece, it was the first study to assess 
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the effectiveness of a community delivered exercise and educational programme and 
report the number and characteristics of falls in Greek population living with PD. 
 
The CONSORT guidelines were followed to increase the quality of the study; ensuring less 
possibilities for bias; and achieving adequate internal and external validity (Moher et al., 
2010). The strict eligibility criteria ensured that the participants met the standards to 
participate in the study, they were not vulnerable to harm from the study intervention, and 
that any improvement was a result of the intervention. (Elkin and Moseley, 2015). The 
inclusion criteria also enabled to have an homogeneity of participants, which allowed 
researchers to generalise the results and conclusions to the population being studied 
(Leonard et al., 2003).  The randomisation procedure guaranteed that none of the study 
groups had an advantage over the other. Trials with inadequate or unclear randomisation 
tend to overestimate treatment effects up to 40% compared with those that use proper 
randomisation (Schul and Grimes, 2009).  The rigorous eligibility criteria, the randomisation 
procedure and the concealed allocation reduced the possibilities for selection bias, and any 
difference between the study groups at baseline reflected chance (Pannucci and Wilkins, 
2010).  
 
A sample size calculation was performed to determine the number of participants needed 
to detect a clinically relevant treatment effect. Thus, based on the sample size 
determination, the study had sufficient power to detect a worthwhile change. In order to 
avoid attrition bias, due to the loss of the participants through the whole study period, 
more participants were enrolled than the minimum required sample size. However, 
although this step is important, it is not sufficient to totally avoid bias, even if the number 
of remaining patients is enough to give the required statistical power (Nunan et al. 2018). 
 
The design of the intervention was appropriate for the target population, the landscape of 
Greece and the purpose of the study. Due to the scarcity of indoors equipped exercise 
venues in the Greek municipalities; it was decided to design a low-cost programme, without 
expensive and sophisticated equipment, which could be performed even in the small cities 
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of the country, under the supervision of experienced healthcare providers. The training 
protocol combined evidence-based elements of exercise in PD and depressed population. 
In addition, some lectures of the educational programme were designed based on the 
findings of the present survey, to cover the needs of Greek patients with PD. The treatment 
setting was the same for all the groups of the IG; hence, there was not an advantage of one 
group against another (Dekkers et al., 2010). The pilot work enabled to test the preliminary 
design, before the conduction of the main study (Thabane et al., 2010). The interventions 
were described thoroughly, allowing the clinicians to know exactly how to administer the 
interventions that were evaluated in the trial (Moher et al., 2010). Lastly, in an era that 
there is increasing interest for long-lasting effects in healthcare, the current RCT assessed 
both the shorter- and longer-term effects of the intervention. 
 
Special emphasis was given to the screening and assessment procedure to avoid patients’ 
fatigue, any flaws during the whole procedure, and to reduce assessment time. There was 
an attempt to use tools with high clinimetric properties to reduce measurement error, 
which have translated and validated in the Greek language. The HADS-D was the selected 
measurement tool for depression, the primary outcome of the study; because it is valid 
tool in PD to monitor changes in depression, irrespectively the progress and the severity of 
motor symptoms. A strict procedure was followed for the construction of FQ and SQ, as 
described in the surve, to eliminate possible type of bias and receive accurate responses 
(Choi and Pak, 2005). The printed versions of self-administered instruments were friendly 
for the current population to facilitate their completion. The absence of an interviewer for 
the completion of FQ and SQ provided greater freedom to the respondent; and there was 
no interviewer bias, caused by the variability in interviewers’ skills (Choi and Pak, 2005). 
The screening procedure and assessments were performed by trained staff, and a specialist 
neurologist ensured that only patients with PD were included in the study. In addition, the 
more sensitive tools for the confirmation of PD and detection of depression were 
conducted first. Thus, individuals that were ineligible for participation became apparent 
early in the process. With respect to the assessments, all the clinical tests were performed 
by the same assessor (chief investigator), who had previous experience in using these tools, 
following specific protocols. Moreover, the pre- post- and follow-up assessments were 
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performed about the same time of the day to minimise within-day variability. Lastly, it is 
believed that due to the systematic design of the whole study, detrimential effects were 
not seen. 
 
Regarding the data analysis, a mixed methodological approach by collecting and 
interpreting both objective and subjective data, was selected to strength the effectiveness 
of the intervention. Although the p value indicates whether an effect exists, it does not 
reveal the size of the effect (Sullivan and Feinn, 2012). Therefore, both the substantive 
(effect size), statistical (p value) and clinical significance (MCID) were reported in the 
results. In addition, the responses of participants in the SQ established the views on group-
based therapeutic exercise intervention, highlighting its benefits. The study also reported 
both the statistically significant and non-significant results minimising the danger of 
selective reporting bias (Pannucci and Wilkins, 2010). 
 
Despite the aforementioned strengths, it seems that the most positive outcomes of the 
community-based programme were that: it enhanced the socialisation of participants, 
provided them the feeling of being a member in a community, and motivated them to 
increase their outdoor activities. As both the participants’ feedback was positive, and the 
objective data showed that the study was effective; the HPDA ‘Epikouros-kinisi’ decided to 
offer the group-based programme free-of-charge to its members living in Athens in co-
operation with volunteer physiotherapists. This was the first time the HPDA has offered a 
treatment to its members, as until that time its main aim was the information of patients 
and their families about the treatment options of the disease and healthcare advice. The 
first exercise classes started in December 2015 in four municipalities, and three more 
municipalities were added the following year. The programme was enhanced with: speech 
therapy sessions, education and psychological support of carers and families of people 
living with PD, and lectures in public venues to inform Greek population about PD. In an 
attempt to establish active PD communities in the municipalities of Athens, and promote 
socialisation between its members, the HPDA arranged meetings in each municipality on a 
monthly basis and half-day trips once a month. Bazaars and sponsorships helped the 
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organisation to collect money for this purpose. There were also plans to incorporate and 
alternatives types of physical activity, such as traditional Greek dances and Tai Chi training. 
Unfortunately, due to the small number of volunteers and for logistical reasons, the 
programmes stopped in June 2017. However, there are plans to start again in the near 
future. 
 
10.3.2. Limitations of the current study 
Certain limitations of the study should be acknowledged. Firstly, it is important to cite the 
main drawbacks on the generalisability of the current findings. Despite the fact that the 
participants were outpatients and strict eligibility criteria were defined; it seems that in 
studies in PD, which examine the effectiveness of an approach; younger PD patients, 
females, with higher educational level are more likely to participate. Thus, there is a danger 
for volunteer bias (Moore et al., 2014). In addition, in the present RCT, the participants had 
to be members of the HPDA. Perhaps, some potential participants may have refused to 
participate in the study, as they were reluctant to enroll with the HPDA. 
 
Secondly, the determination of depression was adapted by the self-rated HADS-D, and a 
clinical diagnostic assessment using the gold standards (semi-structured interview DSM or 
ICD criteria) was not performed. Thus, it is possible that some participants did not meet 
diagnosis for clinical levels of MDD. When a cut-off of 11 was selected to distinguish 
depressed from non-depressed population; only 24 out of 62 participants exceeded the 
minimum score for clinical depression. However, the results at post-intervention and 
follow-up indicated that the community-based exercise and educational programme 
reduced significantly the depressive symptoms. 
 
Although there was an effort to select assessment tools with high clinimetric properties, 
this was not always possible; due to the unavailability of equipment, non-translation and 
validation of some instruments in the Greek language. Thus, measurement tools with 
higher clinimetric properties, which are recommended to the target population were 
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rejected. Moreover, in contrast with previous studies in PD, neither the total UPDRS nor 
the UPDSR-III (motor subscale) scores were used to assess the effectiveness of the 
intervention at the end of the treatment. Although the self-administered tools, which were 
selected, appear high clinimetric properties and are proposed in PD (HADS, PDQ-39, FES-I); 
the accuracy of responses was solely based on participants’ views. As the participants were 
not blinded to the allocation, the members of the IG may have overestimated the 
treatment effects, increasing the possibilities for measurement bias. There is also danger 
for recall bias, because the subjects may have not remembered previous events, 
behaviours and experiences accurately (Pannucci and Wilkins, 2010). 
 
The self-administered questionnaires (FQ, SQ), designed by the chief investigator, were not 
free of limitations. The SQ did not include any question about the educational sessions. 
Hence, the individuals’ satisfaction relevant to the educational component, was not 
recorded. Furthermore, the open-ended questions of both questionnaires may have been 
inappropriate for the target population, due to writing difficulties even from the first stages 
of the disease. This may partly explain the low response rate in the SQ, and the inaccurate 
responses about the mechanism of falls (question four) in the FQ. 
 
In addition, the study did not aim to explore the mechanisms that may have been 
responsible for the improvements in depression and the secondary outcomes. The 
participants did not complete any physical or physiological test or self-report questionnaire 
for this purpose. Hence, it is unclear whether some mechanisms, which are proposed in the 
literature, contributed to the study’s outcomes. 
 
Despite the fact that an attempt was made to minimise potential bias, this was not always 
possible. As both subjects and therapists were unblinded to subjects’ allocation, the study 
was prone to performance bias. However, in studies where exercise is the intervention, the 
masking of participants and therapists is not possible. Furthermore, as the assessors were 
also unblinded, there was risk for detection bias, which could overestimate or 
underestimate the intervention’s effect (Pannucci and Wilkins, 2010). Lastly, an intention-
Chapter 10: RCT-discussion 
292 
 
to-treat analysis, based on the worst or best case scenario, to identify the real effect of the 
intervention (Elkin and Moseley, 2015), was not performed, as it was not in the initial plan 
of the study.   
 
10.4. Recommendations for future research 
A small number of studies rarely provides enough evidence to guide clinical and research 
practice. Furthermore, there is need for effective community-based programmes, due to 
their lower cost compared to individual supervised training. Thus, future studies should 
explore further the impact of exercise interventions on depression in patients with PD. 
However, it is difficult to make a prior estimation on the effectiveness of the present 
intervention in different countries. As different cultures may influence mood (Dekkers et 
al., 2010), it would be useful to conduct the current intervention protocol in other countries 
to conclude whether would reveal any antidepressant effect.  
 
It is recommended for future studies to focus on depressed population with PD, using 
accurate diagnostic tools for the clinical diagnosis of depression. The most commonly tool 
is the Structured Clinical Interview for DSM, through which diagnosis is made by 
psychologists according to DSM criteria (Gazzaniga et al., 2010). Thus, it will be investigated 
whether the present intervention could produce significant antidepressant effects in a 
clinically depressed population with PD. Longer periods of follow-up will provide further 
information about the longer-term effects of the intervention. 
 
It is also recommended to select tools with higher clinimetric properties for the screening 
procedure and assessments, which were not translated and validated in the Greek 
language at the time this study was conducted. This is feasible in trials with English-
speaking population, as all the tools are available in the English language. To illustrate the 
point, the clinician-rated scales HAM-D and MADRS could be selected to monitor changes 
on depression; the MoCA test to assess cognitive function; FOG Questionnaire for the 
severity and frequency of FOG episodes; Mini-BESTest for functional balance; and M-PAS 
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for functional mobility. Lastly, a design of a FQ and SQ consisting mainly of close-ended 
questions, may be more suitable for this population, due to the writing difficulties. 
 
Moreover trials of higher methodological quality than the present study, will produce less 
bias, increase the internal and external validity, and allow to strong firm conclusions about 
the effectiveness of exercise in PD population suffering from depression. Hence, based on 
the limitations of the present study, it is recommended to use blinded assessors; and to 
conduct an intention-to-treat analysis in order to estimate the real effect of the 
intervention.  
 
In addition, the mechanisms of action should be explored further, in order to provide an 
in-depth understanding about the mechanisms that contribute and interact to each other 
to improve depression and anxiety in PD. Thus, the participants could complete physical or 
physiological tests to investigate the presence of biological mechanisms, such as: the 
enzyme-linked immunosorbent assay (ELISA) test for markers of neuroprotection, 
endorphins, and inflammatory cytokines (e.g. BDNF, VEGF, β-endorphins, IL-6) in blood; the 
dexamethasone suppression test (DST) to assess adrenal gland function by measuring the 
cortisol levels; the urinary neurotransmitter testing (UNT), which may indicate imbalances 
between the neurotransmitters; MRI for the measurement of brain volumes (i.e. amygdala, 
thalamus, hippocampus), which are associated with anxiety and depression. Similarly, self-
report questionnaires could explore the role of socio-psychological theories. Indeed, SEE 
scale and questionnaire could provide evidence about the ‘self-efficacy theory’. Self-report 
questionnaires designed by the researchers, could reveal information about the role of the 
‘distraction hypothesis’ and ‘social interaction hypothesis’ in reducing depression in PD, 
due to exercise and education. 
 
As improvements in depression may be correlated with improvements in sleep, due to 
exercise; (Singh et al., 1997); future studies in depressed patients with PD should examine 
if any beneficial effect of training on depression is related with better quality of sleep or 
more sleeping hours. For this purpose, the SCOPA-S and Parkinson’s disease Sleep Scale 
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could be used to assess the quality of sleep before and after treatment (Chaudhuri et al., 
2002). The mechanism of action could also be explored for the secondary outcomes of the 
study. Indeed, the muscle strength test, cardiorespiratory test and gait analysis, will provide 
information about the results of the intervention on mobility; whereas a MIP device about 
lung function. 
 
Modifications of the present exercise protocol, based on the available equipment and 
exercise dose; could produce further antidepressant effects, improvements on mobility 
and lung function. Current evidence supports the use of CMS to facilitate learning and 
movement, and increase the muscle strength; exercise on the floor could improve trunk 
mobility; indoors aerobic exercise in a prescribed intensity using equipment (e.g. treadmill 
and stationary bicycle) could improve cardiorespiratory fitness and alleviate symptoms of 
depression; and expiratory muscle training (EMT) could improve the obstructive 
respiratory pattern of patients with PD. Suggested methods of prescribing relative exercise 
intensity are: the measurement of HRR for aerobic training; and PImax and maximal 
expiratory mouth pressure for respiratory muscle training (Mann et al., 2013). As some 
participants cited that they did enjoy the ball exercises, future studies could incorporate to 
their programme more activities that promote interaction among the trainees of the 
exercise group. Alternative, unstructured physical activity –such as Tai Chi, Yoga, box and 
dance- may provide more enjoyment and be more effective to improve mood than 
structured exercise. Regarding, the unsupervised home-based training; a CD or a 
smartphone/tablet application including videos with exercises, could facilitate patients to 
perform the training by themselves. This may be important for some regional and rural 
patients with PD, who lack access to healthcare facilities. 
 
An additional control arm receiving usual care will allow direct comparison of intervention 
with no intervention. Similarly, the split of IG in two groups, one receiving group exercise 
and another educational classes, will reveal the degree at which each component 
contributes to antidepressant effects. At a time that there are many recommended 
treatment options for depression, and as some studies in depressed population revealed 
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that exercise is comparable or more effective than psychological approaches to improve 
mood (Schuch et al., 2016b); it would be of particular interest for future studies in PD, to 
compare exercise with psychological approaches (e.g. CBT), or combine both treatments, 
in order to find the treatment that produces the best results. As the direct and indirect cost 
of PD is high, a final avenue that should be explored is the financial cost of all the effective 
treatment options for depression in PD, in order to promote the less cost effective option. 
 
The present RCT revealed also some additional gaps in the research and in the healthcare 
services in Greece, which should be addressed. As the MCID is important in clinical practice 
to assess the progress of a treatment; future research is recommended to establish the 
MCIDs values for the HADS-A, HADS-D, BBS, FES-I, TUG and 2MWD in PD population.  
Further research should also determine the optimum cut-off score to distinguish depressed 
and non-depressed population in PD using the HADS-D. In addition, the knowledge of Greek 
healthcare professionals working with those with PD should be investigated. Their 
continuing professional development will assist them to provide their clients with the most 
effective treatment. Lastly, as some patients reported low social support or abuse by their 
family, and given the fact that family is the main caregiver of patients with chronic diseases 
in Greece; the education of family will reduce caregiver’s burden, improve the provided 
services for patients at home, and in turn will probably improve patients’ emotional well-
being and QoL. 
 
10.5. Conclusion 
In conclusion, the current RCT revealed that only the community-based intervention 
managed to alleviate depressive symptoms; however, there was not any significant 
difference between the two groups at post-intervention and follow-up. Not only the p value 
and the effect size revealed that the group exercise and educational classes produced 
antidepressant effects; but the participants of the IG did cite that the training assisted them 
in a significant extent on mobility and emotional well-being, enhancing the findings of the 
statistical tests. Within the PD therapeutic exercise literature, similar significant 
improvements in depression have also been reported. However, the current study was the 
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first that included PD population with elevated levels of depression, and a sample size 
determination confirmed that the trial had sufficient power to detect a worthwhile change. 
As the results of a single RCT cannot draw strong conclusions about the effectiveness of 
community-based therapeutic exercise and education in PD population with elevated levels 
of depression, there is scope for continued clinically relevant research for those with PD, 
with an improvement in study quality. Despite the significant results and the provision of 
useful information in clinical setting, the most positive outcome of the present RCT was the 
establishment of PD communities in sevens municipalities of Athens Metropolitan Area, 
and the free-of-charge multidisciplinary approach that was offered to PD patients and their 
carers by experienced healthcare professionals under the auspices of the HPDA ‘Epikouros-
kinisi’.  
 
10.6. Summary of Chapter 10 
 The study groups were similar at baseline regarding the basic socio-demographic 
characteristics, health status, and outcome measures; probably due to proper 
randomisation procedure and concealed allocation. 
 The small or medium relationship of anxiety and depression with anthropometric 
characteristics, health status and secondary outcome measures may have resulted due 
to the complex concepts of mental disorders in PD. 
 The lack of physiological and physical tests did not allow the establishment of the 
biological and psychological mechanisms that improved mood. Thus, only assumptions 
were made. 
 The motivation provided by the healthcare providers, the social interaction between 
the participants, the dose and type of exercise, the improvements in mobility, and the 
content of educational classes; may have been the determinants for the significant 
antidepressant effects in the IG.  
 The current findings were in line with previous research in PD; where therapeutic 
exercise programmes, educational classes and multidisciplinary approaches managed 
to alleviate depressive symptoms. However, the present RCT was the first that included 
only PD patients with elevated levels of depression. Before the submission of the 
Chapter 10: RCT-discussion 
297 
 
current thesis, a study (Sajatovic et al., 2017) with similar design, which included only 
PD patients diagnosed with MDD, was published. 
 Caution is needed for the interpretation of secondary outcomes as the study’s design 
was based on the key outcome, and any change may reflect chance. 
 It seems that the effects of exercise on neuroprotection and neuroplasticity may have 
been responsible for the improvements in mobility in both study groups. 
 The trivial improvements in FES-I scores may be explained by the fact that FOF in PD is 
complex, and is affected by many factors. 
 The improvements in anxiety, depression and mobility may partly explain the beneficial 
effects of the community-based exercise and education on QoL. 
 Despite the fact that the pathophysiology of respiratory impairments in PD is not well-
established, the IG showed some improvements in lung function, as measured by the 
spirometre. However, it is unknown whether the antidepressant effects of training 
were partly responsible for these benefits.  
 The most valuable outcome of the present study was the establishment of PD 
communities in seven municipalities of Athens and the free-of-charge treatments 
provided to patients with PD and their carers by the HPDA. 
 The present RCT also confirmed that exercise is safe in PD population, when strict 
eligibility criteria are used for the selection of participants, and the whole programme 
is supervised by healthcare providers with expertise in PD. 
 Additional studies are proposed using rigorous methodology, to draw strong 
conclusions about the effectiveness of therapeutic exercise and education in PD 
patients with clinical levels of depression. The mechanism of action of exercise and 
education on mood in people with PD should be explored. 
 The analysis of FQ revealed that the majority of falls were recorded at the patients’ 
home, maybe due to the restriction of outdoor activities; however, the largest 
proportion of fall-related injuries occurred outdoors, caused mainly by extrinsic factors.
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11.1. Introduction 
Depression is one of the most common non-motor symptoms in PD population.  It is 
associated with worse physical functioning, increased fall rates, reduced QoL, further direct 
and indirect cost, and it is an important predictor of mortality in PD. Despite its high 
frequency and significant burden in PD, depression is seldom diagnosed and often 
untreated. Although therapeutic exercise seems to be an important adjunct to the available 
pharmacological and psychological treatment for the management of depression in the 
overall population, the role of exercise to relieve depressive symptoms in those affected 
by PD, has received less attention. 
 
Thus, the overall aim of the present thesis was to address gaps within the research, relating 
to the role of the therapeutic exercise to alleviate depressive symptoms in patients with 
PD and co-morbid depression. In particular, the systematic review aimed to summarise and 
evaluate the evidence deriving from all the available RCTs, which examined the 
effectiveness of therapeutic exercise on depression in PD population. Further, a survey was 
performed to detect and list the impacts of PD on ADLs and emotional status in patients 
with PD living in Greece; whilst the most prevalent responses were considered for the 
design of the RCT’s intervention. Lastly, an RCT was conducted to examine the effectiveness 
of a community-based exercise and educational programme on depression in Greek 
population living with PD.  
 
11.2. Innovative studies and contribution to knowledge 
All three studies were innovative in a number of ways and added unique knowledge to the 
literature.  
 
The current systematic review was the first that provided an insight into the connection of 
physical activity with depression and anxiety in PD.  The review revealed that depression 
and anxiety in PD were rarely examined as primary endpoint; and the presence of 
depressive and anxiety disorders was not among the eligibility criteria of the studies, as 
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detected by accurate diagnostic criteria or rating scales. As the findings of previous RCTs 
were controversial, there was insufficient evidence to determine whether exercise was 
able to elicit short- and longer-term antidepressant and anxiolytic effects. Hence, future 
studies were recommended to fill this gap. In addition, the review did not manage to inform 
clinicians about the optimal type and dose of exercise to manage depression and anxiety 
in PD, due to the diversity of the interventions among the effective trials. On the contrary, 
it was proved that exercise is a safe, non-harmful approach for this population. 
 
Regarding the survey, no previous work was found to record the level of mobility and 
emotional status in Greek population living with PD.  A disease-specific questionnaire, with 
both close- and open-ended items, was designed for this purpose. The fact that the 
respondent could be either a patient with PD or carer, may have assisted to include in the 
survey’s sample patients, who may have being unable to complete the questionnaire for a 
variety of reasons, such as writing difficulties and advanced levels of disability. The items 
of the questionnaire relevant to the socio-demographic features and health status, were in 
accordance to Greece’s landscape. The open-ended question, at the end of the instrument, 
allowed respondents to record personal beliefs about their experience living with PD. The 
results demonstrated that PD does not only affect physical function, even from the first 
stages of the disease, reducing the social life of patients; but it also affects mental health 
and provokes negative thoughts, both for the patients and their carers. Despite the survey’s 
small sample, the results indicated that due to restrictions in mobility and emotional well-
being, there is need for improved care and better overall treatment options for those with 
PD living in Greece. 
 
Lastly, the RCT was unique in a number of areas, and as such adds substantial knowledge 
to the literature surrounding therapeutic exercise in PD. It was the first to: establish the 
impact of a therapeutic exercise and educational programme on depression in patients 
with PD; and  include only of individuals with elevated levels of depression, as measured 
by the HADS-D. As the RCT was held in Athens; this was the first study that promoted 
community-based exercise in Greece, and recorded the number and features of falls in 
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Greek PD population. The strict eligibility criteria enabled to have an homogeneity of 
participants and reduce the external factors that may have affected the results.  
 
In order to meet the study’s aim; a group-based exercise and educational programme, and 
a booklet for individulised home-based exercise were designed by the author. As the results 
of the current survey were consulted for the whole design of the intervention, it is believed 
that the major needs of patients with PD living in Greece were covered. In an era that there 
is an increasing interest about the treatment cost, inexpensive and sophisticated 
equipment was used for the exercise classes. Simple exercises and measurement tools 
were selected, which did not require special training of therapists and are completed in a 
short time. As the whole protocol is described thoroughly, the programme can be 
reproduced even from physiotherapists not specialised in PD. 
 
 In addition, due to the sample size determination, the RCT had sufficient power to detect 
a worthwhile change. Apart from the statistical (p value); the substantive (effect size) and 
clinical (MCID value) were reported in the results. The MCID value is necessary to clinicians 
in order to check the response to the treatment. In addition, the participants’ satisfaction 
on the group-based exercise programme was recorded, adding much to the qualitative 
research in therapeutic exercise in PD.  
 
The results of the RCT demonstrated that depressed patients with PD are able to obtain 
short- and longer-term antidepressant benefits from commencing a well-designed, 
structured exercise and educational programme, provided by allied healthcare 
professionals with expertise in PD. The fact that the intervention was able to elicit 
antidepressant effects is extremely important, since this was the first study to recruit only 
PD patients with elevated levels of depression. The intervention managed to relieve 
depression, in spite of the events that occurred that period in Greece, and could have had 
a negative impact on the outcome. Despite the fact that the subjects did not perform any 
test, in order to detect the biological and psychological mechanisms that improved 
depressive scores; assumptions were made based on the literature. Not only the benefits 
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were produced in a relevant short time frame; but the intervention had also positive effects 
on mobility, QoL and lung function. The positive results in the primary and secondary 
outcomes were also confirmed by the participants, enhancing the effectiveness of the 
treatment. Moreover, an important finding of this study was that no adverse effects due 
to exercise were noted. However, it seems that the most positive outcome was the 
establishment of PD communities in seven municipalities of Athens Metropolitan Area, 
where the group-based exercise programme was offered free-of-charge by the HPDA 
‘Epikouros-kinisi’ and its volunteers.   
 
Until the submission of the current surveys a similar systematic review (Wu et al., 2017) 
and a RCT (Sajatovic et al., 2017) were published.  However, the present work was superior 
for a number of reasons. The review by Wu et al. (2017) included both experimental and 
quasi-experimental studies, which increase the possibilities for selection bias; and trials, 
where exercise was combined with an additional treatment, making it difficult to know the 
extent to which exercise influenced depression. In addition, the literature search was 
limited from 2006 to 2017. The RCT by Sajatovic et al. (2017) presented the findings only 
for the combined group, not allowing conclusions to be drawn for the group-based exercise 
and education intervention; and limited information was provided for participants’ 
satisfaction. 
 
11.3. Recommendations 
Clinical and research reccomendations emerged from this thesis. The current Section 
summarises the proposals for implementations and future research, which have already 
been reported in Sections 4.7.7, 7.5 and 10.4. 
 
11.3.1. Recommendations for rehabilitation practice   
Community-based programmes combining exercise and educational classes seem to be an 
effective adjunct treatment to relieve depressive symptoms and improve mobility and QoL 
in PD population with elevated levels of depression. Hence, group-based exercise and 
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education could be used as an alternative, affordable therapeutic option for depression in 
PD. Along with the benefits on emotional well-being, therapeutic exercise is the only 
treatment that could improve mobility and cardiorespiratory fitness. The programme could 
be feasible even in small cities of Greece and in different countries, as expensive and 
sophisticated equipment is not required; just healthcare providers with some expertise in 
PD. In addition, the supervision of exercise by expert staff negates the risk of adverse 
effects. As the design of exercise was based on combined data in depression and PD, in 
order to improve both the primary and secondary outcome measures; it is believed that 
the programme is suitable even for those with mild to moderate PD (H&Y stages one to 
three) without elevated levels of depression.  
 
Furthermore, the healthcare professionals in order to develop and propose new strategies 
for the management of the disease, they should recognise and understand the needs of PD 
patients, and the aspects of the disease that may have a determinant impact on their daily 
lives. Thus, it is believed that an instrument similar to what was designed for the survey, 
could be a valuable tool to assess the extent to which each activity or emotional symptom 
may affect the daily life of patients; and should be included as a standard procedure for 
monitoring and evaluation of both individual and group rehabilitation programmes. 
 
11.3.2. Recommendations for future research 
The positive results of a limited number of experimental studies are not enough to draw 
strong conclusions for the benefits of a treatment. Accordingly, further work is required to 
ascertain the potential effect of exercise, combined or not with education, on depression 
in PD; and provide guidance to clinical practitioners. It is recommended to future trials to 
focus on clinically depressed population, as defined by the DSM or ICD criteria; and select 
screening and assessment tools, which are highly recommended on this population. As 
different cultures may influence mood, it would be useful to conduct the current 
intervention protocol to other countries to conclude whether it is effective or not. 
Modifications of the current protocol for both the group-based and individualised 
programme, may produce more antidepressant effects. As the p-value is not considered 
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enough to conclude the success of an approach; the effect size, confidence interval, the 
MCID value, the participants' satisfaction and the intervention's safety should be recorded. 
 
In addition future studies of high methodological quality should detect the exercise type 
and its dose to relieve depression in PD population. Thus, they should focus on several 
types and doses of exercise, compare and/or combine exercise with other treatments; in 
order to assist healthcare professionals to offer the best treatment option to patients, 
based on their needs and preferences. Moreover, the evaluation of the financial cost of all 
the effective treatment options for depression in PD, will assist the NHS and private 
companies in the health sector to promote the most cost effective option. The biological 
and psychological mechanisms, responsible for the relief of depressive symptoms in PD, 
population should also be explored; whereas the establishment of the MCID values for 
rating scales that assess depression in PD population, will assist clinical practitioners to 
evaluate the effects of the treatment. 
 
Regarding the limitations of the present survey, there is need for larger nationwide studies 
in Greece to ensure the geographical coverage of the whole country, and for a study that 
will reach social groups, which are hard to participate in surveys (e.g. ethnic minorities, 
immigrants).  It is believed that a shorter questionnaire may increase the response rate. 
Similar international studies could detect the socio-demographic characteristics, health 
status, level of mobility and emotional well-being of patients with PD. However, patients 
with PD should be consulted for the construction of the instruments, and the steps 
proposed by the WHO should be followed for the translation and adaption of the 
questionnaire in different languages. The recording of restrictions in the daily life of 
patients with PD, will contribute to a deeper understanding of their needs, and will assist 
the NHS of each country to set new goals for the management of PD, and promote the 
most effective treatment options for this purpose.
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Appendix 3.1.Types and diagnostic criteria of depressive disorders. 
 
Major depressive disorder 
MDD -also called ‘major depression’ or ‘clinical depression’- is defined by one or more 
major depressive episodes (MDE) and the lifetime absence of mania and hypomania. It is 
characterised by severe negative moods; such as sad, hopeless, lack of interest in normally 
pleasurable activities. To meet the criteria for a MDE, it is required that five of nine 
symptoms, as seen in table A.1, are present during the same two-week period (Uher et al., 
2014). 
 
Table Α.1. DSM-V criteria for major depressive disorder (adopted from Uher et al., 2014). 
A Five or more out of nine symptoms (including at least one of depressed mood and loss of interest or pleasure) in the 
same 2-week period. Each of these symptoms represents a change from previous functioning. 
 
Note: symptoms that are clearly attributable to another medical condition are not included. 
Symptoms Frequency requirements 
1. Depressed mood (subjective or observed) Most of the day, nearly every day 
2. Loss of interest or pleasure Most of the day, nearly every day 
3. Change in weight or appetite Appetite: Nearly every day 
Weight: 5% change over one month 
4. Insomnia or hypersomnia Nearly every day 
5. Psychomotor retardation or agitation (observed) Nearly every day 
6. Loss of energy or fatigue Nearly every day 
7. Feelings of worthlessness or guilt Nearly every day 
8. Impaired concentration or indecisiveness Nearly every day 
9. Thoughts of death or suicidal ideation or attempt Thoughts: recurrent   
Attempt: any 
B. The symptoms cause clinically significant distress or impairment in social, occupational or other important areas of 
functioning. 
C. The episode is not attributable to the physiological effects of a substance or to another medical condition. 
D. The occurrence of the major depressive episode is not better explained by schizoaffective disorder, schizophrenia, 
schizophreniform disorder, delusional disorder, or other specified and unspecified schizophrenia spectrum and other 
psychotic disorders. 
E. There has never been a manic or hypomanic episode 
 
 
Between MDEs, more sufferers are asymptomatic, but about 30% experience some 
residual symptoms; which are grouped in four categories: sleep disturbances, affective, 
somatic and cognitive symptoms.  The most frequent affective symptoms are: depressed 
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mood, loss of interest and pleasure, and low interest in work; whereas the most frequent 
somatic symptoms include: fatigue, gastrointestinal symptoms, back pain, muscle ache, 
joint pain and sexual dysfunctions (Uher et al., 2014). 
 
The DSM-IV-TR recognises five subtypes of MDD, which are listed as follows: 
 Atypical depression, which is characterised by improved moods in response to positive 
events (Benazzi, 2006). 
 Catatonic depression is diagnosed when someone who is suffering from MDD develops 
physical symptoms; such as being unable to move, speak or respond to external stimuli 
(Benazzi, 2006). 
 Melancholic depression, which is characterised at least by anhedonia or lack of mood 
reactivity (Benazzi, 2006).  
 Postpartum depression, which affects mainly female population after childbirth 
(Benazzi, 2006). 
 Seasonal affective disorder is a cyclical pattern of depression, in which individuals 
exhibit depressive symptoms at the same period of each year, more commonly during 
winter months. It is usually reported in northern latitudes during the shorter days of 
winter (Benazzi, 2006). 
 
 
Dysthymic disorder 
Dysthymic disorder is also called ‘mild depression’ or ‘chronic depression’. It is a low-grade, 
persistent depression (Benazzi, 2006). Periods of dysthymia last for two to twenty years, 
although the typical duration is about five to ten years (Paykel, 2008). Dysthymic disorder 
sufferers typically experience milder depressive symptoms than MDD (Benazzi, 2006). 
However, in DSM-V, the new category of persistent depressive disorder (PDD) aims to 
combine dysthymia and chronic depression. Thus, except DSM-IV diagnosis for dysthymia, 
individuals whose symptoms meet MDD criteria for two years are given a diagnosis of PDD. 
In addition, the sufferers should not be without symptoms for more than two months (Uher 
et al., 2014). The criteria of PDD, according to DSM-V, are presented in table A.2. 
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Table A.2. DSM-V criteria for persistent depressive disorder (adopted from Paykel, 2008). 
A. Depressed mood for most of the day, for more days than not, as indicated by either subjective account or 
observation by others, for at least 2 years. 
B. Presence, while depressed, at least two of the following: 
1. Poor appetite or overeating. 
2. Insomnia or hypersomnia. 
3. Low energy or fatigue. 
4. Low self-esteem. 
5. Poor concentration or difficulty making decisions. 
6. Feelings of hopelessness. 
C. During the two-year period of the disturbance, the individual has never been without the symptoms in Criteria A 
and B for more than two months at a time. 
D. Criteria for a major depressive disorder may be continuously present for two years. 
E. There has never been a manic or hypomanic episode, and criteria have never been met for cyclothymic disorder. 
F. The disturbance is not better explained by a persistent schizoaffective disorder, schizophrenia, delusional disorder, 
or other specified or unspecified schizophrenia spectrum and other psychotic disorder. 
G. The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication) 
or another medical condition (e.g., hypothyroidism). 
H. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of 
functioning. 
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Appendix 4.1. Data extraction tool. 
 
Publication data 
First name author  
Year of publication  
Country  
Participants 
Sample size  
Gender proportion  
Disease severity  
Mean age  
Mean duration of PD  
Intervention 
Type of exercise  
Setting   
Exercise format  
Supervision  
Description of exercise protocol 
 
 
Programme duration  
Exercise frequency   
Session length  
Exercise intensity  
Comparison 
Type of comparison   
Description of protocol 
 
 
 
Outcomes 
Outcome measure  
Primary/secondary outcome  
Assessment tool  
Mid-term results  
Post-intervention results  
Follow-up results  
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Appendix 4.2. Brief description of the PEDro scale. 
 
The PEDro scale contains 11 items. For each item, a ‘yes’ or ‘no’ response is obtained. A 
‘yes’ response earns one point, whereas a ‘no’ response receives zero points. Points are 
only awarded when a criterion is clearly satisfied and reported.  Item one is excluded from 
the total score, as it is related to the external validity of the study. Criteria two to nine 
examine the study’s internal validity, and criteria ten and 11 are related to the 
interpretation of results. Thus, the total PEDro scale score ranges from zero to ten, with a 
higher score indicating better methodological quality (Sherrington et al., 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices 
394 
 
Appendix 4.3. Quality appraisal tool. The guidelines how to complete the PEDro scale are reported 
in the link: https://www.pedro.org.au/english/downloads/pedro-scale/ 
 
PEDro Scale 
First author name: 
Year of publication: 
Title of article: 
Criterion 
number 
PEDro criteria YES NO 
01 Eligibility criteria were specified 
 
  
02 Subjects were randomly allocated to groups (in a crossover study, 
subjects were randomly allocated an order in which treatments were 
received) 
  
03 Allocation was concealed 
 
  
04 The groups were similar at baseline regarding the most important 
prognostic indicators 
  
05 There was blinding of all subjects 
 
  
06 There was blinding of all therapists who administered the therapy 
 
  
07  There was blinding of all assessors who measured at least one key 
outcome 
  
08 Measures of at least one key outcome were obtained from more than 
85% of the subjects initially allocated to groups 
  
09 All subjects for whom outcome measures were available received the 
treatment or control condition as allocated or, where this was not the 
case, data for at least one key outcome was analysed by “intention to 
treat” 
  
10 The results of between-group statistical comparisons are reported for 
at least one key outcome 
  
11  The study provides both point measures and measures of variability 
for at least one key outcome 
  
 
Total score:     
  
Overall quality: 
Excellent (9-10)  
Good (6-8)  
Fair (4-5)  
Poor (0-3)  
 
     /10 
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Appendix 4.4. Excluded full-text articles and reasons of exclusion. 
Number of 
studies 
(All 27) 
First author name and year of 
publication 
Reason of exclusion 
7  Blandy (2015) 
 Boulgarides (2014) 
 Cheon (2013) 
 Cruise (2011) 
 Dereli (2010) 
 Pellecchia (2004) 
 Tanaka (2009) 
Lack or randomisation 
4  Guo (2009) 
 Trend (2002) 
 Van der Marck (2013) 
 Wade (2003) 
Exercise was component of multidisciplinary rehabilitation 
4  Lee (2015) 
 Mohr (1996) 
  Müller (1997) 
  Ridgel (2016) 
Exercise was combined with an additional treatment (e.g. 
functional electrical stimulation, psychoeducation) 
2  Comella (1994) 
  Nieuwboer (2007). 
Crossover design: anxiety and depression were not assessed at the 
end of  the first  period  
2  Clarke (2009) 
 Sturkenboom (2014) 
Occupational therapy programme, rather than a physical activity 
intervention 
1  Foster (2013) Depressive symptoms were not reported at post-intervention and 
follow-up  assessment 
1  Gauthier (1987) Assessment of  psychological well-being  
1  Hackney (2007) Assessment of morale 
1  Lewis (2016) Not only PD patients in the sample population 
1  Park (2014) Delayed-start design: not assessment of  anxiety and depression at 
the end of the first period 
1  Rochester (2005) Single bout of exercise 
1  Stallibrass (2002) Alexander technique as intervention, which is considered an 
educational process rather than a form of exercise 
1  Christofoletti (2012) Published in Portuguese  
 
 
References of excluded trials 
Blandy, L.M., Beevers, W.A., Fitzmaurice, K. and Morris, M.E. (2015) ‘Therapeutic Argentine 
tango dancing for people with mild Parkinson’s disease: a feasibility study.’ Frontiers in 
Neurology, 6, June. [online] [accessed on 2nd December 2016] 
 
Boulgarides, L.K., Barakatt, E. and Coleman-Salgado, B. (2014) ‘Measuring the effect of an 
eight-week adaptive yoga program on the physical and psychological status of individuals 
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Appendix 4.5. Classification of exercise intensity (adopted from ACSM’s, 2006). 
Exercise intensity HRR (%) HRmax (%) 
Very light <20 <35 
Light 20-39 35-54 
Moderate 40-59 55-69 
Heavy  60-84 70-89 
Very heavy 85-99 90-99 
Maximal  100 100 
 
Abbreviations. HRmax: heart rate maximum; HRR: heart rate reverse  
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Appendix 4.6. Exercise characteristics of effective trials on depression. 
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Appendix 5.1. Ethical approval for the entire study granted by the HPDA (Greek version). 
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Appendix 5.2. Ethical approval for the entire study granted by the HPDA (English version). 
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Appendix 5.3. Ethical approval for the ‘Step one’ (survey) granted by the HPDA. 
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Appendix 5.4. Invitation e-mail for the online survey (Greek version). 
 
ΕΡΩΤΗΜΑΤΟΛΟΓΙΟ ΓΙΑ ΑΣΘΕΝΕΙΣ ΜΕ ΠΑΡΚΙΝΣΟΝ 
 
Αγαπητά μέλη της ΕΠIΚΟΥΡΟΣ κίνηση, 
 
Αν είστε Άτομο με Πάρκινσον (ΑμΠ) ή φροντιστής ΑμΠ σας καλούμε να μας βοηθήσετε 
ανώνυμα στην σημαντική έρευνα που διεξάγουμε για την νόσο Πάρκινσον στην Ελλάδα. 
Η έρευνα πραγματοποιείται στο πλαίσιο διδακτορικών σπουδών του κου Θεόδωρου 
Χατζηδαμιανού στο Μητροπολιτικό Πανεπιστήμιο του Μάντσεστερ, Ηνωμένο Βασίλειο. 
Αν θέλετε να συμμετάσχετε, σας παρακαλούμε να συμπληρώσετε το ερωτηματολόγιο που 
βρίσκεται στον παρακάτω σύνδεσμο: 
 
http://docs.google.com/forms/d/1JYku5P_ItJGvGwVTriSBVCQ0A-
HAh0iTptYTive2Rbo/viewform 
 
O χρόνος συμπλήρωσης του ερωτηματολογίου είναι 4 με 20 λεπτά. Η έρευνα αφορά 
ΜΟΝΟ Άτομα που πάσχουν από Πάρκινσον και μπορεί να συμπληρωθεί και από 
φροντιστές τους. Στο τέλος του ερωτηματολογίου πατήστε ‘Υποβολή’ / «submit» ώστε να 
λάβουμε την απάντησή σας. Σας παρακαλούμε να συμπληρώσετε το ερωτηματολόγιο 
εντός 30 ημερών. 
 
Σκοπός 
Σκοπός του ερωτηματολογίου που καλείστε να συμπληρώσετε είναι η διερεύνηση των 
επιπτώσεων των καθημερινών δραστηριοτήτων και της συναισθηματικής κατάστασης σε 
ΑμΠ. Τα δεδομένα που θα συλλεχθούν, θα μας βοηθήσουν να κατανοήσουμε τα κύρια 
προβλήματα που αντιμετωπίζουν τα ΑμΠ στην καθημερινότητα τους, ώστε να 
σχεδιάσουμε ένα πρόγραμμα θεραπευτικής άσκησης κι εκπαίδευσης, κατάλληλο για την 
συγκεκριμένη πάθηση. 
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Εμπιστευτικότητα πληροφοριών 
Οι απαντήσεις σας και τα προσωπικά σας στοιχεία δεν θα γνωστοποιηθούν πέρα των 
ερευνητών. Μόνο οι ερευνητές θα έχουν πρόσβαση στο ερωτηματολόγιο που έχετε 
συμπληρώσει. Η ανωνυμία σας διασφαλίζεται καθ’ όλη την διεξαγωγή της έρευνας. Η 
συμμετοχή σας στη συμπλήρωση του ερωτηματολογίου είναι εθελοντική. 
 
Δομή ερωτηματολογίου 
Το ερωτηματολόγιο αποτελείται από 5 τμήματα. Το πρώτο τμήμα περιέχει γενικές 
ερωτήσεις και τα υπόλοιπα ερωτήσεις που αφορούν τις καθημερινές σας δραστηριότητες 
και τη συναισθηματική σας κατάσταση. Στην ερώτηση στο τέλος του ερωτηματολογίου, 
μπορείτε να γράψετε επιπλέον σχόλιά για την εμπειρία σας ως ΑμΠ ή φροντιστής ΑμΠ. Σε 
κάθε περίπτωση, θα πρέπει να είστε ειλικρινείς στις απαντήσεις σας για την συλλογή 
έγκυρων και αξιόπιστων αποτελεσμάτων.  
 
Για περισσότερες πληροφορίες, παρακαλώ επικοινωνήστε με τον κο Θεόδωρο 
Χατζηδαμιανό. 
 
 
Σας ευχαριστούμε για τον χρόνο σας και την συμμετοχή σας. 
 
 
Ερευνητική ομάδα: 
Θεόδωρος Χατζηδαμιανός, φυσικοθεραπευτής 
Τηλέφωνο: 69470057ΧΧ 
Ηλεκτρονικό ταχυδρομείο: thchdamianos@yahoo.gr 
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Appendix 5.5. Invitation e-mail for the online survey (English version). 
 
QUESTIONNAIRE FOR PATIENTS WITH PARKINSON’S DISEASE 
 
Dear members of Epkouros-kinisi, 
 
If you are patient with Parkinson’s disease (PD) or carer of a patient with PD, we invite you 
to take part in our research study about PD in Greek population. The research is part of the 
doctorate studies of Mr. Theodoros at Manchester Metropolitan University, United 
Kingdom. If you wish to participate in the study, please complete the online questionnaire 
at the following link: 
 
http://docs.google.com/forms/d/1JYku5P_ItJGvGwVTriSBVCQ0A-
HAh0iTptYTive2Rbo/viewform  
 
The required time to complete the questionnaire is between 4 and 20 minutes. The study 
refers only to people suffering from PD and it can be completed by themselves or their 
carer. At the end of the questionnaire press the ‘submit’ button to receive your 
questionnaire. The deadline for the completion of questionnaire is 30 days. 
   
Objective 
The objective of the questionnaire is the investigation of activities of daily living and 
psychological well-being in patients with PD. The collection of data will help us to 
understand the major problems of individuals with PD in their daily life, in order to design 
an exercise and education programme for this population. 
  
Confidentiality 
Your answers and all your personal information will be known only to researchers. Only the 
researchers of the current study will have access to your questionnaire. The anonymity is 
ensured throughout the survey. Your participation in completing the questionnaire is 
voluntary. 
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Questionnaire structure 
The questionnaire consists of 5 sections. The first section includes general questions for 
your life and health. The following sections are relevant to your daily activities and your 
emotional state. At the end of the questionnaire there is an extra question, where you can 
give us more relevant information about your experience living with PD. In any case, you 
should be honest in your answers for the collection of valid and reliable data. 
 
 
For further information please contact Mr. Theodoros Chatzidamianos 
 
Thank you in advance for your assistance! 
 
 
Research team 
Theodoros Chatzidamianos, physiotherapist 
mobile phone: 69470057XX 
e-mail: thchdamianos@yahoo.gr 
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Appendix 5.6. Invitation and consent form for the paper survey (Greek version). 
 
 
 
ΕΡΩΤΗΜΑΤΟΛΟΓΙΟ ΓΙΑ ΑΣΘΕΝΕΙΣ ΜΕ ΝΟΣΟ ΠΑΡΚΙΝΣΟΝ 
 
Αγαπητή κυρία/ αγαπητέ κύριε, 
  
Αν είστε Άτομο με Πάρκινσον (ΑμΠ) ή φροντιστής ΑμΠ σας καλούμε να μας βοηθήσετε 
ανώνυμα στην σημαντική έρευνα που διεξάγουμε για την νόσο Πάρκινσον στην Ελλάδα.  
Αυτό μπορεί να γίνει συμπληρώνοντας το ερωτηματολόγιο που θα σας δώσουμε. Η 
έρευνα πραγματοποιείται στο πλαίσιο διδακτορικών σπουδών του κου Θεόδωρου 
Χατζηδαμιανού στο Μητροπολιτικό Πανεπιστήμιο του Μάντσεστερ, Ηνωμένο Βασίλειο. 
O χρόνος συμπλήρωσης του ερωτηματολογίου είναι 4 με 20 λεπτά. Η έρευνα αφορά 
ΜΟΝΟ Άτομα που Πάσχουν από Πάρκινσον και μπορεί να συμπληρωθεί και από 
φροντιστές τους. 
 
  
Σκοπός 
Σκοπός του ερωτηματολογίου, που καλείστε να συμπληρώσετε, είναι η διερεύνηση των 
επιπτώσεων των καθημερινών δραστηριοτήτων και της συναισθηματικής κατάστασης σε 
ΑμΠ. Τα δεδομένα που θα συλλεχθούν, θα μας βοηθήσουν να κατανοήσουμε τα κύρια 
προβλήματα που αντιμετωπίζουν τα ΑμΠ στην καθημερινότητα τους, ώστε να 
σχεδιάσουμε ένα πρόγραμμα θεραπευτικής άσκησης κι εκπαίδευσης, κατάλληλο για την 
συγκεκριμένη πάθηση. 
  
Εμπιστευτικότητα πληροφοριών 
Οι απαντήσεις σας και τα προσωπικά σας στοιχεία δεν θα γνωστοποιηθούν πέρα των 
ερευνητών. Μόνο οι ερευνητές θα έχουν πρόσβαση στο ερωτηματολόγιο που έχετε 
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συμπληρώσει. Η ανωνυμία σας διασφαλίζεται καθ’ όλη την διεξαγωγή της έρευνας. Η 
συμμετοχή σας στη συμπλήρωση του ερωτηματολογίου είναι εθελοντική. Αν τελικά 
αλλάξετε γνώμη για τη συμμετοχή σας, μπορείτε να αποσυρθείτε όποτε θέλετε εσείς κατά 
την διάρκεια  ή μετά το τέλος της συμπλήρωσης του ερωτηματολογίου. 
  
Δομή ερωτηματολογίου 
Το ερωτηματολόγιο αποτελείται από 5 τμήματα. Το πρώτο τμήμα περιέχει γενικές 
ερωτήσεις και τα υπόλοιπα ερωτήσεις που αφορούν τις καθημερινές σας δραστηριότητες 
και τη συναισθηματική σας κατάσταση. Στην ερώτηση στο τέλος του ερωτηματολογίου, 
μπορείτε να γράψετε επιπλέον σχόλιά για την εμπειρία σας ως ΑμΠ ή φροντιστής ΑμΠ. Σε 
κάθε περίπτωση, θα πρέπει να είστε ειλικρινείς στις απαντήσεις σας για την συλλογή 
έγκυρων και αξιόπιστων αποτελεσμάτων.  
 
Σας ευχαριστούμε για τον χρόνο σας και την συμμετοχή σας! 
  
Ερευνητική ομάδα: 
Παναγιώτης Ζήκος, ειδικός νευρολόγος 
Θεόδωρος Χατζηδαμιανός, φυσικοθεραπευτής 
 
Επικοινωνία 
Αν θέλετε περισσότερες πληροφορίες μπορείτε να επικοινωνήσετε με τον κο Θεόδωρο 
Χατζηδαμιανό. 
Τηλέφωνο: 69470057ΧΧ 
Ηλεκτρονικό ταχυδρομείο: thchdamianos@yahoo.gr 
 
 
ΔΗΛΩΣΗ ΣΥΓΚΑΤΑΘΕΣΗΣ 
Ενημερώθηκα για την μελέτη και έχω καταλάβει το σκοπό της. Αποφάσισα να συμμετάσχω 
εθελοντικά γνωρίζοντας ότι οι πληροφορίες που θα δώσω θα μείνουν απόρρητες και ότι 
μπορώ  να αποσυρθώ όποτε θέλω. 
 
Υπογραφή συμμετέχοντα: ……………………………………………… 
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Appendix 5.7. Invitation and consent form for the paper survey (English version). 
 
 
QUESTIONNAIRE FOR PATIENTS WITH PARKINSON’S DISEASE 
 
Dear Madame/Sir, 
 
If you are patient with Parkinson’s disease (PD) or carer of a patient with PD, we invite you 
to take part in our research study about PD in Greek population. The research is part of the 
doctorate studies of Mr. Theodoros at Manchester Metropolitan University, United 
Kingdom. If you wish to participate in the study, please complete the questionnaire that 
will give you. The required time to complete the questionnaire is between 4 and 20 
minutes. The study refers only to people suffering from PD and it can be completed by 
themselves or their carer.  
   
Objective 
The objective of the questionnaire is the investigation of activities of daily living and 
psychological well-being in patients with PD. The collection of data will help us to 
understand the major problems of individuals with PD in their daily life, in order to design 
an exercise and education programme for this population. 
  
Confidentiality 
Your answers and all your personal information will be known only to researchers. Only the 
researchers of the current study will have access to your questionnaire. The anonymity is 
ensured throughout the survey. Your participation in completing the questionnaire is 
voluntary. 
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Questionnaire structure 
The questionnaire consists of 5 sections. The first section consists of general questions for 
your life and health. The following sections are relevant to your daily activities and your 
emotional state. At the end of the questionnaire there is an extra question, where you can 
give us more relevant information about your experience living with PD. In any case, you 
should be honest in your answers for the collection of valid and reliable data. 
 
Thank you in advance for your time! 
  
Research team: 
Panagiotis Zikos, neurologist 
Theodoros Chatzidamianos, physiotherapist 
 
Contact details 
For further information, please contact Mr. Theodoros Chatzidamianos 
Mobile phone: 69470057ΧΧ 
e-mail: thchdamianos@yahoo.gr 
  
 
 
 
CONSENT FORM 
I confirm that I have read and understood the information sheet for the current study. I 
decided to participate voluntary, as the information I give will remain confidentially. 
 
Participant’s signature: ……………………………………………… 
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Appendix 5.8. Items of the ‘feedback questionnaire’ for the pilot work. 
 
Number Question 
01 How much time did you take to complete the questionnaire? 
 
02 Were the instructions understood?      □ Yes      □ No      
If you answered ‘no’ to the previous question, please explain the reason(s) 
the instructions were not understood.  
 
 
 
03 Were all the questions understood?      □ Yes      □ No      
If you answered ‘no’ to the previous question, please explain the reason(s) 
the question(s) were not understood. 
 
 
 
04 Did you answer all the questions?       □ Yes      □ No      
If you answered ‘no’ to the previous question, please explain the reason(s) 
you didn’t answer all the questions. 
 
 
 
05 Is there any other activity of your daily living, that has been affected due to 
Parkinson’s disease, and it is not included in the questionnaire?     
   □ Yes      □ No      
If you answered ‘no’ to the previous question, please specify the affected 
activity. 
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06 Was the questionnaire easy to complete it?     □ Yes      □ No      
If you answered know to the previous question, please indicate the 
reason(s). 
 
 
 
07 Was the questionnaire well-designed?     □ Yes      □ No      
08 Please mark the questionnaire. 
                                   no good  0  1  2  3  4  5  6  7  8  9  10   excellent  
09 If you have any additional comments or ideas, that will help us to improve 
the questionnaire, please write them in the provided space. 
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Appendix 8.1.  Criteria of the Article 4 of the ‘Hellenic General Specifications for the authorisation 
of a fitness centre’ (Government Newspaper of the Hellenic Republic, 2006). 
 
The criteria of the Article 4 are listed as follows: 
 Each trainer requires at least five square metres (m2) for exercise. 
 Height of the exercise room at least 2.60 metres. 
 Adequate natural and/or artificial lighting 
 Adequate natural and/or artificial ventilation 
 Slip resistant coating to the entire surface of the floor 
 Fire safety 
 First aid kit 
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Appendix 8.2.  Brochure to reach patients for the study (in Greek). 
 
 
 
 
Appendices 
417 
 
 
 
 
 
 
 
Appendices 
418 
 
 
 
 
 
 
 
Appendices 
419 
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Appendix 8.3.  Poster to reach patients for the study (in Greek). 
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Appendix 8.4.  Participant Information Sheet’ (Greek version). 
 
EΝΤΥΠΟ ΕΝΗΜΕΡΩΣΗΣ 
 
Η παρούσα έρευνα στοχεύει στην διερεύνηση της αποτελεσματικότητας ενός ομαδικού 
προγράμματος άσκησης και εκπαίδευσης σε Άτομα με νόσο Πάρκινσον (ΑμΠ) στους 
δείκτες κατάθλιψης και άγχους, στην κινητικότητα, στην ποιότητα ζωής και στην 
αναπνευστική λειτουργία. 
 
Σας προσκαλούμε να λάβετε μέρος στην έρευνά μας. Προτού όμως αποφασίσετε για την 
συμμετοχή σας, είναι σημαντικό να διαβάσετε προσεκτικά το παρόν φυλλάδιο, ώστε να 
καταλάβετε τον σκοπό της έρευνας και την όλη διαδικασία.   
 
 1. Ποιος είναι ο σκοπός της έρευνας; 
Η νόσος του Πάρκινσον είναι η δεύτερη πιο εκφυλιστική πάθηση σε παγκόσμιο επίπεδο. 
Τα κινητικά συμπτώματα της νόσου ευθύνονται για τον αυξημένο αριθμό πτώσεων, που 
είναι δυο φορές μεγαλύτερος σε σχέση με τον γενικό πληθυσμό, και για τους σχετικούς 
τραυματισμούς. Τα μη κινητικά συμπτώματα της νόσου είναι λιγότερο γνωστά στους 
ασθενείς. Η κατάθλιψη και οι αγχώδεις διαταραχές είναι από τα πιο συχνά μη κινητικά 
συμπτώματα της νόσου, με διπλάσια συχνότητα εμφάνισης συγκριτικά με τον γενικό 
πληθυσμό. Όλα αυτά τα συμπτώματα επιφέρουν αρνητικές επιπτώσεις στην ποιότητα  
ζωής των ΑμΠ. 
 
Ένα πρόγραμμα θεραπευτικής άσκησης και εκπαίδευσης, συμπληρωματικό της 
φαρμακευτικής αγωγής, θα μπορούσε να επωφελήσει τα ΑμΠ. Τα αποτελέσματα 
προηγούμενων ερευνών αποδεικνύουν ότι η ομαδική άσκηση σε υγιή πληθυσμό είναι 
αποτελεσματική για τη βελτίωση της μυϊκής δύναμης, ισορροπίας, ποιότητας ζωής και για 
τη μείωση του αριθμού των πτώσεων. Επιπλέον, πιστεύεται ότι η άσκηση συνεισφέρει στη 
μείωση των συμπτωμάτων κατάθλιψης και άγχους. 
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2. Γιατί προσκλήθηκα να συμμετάσχω στην έρευνα; 
Έχετε προσκληθεί, γιατί έχετε διαγνωστεί με τη νόσο του Πάρκινσον και με συμπτώματα 
κατάθλιψης. Επίσης, δεν πάσχετε από κάποια σοβαρή μυοσκελετική πάθηση, 
καρδιαγγειακή πάθηση ή άλλη νευρολογική πάθηση που να επηρεάζει την συμμετοχή σας 
στο πρόγραμμα άσκησης. 
 
3. Πρέπει να λάβω μέρος στην έρευνα; 
Αυτό εξαρτάται από εσάς.  Αν δεν θέλετε να συμμετάσχετε, απλώς δεν υπογράφετε το 
έντυπο συγκατάθεσης. Επιπλέον, μπορείτε να αποχωρήσετε από την έρευνα όποια στιγμή 
θέλετε. 
 
4. Τι θα συμβεί αν λάβω μέρος; 
Αν θέλετε να λάβετε μέρος στην έρευνα, απλά συμπληρώνετε το έντυπο συγκατάθεσης 
και το επιστρέφετε σε εμάς. Έπειτα θα λάβετε ενημέρωση για την συμμετοχή σας. 
Προηγουμένως ένας νευρολόγος θα σας εξετάσει για να πιστοποιήσει ότι είστε ικανός να 
συμμετάσχετε στην έρευνα και ότι έχετε συμπτώματα κατάθλιψης, καθώς αυτό είναι το 
βασικό μας κριτήριο. 
 
5. Τι θα συμβεί έπειτα; 
Αν πληροίτε όλα τα κριτήρια, θα συμμετάσχετε στην έρευνα. Τις περισσότερες φορές δεν 
γνωρίζουμε αν μια θεραπεία είναι ωφέλιμη ή όχι. Γι’ αυτό τον λόγο θα χωριστείτε τυχαία 
σε μια από τις δύο ομάδες της έρευνας: ομάδα θεραπευτικής άσκησης και εκπαίδευσης, 
και ομάδα σύγκρισης. 
 
Τα μέλη της πρώτης ομάδας θα χωριστούν σε επιπλέον υπο-ομάδες των 5 ή 6 ατόμων. Θα 
συμμετάσχουν  σε ένα ομαδικό πρόγραμμα άσκησης και εκπαίδευσης σε κλειστό χώρο. Η 
διάρκεια του προγράμματος θα είναι 8 εβδομάδες, με δύο θεραπείες τη βδομάδα 
διάρκειας μιας ώρας. Το πρόγραμμα άσκησης θα περιλαμβάνει μια ποικιλομορφία  
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ασκήσεων, όπως διατάσεις, βάδιση και ενδυνάμωση. Το όλο πρόγραμμα θα 
πραγματοποιηθεί σε πέντε δήμους της πρωτεύουσας.  
 
Η ομάδα σύγκρισης θα συμμετάσχει σε ένα ατομικό πρόγραμμα άσκησης στο σπίτι για το 
ίδιο χρονικό διάστημα. Η ερευνητική ομάδα θα επικοινωνεί μαζί σας μια φορά τη 
βδομάδα καθ’ όλη την περίοδο της έρευνας. 
 
Μετά το τέλος των 8 εβδομάδων, όλοι οι συμμετέχοντες για 3 μήνες θα συμμετάσχουν σ’ 
ένα ατομικό πρόγραμμα άσκησης στο σπίτι. Τέλος, όλοι οι συμμετέχοντες θα εξεταστούν 
τρεις φορές από την ερευνητική ομάδα: στην αρχή της έρευνας, μετά το πρόγραμμα 
άσκησης 8 εβδομάδων, και τρεις μήνες έπειτα. 
 
6. Τι θα γίνε με τη φαρμακευτική μου αγωγή κατά την διάρκεια της έρευνας; 
Καθ’ όλη την διάρκεια της έρευνας θα συνεχίζετε να παίρνετε κανονικά τα φάρμακά σας.  
 
7. Πρέπει να πληρώσω για την συμμετοχή μου; 
Όχι. Η συμμετοχή σας είναι εθελοντική και δωρεάν.  
 
8. Ποια θα είναι τα πιθανά οφέλη της συμμετοχής μου; 
Πολύ πιθανόν να βελτιώσετε την ισορροπία σας, την ποιότητα ζωή σας, την αναπνευστική 
σας λειτουργία και να μειωθεί ο αριθμός των πτώσεων. Επίσης τα συμπτώματα 
κατάθλιψης και άγχους πιθανόν να υποχωρήσουν. 
 
9. Ενδέχεται να υπάρξουν κάποιες παρενέργειες; 
Τα προγράμματα θεραπευτικής άσκησης είναι γενικά ασφαλή και προτείνονται σε ΑμΠ. 
Για να είμαστε σίγουροι, ένας γιατρός θα σας εξετάσει προτού λάβετε μέρος. Οι 
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φυσικοθεραπευτές  που θα σας διδάσκουν τις ασκήσεις έχουν εμπειρία σε αυτό το 
κομμάτι και έχουν δουλέψει με ΑμΠ. Επίσης, αν παρατηρηθούν μερικά συμπτώματα κατά 
την διάρκεια της άσκησης, όπως ζαλάδα, θα γίνει διακοπή της άσκησης. Αν αποφασίσετε 
τελικά να λάβετε μέρος στην έρευνα, πρέπει να έχετε υπόψην το χρόνο που απαιτείται να 
αφιερώνετε εβδομαδιαίως για την παρέμβαση, αλλά και την συνολική διάρκεια της 
έρευνας (περίπου 5 μήνες). 
 
10. Υπάρχουν κάποιοι περιορισμοί; 
Για να ασκηθείτε πρέπει να φοράτε αθλητικά ρούχα και παπούτσια. Το κάπνισμα και το 
φαγητό απαγορεύονται 2 ώρες πριν την άσκηση. 
 
11. Η συμμετοχή μου θα είναι εμπιστευτική; 
Η συμμετοχή σας θα είναι εμπιστευτική και το όνομά σας δεν θα δημοσιευθεί. Οι 
προσωπικές σας πληροφορίες θα σφραγιστούν  σ’ ένα αρχείο, στο οποίο θα έχει 
πρόσβαση μόνο η ερευνητική ομάδα. Σ’ όλα τα έγγραφα το όνομα σας θα αντικατασταθεί 
από έναν κωδικό. 
 
12. Και αν αποφασίσω στη μέση της έρευνας να αποχωρήσω; 
Μπορείτε να αποχωρήσετε από την έρευνα οποιαδήποτε στιγμή, αν επιθυμείτε. Μπορείτε 
να αναφέρετε προαιρετικά τον λόγο της αποχώρησής σας. 
 
13. Τι γίνεται αν υπάρξει οποιοδήποτε πρόβλημα; 
Σε αυτή την περίπτωση μπορείτε να αναφέρετε το πρόβλημα σας τηλεφωνικά στην 
Επίκουρος-κίνηση, που είναι μέλος του ευρωπαϊκού συνδέσμου για την νόσο του 
Πάρκινσον.   
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14. O προσωπικός μου ιατρός πρέπει να ενημερωθεί για την συμμετοχή μου στην 
έρευνα; 
 Ο γιατρός σας πρέπει να ενημερωθεί από εσάς για την συμμετοχή σας στην έρευνα και 
να σας δώσει έγκριση. 
 
15. Πώς θα χρησιμοποιηθούν οι πληροφορίες που θα πάρετε από μένα; 
Τα συνολικά, και όχι τα ατομικά αποτελέσματα της έρευνας θα δημοσιευθούν στην 
διδακτορική διατριβή και σε κάποιο επιστημονικό περιοδικό υγείας. 
 
16. Ποιος διοργανώνει και χρηματοδοτεί την παρούσα έρευνα; 
Ο κος Θεόδωρος Χατζηδαμιανός  είναι ο συντονιστής της παρούσας έρευνας. Είναι 
διδακτορικός φοιτητής στο Μητροπολιτικό Πανεπιστήμιο του Μάντσεστερ, και έχει 
κερδίσει υποτροφία από το ΙΚΥ για τις σπουδές του. 
 
17. Από ποιον έχει λάβει έγκριση η έρευνα; 
Η παρούσα έρευνα έχει εγκριθεί από την επιτροπή ηθικής του Μητροπολιτικού 
πανεπιστημίου του Μάντσεστερ και την ‘Επίκουρος-κίνηση’. 
 
18. Επικοινωνία για επιπλέον πληροφορίες. 
Για περισσότερες πληροφορίες σχετικά με την παρούσα έρευνα, μπορείτε να 
επικοινωνήσετε με τον κο Θεόδωρο Χατζηδαμιανό. 
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Κινητό τηλέφωνο: 694 700 57 XX 
Ηλεκτρονικό ταχυδρομείο: thchdamianos@yahoo.gr 
 
 
Σας ευχαριστούμε που διαβάσατε το παρόν έντυπο. Παρακαλείσθε να το κρατήσετε. Αν 
συμφωνείτε να συμμετάσχετε στην έρευνα, συμπληρώστε το έντυπο συγκατάθεσης και 
ένα φωτοαντίγραφο αυτού θα σας δοθεί. 
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Appendix 8.5.  Participant Information Sheet’ (English version). 
 
PATIENT INFORMATION SHEET 
 
This study is about the investigation of the effects of a group-based exercise and 
educational programme on depression and anxiety, motor function, quality of life and 
respiratory function in individuals suffering from Parkinson’s disease (PD). 
 
We are inviting you to take part in this research study. Before you decide whether to 
participate or not it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully and to 
decide whether or not you wish to be involved. 
 
1. What is the purpose of the study? 
PD is currently the second most common neurodegenerative disease. The motor symptoms 
of the disease often contribute to an increased number of falls, which is higher compared 
to healthy individuals, and a greater incidence of fall-related injuries. In addition, the non-
motor symptoms of the disease are less known to the patients. Anxiety and depressive 
symptoms are some of the non-motor symptoms of the disease, which are twice higher in 
PD sufferers compared the general healthy population. Both the increased frequency of 
falls and the high levels of anxiety and depression have negative impacts on patients’ 
quality of life. 
 
An exercise and educational programme, in conjunction with pharmacological therapy, 
might be effective in individuals suffering from PD. The results of previous studies in healthy 
population indicate that group exercise programmes are effective to improve muscle 
strength and balance, to reduce the risk of falls and to improve quality of life. Furthermore, 
it is believed that exercise is associated with lower depression and anxiety scores. 
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2. Why have I been invited to participate? 
You have been chosen because you are have been diagnosed with PD and depressive 
symptoms; and you are not suffering from severe musculoskeletal, uncontrolled 
cardiovascular or other neurological diseases. 
 
3. Do I have to take part? 
It is up to you to decide whether or not to take part. If you do not wish to participate, you 
do not have to do anything in response to this request. Moreover, you are free to withdraw 
from the study at any time. 
 
4. What will happen to me if I take part? 
If you are happy to participate in the research, you should sign the consent form and return 
it to us. When we receive this, we will contact you to discuss your participation in the study. 
A doctor will examine you to ensure that you could participate and whether you are 
suffering from depressive symptoms, as only patients suffering from depressive symptoms 
will take part in this study.  
 
5. What will happen next? 
Whether you fulfill the criteria, you will participate in this study. Sometimes we don’t know 
whether a treatment is helpful or not. To find out, we need to make comparisons between 
different groups. To do this we will randomly allocate you to one of the following groups: 
(i) exercise and educational group and (ii) comparison group. 
 
The members of the first group will be divided into small subgroups of five to six 
participants and will participate in an indoor group-based exercise and educational 
programme. The length of the training period will be eight weeks. The duration of each 
session will be one hour and the frequency will be twice a week. The programme will 
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include a variety of exercises, such as stretching, walking, balance and strengthening 
exercises. The exercise programme will held at five municipalities of Athens. 
 
The comparison group will participate in an individualised home-based exercise 
programme. The research team will monitor the patient’s well-being once a week through 
telephone calls for the entire period of study. 
 
After the end of the eight-week period, the participants of both groups will follow a home-
based individualised exercise programme for three months. The subjects will be assessed 
three times: at the entry of the study, at the end of the eight-week exercise programme 
and three months after the ending of the exercise programme. 
 
6. What about my medication during the study period? 
All the individuals will continue taking their usual care medication during the whole study 
period.  
 
7. Expenses and payments. 
You do not have to pay to participate in this study.  
 
8. What are the possible benefits of taking part? 
There is possibility to improve your balance, levels of depression and anxiety,quality of life 
and respiratory function; and minimise the fall risk. 
 
9. What are the possible risks and disadvantages of taking part? 
Exercise programmes are generally safe and recommended to patients with PD. A doctor 
will examine you before taking part to the study to minimise any possible risk of injury. The 
Appendices 
430 
 
instructor of the exercise and the assistant physiotherapists have experience in therapeutic 
exercise on PD population. When something will happen unexpectedly during the exercise, 
such as dizziness or paleness, the exercise will be stopped immediately. If you decide to 
take part as a volunteer, you should think the weekly time involved and the total duration 
of the study. 
 
10. Are there any limitations? 
Whether you are selected on the exercise programme group, you should be dressed 
sportswear. Furthermore, you should avoid smoking and eating at least two hours before 
the start of each session. 
 
11. Will my taking part be kept confidential? 
All patient information will be stored on password protected computer databases or in 
locked filing cabinets. You will be allocated a study number, and staff not directly involved 
with you will know you only by this number. When the results of the study will be reported, 
individuals who have taken part will not be identified in any way. 
 
12. What if I change my mind about taking part? 
If you decide to take part you are still free to withdraw at any time and without giving a 
reason. However, it wil be useful for us to know the reason of your withdraw. 
 
13. What if there is a problem? 
If there is any problem, you can contact ‘Epikouros-kinisi’, which is a member of the 
European Parkinson’s Disease Association, and report it. 
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14. Will my GP be informed of my involvement in the study? 
With your consent, your GP will be notified of your participation in this study. 
 
15. How will the information I provide be used? 
We plan to publish the results in a health journal and in the PhD dissertation of the 
researcher, so others can read about and learn from the results of the study. 
 
16. Who is organising and funding the research? 
The researcher, Mr. Theodoros Chatzidamianos, is conducting the research as a PhD 
student at the Department of Physiotherapy, of School of Health, Psychology and Social 
Care at Manchester Metropolitan University. He has earned a scholarship by the IKY for the 
conduction of this project. 
 
17. Who has reviewed this study? 
The research has been approved by the University Research Ethics Committee, Manchester 
Metropolitan University and the Hellenic Parkinson’s Disease Association ‘Epikouros-kinisi’. 
 
18. Contact for further Information 
If you require more information about this study please contact Mr. Theodoros 
Chatzidamianos. 
 
Telephone number: 694 700 57 XX 
e-mail: thchdamianos@yahoo.gr 
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Thank you for reading this. 
Please keep this information sheet. 
If you agree to enter the study, please sign the consent form and we will return a copy to 
you. 
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Appendix 8.6.  Informed Consent Form (Greek version). 
 
ΕΝΤΥΠΟ ΣΥΓΚΑΤΑΘΕΣΗΣ 
‘Η αποτελεσματικότητα ενός ομαδικού προγράμματος άσκησης και εκπαίδευσης στην 
κοινότητα Ελλήνων ασθενών με νόσο Πάρκινσον και κατάθλιψη’ 
 
 Έχω διαβάσει το ενημερωτικό φυλλάδιο για την παρούσα έρευνα και όλες οι 
απορίες μου έχουν απαντηθεί. 
 Η συμμετοχή μου είναι εθελοντική και μπορώ να αποχωρήσω από την έρευνα 
όποια στιγμή επιθυμώ. 
 Συμφωνώ ότι μπορεί να γίνει βιντεοσκόπηση και φωτογράφιση, χωρίς όμως να 
εμφανίζονται τα χαρακτηριστικά του προσώπου μου. 
 Συμφωνώ ότι τα δεδομένα θα φυλαχθούν (η φύλαξη θα είναι ανώνυμη) για την 
πραγματοποίηση της έρευνας. 
 Συμφωνώ να λάβω μέρος στην παρούσα έρευνα. 
 
 
 
 Όνομα συμμετέχοντα       Ημερομηνία  Υπογραφή  
 
 
 
Όνομα ερευνητή           Ημερομηνία             Υπογραφή 
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Appendix 8.7.  Informed Consent Form (English version). 
 
PARTICIPANT CONSENT FORM 
‘The effectiveness of a community-based exercise and educational programme  on 
depression in Greek population with Parkinson’s disease’ 
 
 I confirm that I have read and understood the information sheet for the above study 
and have had the opportunity to ask questions. 
 I understand that my participation is voluntary and that I am free to withdraw at 
any time. 
 I agree that video recording and photos can be used without reveal my facial 
features 
 I agree that my data gathered in this study will be stored (after it has been 
anonymised) in a specialist data centre for the conduction of the study. 
 I agree to take part in the present study. 
 
 
 
 Name of Participant    Date   Signature 
 
 
 
Name of Researcher    Date   Signature 
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Appendix 8.8. Description of the Hospital Anxiety and Depression Scale (HADS) 
 
The HADS has 14 items; seven of which address depression, and seven anxiety. Questions 
related to anxiety are marked with A; whereas questions related to depression with D. 
(Zigmond and Snaith 1983). The individuals respond to the question in relation to how they 
felt the last week (Snaith, 2003). Each item has four graded response options on a Likert 
scale, scored from zero to three. Depressive symptoms are rated separately from anxiety 
symptoms. The total score of each subscale ranges from 0 to 21 points, with higher scores 
reflecting greater levels of anxiety and depression. Scores for each subscale could be 
categorised as follows: normal (0-7), mild (8-10), moderate (11-14), and severe (15-21) 
(Zigmond and Snaith 1983). However, some researchers also calculate the total HADS score 
(0-42) as a measure of total psychological distress, due to the frequent difficulty in 
distinguishing between anxiety and depression in clinical settings (Roberts et al., 2001). In 
the current study, the HADS was completed by the participants, as it is a self-report 
instrument. 
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Appendix 8.9. Hospital Anxiety and Depression Scale (HADS) (Greek version) 
 
Νοσοκομειακή Κλίμακα Κατάθλιψης και Άγχους (HADS) 
 
Αυτό το ερωτηματολόγιο είναι σχεδιασμένο ώστε να βοηθήσει τον κλινικό ιατρό σας να 
γνωρίσει πώς αισθάνεστε. Διαβάστε κάθε ερώτημα και υπογραμμίστε με Χ την 
απάντηση η οποία είναι πλησιέστερη στα συναισθήματά σας της προηγούμενης 
εβδομάδας. Πρέπει να επιλέξετε μία απάντηση από τις τέσσερις πιθανές επιλογές κάθε 
ερώτησης. Μην πάρετε πολύ χρόνο για να απαντήσετε, η άμεση ανταπόκριση είναι 
προτιμότερη. 
 
Όνομα:  ……………………………………………………………………………….. 
 
Ημερομηνία:  ………………………….. 
 
Α.1 Νιώθω ανήσυχος ή τρομαγμένος:  
 Τον περισσότερο καιρό 3 
 Πολύ καιρό 2 
 Από καιρό σε καιρό, περιστασιακά 1 
 Καθόλου 0 
 
 
D.1 Εξακολουθώ να απολαμβάνω τα πράγματα που συνήθιζα να απολαμβάνω:  
 Σαφέστατα, στον ίδιο βαθμό 0 
 Όχι στον ίδιο βαθμό 1 
 Λίγο μόνο 2 
 Καθόλου  3 
 
 
A.2 Αντιμετωπίζω κάποιο συναίσθημα φόβου σαν να πρόκειται κάτι τρομακτικό να 
συμβεί: 
 
 Ακριβώς, μάλιστα σε σοβαρό βαθμό 3 
 Ναι, αλλά όχι τόσο σοβαρά 2 
 Ελάχιστα, αλλά δεν μ’ ανησυχεί 1 
 Kαθόλου 0 
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D.2 Μπορώ να γελάω και να βλέπω την χαρωπή όψη των πραγμάτων:  
 Βεβαίως, έτσι όπως πάντα μπορούσα 0 
 Μάλλον όχι τόσο, όπως στο παρελθόν 1 
 Σίγουρα όχι τώρα τόσο πολύ 2 
 Καθόλου  3 
 
A.3 Ανήσυχες σκέψεις περνούν από το μυαλό μου:  
 Πάρα πολύ καιρό 3 
 Πολύ καιρό 2 
 Όχι τόσο συχνά 1 
 Πολύ λίγο 0 
 
 
D.3 Νιώθω κεφάτος:  
 Ποτέ  3 
 Όχι συχνά 2 
 Μερικές φορές 1 
 Τον περισσότερο καιρό  0 
 
 
A.4 Μπορώ να κάθομαι άνετα και να νιώθω  χαλαρωμένος:  
 Ακριβώς 0 
 Συνήθως 1 
 Όχι συχνά 2 
 Καθόλου  3 
 
 
D.4 Νιώθω σαν να έχουν πέσει οι ρυθμοί μου:  
 Σχεδόν όλο τον καιρό 3 
 Πολύ συχνά 2 
 Μερικές φορές  1 
 Καθόλου  0 
 
A.5 Αντιμετωπίζω κάποιο συναίσθημα φόβου σαν να έχω «πεταλούδες» στο 
στομάχι μου: 
 
 Καθόλου 0 
 Περιστασιακά 1 
 Αρκετά συχνά 2 
 Πολύ συχνά  3 
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D.5 Έχασα το ενδιαφέρον για την εμφάνισή μου:   
 Ακριβώς  3 
 Δεν τη φροντίζω όσο θα έπρεπε 2 
 Ίσως δεν τη φροντίζω όσο θα έπρεπε 1 
 Την φροντίζω όπως πάντοτε 0 
 
A.6 Νιώθω νευρικός και ανήσυχος σαν να πρέπει συνέχεια να κινούμαι:  
 Μάλιστα σε πολύ μεγάλο βαθμό 3 
 Σε αρκετά μεγάλο βαθμό 2 
 Όχι σε τόσο μεγάλο βαθμό 1 
 Καθόλου  0 
 
 
D.6 Προσμένω με χαρά διάφορα πράγματα:  
 Τόσο όπως και στο παρελθόν 0 
 Μάλλον λιγότερο απ’ όσο συνήθιζα 1 
 Σίγουρα λιγότερο απ’ ότι συνήθιζα 2 
 Καθόλου  3 
 
 
A.7 Αντιμετωπίζω αιφνίδια συναισθήματα πανικού:  
 Πράγματι πολύ συχνά 3 
 Αρκετά συχνά 2 
 Όχι τόσο συχνά 1 
 Καθόλου  0 
 
 
D.7 Μπορώ να απολαμβάνω ένα ενδιαφέρον βιβλίο ή ένα 
ραδιοφωνικό/τηλεοπτικό πρόγραμμα: 
 
 Συχνά 0 
 Μερικές φορές 1 
 Όχι συχνά  2 
 Πολύ σπάνια  3 
 
 
Παρακαλώ ελέγξτε ότι έχετε απαντήσει όλες τις ερωτήσεις. 
 
A  D  T  
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Appendix 8.10. Hospital Anxiety and Depression Scale (HADS) (English version) 
 
HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
 
Tick the box beside the reply that is closest to how you have been feeling in the past 
week. Don’t take too long over you replies: your immediate is best. 
 
Name:  ……………………………………………………………………………….. 
Date:  ………………………….. 
 
Α.1 I feel tense or 'wound up':  
 Most of the time 3 
 A lot of the time 2 
 From time to time, occasionally 1 
 Not at all 0 
 
 
D.1 I still enjoy the things I used to enjoy:  
 Definitely as much 0 
 Not quite so much 1 
 Only a little 2 
 Hardly at all 3 
 
 
A.2 I get a sort of frightened feeling as if something awful is about to 
happen: 
 
 Very definitely and quite badly 3 
 Yes, but not too badly 2 
 A little, but it doesn't worry me 1 
 Not at all 0 
 
 
 
D.2 I can laugh and see the funny side of things:  
 As much as I always could 0 
 Not quite so much now 1 
 Definitely not so much now 2 
 Not at all 3 
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A.3 Worrying thoughts go through my mind:  
 A great deal of the time 3 
 A lot of the time 2 
 From time to time, but not too often 1 
 Only occasionally 0 
 
 
D.3 I feel cheerful:  
 Not at all 3 
 Not often 2 
 Sometimes 1 
 Most of the time 0 
 
 
A.4 I can sit at ease and feel relaxed:  
 Definitely 0 
 Usually 1 
 Not Often 2 
 Not at all 3 
 
 
D.4 I feel as if I am slowed down:  
 Nearly all the time 3 
 Very often 2 
 Sometimes 1 
 Not at all 0 
 
A.5 I get a sort of frightened feeling like ‘butterflies' in the stomach:  
 Not at all 0 
 Occasionally 1 
 Quite Often 2 
 Very Often 3 
 
 
D.5 I have lost interest in my appearance:  
 Definitely 3 
 I don't take as much care as I should 2 
 I may not take quite as much care 1 
 I take just as much care as ever  0 
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A.6 I feel restless as I have to be on the move:  
 Very much indeed 3 
 Quite a lot 2 
 Not very much 1 
 Not at all 0 
 
 
D.6 I look forward with enjoyment to things:  
 As much as I ever did 0 
 Rather less than I used to 1 
 Definitely less than I used to 2 
 Hardly at all 3 
 
 
A.7 I get sudden feelings of panic:  
 Very often indeed 3 
 Quite often 2 
 Not very often 1 
 Not at all 0 
 
 
D.7 I can enjoy a good book or radio or TV program:  
 Often 0 
 Sometimes 1 
 Not often 2 
 Very seldom 3 
 
Please check you have answered all the questions 
 
 
 
 
 
 
 
A  D  T  
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Appendix 8.11. UK PDS Brain Bank Criteria (adopted by NICE, 2006) 
 
Step 1. Diagnosis of a parkinsonian syndrome 
 
Bradykinesia and at least one of the following: 
 
• muscular rigidity 
• rest tremor (4–6 Hz) 
• postural instability unrelated to primary visual, cerebellar, vestibular or proprioceptive dysfunction. 
Step 2. Exclusion criteria for PD 
 
History of: 
 
• repeated strokes with stepwise progression 
• repeated head injury 
• antipsychotic or dopamine-depleting drugs 
• definite encephalitis and/or oculogyric crises on no drug treatment 
• more than one affected relative 
• sustained remission 
• negative response to large doses of levodopa (if malabsorption excluded) 
• strictly unilateral features after 3 years 
• other neurological features: supranuclear gaze palsy, cerebellar signs, early severe autonomic 
involvement, Babinski sign, early severe dementia with disturbances of language, memory or praxis 
• exposure to known neurotoxin 
• presence of cerebral tumour or communicating hydrocephalus on neuroimaging. 
Step 3. Supportive criteria for PD 
 
Three or more required for diagnosis of definite PD: 
 
• unilateral onset  
• excellent response to levodopa 
• rest tremor present 
 • severe levodopa-induced chorea 
• progressive disorder  
• levodopa response for over 5 years 
• persistent asymmetry affecting the side of  
• clinical course of over 10 years. 
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Appendix 8.12. Description of the Unified Parkinson’s Disease Rating Scale (UPDRS). 
 
The UPDRS is a combination of patient interview and physical examination. It consists of 
four parts and 42 items (Ebersbach et al., 2006). Specifically: 
 Part I (mentation, behavior, and mood) includes four interview items. 
 Part II (ADLs) includes 13 interview items. 
 Part III (motor examination) includes 14 examination items. 
 Part IV (complications of therapy) includes 11 items, a mixture of interview assessment 
plus yes/no responses based on rater judgment (Ebersbach et al., 2006). 
 
The responses of the items are on a five-Likert scale rated from zero (normal) to four 
(severely affected); except the dichotomous items of part IV. Higher scores indicate greater 
impact of PD symptoms. The scores of all the subscales can be summed to a total UPDRS 
score. (Ebersbach et al., 2006). The (modified) H&Y scale and the SEADL scale are usually 
administered with the UPDRS (Sampaio et al., 2012). In the current study, the UPDRS was 
completed by the neurologist. 
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Appendix 8.13. Unified Parkinson’s Disease Rating Scale (UPDRS) (Greek version). 
 
ΕΝΟΠΟΙΗΜΕΝΗ ΚΛΙΜΑΚΑ ΔΙΑΒΑΘΜIΣΗΣ ΠΑΡΚΙΝΣΟΝ (UPDRS) 
Όνομα:       Ημερομηνία:  
 
A. Συμπεριφορά και διάθεση 
Ι. Διανοητικές διαταραχές: 
0 = καμμιά 
1 = ήπια. Μερική δυσκολία 
2 = μέτρια απώλεια μνήμης, μερικώς αποπροσανατολισμός και δυσκολία στην αντιμετώπιση δύσκολων  
προβλημάτων 
3 = σοβαρή απώλεια μνήμης με αποπροσανατολισμό στον χρόνο και συχνά στον τόπο 
4 = πολύ σοβαρή απώλεια μνήμης με πλήρη αποπροσανατολισμό. Ανίκανος να αντιμετωπίσει 
οποιοδήποτε 
      πρόβλημα. Έχει ανάγκη από προσωρινή φροντίδα. Δεν μπορεί να μείνει μόνος του. 
 
ΙΙ. Διαταραχές σκέψης: 
0 = καμμιά διαταραχή 
1 = έντονα όνειρα 
2 = παραισθήσεις 
3 = παραισθήσεις αυτόματες. Μπορεί να ανταποκριθεί στις καθημερινές του δραστηριότητες 
4 = παραισθήσεις επίμονες, αυταπάτες ή ψυχωτικές διαταραχές. Ανίκανος να φροντίζει τον εαυτό του. 
 
ΙΙΙ. Κατάθλιψη: 
1 = περίοδοι θλίψης ή ενοχές περισσότερο από το κανονικό. Δεν παραμένει ποτέ για μέρες ή για βδομάδες 
2 = συνεχής κατάθλιψη (για 1 εβδομάδα ή παραπάνω) 
3 = συνεχής κατάθλιψη, η οποία συνοδεύεται από αϋπνίες, ανορεξία, χάσιμο βάρους, απώλεια 
ενδιαφέροντος 
4 = συνεχής κατάθλιψη με συμπτώματα αυτοκαταστροφής. 
 
ΙV. Κίνητρα-Πρωτοβουλίες: 
0 = κανονικός 
1 = λιγότερο κατανοητός από ότι συνήθως – περισσότερο παθητικός 
2 = απώλεια πρωτοβουλίας σε ορισμένες δραστηριότητες 
3 = απώλεια πρωτοβουλίας σε όλες τις καθημερινές δραστηριότητες 
4 = απόσυρση - πλήρη απώλεια κινήτρων 
 
Β. Δραστηριότητες της καθημερινής ζωής (ΟΝ και ΟFF φάση) 
Ι. Ομιλία: 
0 = φυσιολογική 
1 = ήπια επηρεασμένη - εύκολα κατανοητή 
2 = λίγο επηρεασμένη. Μερικές φορές ζητείται από τον ασθενή να επαναλάβει τα λεγόμενά του 
3 = σοβαρά επηρεασμένη ομιλία. Συχνά ζητείται από τον ασθενή να επαναλάβει τα λεγόμενά του 
4 = δεν είναι κατανοητός ο λόγος του. 
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ΙΙ. Σιελόρροια: 
0 = καθόλου 
1 = μικρή σιελόρροια, αλλά καθοριστική συγκέντρωση σιέλων στο στόμα. Μπορεί να έχει νυχτερινή 
σιελόρροια. 
2 = μικρή σιελόρροια - μέτρια συγκέντρωση σιέλου στο στόμα 
3 = σιελόρροια - αρκετή συγκέντρωση σιέλου στο στόμα 
4 = πολύ σιελόρροια – απαιτείται η χρησιμοποίηση χαρτομάντιλου. 
 
ΙΙΙ. Κατάποση: 
0 = φυσιολογική 
1 = σπάνια πνιγμός 
2 = περιστασιακά πνιγμός 
3 = απαιτείται μαλακό φαγητό 
4 = απαιτείται οισοφαγικός σωλήνας. 
 
ΙV. Γραφή: 
0 = φυσιολογική 
1 = λίγο αργά. Όλες οι λέξεις δεν είναι αναγνώσιμες 
2 = σχετικά αργά. Όλες οι λέξεις δεν είναι αναγνώσιμες 
3 = σοβαρά επηρεασμένη η γραφή. Δεν είναι όλες οι λέξεις αναγνώσιμες 
4 = η πλειοψηφία των λέξεων δεν είναι αναγνώσιμες. 
 
V. Κόψιμο φαγητού: 
0 = φυσιολογικά 
1 = λίγο αργά, αλλά δεν χρειάζεται βοήθεια 
2 = μπορεί να κόψει τα περισσότερα φαγητά αν και αδέξια και αργά. Χρειάζεται λίγη βοήθεια 
3 = το φαγητό πρέπει να κοπεί από κάποιον άλλον, αλλά μπορεί ακόμα να φάει μόνος του αργά 
4 = χρειάζεται κάποιον να τον ταΐσει. 
 
VI. Ντύσιμο: 
0 = κανονικό 
1 = κάπως αργά, αλλά δεν χρειάζεται βοήθεια 
2 = περιστασιακά χρειάζεται βοήθεια για το κούμπωμα, να βάλει το χέρι του στα μανίκια 
3 = απαιτείται βοήθεια, αλλά μπορεί ακόμα να κάνει κάποια πράγματα μόνος του 
4 = ανίσχυρος. 
 
VII. Υγιεινή: 
0 = φυσιολογική 
1 = κάπως αργά, αλλά δεν χρειάζεται βοήθεια 
2 = χρειάζεται βοήθεια για να κάνει ντους ή μπάνιο 
3 = χρειάζεται βοήθεια για να πλυθεί, να πλύνει τα δόντια του, να φτιάξει τα μαλλιά του, να πάει στο 
μπάνιο 
4 = είναι απαραίτητος ουροκαθετήρας ή άλλη μηχανική βοήθεια. 
 
VIII. Γύρισμα στο κρεβάτι και αλλαγή σεντονιών: 
0 = φυσιολογικός 
1 = κάπως αργά και αδέξια, αλλά δεν χρειάζεται βοήθεια 
2 = μπορεί να γυρίσει στο κρεβάτι ή να αλλάξει τα σεντόνια, αλλά με μεγάλη δυσκολία 
3 = μπορεί να αρχίσει, αλλά να μην τελειώσει τις παραπάνω δραστηριότητες 
4 = ανίσχυρος. 
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IX. Πτώση: (ανεξάρτητη από το φαινόμενο του freezing) 
0 = καμμιά 
1 = σπάνιες πτώσεις 
2 = περιστασιακές πτώσεις, λιγότερες από μια φορά την ημέρα 
3 = πτώση κατά μέσο όρο μία την ημέρα 
4 = πτώσεις περισσότερες από μία την ημέρα 
 
X. Πάγωμα (freezing) 
0 = καμμιά 
1 = σπάνια. Μπορεί να έχουν διστακτικότητα στην αρχή 
της κίνησης 
2 = περιστασιακά όταν περπατά 
3 = συχνά - περιστασιακές πτώσεις λόγω παγώματος 
4 = συχνές πτώσεις από το πάγωμα 
 
XI. Βάδιση: 
0 = φυσιολογική 
1 = ελάχιστη δυσκολία 
2 = λίγη δυσκολία, αλλά χρειάζεται λίγη ή και καθόλου βοήθεια 
3 = σοβαρές διαταραχές της βάδισης - απαιτείται βοήθεια 
4 = δεν μπορεί να περπατήσει καθόλου ακόμα και με βοήθεια. 
 
XII. Τρόμος: 
0 = απών 
1 = ελάχιστος και εμφανίζεται σπανίως 
2 = λίγο - ενοχλητικός για τον ασθενή 
3 = σοβαρός-παρεμποδίζει πολλές δραστηριότητες 
4 = εγκατεστημένος - παρεμποδίζει σχεδόν όλες τις δραστηριότητες. 
 
XIII. Αισθητικές διαταραχές σχετικές με το Πάρκινσον: 
0 = καμμιά 
1 = περιστασιακή αιμωδία, τσούξιμο ή ήπιο πόνο 
2 = συνεχείς αιμωδίες, τσούξιμο, πόνο 
3 = συχνός πόνος 
4 = βασανιστικός πόνος. 
 
Γ. Κινητική αξιολόγηση 
I. Ομιλία: 
0 = φυσιολογική 
1 = ελάχιστη διαταραχή της έκφρασης, άρθρωσης ή και φωνής 
2 = μετρίως επηρεασμένη, μονότονη, ασαφής, αλλά κατανοητή 
3 = αρκετά επηρεασμένη - δύσκολη στην κατανόηση 
4 = ακατανόητη. 
 
II. Έκφραση προσώπου: 
0 = φυσιολογική 
1 = ελάχιστη διαταραχή 
2 = φανερή διαταραχή της έκφρασης του προσώπου 
3 = μεγάλη δυστονία 
4 = ανέκφραστο προσωπείο. 
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III. Τρόμος ηρεμίας: 
0 = απών 
1 = ελάχιστα και με πολύ μικρή συχνότητα εμφάνισης 
2 = μικρή σε ένταση και διάρκεια ή μέση ένταση, αλλά μόνο μικρή συχνότητα 
3 = μέση ένταση και συχνότητα εμφάνισης τις περισσότερες ώρες της ημέρας 
4 = πολύ μεγάλης έντασης και εμφανίζεται τις περισσότερες ώρες της ημέρας. 
 
IV. Τρόμος στα χέρια κατά την ηρεμία και την κίνηση: 
0 = απών 
1 = ελάχιστος – παρουσιάζεται κατά την κίνηση 
2 = μικρής έντασης – εμφανίζεται μόνο στην κίνηση 
3 = μικρής έντασης – εμφανίζεται και στην κίνηση και στην ηρεμία 
4 = μεγάλης έντασης – επηρεάζει την αυτοεξυπηρέτηση 
 
 
V. Ακαμψία: 
0 = απουσία 
1 = ελάχιστη ή ανεκτική 
2 = μικρού προς μέσου βαθμού 
3 = εγκατεστημένη, αλλά η ολοκλήρωση της τροχιάς επιτυγχάνεται εύκολα 
4 = μεγάλου βαθμού – η τροχιά κίνησης επιτυγχάνεται με δυσκολία. 
 
VI. Κίνηση δακτύλων: (ο ασθενής προσπαθεί να ακουμπήσει με τον αντίχειρα του τα υπόλοιπα δάκτυλα) 
0 = φυσιολογική 
1 = μικρή επιβάρυνση ή και μικρή ένταση της κίνησης 
2 = μέση διαταραχή – καθοριστική και πρόωρη κόπωση 
3 = μεγάλη διαταραχή – διστακτικότητα στην έναρξη της κίνησης ή της σύλληψης 
4 = μόλις που μπορεί να ακουμπήσει τα υπόλοιπα δάκτυλα. 
 
VII. Κινήσεις της άκρας χείρας: (ο ασθενής προσπαθεί να ανοίξει και να κλείσει τα χέρια του με μεγάλη 
ταχύτητα) 
0 = φυσιολογική 
1 = μικρή επιβάρυνση ή και μικρή ένταση της κίνησης 
2 = μέση διαταραχή – καθοριστική και πρόωρη κόπωση 
3 = μεγάλη διαταραχή – διστακτικότητα στην έναρξη της κίνησης ή της σύλληψης 
4 = μόλις που μπορεί να ακουμπήσει τα υπόλοιπα δάκτυλα. 
 
VIII. Γρήγορη εναλλαγή των κινήσεων των χεριών: (πρηνισμός – υπτιασμός και των δύο χεριών μαζί) 
0 = φυσιολογική 
1 = μικρή επιβάρυνση ή και μικρή ένταση της κίνησης 
2 = μέση διαταραχή – καθοριστική και πρόωρη κόπωση 
3 = μεγάλη διαταραχή – διστακτικότητα στην έναρξη της κίνησης ή της σύλληψης 
4 = μόλις που μπορεί να ακουμπήσει τα υπόλοιπα δάκτυλα. 
 
IX. Ελαστικότητα – Ευκινησία κάτω άκρων: (ο ασθενής πατά την πτέρνα στο έδαφος με γρήγορη κίνηση 
ακολουθώντας μετά ολόκληρο το πέλμα) 
0 = φυσιολογική 
1 = μικρή επιβάρυνση ή και μικρή ένταση της κίνησης 
2 = μέση διαταραχή – καθοριστική και πρόωρη κόπωση 
3 = μεγάλη διαταραχή – διστακτικότητα στην έναρξη της κίνησης ή της σύλληψης 
4 = μόλις που μπορεί να ακουμπήσει τα υπόλοιπα δάκτυλα. 
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X. Να σηκωθεί από την καρέκλα: 
0 = φυσιολογικό 
1 = αργά ή μπορεί να χρειαστεί περισσότερες από μία προσπάθειες 
2 = σηκώνεται χρησιμοποιώντας τα χέρια του 
3 = έχει την τάση να ξαναπέσει πίσω και μπορεί να χρειαστεί περισσότερες από μία προσπάθειες. Μπορεί, 
όμως να σηκωθεί και χωρίς βοήθεια 
4 = ανίκανος να σηκωθεί χωρίς βοήθεια. 
 
XI. Στάση: 
0 = φυσιολογική 
1 = δεν είναι εντελώς κάθετη με το έδαφος, μπορεί να είναι φυσιολογική για ηλικιωμένα άτομα 
2 = μη φυσιολογική στάση – μπορεί να γέρνει προς την μία πλευρά 
3 = μεγάλη διαταραχή της στάσης με κύφωση 
4 = μεγάλη κάμψη της Σ.Σ. με έντονες διαταραχές της στάσης. 
 
XII. Βάδιση: 
0 = φυσιολογική 
1 = περπατά αργά – πραγματοποιείται η εναλλαγή του βήματος με μικρό δρασκέλισμα 
2 = περπατά με δυσκολία, αλλά απαιτείται μικρή ή ελάχιστη βοήθεια 
3 = μεγάλη διαταραχή της βάδισης, απαιτείται βοήθεια 
4 = δεν μπορεί να περπατήσει ακόμα και με βοήθεια. 
 
XIII. Ισορροπία: (με τα μάτια ανοιχτά) 
0 = φυσιολογική 
1 = μερική έλλειψη ισορροπίας σε δοκιμασία διαταραχής της με τάση επανάκτησής της 
2 = σε διαταραχή της ισορροπίας από τον εξεταστή υπάρχει κίνδυνος πτώσης εάν ο τελευταίος δεν τον 
κρατήσει 
3 = μεγάλη αστάθεια – έχει την τάση να χάνει την ισορροπία του χωρίς εξωτερική διαταραχή 
4 = δεν μπορεί να σταθεί όρθιος χωρίς βοήθεια. 
 
XIV. Βραδυκινησία και υποκινησία: 
0 = καμμιά 
1 = ελάχιστη βραδύτητα που δίνει στην μετακίνηση ένα σκόπιμο χαρακτήρα. Μπορεί να είναι φυσιολογικό 
για ορισμένους ανθρώπους. Ενδεχόμενο μειωμένο εύρος 
2 = μικρού βαθμού βραδυκινησία και έλλειψη της κίνησης, η οποία είναι διαταραγμένη. Μειωμένο εύρος 
κίνησης 
3 = μεσαίου βαθμού βραδυκινησία, έλλειψη ή μικρού εύρους κίνηση 
4 = χαρακτηριστική βραδύτητα, έλλειψη ή μικρού εύρους κίνηση. 
 
Δ. Επιπλοκές κατά την διάρκεια της θεραπείας (τη περασμένη εβδομάδα) 
I. Δυσκινησία: 
a) Διάρκεια: σε τι ποσοστό της ημέρας εμφανίζεται η δυσκινησία (ιστορικό ασθενή) 
0 = καθόλου 
1 = 1 – 25% την ημέρα 
2 = 26 – 50% την ημέρα 
3 = 51 – 75% την ημέρα 
4 = 76 – 100% την ημέρα 
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b) Ανικανότητα λόγω δυσκαμψίας (ιστορικό ασθενή και εξέταση) 
0 = καμμιά 
1 = μικρή 
2 = μεσαία 
3 = μεγάλη 
4 = τέλεια 
 
c) Επίπονη δυσκινησία: 
0 = καθόλου 
1 = πολύ μικρή 
2 = μεσαία 
3 = πολύ μικρή 
4 = εγκατεστημένη 
 
d) Παρουσία δυστονίας νωρίς το πρωί 
0 = όχι 
1 = ναι 
 
II. Κλινικές διακυμάνσεις: 
a) Είναι το τέλος (OFF)  της περιόδου προβλεπόμενο; 
0 = όχι 
1 = ναι 
 
b) Είναι το τέλος (OFF)  της περιόδου απρόβλεπτο; 
0 = όχι 
1 = ναι 
 
c) Το τέλος (OFF)  των συμπτωμάτων έρχεται ξαφνικά; Μέσα σε λίγα δευτερόλεπτα; 
0 = όχι 
1 = ναι 
 
d) Ποιο ποσοστό της ημέρας (όταν ο ασθενής ξυπνά) είναι ο ασθενής χωρίς  (OFF) συμπτώματα κατά μέσο 
όρο; 
0= κανένα 
1= 1 – 25% της ημέρας 
2= 26 – 50% της ημέρας 
3= 51 – 75% της ημέρας 
4= 76 – 100%  της ημέρας 
 
III. Άλλες κλινικές επιπλοκές 
O ασθενής έχει ανορεξία, ναυτία, εμετό: 
0 = όχι 
1 = ναι 
 
Υπάρχουν επιπλοκές ύπνου, όπως αϋπνίες ή υπνηλία: 
0 = όχι 
1 = ναι 
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Έχει ο ασθενής ορθοστατική υπόταση; 
0 = όχι 
1 = ναι 
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Appendix 8.14. Unified Parkinson’s Disease Rating Scale (UPDRS) (English version). 
 
UNIFIED PARKINSON'S DISEASE RATING SCALE 
Name:           Date: 
A. MENTATION, BEHAVIOR AND MOOD 
I. Intellectual Impairment 
0 = None.  
1 = Mild. Consistent forgetfulness with partial recollection of events and no other difficulties.  
2 = Moderate memory loss, with disorientation and moderate difficulty handling complex problems. Mild but 
definite impairment of function at home with need of occasional prompting. 
3 = Severe memory loss with disorientation for time and often to place. Severe impairment in handling 
problems. 
4 = Severe memory loss with orientation preserved to person only. Unable to make judgements or solve 
problems. Requires much help with personal care. Cannot be left alone at all. 
 
II. Thought Disorder (Due to dementia or drug intoxication) 
0 = None. 
1 = Vivid dreaming.  
2 = "Benign" hallucinations with insight retained.  
3 = Occasional to frequent hallucinations or delusions; without insight; could interfere with daily activities. 
4 = Persistent hallucinations, delusions, or florid psychosis. Not able to care for self. 
 
III. Depression 
0 = None.  
1 = Periods of sadness or guilt greater than normal, never sustained for days or weeks.  
2 = Sustained depression (1 week or more).  
3 = Sustained depression with vegetative symptoms (insomnia, anorexia, weight loss, loss of interest).  
4 = Sustained depression with vegetative symptoms and suicidal thoughts or intent. 
 
IV. Motivation/Initiative 
0 = Normal.  
1 = Less assertive than usual; more passive.  
2 = Loss of initiative or disinterest in elective (nonroutine) activities.  
3 = Loss of initiative or disinterest in day to day (routine) activities.  
4 = Withdrawn, complete loss of motivation. 
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B. ACTIVITIES OF DAILY LIVING (for both “on” and “off”) 
I. Speech 
0 = Normal.  
1 = Mildly affected. No difficulty being understood.  
2 = Moderately affected. Sometimes asked to repeat statements.  
3 = Severely affected. Frequently asked to repeat statements.  
4 = Unintelligible most of the time. 
 
II. Salivation 
0 = Normal.  
1 = Slight but definite excess of saliva in mouth; may have nighttime drooling.  
2 = Moderately excessive saliva; may have minimal drooling.  
3 = Marked excess of saliva with some drooling.  
4 = Marked drooling, requires constant tissue or handkerchief. 
 
III. Swallowing 
0 = Normal.  
1 = Rare choking.  
2 = Occasional choking.  
3 = Requires soft food.  
4 = Requires NG tube or gastrotomy feeding. 
 
IV. Handwriting 
0 = Normal.  
1 = Slightly slow or small.  
2 = Moderately slow or small; all words are legible.  
3 = Severely affected; not all words are legible.  
4 = The majority of words are not legible. 
 
V. Cutting food and handling utensils 
0 = Normal.  
1 = Somewhat slow and clumsy, but no help needed.  
2 = Can cut most foods, although clumsy and slow; some help needed.  
3 = Food must be cut by someone, but can still feed slowly.  
4 = Needs to be fed. 
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VI. Dressing 
0 = Normal.  
1 = Somewhat slow, but no help needed.  
2 = Occasional assistance with buttoning, getting arms in sleeves.  
3 = Considerable help required, but can do some things alone.  
4 = Helpless. 
 
VII. Hygiene 
0 = Normal.  
1 = Somewhat slow, but no help needed.  
2 = Needs help to shower or bathe; or very slow in hygienic care.  
3 = Requires assistance for washing, brushing teeth, combing hair, going to bathroom.  
4 = Foley catheter or other mechanical aids. 
 
VIII. Turning in bed and adjusting bed clothes 
0 = Normal.  
1 = Somewhat slow and clumsy, but no help needed.  
2 = Can turn alone or adjust sheets, but with great difficulty.  
3 = Can initiate, but not turn or adjust sheets alone.  
4 = Helpless. 
 
IX. Falling (unrelated to freezing) 
0 = None. 
1 = Rare falling.  
2 = Occasionally falls, less than once per day.  
3 = Falls an average of once daily.  
4 = Falls more than once daily. 
 
X. Freezing when walking 
0 = None.  
1 = Rare freezing when walking; may have start hesitation.  
2 = Occasional freezing when walking.  
3 = Frequent freezing. Occasionally falls from freezing.  
4 = Frequent falls from freezing. 
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XI. Walking 
0 = Normal.  
1 = Mild difficulty. May not swing arms or may tend to drag leg.  
2 = Moderate difficulty, but requires little or no assistance.  
3 = Severe disturbance of walking, requiring assistance.  
4 = Cannot walk at all, even with assistance. 
 
XII. Tremor (Symptomatic complaint of tremor in any part of body) 
0 = Absent. 
1 = Slight and infrequently present.  
2 = Moderate; bothersome to patient.  
3 = Severe; interferes with many activities.  
4 = Marked; interferes with most activities. 
 
XIII. Sensory complaints related to parkinsonism 
0 = None.  
1 = Occasionally has numbness, tingling, or mild aching.  
2 = Frequently has numbness, tingling, or aching; not distressing.  
3 = Frequent painful sensations.  
4 = Excruciating pain. 
 
C. MOTOR EXAMINATION 
I. Speech 
0 = Normal.  
1 = Slight loss of expression, diction and/or volume.  
2 = Monotone, slurred but understandable; moderately impaired.  
3 = Marked impairment, difficult to understand.  
4 = Unintelligible. 
 
II. Facial Expression 
0 = Normal.  
1 = Minimal hypomimia, could be normal "Poker Face".  
2 = Slight but definitely abnormal diminution of facial expression.  
3 = Moderate hypomimia; lips parted some of the time.  
4 = Masked or fixed facies with severe or complete loss of facial expression; lips parted 1/4 inch or more. 
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III. Tremor at rest (head, upper and lower extremities)  
0 = Absent.  
1 = Slight and infrequently present.  
2 = Mild in amplitude and persistent. Or moderate in amplitude, but only intermittently present.  
3 = Moderate in amplitude and present most of the time.  
4 = Marked in amplitude and present most of the time. 
 
IV. Action or Postural Tremor of hands 
0 = Absent.  
1 = Slight; present with action.  
2 = Moderate in amplitude, present with action.  
3 = Moderate in amplitude with posture holding as well as action.  
4 = Marked in amplitude; interferes with feeding. 
 
V. Rigidity (Judged on passive movement of major joints with patient relaxed in sitting position. Cog wheeling 
to be ignored.) 
 0 = Absent.  
1 = Slight or detectable only when activated by mirror or other movements.  
2 = Mild to moderate.  
3 = Marked, but full range of motion easily achieved.  
4 = Severe, range of motion achieved with difficulty. 
 
VI. Finger Taps (Patient taps thumb with index finger in rapid succession) 
 0 = Normal.  
1 = Mild slowing and/or reduction in amplitude.  
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.  
4 = Can barely perform the task. 
 
VII. Hand Movements (Patient opens and closes hands in rapid succession) 
0 = Normal.  
1 = Mild slowing and/or reduction in amplitude.  
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.  
4 = Can barely perform the task. 
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VIII. Rapid Alternating Movements of Hands (Pronation-supination movements of hands, vertically and 
horizontally, with as large an amplitude as possible, both hands simultaneously)  
0 = Normal.  
1 = Mild slowing and/or reduction in amplitude.  
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.  
4 = Can barely perform the task. 
 
IX. Leg Agility (Patient taps heel on the ground in rapid succession picking up entire leg. Amplitude should be 
at least 3 inches) 
 0 = Normal.  
1 = Mild slowing and/or reduction in amplitude.  
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.  
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.  
4 = Can barely perform the task. 
 
X. Arising from chair (Patient attempts to rise from a straight backed chair, with arms folded across chest)  
0 = Normal.  
1 = Slow; or may need more than one attempt.  
2 = Pushes self-up from arms of seat.  
3 = Tends to fall back and may have to try more than one time, but can get up without help.  
4 = Unable to arise without help. 
 
XI. Posture 
0 = Normal erect.  
1 = Not quite erect, slightly stooped posture; could be normal for older person.  
2 = Moderately stooped posture, definitely abnormal; can be slightly leaning to one side.  
3 = Severely stooped posture with kyphosis; can be moderately leaning to one side.  
4 = Marked flexion with extreme abnormality of posture. 
 
XII. Gait 
0 = Normal.  
1 = Walks slowly, may shuffle with short steps, but no festination (hastening steps) or propulsion.  
2 = Walks with difficulty, but requires little or no assistance; may have some festination, short steps, or 
propulsion. 
3 = Severe disturbance of gait, requiring assistance. 
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4 = Cannot walk at all, even with assistance. 
 
XIII. Postural Stability (Response to sudden, strong posterior displacement produced by pull on shoulders 
while patient erect with eyes open and feet slightly apart. Patient is prepared)  
0 = Normal.  
1 = Retropulsion, but recovers unaided.  
2 = Absence of postural response; would fall if not caught by examiner.  
3 = Very unstable, tends to lose balance spontaneously.  
4 = Unable to stand without assistance. 
 
XIV. Body Bradykinesia and Hypokinesia (Combining slowness, hesitancy, decreased arm swing, small 
amplitude, and poverty of movement in general) 
0 = None. 
1 = Minimal slowness, giving movement a deliberate character; could be normal for some persons. Possibly 
reduced amplitude. 
2 = Mild degree of slowness and poverty of movement which is definitely abnormal. Alternatively, some 
reduced amplitude. 
3 = Moderate slowness, poverty or small amplitude of movement. 
4 = Marked slowness, poverty or small amplitude of movement. 
 
D. COMPLICATIONS OF THERAPY (In the past week) 
DYSKINESIAS 
I. Duration: What proportion of the waking day are dyskinesias present? 
0 = None. 
1 = 1-25% of day. 
2 = 26-50% of day.  
3 = 51-75% of day.  
4 = 76-100% of day. 
 
II. Disability: How disabling are the dyskinesias? 
0 = Not disabling. 
1 = Mildly disabling.  
2 = Moderately disabling.  
3 = Severely disabling.  
4 = Completely disabled. 
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III. Painful Dyskinesias: How painful are the dyskinesias? 
0 = No painful dyskinesias.  
1 = Slight.  
2 = Moderate.  
3 = Severe.  
4 = Marked. 
 
IV. Presence of Early Morning Dystonia  
0 = No 
1 = Yes 
 
CLINICAL FLUCTUATIONS 
I. Are "off" periods predictable? 
0 = No 
1 = Yes 
 
II. Are "off" periods unpredictable? 
0 = No 
1 = Yes 
 
III. Do "off" periods come on suddenly, within a few seconds? 
0 = No 
1 = Yes 
 
IV. What proportion of the waking day is the patient "off" on average? 
0 = None 
1 = 1-25% of day. 
2 = 26-50% of day.  
3 = 51-75% of day.  
4 = 76-100% of day. 
 
OTHER COMPLICATIONS 
I. Does the patient have anorexia, nausea, or vomiting? 
0 = No 
1 = Yes 
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II. Any sleep disturbances, such as insomnia or hypersomnolence? 
0 = No 
1 = Yes 
 
III. Does the patient have symptomatic orthostasis?  
(Record the patient's blood pressure, height and weight on the scoring form)  
0 = No 
1 = Yes 
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Appendix 8.15. Description of the Modified Hoehn and Yahr (H&Y) Scale. 
 
The Modified H&Y scale is a more recent version of the original H&Y scale with the addition 
of stages 1.5 and 2.5. Thus, it has seven stages instead of five. It is a “rate-as-you-see” 
approach, based on observation and examination of functional mobility (Sampaio et al., 
2012).  In the present project, the Modified H&Y Scale was completed by the neurologist. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices 
461 
 
Appendix 8.16. Modified Hoehn and Yahr (H&Y) Scale (Greek version). 
 
ΤΡΟΠΟΠΟΙΗΜΕΝΗ ΚΛΙΜΑΚΑ HOEHN & YAHR 
Όνομα: 
Ημερομηνία:  
 
ΣΤΑΔΙΟ 
 
ΣΥΜΠΤΩΜΑΤΑ ΕΠΙΛΟΓΗ 
(Χ) 
Στάδιο 0 
 
Κανένα εμφανές σύμπτωμα της νόσου του Πάρκινσον.  
Στάδιο 1 
 
 
Μονόπλευρη πάθηση: Εμφάνιση συμπτωμάτων μόνο 
στην μία πλευρά του σώματος. 
 
Στάδιο 1,5 
 
Μονόπλευρη πάθηση και συμμετοχή κορμού  
Στάδιο 2 
 
 
 
Μονόπλευρη πάθηση: Εμφάνιση συμπτωμάτων και 
στις δύο πλευρές του σώματος αλλά καμμιά 
διαταραχή στην ισορροπία και καμμιά δυσκολία στην 
βάδιση. 
 
Στάδιο 2,5 
 
Μονόπλευρη πάθηση με ανάκτηση στο pull test.  
Στάδιο 3 
 
 
 
 
Ήπια προς μεσαίου βαθμού αμφοτερόπλευρη 
πάθηση: Εμφάνιση ήπιας και μέτριας βαρύτητας 
συμπτωμάτων και στις δύο πλευρές του σώματος, 
κάποια διαταραχή στην ισορροπία και ελάχιστη 
δυσκολία στην βάδιση. Ο ασθενής είναι πλήρως 
ανεξάρτητος. 
 
Στάδιο 4 
 
 
 
Εμφάνιση σοβαρών συμπτωμάτων και στις δύο 
πλευρές του σώματος και μέτρια δυσκολία στην 
βάδιση. Ο ασθενής είναι ικανός να σταθεί και να 
βαδίσει χωρίς βοήθεια. 
 
Στάδιο 5 
 
 
 
Εμφάνιση συμπτωμάτων και στις δύο πλευρές του 
σώματος και ανικανότητα βάδισης. Ο ασθενής είναι 
καθηλωμένος στην αναπηρική καρέκλα και μπορεί να 
σηκωθεί μόνο με την βοήθεια άλλων. 
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Appendix 8.17. Modified Hoehn and Yahr (H&Y) Scale (English version). 
 
MODIFIED HOEHN AND YAHR STAGING 
 
Name: 
Date: 
 
STAGE 
 
SYMPTOMS CHOICE (Χ) 
0 No signs of disease.  
1 Unilateral disease.  
1.5 Unilateral plus axial involvement.  
2 Bilateral disease, without impairment of balance.  
2.5 Mild bilateral disease, with recovery on pull test.  
3 Mild to moderate bilateral disease; some postural instability;             
physically    independent. 
 
4 Severe disability; still able to walk or stand unassisted.  
5 Severe disability; still able to walk or stand unassisted.  
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Appendix 8.18. Description of the Schwab and England Activities of Daily Living (SEADL) Scale. 
 
The SEADL includes 11 stages, and rates the ability of PD patients to perform ADLs from 
100% (essential normal) to 0% (vegetative) (McRae et al., 2002). In the current study, the 
scale was shown to the individuals to select the rating that most accurately described their 
level of functional independence. 
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Appendix 8.19. Schwab and England Activities of Daily Living (SEADL) Scale (Greek version) 
 
ΚΛΙΜΑΚΑ ΚΑΘΗΜΕΡΙΝΩΝ ΔΡΑΣΤΗΡΙΟΤΗΤΩΝ SEADL 
Όνομα: 
Ημερομηνία:  
ΣΤΑΔΙΟ ΕΠΙΛΟΓΗ  
100% Εντελώς ανεξάρτητος. Είναι σε θέση να κάνει όλες τις δουλειές χωρίς 
καθυστέρηση, δυσκολία ή βλάβη. Ουσιαστικά φυσιολογικός. Δεν 
γνωρίζει καμία δυσκολία 
 
90% Εντελώς ανεξάρτητος. Είναι σε θέση να κάνει όλες τις δουλειές με 
κάποιο βαθμό βραδύτητας, δυσκολίας και δυσλειτουργίας. Μπορεί να 
πάρει δύο φορές περισσότερο χρόνο. Ξεκινά να υπάρχει δυσκολία. 
 
80% Πλήρως ανεξάρτητος στις περισσότερες δουλειές. Διαρκεί δύο φορές 
περισσότερο χρόνο. Υπάρχει επίγνωση της δυσκολίας και της 
βραδύτητας. 
 
70% Όχι εντελώς ανεξάρτητος. Περισσότερες δυσκολίες με κάποιες 
δουλειές. Τρεις έως τέσσερις φορές περισσότερος χρόνος. Μπορεί να 
κάνει δουλειές τις περισσότερες ώρες της ημέρας.  
 
60% Κάποια εξάρτηση. Μπορεί να κάνει τις περισσότερες δουλειές, αλλά 
εξαιρετικά αργά και με μεγάλη προσπάθεια. Σφάλματα σε μερικές, ενώ 
άλλες είναι αδύνατες. 
 
50% Περισσότερη εξάρτηση. Δυσκολία με τα πάντα. 
 
 
40% Μεγάλη εξάρτηση. Χρειάζεται βοήθεια στις περισσότερες δουλειές. 
 
 
30% Με μεγάλη προσπάθεια, γίνονται κάποιες δουλειές ή ξεκινούν να 
γίνονται. Χρειάζεται μεγάλη βοήθεια. 
 
20% Τίποτα μόνος. Σπάνια κάνει κάποια δουλειά μόνος.  
 
 
10% Εντελώς εξαρτημένος και ανήμπορος. 
 
 
0% Κλινήρης. Ζωτικές λειτουργίες είναι σε καταστολή. 
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Appendix 8.20. Schwab and England Activities of Daily Living (SEADL) Scale (English version). 
 
SCHWAB AND ENGLAND ACTIVITIES OF DAILY LIVING SCALE 
Name: 
Date: 
STAGE CHOICE  
100% Completely independent. Able to do all chores without slowness, 
difficulty or impairment. Essentially normal. Unaware of any difficulty. 
 
90% Completely independent. Able to do all chores with some degree of 
slowness, difficulty and impairment. Might take twice as long. Beginning 
to be aware of difficulty. 
 
80% Completely independent in most chores. Takes twice as long. Conscious 
of difficulty and slowness. 
 
70% Not completely independent. More difficulty with some chores. Three 
to four times as long in some. Must spend a large part of the day with 
chores. 
 
60% Some dependency. Can do most chores, but exceedingly slowly and 
with much effort. Errors; some impossible. 
 
50% More dependent. Help with half, slower, etc. Difficulty with everything 
. 
 
40% Very dependent. Can assist with all chores, but few alone. 
 
 
30% With effort, now and then does a few chores alone or begins alone. 
Much help needed. 
 
20% Nothing alone. Can be a slight help with some chores. Severe invalid. 
 
 
10% Totally dependent, helpless. Complete invalid. 
 
 
0% Vegetative functions such as swallowing, bladder and bowel functions 
are not functioning. Bedridden. 
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Appendix 8.21. Description of the Mini Mental State Examination (MMSE). 
 
The MMSE consists of 11 tasks, grouped into seven cognitive domains: orientation to time, 
orientation to place, registration of three words, attention and calculation, recall of three 
words, language, and visual construction. The maximum score is 30 points. High scores 
indicate good performance, whereas 24 points and below indicate an abnormal result 
(cognitive impairment). Dementia is assumed for less than 20 points. (Sampaio et al., 2012).  
In the current project, the MMSE was completed by the assistant physiotherapist. 
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Appendix 8.22. Mini Mental State Examination (MMSE) (Greek version). 
 
ΠΡΟΚΑΘΟΡΙΣΜΕΝΟ ΣΥΝΤΟΜΟ ΤΕΣΤ ΜΝΗΜΗΣ (MMSE) 
Όνομα:  
Ημερομηνία: 
Α/Α ΕΡΩΤΗΣΗ ΧΡΟΝΟΣ 
ΑΠΑΝΤΗΣΗΣ 
ΒΑΘΜΟΛΟΓΙΑ 
ΠΡΟΣΑΝΑΤΟΛΙΣΜΟΣ 
01Α Τι έτος έχουμε; 10 
δευτερόλεπτα 
/1 
 
01Β Ποια εποχή; 10 
δευτερόλεπτα 
/1 
 
01Γ Τι μήνα; 10 
δευτερόλεπτα 
/1 
 
01Δ Πόσο του μήνα έχουμε; 10 
δευτερόλεπτα 
/1 
 
01Ε Ποια μέρα της εβδομάδας; 10 
δευτερόλεπτα 
/1 
 
01ΣΤ Σε ποια χώρα βρισκόμαστε; 10 
δευτερόλεπτα 
/1 
 
01Ζ Σε ποια πόλη; 10 
δευτερόλεπτα 
/1 
 
01Η Σε ποια περιοχή ή διεύθυνση; 10 
δευτερόλεπτα 
/1 
 
01Θ Σε πιο μέρος (όνομα κτηρίου) βρίσκεστε 
αυτή τη στιγμή; 
10 
δευτερόλεπτα 
/1 
 
01Ι Σε ποιο όροφο; 10 
δευτερόλεπτα 
/1 
 
ΚΑΤΑΓΡΑΦΗ 
02 Θα σας πω 3 λέξεις που θέλω να 
επαναλάβετε μετά από μένα και να τις 
θυμάστε όταν τις ξαναρωτήσω: 
λεμόνι-κλειδί-μολύβι 
 
 
20 
δευτερόλεπτα 
 
/3 
ΣΥΓΚΕΝΤΡΩΣΗ/ΔΥΝΑΤΟΤΗΤΑ ΑΡΙΘΜΗΤΙΚΩΝ ΠΡΑΞΕΩΝ 
03 Αφαιρέστε από το 100 διαδοχικά 7 
μονάδες κάθε φορά / Εναλλακτικά: 
Γράψτε τη λέξη «πόρτα» ανάποδα 
(απάντηση: 93-86-79-72-65 / ΑΤΡΟΠ) 
 
 
 
30 
δευτερόλεπτα 
 
/5 
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ΑΝΑΚΛΗΣΗ 
04 Επαναλάβετε παρακαλώ τις 3 λέξεις που 
σας είχα ζητήσει προηγουμένως 
(απάντηση: λεμόνι-κλειδί-μολύβι) 
 
10 
δευτερόλεπτα 
 
/3 
ΚΑΤΟΝΟΜΑΣΙΑ 
05 Δείχνουμε στον ασθενή 2 αντικείμενα και 
ζητούμε να τα κατονομάσει – τι είναι 
αυτό; 
(π.χ. ρολόι, μολύβι) 
 
20 
δευτερόλεπτα 
 
/2 
ΕΠΑΝΑΛΗΨΗ 
06 Ζητήστε από τον ασθενή να επαναλάβει 
μετά από σας: «Όχι αν και ή αλλά» 
10 
δευτερόλεπτα 
 
/1 
ΕΚΤΕΛΕΣΗ ΕΝΤΟΛΗΣ 3 ΣΤΑΔΙΩΝ 
07 Ρωτήστε τον ασθενή αν είναι δεξιόχειρας 
ή αριστερόχειρας. Δώστε στον ασθενή ένα 
λευκό φύλλο χαρτί και πείτε του: 
Α) Πάρτε το χαρτί στο δεξί/αριστερό σας 
χέρι, Β) Διπλώστε το στη μέση, Γ) Αφήστε 
το στο πάτωμα 
 
30 
δευτερόλεπτα 
 
/3 
ΑΝΤΙΔΡΑΣΗ 
08 Δείξτε στον ασθενή ένα χαρτί που να 
γράφει: «Κλείστε τα μάτια σας». Πείτε του 
να κάνει ό,τι γράφει το χαρτί που του 
δείχνετε. Αν ο ασθενής το διαβάσει και 
δεν κλείσει τα μάτια του, επαναλάβετε 3 
φορές. 
 
10 
δευτερόλεπτα 
 
/1 
ΑΥΤΟΜΑΤΗ ΓΡΑΦΗ 
09 Δώστε στον ασθενή χαρτί και μολύβι και 
πείτε του να γράψει μια ολοκληρωμένη 
πρόταση (πρέπει να περιέχει υποκείμενο 
– ρήμα και η πρόταση να βγάζει νόημα, 
αγνοήστε τα ορθογραφικά λάθη) 
 
30 
δευτερόλεπτα 
 
/1 
ΑΝΤΙΓΡΑΦΗ 
10 Ζητήστε από τον ασθενή να αντιγράψει 
ένα σχήμα δύο τεμνόμενων πενταγώνων.  
 
 
 
 
60 
δευτερόλεπτα 
 
/1 
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Επιτρέψτε πολλές προσπάθειες. 
Περιμένετε μέχρι να τελειώσει. 
 
 
 
ΣΥΝΟΛΙΚΟ ΑΘΡΟΙΣΜΑ MMSE: _______________ 
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Appendix 8.23. Mini Mental State Examination (MMSE) (English version). 
 
MINI MENTAL STATE EXAMINATION (MMSE) 
Name:  
Date: 
No QUESTION TIME 
ALLOWED 
SCORE 
 
ORIENTATION TO TIME 
01Α What year is this? 10 seconds /1 
 
01Β Which season is this? 10 seconds /1 
 
01C What month is this? 10 seconds /1 
 
01D What is today’s date? 10 seconds /1 
 
01Ε What day of the week is this? 10 seconds /1 
 
ORIENTATION TO PLACE 
01F What country are we in? 10 seconds /1 
 
01G What province are we in? 10 seconds /1 
 
01Η What city/town are we in? 10 seconds /1 
 
01I What is the name of this building? 
 
 
10 seconds /1 
 
01J What floor are we on? 10 seconds /1 
 
REGISTRATION 
02 SAY: I am going to name three objects. When I am finished, I 
want you to repeat them. Remember what they are because I 
am going to ask you to name them again in a few minutes.  
(Say the following words slowly at 1‐second intervals ‐ ball/ car/ 
man) 
 
20 seconds 
 
/3 
ATTENTION & CALCULATION 
03 Spell the word WORLD. Now spell it backwards.  
30 seconds 
 
/5 
RECALL 
04 Now what were the three objects I asked you to remember?  
10 seconds 
 
/3 
LANGUAGE 
05 SHOW wristwatch. ASK: What is this called? 
SHOW pencil. ASK: What is this called? 
 
20 seconds 
 
/2 
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06 SAY: I would like you to repeat this phrase after me: No ifs, ands 
or buts. 
 
10 seconds 
 
/1 
07 ASK the person if he is right or left‐handed. Take a piece of paper 
and hold it up in front of the person. SAY: Take this paper in your 
right/left hand (whichever is non‐dominant), fold the paper in 
half once with both hands and put the paper down on the floor . 
Score 1 point for each instruction executed correctly. 
Takes paper correctly in hand 
Folds it in half 
Puts it on the floor 
 
30 seconds 
 
 
 
 
 
/1 
/1 
/1 
08 SAY: Read the words on the page and then do what it says. Then 
hand the person the sheet with CLOSE YOUR EYES on it. If the 
subject reads and does not close their eyes, repeat up to three 
times. Score only if subject closes eyes 
 
10 seconds 
 
/1 
09 HAND the person a pencil and paper. SAY: Write any complete 
sentence on that piece of paper. (Note: The sentence must make 
sense. Ignore spelling errors) 
 
30 seconds 
 
/1 
VISUAL CONSTRUCTION 
10 PLACE design, eraser and pencil in front of the person. SAY: Copy 
this design please. 
 
 
 
Allow multiple tries. Wait until person is finished and hands it 
back. Score only for correctly copied diagram with a 4‐sided 
figure between two 5‐sided figures. 
 
60 seconds 
 
/1 
 
 
TOTAL TEST SCORE: _______________ 
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Appendix 8.24. General Health Questionnaire (GHQ) (Greek version). 
 
ΓΕΝΙΚΟ ΕΡΩΤΗΜΑΤΟΛΟΓΙΟ (GHQ) 
 
(Α) ΓΕΝΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ 
 
 
01 
 
Όνομα 
 
 
02 
 
Ημερομηνία 
  
03 
 
Κωδικός  
 
 
04 
 
Δήμος 
  
05 
 
Τηλέφωνο 
 
 
06 
 
Επάγγελμα 
□ συνταξιούχος           □ οικιακά          □ άνεργος           □ εργαζόμενος 
 
Αν είστε εργαζόμενος, συμπληρώστε το επάγγελμά σας:   
 
      
 
07 
 
 
Οικογενειακή 
κατάσταση 
□ παντρεμένος           □ χωρισμένος          □ χήρος          □ ελεύθερος 
□ διαζευγμένος            □ σε σχέση           
 
08 
 
Ομιλούμενη 
γλώσσα 
□ ελληνικά           □ αγγλικά         □ άλλη:  
 
Ξέρετε να διαβάζετε  και να γράφετε ελληνικά;  □ ναι           □ όχι           
         
 
09 
Μπορείτε να παρακολουθήσετε το πρόγραμμα άσκησης (συχνότητα:2 φορές τη 
βδομάδα, διάρκεια συνεδρίας: 1 ώρα, συνολική διάρκεια προγράμματος: 8 
εβδομάδες, 3 αξιολογήσεις) 
□ ναι           □ όχι           
 
 
(Β) ΣΩΜΑΤΟΜΕΤΡΙΚΑ ΧΑΡΑΚΤΗΡΙΣΤΙΚΑ 
 
 
01 
 
Φύλο  
□ άνδρας           □ γυναίκα          
 
02 
 
Ηλικία 
 (σε έτη) 
  
03 
 
Ύψος 
 (σε μέτρα) 
 
 
04 
 
Βάρος 
 (σε κιλά) 
  
05 
 
ΔΜΣ 
 
 
06 
 
Εθνικότητα 
□ ελληνική           □ άλλη:      
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(Γ) ΑΤΟΜΙΚΟ ΙΣΤΟΡΙΚΟ ΓΙΑ ΠΑΡΚΙΝΣΟΝ 
 
 
01 
 
Πάθηση 
□ Πάρκινσον           □ εξωπυραμυδική συνδρομή 
        
 □ παρκινσονικό σύνδρομο            
 
02 
 
Τύπος Πάρκινσον 
□ ιδιοπαθής            □ δευτεροπαθής           
 
03 
 
Ιατρική διάγνωση 
□ ναι                       □ όχι           
 
04 
 
Πόσο καιρό έχετε διαγνωστεί με Πάρκινσον; 
 
 
05 
 
H&Y στάδιο 
 
 
06 
 
Φάρμακα για Πάρκινσον 
 
 
 
 
07 
 
Έχει αλλάξει η φαρμακευτική σας αγωγή της τελευταίες 4 βδομάδες ή πρόκειται ν’ 
αλλάξει σύντομα; 
□ ναι           □ όχι         □ άλλο:   
         
 
08 
 
Ποιες ώρες της ημέρας λειτουργεί καλύτερα η φαρμακευτική σας αγωγή για το 
Parkinson / Ποιες ώρες της ημέρας είστε καλύτερα κινητικά; 
 
 
 
09 
 
Έχετε υποβληθεί σε χειρουργική επέμβαση (π.χ  εν τω βάθει ηλεκτρικός ερεθισμός / 
deep brain stimulation) λόγω του Πάρκινσον; 
 
□ ναι           □ όχι         □ στο μέλλον (προσδιορίστε χρόνο:  ................................................) 
 
10 
Λαμβάνετε κάποια μη φαρμακευτική αγωγή για το Πάρκινσον;    □ ναι           □ όχι     
    
 
Αν απαντήσατε ναι, παρακαλώ προσδιορίστε: 
□ φυσικοθεραπεία          □ λογοθεραπεία         □ ψυχολογική θεραπεία         □ διατροφή 
□ άλλο:  
............................................................................................................................. ........          
 
 
(Δ) ΥΠΟΛΟΙΠΟ ΑΤΟΜΙΚΟ ΙΑΤΡΙΚΟ ΙΣΤΟΡΙΚΟ 
 
 
01 
 
Kάπνισμα 
□ όχι          □ συστηματικά        □ περιστασιακά         □ στο παρελθόν 
 
02 
 
Περπάτημα 
□ ανεξάρτητα          □ με βοηθητικό μέσο:   
 
Προσδιορίστε:        
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03 
Βαθμολογία  
MMSE 
 
 
04 
 
Καρδιολογική 
πάθηση 
□ στεφανιαία νόσος     □ στηθάγχη      □ έμφραγμα        □ υπέρταση 
□ άλλο. Προσδιορίστε:          
 
05 
Αναπνευστική 
πάθηση 
□ ΧΑΠ     □ άσθμα      □ άλλο. Προσδιορίστε :  
 
06 
Νευρολογική 
πάθηση 
□εγκεφαλικό επεισόδιο      □ άλλο:      
 
07 
 
Μυοσκελετική 
πάθηση 
□ αυχενικό     □ οσφυαλγία      □ οστεοαρθρίτιδα     □ οστεοπόρωση    
     
 □ ρευματικά. Προσδιορίστε: 
 
□ τραυματισμός. Προσδιορίστε: 
   
□ άλλο. Προσδιορίστε:      
 
08 
 
Άλλη πάθηση 
/ άλλα 
προβλήματα 
□ διαβήτης (ινσουλοεξαρτώμενος)    □ ίλιγγος/ζαλάδες     □χοληστερίνη  
       
 □ άλλο. Προσδιορίστε:      
 
09 
  
Χειρουργική 
επέμβαση 
 
□ ναι          □  όχι   
 
Αν ναι, που και πότε:  
    
 
10 
 
Σωματικός 
πόνος 
□ ναι          □  όχι   
 
Αν ναι, προσδιορίστε:  
 
11 
 
Πρόβλημα 
ακοής 
/όρασης 
□ ναι          □  όχι   
 
Αν ναι, προσδιορίστε: 
 
12 
Πτώση τους τελευταίους 2 
μήνες 
□ ναι          □  όχι   
 
 
13 
Κάνετε κάποιου είδους δίαιτα ή διατροφή;  □ ναι          □  όχι   
 
Αν ναι, για ποιο λόγο:  
 
 
14 
 
Ψυχικά 
νοσήματα 
□ κατάθλιψη     □ αγχώδης διαταραχή      
 
 □ άλλο. Προσδιορίστε:  
 
Αν έχετε διαγνωστεί με κάποιο ψυχικό νόσημα, έχει διαγνωστεί πριν 
από το Πάρκινσον; 
□ ναι          □  όχι   
 
15 
 
Λοιπή 
φαρμακευτική 
αγωγή  
(εκτός 
Πάρκινσον) 
 
Φάρμακα: 
 
 
Eίναι σταθερή η αντικαταθλιπτική αγωγή τις τελευταίες 5 βδομάδες ή 
πρόκειται  να αλλάξει σύντομα; 
 
□ ναι          □  όχι   
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(Ε) ΟΙΚΟΓΕΝΕΙΑΚΟ ΙΑΤΡΙΚΟ ΙΣΤΟΡΙΚΟ 
 
Γνωρίζετε αν κάποιος από την οικογένειά σας είχε κάποια πάθηση; Αν ναι, αναφέρατε πάθηση 
και βαθμό συγγένειας 
 
 
01 
 
Καρδιολογική πάθηση 
□ όχι       □ ναι       
 
 πάθηση:                                          συγγένεια:   
 
02 
 
Αναπνευστική πάθηση 
□ όχι        □ ναι      
 
πάθηση:                                          συγγένεια:   
 
03 
 
Νευρολογική πάθηση 
□ όχι       □ ναι       
 
 πάθηση:                                          συγγένεια:   
 
04 
 
Μυοσκελετική πάθηση 
□ όχι        □ ναι      
 
πάθηση:                                          συγγένεια:   
 
05 
 
Άλλη πάθηση 
□ όχι       □ ναι       
  
πάθηση:                                          συγγένεια:   
 
 
 
(ΣΤ ) ΕΓΚΡΙΣΗ / ΑΠΟΡΡΙΨΗ 
 
 
01 
□ έγκριση ασθενή           □ απόρριψη ασθενή          
 
02 
 
Αν στην προηγούμενη ερώτηση επιλέξατε ‘απόρριψη ασθενή’, παρακαλώ αναφέρατε 
τον λόγο της απόρριψης: 
 
□ HADS-D < 8   
 
□>3 H&Y στάδιο   
              
□24< ΜΜSE       
       
□ πρόβλημα όρασης  
   
□ πρόβλημα όρασης  
 
□ δευτεροπαθές PD, παρκινσονισμός, εξωπυραμυδική συνδρομή          
 
□  σωματική νόσος: 
 
□ ψυχική νόσος: 
 
□ εγχείρηση για Πάρκινσον   
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□ άλλη εγχείρηση:  
 
□  μη σταθερή φαρμακευτική αγωγή για Πάρκινσον  
 
□  μη σταθερή φαρμακευτική αγωγή για κατάθλιψη 
 
□ φάρμακα:  
 
□ μη φαρμακολογική θεραπεία για Πάρκινσον: 
    
□ αδυναμία παρακολούθησης προγράμματος 
 
□ μη γνώση ελληνικών    
 
□ άλλος λόγος:   
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Appendix 8.25. General Health Questionnaire (GHQ) (English version). 
 
GENERAL HEALTH QUESTIONNAIRE (GHQ) 
 
(Α) BACKGROUND INFORMATION 
 
 
01 
 
Name 
 
 
02 
 
Date 
  
03 
 
Patient’s code  
 
 
04 
 
Municipality 
  
05 
 
Telephone 
 
 
06 
 
Occupation 
□ retired           □ household          □ unemployed           □ employee 
 
If ‘employee’, specify the occupation:   
 
      
 
07 
 
 
Marital 
status 
□ maried           □ separated          □ widower          □ single 
□ divorced        □ in a relationship          
 
08 
 
Language  
□ Greek           □ English         □ other:  
 
Do you know to read and write in Greek;  □ yes           □ no           
         
 
09 
Will you be available for the entire period of study? (exercise programme and 
assessments) 
 
□ yes          □ no 
          
 
 
(Β) ANTROPOMETRIC CHARACTERISTICS 
 
 
01 
 
Gender  
□ male            □ female         
 
02 
 
Age 
 (in years) 
  
03 
 
Height 
 (in metres) 
 
 
04 
 
Weight  
 (in kilos) 
  
05 
 
BMI 
 
 
06 
 
Nationality 
□ Greek           □ other:      
 
 
Appendices 
478 
 
(C) MEDICAL HISTORY OF PD 
 
 
01 
 
Disease 
□ PD           □ extrapyramidal syndrome 
        
 □ parkinsonian syndrome            
 
02 
 
Type of PD 
□ idiopathic (primary)            □ secondary           
 
03 
Medical diagnosis □ yes                      □ no          
 
04 
 
How long have you been diagnosed with PD? 
 
 
05 
 
H&Y stage 
 
 
06 
 
PD pharmacological 
treatment 
 
 
 
 
07 
 
Is your PD medication stable the last 4 weeks or is there any possibility to being changed 
shortly? 
□ yes          □ no         □ other:   
         
 
08 
 
What hours of the day does your PD medication works best? / What hours of the day are 
you motor symptoms improved? 
 
 
09 
 
Did you have any surgical operation (e.g.deep brain stimulation) due to PD? 
 
□ yes          □ no        □ in the future (when?:   ................................................) 
 
10 
Do you receive any non-pharmacological treatment for PD?    □ yes          □ no     
    
If the answer is ‘yes’, specify: 
□ physiotherapy/exercise          □ speech therapy         □ psychological  intervention 
□ diet 
□ other :  
............................................................................................................................. ........          
 
 
(D) HEALTH STATUS 
 
 
01 
 
Smoking 
□ no          □ systematic smoker        □ social smoker         □ in the 
past  
 
02 
 
Walking 
□ indepedent         □ with an assistance device:   
 
Specify:        
 
03 
 MMSE score  
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04 
 
Cardiovascular 
disease 
□ CHD     □ chest pain      □  myocardial infarction                           
□ hypertension 
□ other. Specify:          
 
05 
Respiratory disease □ COPD    □ asthma      □ other. Specify :  
 
06 
Neurological 
disease 
□ stroke      □ other. Specify:      
 
07 
 
Musculoskeletal 
disease 
□ cervical syndrome    □ low back pain    □ osteoarthritis                      
□ osteoporosis    
     
 □ rheumatoid disease. Specify: 
 
□ injury. Specify: 
   
□ other. Specify:      
 
08 
 
Other disease 
□ diabetes mellitus type I    □ dizziness  □ high cholesterol  
       
 □ other. Specify:      
 
09 
  
Surgical operation 
 
□ yes          □  no 
 
If yes, what type of operation and when:  
    
 
10 
 
Somatic pain 
□ yes          □  no  
 
If yes, specify:  
 
11 
 
Hearing /visual 
impairment   
□ yes          □  no  
 
Specify: 
 
12 
Falls during the last 2 
months 
□ yes          □  no  
 
 
13 
Do you follow any diet?  □ yes          □  no   
 
If yes, state the reason:  
 
 
14 
 
Mental disorders 
□ depression     □ anxiety      
 
 □ Other. Specify:  
Have you been diagnosed with mental disorder before PD 
diagnosis? 
□ yes          □  no   
 
15 
 
Pharmacological 
treatment 
(apart from PD) 
Medication: 
 
 
 
Is your antidepressant medication stable the last 5 weeks or is 
there any possibility to being changed shortly? 
□ yes          □  no  
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(Ε) FAMILY’S MEDICAL HISTORY 
 
Do you know if a member of your family (relatιve) was/is suffering from a disease? If yes, 
specify the disease and the degree of relationship. 
 
01 
 
Cardiovascular 
disease 
□ yes       □ no       
 disease:                                          degree of relationship:   
 
02 
 
Respiratory 
disease 
□ yes       □ no       
 disease:                                          degree of relationship:   
 
03 
 
Neurological 
disease 
□ yes       □ no       
 disease:                                          degree of relationship:   
 
04 
 
Musculoskeletal 
disease 
□ yes       □ no       
 disease:                                          degree of relationship:   
 
05 
 
Other disease 
□ yes       □ no       
 disease:                                          degree of relationship:   
 
 
(G ) APPROVAL/REFUSAL 
 
 
01 
□ approval           □ refusal          
 
02 
 
Reason(s) of refusal: 
 
□ HADS-D < 8   
 
□>3 H&Y stage   
              
□24< ΜΜSE       
       
□ visual impairment  
   
□ hearing impairment   
 
□ secondary PD, parkinsonian syndrome, extrapyramidal syndrome          
 
□  somatic pain: 
 
□ mental disorder: 
 
□ surgical operation for PD:   
                                  
□ other operation:  
 
□  non stable PD medication  
 
□  non stable antidepressant medication 
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□ pharmacological treatment:  
 
□ non pharmacological treatment for PD: 
    
□ inability to participate 
 
□ inability to write or read in Greek   
 
□ other reason:   
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Appendix 8.26. Descriptions of clinical examinations and calculations for the record of 
somatometric characteristics.  
 
Clinical examination for height 
The height was measured without shoes, with the feet together, standing as tall as possible 
and looking straight ahead, with the back placed firmly against a wall, using a metre (García-
Río et al., 2013; Kleisouras, 1997). In the case of chest deformities, the span was measured 
(crossed arms from middle finger to middle finger), estimating the height from the 
following ratio: height=span/1.06 (Parker et al., 1996). 
 
Clinical examination for weight  
The weight was measured with a digital bathroom scale (Tanita HD-380). The individual 
stranded with minimal movement with hands by their side. Shoes and excess clothing were 
removed (Kleisouras, 1997). 
 
Calculation of the BMI 
The equitation weight (in kilos) / height2 (in metres) calculated the BMI of each participant 
(Kleisouras, 1997). 
 
* The above tests and calculations were performed by the chief investigator 
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Appendix 8.27. Description of the Snijders and Bloem FOG Test. 
 
The instructions for the Snijders and Bloem FOG Test were given by the chief investigator. 
The patients were asked to perform repeated 3600 narrow turns, in both directions, at high 
speed (Snijders et al., 2012). The examination included turning in both directions, because 
FOG often shows a directional sensitivity, and it is sometimes present just in a rightward or 
leftward direction (Snijders et al., 2008). Eight alternate full turns (four into each direction) 
were performed for the classification of freezers and non-freezers. If this did not provoke 
freezing, dual tasks were added to the test while performing four alternate full turns into 
each direction. Participants were asked to count while turning (Snijders et al., 2012). The 
researcher demonstrated first the test to the participants. The only given instructions 
during the test were: ‘turn right’ and ‘turn left’. If FOG was observed, the individual was 
recorded as freezer.  
 
Special emphasis was given to differentiate FOG from festination. In FOG, there is a 
complete stop and the patient experiences the feeling of ‘being glued to the floor’. During 
festination, there is a progressive decrease in step length and increase in cadence, whereas 
the characteristic ‘magnetic feeling’ under the feet is not present (Snijders et al., 2008). 
 
No instructions were given during the test performance, except the initial order ‘go’.  On a 
data sheet the time to complete the test was recorded, and qualitative aspects of walking 
(such as freezing, no arms swinging) were ticked. 
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Appendix 8.28. ‘Snijders and Bloem FOG Test’ form (Greek version) 
 
ΤΕΣΤ ΠΑΓΩΜΑΤΟΣ ‘SNIJDERS AND BLOEM’ 
Όνομα:  ……………………………………………………………………….. 
Ημερομηνία:  ……………. 
 
Μεμονωμένη δραστηριότητα 
Αν ισχύει κάτι από τα παρακάτω, σημειώσατε με (Χ). 
1. ‘Στρίψε αριστερά’ : □ πάγωμα 
2. ‘Στρίψε δεξιά’:  □ πάγωμα  
3. ‘Στρίψε αριστερά’ : □ πάγωμα 
4. ‘Στρίψε δεξιά’:  □ πάγωμα  
5. ‘Στρίψε αριστερά’ : □ πάγωμα 
6. ‘Στρίψε δεξιά’:  □ πάγωμα  
7. ‘Στρίψε αριστερά’ : □ πάγωμα 
8. ‘Στρίψε δεξιά’:  □ πάγωμα 
 
Διπλή δραστηριότητα 
Αν ισχύει κάτι από τα παρακάτω, σημειώσατε με (Χ). 
1. ‘Στρίψε αριστερά’ : □ πάγωμα 
2.  ‘Στρίψε δεξιά’:  □ πάγωμα 
3. ‘Στρίψε αριστερά’ : □ πάγωμα 
4.  ‘Στρίψε δεξιά’:  □ πάγωμα 
5. ‘Στρίψε αριστερά’ : □ πάγωμα 
6.  ‘Στρίψε δεξιά’:  □ πάγωμα 
7. ‘Στρίψε αριστερά’ : □ πάγωμα 
8.  ‘Στρίψε δεξιά’:  □ πάγωμα 
 
Ο ασθενής εμφανίζει πάγωμα:  □ Ναι  □ Όχι 
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Appendix 8.29. ‘Snijders and Bloem FOG Test’ form (English version) 
 
 SNIJDERS AND BLOEM FOG test 
Name:  ……………………………………………………………………….. 
Date:  …………. 
 
Single task  
If any of the following is true, please tick (X): 
1.  ‘Turn left’ : □ FOG 
2. ‘Turn right’:  □ FOG  
3. ‘Turn left’ : □ FOG 
4. ‘Turn right’:  □ FOG  
5. ‘Turn left’ : □ FOG 
6. ‘Turn right’:  □ FOG  
7. ‘Turn left’ : □ FOG 
8. ‘Turn right’:  □ FOG  
 
 
Dual task 
If any of the following is true, please tick (X): 
1. ‘Turn left’ : □ FOG 
2. ‘Turn right’:  □ FOG  
3. ‘Turn left’ : □ FOG 
4. ‘Turn right’:  □ FOG  
5. ‘Turn left’ : □ FOG 
6. ‘Turn right’:  □ FOG  
7. ‘Turn left’ : □ FOG 
8. ‘Turn right’:  □ FOG  
 
 
The patient is: □ freezer □ non-freezer 
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Appendix 8.30. Description of the Parkinson’s Disease Questionnaire 39 (PDQ-39). 
 
The PDQ-39 is a 39-item self-report questionnaire, which assesses the QoL of PD patients 
over the last month. The questions, which are clustered in eight subscales (table A.1), have 
five ordinal response options, rating from zero (never) to four (always) (Sampaio et al., 
2012). 
 
Table A.1. The eight subscales of the PDQ-39 and the number of included items.  
Subscales Number of items 
Mobility  10 (items: 1-10) 
ADLs 6  (items: 11-16) 
Emotional well-being 6 (items: 17-22) 
Stigma  4 (items: 23-26) 
Social support 3 (items: 27-29) 
Cognition  4 (items: 30-33) 
Communication  3 (items: 34-36) 
Bodily discomfort 3 (items: 37-39) 
 
Abbreviations. ADLs: activities of daily living. 
 
Scores can be calculated for each dimension (subscale) (dimension score), and for the 
whole test (PDQ-39 Summary Index- PDQ-39 SI) to assess the overall health-related QoL. 
Each dimension score ranges from zero (never have difficulty) to 100 (always have 
difficulty), with lower scores reflecting better QoL. The dimension score is the sum of scores 
of all the items in the dimension, divided by the maximum possible score of all the items in 
the dimension, multiplied by 100. The PDQ-39 SI is the sum of dimensions total scores 
divided by eight (Jenkinson et al., 1997; Sampaio et al., 2012). 
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Appendix 8.31.  Parkinson’s Disease Questionnaire 39 (PDQ-39) (Greek version) 
 
 
ΕΡΩΤΗΜΑΤΟΛΟΓΙΟ ΠΟΙΟΤΗΤΑΣ ΖΩΗΣ ΣΤΟ ΠΑΡΚΙΝΣΟΝ (PDQ-39) 
 
 
Όνομα:.......................................................................................................    
Ημερομηνία:  ........................... 
 
Παρακαλώ συμπληρώστε το παρακάτω ερωτηματολόγιο. Σημειώστε με Χ μία απάντηση 
σε κάθε ερώτηση. 
 
 
Εξαιτίας του Πάρκινσον πόσο συχνά τον 
τελευταίο μήνα............. 
Ποτέ Περιστασιακά Μερικές 
φορές 
Συχνά Πάντα  
ή δεν 
μπορώ 
καθόλου 
01 Είχατε δυσκολία να  κάνετε τις 
δραστηριότητες αναψυχής που 
θα θέλατε; 
     
02 Είχατε δυσκολία να φροντίσετε 
το σπίτι σας (π.χ. δουλειές του 
σπιτιού, μαγείρεμα); 
     
03 Είχατε δυσκολία να 
μεταφέρετε τσάντες με ψώνια; 
     
04 Είχατε δυσκολία να 
περπατήσετε μισό χιλιόμετρο; 
     
05 Είχατε δυσκολία να 
περπατήσετε 100 μέτρα; 
     
06 Είχατε δυσκολία να 
περπατήσετε μέσα στο σπίτι 
σας όσο εύκολα θα θέλατε; 
     
07 Είχατε δυσκολία να 
περπατήσετε σε δημόσιο χώρο; 
     
08 Χρειαζόσασταν κάποιον να σας 
συνοδεύσει όταν πηγαίνατε 
έξω; 
     
09 Είχατε φόβο η ανησυχία μήπως 
πέσετε σε δημόσιο χώρο; 
     
10 Είχατε περιοριστεί εντός 
σπιτιού περισσότερο απ’ όσο 
θα θέλατε; 
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Εξαιτίας του Πάρκινσον πόσο συχνά τον 
τελευταίο μήνα............. 
Ποτέ Περιστασιακά Μερικές 
φορές 
Συχνά Πάντα  
ή δεν 
μπορώ 
καθόλου 
11 Είχατε δυσκολία να πλυθείτε 
μόνος σας; 
     
12 Είχατε δυσκολία να ντυθείτε 
μόνος σας; 
     
13 Είχατε δυσκολία να δέσετε τα 
κορδόνια των παπουτσιών σας; 
     
14 Είχατε πρόβλημα να γράψετε 
καθαρά; 
     
15 Είχατε δυσκολία να κόψετε το 
φαγητό σας; 
     
16 Είχατε δυσκολία να κρατήσετε 
ένα ποτήρι με νερό χωρίς να το 
χύσετε; 
     
17 Νιώσατε θλιμμένος;      
18 Αισθανθήκατε απομονωμένος 
και μόνος; 
     
19 Δακρύσατε ή κλάψατε;      
20 Νιώσατε θυμωμένος ή 
πικραμένος; 
     
21 Νιώσατε αγχωμένος;      
22 Είχατε ανησυχία για το μέλλον 
σας; 
     
23 Αισθανθήκατε ότι έπρεπε να 
κρύψετε την ασθένειά σας από 
άλλους ανθρώπους; 
     
24 Αποφύγατε καταστάσεις που 
περιλαμβάνουν φαγητό ή ποτό 
σε δημόσιο χώρο; 
     
25 Νοιώσατε άσχημα σε δημόσιο 
χώρο λόγω της ασθένειάς σας; 
     
26 Είχατε ανησυχία εξαιτίας της 
αντίδρασης των άλλων 
ανθρώπων σε εσάς; 
     
27 Είχατε πρόβλημα με τις στενές 
προσωπικές σας σχέσεις; 
     
28 Δεν είχατε υποστήριξη όπως 
θα θέλατε από τον σύζυγό σας 
ή τον σύντροφό σας; 
     
Αν δεν έχετε σύντροφο ή σχέση 
σημειώσατε με Χ εδώ. 
 
29 Δεν είχατε υποστήριξη όπως 
θα θέλατε από την οικογένειά 
σας ή στενούς φίλους; 
     
30 Αποκοιμηθήκατε απροσδόκητα 
κατά την διάρκεια της ημέρας; 
     
31 Είχατε προβλήματα με την 
συγκέντρωσή σας (π.χ. όταν 
διαβάζατε ή όταν βλέπατε 
τηλεόραση); 
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Εξαιτίας του Πάρκινσον πόσο συχνά τον 
τελευταίο μήνα............. 
Ποτέ Περιστασιακά Μερικές 
φορές 
Συχνά Πάντα  
ή δεν 
μπορώ 
καθόλου 
32 Αισθανθήκατε ότι η μνήμη σας 
ήταν κακή;  
     
33 Είχατε εφιάλτες ή 
παραισθήσεις; 
     
34 Είχατε δυσκολία με την ομιλία 
σας; 
     
35 Αισθανθήκατε ανίκανος να 
επικοινωνήσετε με τους 
άλλους ανθρώπους καθαρά; 
     
36 Αισθανθήκατε ότι οι άλλοι 
άνθρωποι σας αγνοούν; 
     
37 Είχατε επώδυνες μυϊκές 
κράμπες ή σπασμούς; 
     
38 Είχατε πόνο στις αρθρώσεις ή 
στο σώμα σας; 
     
39 Νιώσατε αφόρητη ζέστη ή 
κρύο; 
     
 
 
Ελέγξτε ότι έχετε απαντήσει όλες τις ερωτήσεις. Σας ευχαριστούμε για την συμμετοχή 
σας. 
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Appendix 8.32.  Parkinson’s Disease Questionnaire 39 (PDQ-39) (English version) 
 
 
PDQ-39 QUESTIONNAIRE  
 
 
Name:.......................................................................................................  
Date:  ........................... 
 
Please complete the following questionnaire. Tick one box for each question. 
 
Due to having Parkinson’s disease, how often 
during the last month have you.... 
Never  Occasionally Sometimes Often Always or 
cannot at 
all 
01 Had difficulty doing 
the leisure activities which you 
would like to do? 
     
02 Had difficulty looking after your 
home, e.g. DIY, housework, 
cooking? 
     
03 Had difficulty carrying bags of 
shopping? 
     
04 Had problems walking half a 
mile? 
     
05 Had problems walking 100 
yards? 
     
06 Had problems getting around 
the house as easily as you 
would like? 
     
07 Had difficulty getting around in 
public? 
     
08 Needed someone else to 
accompany you when you went 
out? 
     
09 Felt frightened or worried 
about falling over in public? 
     
10 Been confined to the house 
more than you would like? 
     
11 Had difficulty washing yourself? 
 
     
12 Had difficulty dressing 
yourself? 
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Due to having Parkinson’s disease, how often 
during the last month have you.... 
Never  Occasionally Sometimes Often Always or 
cannot at 
all 
13 Had problems doing up your 
shoe laces? 
     
14 Had problems writing clearly? 
 
     
15 Had difficulty cutting up your 
food? 
     
16 Had difficulty holding a drink 
without spilling it? 
     
17 Felt depressed? 
 
     
18 Felt isolated and lonely? 
 
     
19 Felt weepy or tearful? 
 
     
20 Felt angry or bitter? 
 
     
21 Felt anxious? 
 
     
22 Felt worried about your future? 
 
     
23 Felt you had to conceal your 
Parkinson's from people? 
     
24 Avoided situations which 
involve eating or drinking 
in public? 
     
25 Felt embarrassed in public due 
to having Parkinson's disease? 
     
26 Felt worried by other people's 
reaction to you? 
     
27 Had problems with your close 
personal relationships? 
     
28 Lacked support in the ways you 
need from your spouse or 
partner? 
     
If you do not have a spouse or 
partner tick here 
 
29 Lacked support in the ways you 
need from your family or close 
friends? 
     
30 Unexpectedly fallen asleep 
during the day? 
     
31 Had problems with your 
concentration, e.g. when 
reading or watching TV? 
     
32 Felt your memory was bad? 
 
     
33 Had distressing dreams or 
hallucinations? 
     
34 Had difficulty with your 
speech? 
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Due to having Parkinson’s disease, how often 
during the last month have you.... 
Never  Occasionally Sometimes Often Always or 
cannot at 
all 
35 Felt unable to communicate 
with people properly? 
     
36 Felt ignored by people?      
37 Had painful muscle cramps or 
spasms? 
     
38 Had aches and pains in your 
joints or body? 
     
39 Felt unpleasantly hot or cold?      
 
 
Thank you for completing the PDQ 39 questionnaire! 
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Appendix 8.33.  Description of the Berg Balance Scale (BBS). 
 
The BBS is a clinical test, which was originally designed for use in the elderly population. It 
is a 14-item scale evaluating the ability to maintain balance in different positions, postural 
changes and movements. Each item is scored on a five-point ordinal scale ranging from 
zero to four, including a variety of tasks. Zero indicates the lowest level of function (unable 
to perform) and four the highest level (normal performance). The possible highest total 
score of the scale is 56, indicating excellent balance (Berg, 1989). 
 
In the current study, single trials of BBS were performed, without the use of walking aid, 
similarly to the study by Dibble et al. (2008). Basic equipment was used for the test: a chair 
without armrests (chair height: 45- 47.5 cm), a chair with armrests (chair height: 45.5-47 
cm; arm height: 65-67.5 cm), a stopwatch, a ruler, an item on the floor (pencil), and a step 
stool (step stool height: 22 cm). All tasks were demonstrated before by the researcher, to 
ensure that participants had understood how to perform the activity. Then, he gave 
instructions to participants to perform the tasks. The tasks were performed closed to the 
wall or stable furniture for safety reasons: to avoid falls and fall-related injuries. The 
participants were allowed to rest for a while between the tasks, if needed (Steffen and 
Seney, 2008). 
 
Special attention was given to items eight (reaching forward with outstretched arm while 
standing); and 14 (standing on one leg) of the scale. Item eight was performed closed on 
the wall. The participant was instructed not to touch the wall. A stripe was placed on the 
wall for the guidance of participant’s hand during the task. Before the start of the task, the 
tip of his third finger were placed on the edge of the stripe. Regarding item 14, the 
participants was allowed for a few moment to determine which leg would use for the test. 
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Appendix 8.34.  Berg Balance Scale (BBS) (Greek version) 
 
ΚΛΙΜΑΚΑ 
ΙΣΟΡΡΟΠΙΑΣ 
BERG 
 
 
 
Όνομα: _______________________ 
Ημερομηνία: _____________________  
Δοκιμασίες ισορροπίας                                                                                Score (0-4) 
 
1. Από καθιστή σε όρθια θέση _______ 
2. Όρθια θέση χωρίς υποστήριξη _______ 
3. Κάθισμα χωρίς υποστήριξη _______ 
4. Από όρθια σε καθιστή θέση _______ 
5. Μεταφορές _______ 
6. Όρθιος χωρίς υποστήριξη με τα μάτια κλειστά _______ 
7. Όρθιος χωρίς υποστήριξη με τα πόδια ενωμένα _______ 
8. Σκύψιμο προς τα εμπρός με τεντωμένο το χέρι από 
όρθια θέση 
 
_______ 
9. Άρση αντικειμένου από το πάτωμα από όρθια θέση _______ 
10. Στροφή κεφαλής και κορμού προς τα πίσω από 
όρθια θέση 
 
_______ 
11. Στροφή 360 μοιρών από όρθια θέση _______ 
12. Τοποθέτηση των ποδιών εναλλάξ σε σκαλοπάτι ή 
σε σκαμνί από όρθια θέση 
 
_______ 
13. Όρθια θέση χωρίς υποστήριξη με το ένα πόδι 
εμπρός 
 
_______ 
14. Μονοποδική στήριξη σε όρθια θέση _______ 
 
 
      ΣΥΝΟΛΟ  (0-56):______ 
 
 
Ερμηνεία _____________________         
0-20 Υψηλός κίνδυνος πτώσης 
21-40 μέτριος κίνδυνος πτώσης 
41-56 χαμηλός κίνδυνος πτώσης 
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ΔΟΚΙΜΑΣΙΕΣ ΚΛΙΜΑΚΑΣ ΙΣΣΟΡΟΠΙΑΣ BERG  
 
 
01 
ΑΠΟ ΚΑΘΙΣΤΗ ΣΕ ΟΡΘΙΑ ΘΕΣΗ 
Οδηγίες: Σηκωθείτε και προσπαθήστε να μην χρησιμοποιήσετε τα χέρια σας για 
υποστήριξη.  
(  )  4 Μπορεί να σταθεί χωρίς να χρησιμοποιήσει τα χέρια και να σταθεί ανεξάρτητα. 
(  )  3 Είναι σε θέση να σταθεί ανεξάρτητα με τα χέρια. 
(  )  2 Είναι σε θέση να σταθεί χρησιμοποιώντας τα χέρια μετά από αρκετές δοκιμές. 
(  )  1 Χρειάζεται ελάχιστη βοήθεια για να σταθεί ή να σταθεροποιηθεί. 
(  )  0 Χρειάζεται μέτρια ή μέγιστη βοήθεια για να σηκωθεί. 
 
 
02 
ΟΡΘΙΑ ΘΕΣΗ ΧΩΡΙΣ ΥΠΟΣΤΗΡΙΞΗ 
Οδηγίες: Προσπαθήστε να σταθείτε 2 λεπτά χωρίς να κρατηθείτε. 
(  )  4 Είναι σε θέση να σταθεί με ασφάλεια για 2 λεπτά. 
(  )  3 Είναι σε θέση να σταθεί για 2 λεπτά με επίβλεψη. 
(  )  2 Είναι σε θέση να σταθεί για 30 δευτερόλεπτα χωρίς υποστήριξη. 
(  )  1 Χρειάζεται αρκετές προσπάθειες για να σταθεί 30 δευτερόλεπτα χωρίς βοήθεια. 
(  )  0 Αδυνατεί να σταθεί για 30 δευτερόλεπτα χωρίς βοήθεια. 
 
Αν είναι σε θέση να σταθεί με ασφάλεια για 2 λεπτά προχωρήστε στο βήμα 4. 
 
 
03 
ΚΑΘΙΣΜΑ ΜΕ ΤΗΝ ΠΛΑΤΗ ΝΑ ΜΗΝ ΑΚΟΥΜΠΑΕΙ ΚΑΠΟΥ ΚΑΙ ΜΕ ΤΑ ΠΟΔΙΑ ΝΑ 
ΣΤΗΡΙΖΟΝΤΑΙ ΣΤΟ ΔΑΠΕΔΟ Ή ΣΕ ΣΚΑΜΠΟ 
Οδηγίες: Να καθίσετε με σταυρωμένα τα χέρια για 2 λεπτά. 
(  )  4 Είναι σε θέση να καθίσει με ασφάλεια και σιγουριά για 2 λεπτά. 
(  )  3 Είναι σε θέση να καθίσει για 2 λεπτά με επίβλεψη. 
(  )  2 Είναι σε θέση να καθίσει για 30 δευτερόλεπτα. 
(  )  1 Είναι σε θέση να καθίσει για 10 δευτερόλεπτα. 
(  )  0 Δεν είναι σε θέση να καθίσει για 10 δευτερόλεπτα χωρίς υποστήριξη. 
 
 
04 
ΑΠΟ ΟΡΘΙΑ ΣΕ ΚΑΘΙΣΤΗ ΘΕΣΗ 
Οδηγίες: Παρακαλώ να καθίσετε. 
(  )  4 Κάθεται με ασφάλεια με ελάχιστη χρήση των χεριών. 
(  )  3 Ελέγχει τον τρόπο που κάθεται χρησιμοποιώντας τα χέρια. 
(  )  2 Χρησιμοποιεί το πίσω μέρος των ποδιών για ελέγξει το κάθισμα. 
(  )  1 Κάθεται ανεξάρτητα, αλλά ανεξέλεγκτα. 
(  )  0 Χρειάζεται βοήθεια για να καθίσει. 
 
 
05 
ΜΕΤΑΦΟΡΕΣ 
Οδηγίες: Δυο καρέκλες, μία με μπράτσα και η άλλη χωρίς μπράτσα, σε γωνία 90 
μοιρών μεταξύ τους. Ζητήστε από τον εξεταζόμενο να μεταφερθεί από τη μια καρέκλα 
στην άλλη, με όσον το δυνατό λιγότερη στήριξη. Έπειτα πρέπει να μεταφερθεί στην 
αρχική του θέση, δηλαδή προς την αντίθετη κατεύθυνση. 
(  )  4 Μπορεί να μεταφερθεί με ασφάλεια με μικρή χρήση των χεριών. 
(  )  3 Μπορεί να μεταφέρει με ασφάλεια με σαφή χρήση των χεριών. 
(  )  2 Μπορεί να μεταφέρει με καθοδήγηση ή εποπτεία. 
(  )  1 Χρειάζεται βοήθεια από ένα άτομο. 
(  )  0 Χρειάζεται βοήθεια από δύο άτομα ή εποπτεία για να είναι ασφαλής. 
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06 
ΟΡΘΙΟΣ ΧΩΡΙΣ ΥΠΟΣΤΗΡΙΞΗ ΜΕ ΤΑ ΜΑΤΙΑ ΚΛΕΙΣΤΑ 
Οδηγίες: Κλείστε τα μάτια σας και μείνετε ακίνητος για 10 δευτερόλεπτα. 
(  )  4 Είναι σε θέση να σταθεί με ασφάλεια για 10 δευτερόλεπτα. 
(  )  3 Είναι σε θέση να σταθεί για 10 δευτερόλεπτα με εποπτεία. 
(  )  2 Είναι σε θέση να σταθεί για 3 δευτερόλεπτα. 
(  ) 1 Δεν είναι σε θέση να κλείσει τα μάτια για 3 δευτερόλεπτα αλλά παραμένει σταθερός. 
(  )  0 Χρειάζεται βοήθεια για να μην πέσει. 
 
 
07 
ΟΡΘΙΟΣ ΧΩΡΙΣ ΥΠΟΣΤΗΡΙΞΗ ΜΕ ΤΑ ΠΟΔΙΑ ΕΝΩΜΕΝΑ 
Οδηγίες: Τοποθετήστε τα πόδια σας μαζί, το ένα δίπλα στο άλλο, και σταθείτε χωρίς 
βοήθεια. 
(  )  4 Είναι σε θέση να τοποθετήσει τα πόδια του ενωμένα ανεξάρτητα και να σταθεί για 
1 λεπτό με ασφάλεια. 
(  )  3 Είναι σε θέση να τοποθετήσει τα πόδια του ενωμένα ανεξάρτητα και να σταθεί για 
1 λεπτό με επίβλεψη. 
(  )  2 Είναι σε θέση να τοποθετήσει τα πόδια του ενωμένα ανεξάρτητα αλλά δεν μπορεί 
να σταθεί για 30 δευτερόλεπτα. 
(  )  1 Χρειάζεται βοήθεια για να πετύχει τη σωστή θέση αλλά μπορεί να σταθεί για 15 
δευτερόλεπτα. 
( )  0 Χρειάζεται βοήθεια για να πετύχει τη σωστή θέση και δεν μπορεί να σταθεί για 15 
δευτερόλεπτα 
 
 
08 
ΣΚΥΨΙΜΟ ΠΡΟΣ ΤΑ ΕΜΠΡΟΣ ΜΕ ΤΕΝΤΩΜΕΝΟ ΤΟ ΧΕΡΙ ΑΠΟ ΟΡΘΙΑ ΘΕΣΗ 
Οδηγίες: Σηκώστε το χέρι σε 90 μοίρες. Τεντώστε τα δάχτυλα σας και φτάστε όσο πιο 
μακριά μπορείτε. (Ο εξεταστής τοποθετεί ένα χάρακα στο τέλος των δάχτυλων όταν το 
χέρι είναι σε 90 μοίρες. Τα δάχτυλα δεν πρέπει να αγγίζουν το χάρακα ενώ φτάνει προς 
τα εμπρός. Η καταγραφή της μέτρησης είναι η απόσταση από όπου φτάνουν τα 
δάχτυλα έως το σημείο που είναι τοποθετημένο σε μια κοντινή απόσταση. Όταν είναι 
δυνατό, μπορεί να ζητηθεί η χρήση και των 2 χεριών ώστε να αποφευχθεί η 
περιστροφή του κορμού.) 
(  )  4 Μπορεί να φτάσει με ασφάλεια προς τα εμπρός > 25 cm ( 10 ίντσες). 
(  )  3 Μπορεί να φτάσει με ασφάλεια προς τα εμπρός > 12 cm ( 5 ίντσες). 
(  )  2 Μπορεί να φτάσει με ασφάλεια προς τα εμπρός > 5 cm ( 2 ίντσες). 
(  )  1 Μπορεί να φτάσει προς τα εμπρός αλλά χρειάζεται εποπτεία. 
(  )  0 Χάνει την ισορροπία ενώ προσπαθεί / χρειάζεται εξωτερική υποστήριξη. 
 
 
09 
ΑΡΣΗ ΑΝΤΙΚΕΙΜΕΝΟΥ ΑΠΟ ΤΟ ΠΑΤΩΜΑ ΑΠΟ ΟΡΘΙΑ ΘΕΣΗ 
Οδηγίες: Σηκώστε το αντικείμενο που βρίσκεται μπροστά από τα πόδια σας 
(  )  4 Είναι σε θέση να το σηκώσει με ασφάλεια και ευκολία. 
(  )  3 Είναι σε θέση να το σηκώσει με ασφάλεια αλλά χρειάζεται εποπτεία. 
(  )  2 Αδυνατεί να το σηκώσει αλλά φτάνει στα 2-5 εκατοστά από το αντικείμενο και 
κρατά την 
 ισορροπία ανεξάρτητα. 
(  )  1 Δεν είναι σε θέση να το σηκώσει και χρειάζεται επίβλεψη ενώ προσπαθεί. 
(  )  0 Αδυνατεί να δοκιμάσει για να μη χάσει την ισορροπία ή πέσει. 
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10 
ΣΤΡΟΦΗ ΚΕΦΑΛΗΣ ΚΑΙ ΚΟΡΜΟΥ ΠΡΟΣ ΤΑ ΠΙΣΩ ΑΠΟ ΟΡΘΙΑ ΘΕΣΗ 
Οδηγίες: Στρίψτε (κεφάλι και κορμό) όσο περισσότερο μπορείτε αριστερά και 
προσπαθήστε να κοιτάξετε πίσω σας. Επαναλάβατε το ίδιο από τα δεξιά. (Ο εξεταστής 
τοποθετώντας ένα αντικείμενο πίσω από τον εξεταζόμενο, τον ενθαρρύνει να κάνει 
καλύτερη στροφή.) 
(  )  4 Κοιτάζει πίσω από τις δύο πλευρές και το βάρος μετατοπίζεται καλά. 
( ) 3 Κοιτάζει πίσω από τη μια πλευρά μόνο και η άλλη πλευρά δείχνει μικρότερη 
μετατόπιση βάρους. 
(  )  2 Γυρνάει μόνο προς τα πλάγια , αλλά διατηρεί την ισορροπία. 
(  )  1 Χρειάζεται επίβλεψη κατά την περιστροφή. 
(  )  0 Χρειάζεται βοήθεια για να μη χάσει την ισορροπία ή για να μη πέσει. 
 
 
11 
ΣΤΡΟΦΗ 360 ΜΟΙΡΩΝ ΑΠΟ ΟΡΘΙΑ ΘΕΣΗ 
Οδηγίες: Κάνετε μια ολοκληρωμένη στροφή γύρω από τον εαυτό σας. Παύση. Έπειτα 
κάνετε μια ολοκληρωμένη στροφή προς την αντίθετη κατεύθυνση. 
(  )  4 Είναι σε θέση να γυρίσει 360 μοίρες με ασφάλεια σε 4 δευτερόλεπτα ή και λιγότερο. 
( ) 3 Είναι σε θέση να γυρίσει 360 μοίρες με ασφάλεια σε μια πλευρά μόνο σε 4 
δευτερόλεπτα ή και λιγότερο. 
(  )  2 Είναι σε θέση να γυρίσει 360 μοίρες με ασφάλεια, αλλά σιγά σιγά. 
(  )  1 Χρειάζεται στενή επίβλεψη ή καθοδήγηση. 
(  )  0 Χρειάζεται βοήθεια ενώ γυρνάει. 
 
 
12 
ΤΟΠΟΘΕΤΗΣΗ ΤΩΝ ΠΟΔΙΩΝ ΕΝΑΛΛΑΞ ΣΕ ΣΚΑΛΟΠΑΤΙ Ή ΣΕ ΣΚΑΜΝΙ ΑΠΟ ΟΡΘΙΑ ΘΕΣΗ 
ΧΩΡΙΣ ΣΤΗΡΙΓΜΑ 
Οδηγίες: Τοποθετήστε το κάθε πόδι εναλλάξ σε ένα σκαλοπάτι/ σκαμνί, ενώ είστε σε 
όρθια θέση χωρίς στήριγμα Συνεχίστε μέχρι το κάθε πόδι να ακουμπήσει το σκαλοπάτι/ 
σκαμνί για 4 φορές. 
(  )  4 Είναι σε θέση να σταθεί ανεξάρτητα και με ασφάλεια και να ολοκληρώσει 8 βήματα 
σε 20 δευτερόλεπτα. 
(  )  3 Είναι σε θέση να σταθεί ανεξάρτητος και να ολοκληρώσει 8 βήματα σε περισσότερο 
από 20 δευτερόλεπτα. 
(  )  2 Είναι σε θέση να ολοκληρώσει 4 βήματα , χωρίς βοήθεια, με εποπτεία. 
(  )  1 Είναι σε θέση να ολοκληρώσει πάνω από 2 βήματα με ελάχιστη βοήθεια. 
(  )  0 Δεν είναι σε θέση να δοκιμάσει / χρειάζεται βοήθεια για να μην πέσει. 
 
 
13 
ΟΡΘΙΑ ΘΕΣΗ ΧΩΡΙΣ ΥΠΟΣΤΗΡΙΞΗ ΜΕ ΤΟ ΕΝΑ ΠΟΔΙ ΕΜΠΡΟΣ 
Οδηγίες: ( Υπόδειξη στον εξεταζόμενο). Τοποθετήστε το ένα πόδι στην ευθεία μπροστά 
από το άλλο. Αν αισθάνεστε ότι δεν μπορείτε, προσπαθήστε να κάνετε ένα βήμα 
αρκετά μακριά στην ευθεία έτσι ώστε η φτέρνα από το μπροστινό πόδι να είναι στην 
ευθεία από τα δάχτυλα του άλλου ποδιού. (Για  3 βαθμούς το μήκος του βήματος θα 
πρέπει να υπερβαίνει το μήκος άλλου ποδιού) 
(  )  4 Είναι ικανός να κρατήσει τα πόδια του παράλληλα και ανεξάρτητα και να κρατηθεί 
για 30 δευτερόλεπτα. 
(  )  3 Είναι σε θέση να τοποθετήσει το ένα πόδι μπροστά από το άλλο ανεξάρτητα και να 
κρατηθεί για 30 δευτερόλεπτα. 
(  )  2 Είναι σε θέση να κάνει μικρό βήμα ανεξάρτητα και να κρατηθεί για 30 δευτερόλεπτα. 
(  ) 1 Χρειάζεται βοήθεια για να κάνει βήμα αλλά μπορεί να κρατηθεί για 15 δευτερόλεπτα. 
(  )  0 Χάνει την ισορροπία του ενώ στέκεται ή περπατάει 
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14 
ΜΟΝΟΠΟΔΙΚΗ ΣΤΗΡΙΞΗ ΣΕ ΟΡΘΙΑ ΘΕΣΗ 
Οδηγίες: Σταθείτε στο ένα πόδι όσο μπορείτε χωρίς βοήθεια. 
(  )  4 Είναι σε θέση να σηκώσει το πόδι ανεξάρτητα και να σταθεί για περισσότερο από 
10 δευτερόλεπτα. 
( ) 3 Είναι σε θέση να σηκώσει το πόδι ανεξάρτητα και να σταθεί για 5-10 
δευτερόλεπτα. 
(  )  2 Είναι σε θέση να σηκώσει το πόδι ανεξάρτητα και να σταθεί για περισσότερο από 
3 δευτερόλεπτα. 
(  )  1 Προσπαθεί να σηκώσει το πόδι αλλά δεν είναι σε θέση να το κρατήσει πάνω από 
3 δευτερόλεπτα, αλλά εξακολουθεί να στέκεται ανεξάρτητα. 
(  )  0 Αδυνατεί να δοκιμάσει ή χρειάζεται βοήθεια για την πρόληψη των πτώσεων. 
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Appendix 8.35.  Berg Balance Scale (BBS) (English version) 
 
 
BERG 
BALANCE 
SCALE 
 
 
 
Name: _______________________ 
Date: _____________________  
Item description                                                                                                          Score (0-4) 
 
1. Sitting to standing _______ 
2. Standing unsupported   _______ 
3. Sitting unsupported _______ 
4. Standing to sitting _______ 
5. Transfers _______ 
6. Standing with eyes closed _______ 
7. Standing with feet together _______ 
8. Reaching forward with outstretched arm                                      _______ 
9. Retrieving object from floor _______ 
10. Turning to look behind                                      _______ 
11. Turning 360 degrees _______ 
12. Placing alternate foot on stool                                      _______ 
13. Standing with one foot in front                                      _______ 
14. Standing on one foot   _______ 
 
 
 
 
    TOTAL   (0-56):______ 
 
 
Interpretation _________________         
41-56 = low fall risk 
21-40 = medium fall risk 
0 –20 = high fall risk 
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BERG BALANCE SCALE TASKS 
 
 
01 
SITTING TO STANDING 
INSTRUCTIONS: Please stand up. Try not to use your hand for support. 
 
( ) 4 able to stand without using hands and stabilize independently 
( ) 3 able to stand independently using hands 
( ) 2 able to stand using hands after several tries 
( ) 1 needs minimal aid to stand or stabilize 
( ) 0 needs moderate or maximal assist to stand 
 
 
02 
STANDING UNSUPPORTED 
INSTRUCTIONS: Please stand for two minutes without holding on. 
 
( ) 4 able to stand safely for 2 minutes 
( ) 3 able to stand 2 minutes with supervision 
( ) 2 able to stand 30 seconds unsupported 
( ) 1 needs several tries to stand 30 seconds unsupported 
( ) 0 unable to stand 30 seconds unsupported 
If a subject is able to stand 2 minutes unsupported, score full points for sitting 
unsupported. Proceed to item #4. 
 
 
03 
SITTING WITH BACK UNSUPPORTED BUT FEET SUPPORTED ON FLOOR OR ON A STOOL 
INSTRUCTIONS: Please sit with arms folded for 2 minutes. 
 
( ) 4 able to sit safely and securely for 2 minutes 
( ) 3 able to sit 2 minutes under supervision 
( ) 2 able to able to sit 30 seconds 
( ) 1 able to sit 10 seconds 
( ) 0 unable to sit without support 10 seconds 
 
 
04 
STANDING TO SITTING 
INSTRUCTIONS: Please sit down. 
 
( ) 4 sits safely with minimal use of hands 
( ) 3 controls descent by using hands 
( ) 2 uses back of legs against chair to control descent 
( ) 1 sits independently but has uncontrolled descent 
( ) 0 needs assist to sit 
 
 
05 
TRANSFERS 
INSTRUCTIONS: Arrange chair(s) for pivot transfer. Ask subject to transfer one way 
toward a seat with armrests and one way toward a seat without armrests. You may 
use two chairs (one with and one without armrests) or a bed and a chair. 
 
( ) 4 able to transfer safely with minor use of hands 
( ) 3 able to transfer safely definite need of hands 
( ) 2 able to transfer with verbal cuing and/or supervision 
( ) 1 needs one person to assist 
( ) 0 needs two people to assist or supervise to be safe 
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06 
STANDING UNSUPPORTED WITH EYES CLOSED 
INSTRUCTIONS: Please close your eyes and stand still for 10 seconds. 
 
( ) 4 able to stand 10 seconds safely 
( ) 3 able to stand 10 seconds with supervision 
( ) 2 able to stand 3 seconds 
( ) 1 unable to keep eyes closed 3 seconds but stays safely 
( ) 0 needs help to keep from falling 
 
 
07 
STANDING UNSUPPORTED WITH FEET TOGETHER 
INSTRUCTIONS: Place your feet together and stand without holding on. 
 
( ) 4 able to place feet together independently and stand 1 minute safely 
( ) 3 able to place feet together independently and stand 1 minute with supervision 
( ) 2 able to place feet together independently but unable to hold for 30 seconds 
( ) 1 needs help to attain position but able to stand 15 seconds feet together 
( ) 0 needs help to attain position and unable to hold for 15 seconds 
 
 
08 
REACHING FORWARD WITH OUTSTRETCHED ARM WHILE STANDING 
INSTRUCTIONS: Lift arm to 90 degrees. Stretch out your fingers and reach forward as far 
as you can. (Examiner places a ruler at the end of fingertips when arm is at 90 degrees. 
Fingers should not touch the ruler while reaching forward. The recorded measure is the 
distance forward that the fingers reach while the subject is in the most forward lean 
position. When possible, ask subject to use both arms when reaching to avoid rotation 
of the trunk.) 
 
( ) 4 can reach forward confidently 25 cm (10 inches) 
( ) 3 can reach forward 12 cm (5 inches) 
( ) 2 can reach forward 5 cm (2 inches) 
( ) 1 reaches forward but needs supervision 
( ) 0 loses balance while trying/requires external support 
 
 
09 
PICK UP OBJECT FROM THE FLOOR FROM A STANDING POSITION 
INSTRUCTIONS: Pick up the shoe/slipper, which is in front of your feet. 
 
( ) 4 able to pick up slipper safely and easily 
( ) 3 able to pick up slipper but needs supervision 
( ) 2 unable to pick up but reaches 2-5 cm(1-2 inches) from slipper and keeps balance 
independently 
( ) 1 unable to pick up and needs supervision while trying 
( ) 0 unable to try/needs assist to keep from losing balance or falling 
 
 
10 
TURNING TO LOOK BEHIND OVER LEFT AND RIGHT SHOULDERS WHILE STANDING 
INSTRUCTIONS: Turn to look directly behind you over toward the left shoulder. Repeat 
to the right. (Examiner may pick an object to look at directly behind the subject to 
encourage a better twist turn.) 
( ) 4 looks behind from both sides and weight shifts well 
( ) 3 looks behind one side only other side shows less weight shift 
( ) 2 turns sideways only but maintains balance 
( ) 1 needs supervision when turning 
( ) 0 needs assist to keep from losing balance or falling 
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11 
TURN 360 DEGREES 
INSTRUCTIONS: Turn completely around in a full circle. Pause. Then turn a full circle in 
the other direction. 
 
( ) 4 able to turn 360 degrees safely in 4 seconds or less 
( ) 3 able to turn 360 degrees safely one side only 4 seconds or less 
( ) 2 able to turn 360 degrees safely but slowly 
( ) 1 needs close supervision or verbal cuing 
( ) 0 needs assistance while turning 
 
 
 
12 
PLACE ALTERNATE FOOT ON STEP OR STOOL WHILE STANDING UNSUPPORTED 
INSTRUCTIONS: Place each foot alternately on the step/stool. Continue until each foot 
has touched the step/stool four times. 
 
( ) 4 able to stand independently and safely and complete 8 steps in 20 seconds 
( ) 3 able to stand independently and complete 8 steps in > 20 seconds 
( ) 2 able to complete 4 steps without aid with supervision 
( ) 1 able to complete > 2 steps needs minimal assist 
( ) 0 needs assistance to keep from falling/unable to try 
 
 
 
13 
STANDING UNSUPPORTED ONE FOOT IN FRONT 
INSTRUCTIONS: (DEMONSTRATE TO SUBJECT) Place one foot directly in front of the 
other. If you feel that you cannot place your foot directly in front, try to step far enough 
ahead that the heel of your forward foot is ahead of the toes of the other foot. (To score 
3 points, the length of the step should exceed the length of the other foot and the width 
of the stance should approximate the subject’s normal stride width.) 
 
( ) 4 able to place foot tandem independently and hold 30 seconds 
( ) 3 able to place foot ahead independently and hold 30 seconds 
( ) 2 able to take small step independently and hold 30 seconds 
( ) 1 needs help to step but can hold 15 seconds 
( ) 0 loses balance while stepping or standing 
 
 
 
14 
STANDING ON ONE LEG 
INSTRUCTIONS: Stand on one leg as long as you can without holding on. 
 
( ) 4 able to lift leg independently and hold > 10 seconds 
( ) 3 able to lift leg independently and hold 5-10 seconds 
( ) 2 able to lift leg independently and hold L 3 seconds 
( ) 1 tries to lift leg unable to hold 3 seconds but remains standing independently. 
( ) 0 unable to try of needs assist to prevent fall 
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Appendix 8.36.  Description of the Timed Up and Go (TUG) test. 
 
The TUG is a clinical test that measures, in seconds, the time needed by an individual to 
stand up from a standard arm chair with arms, walk a distance of 3 metres, turn, walk back 
to the chair and sit down again (Podsiadlo and Richardson, 1991). In the current study, the 
height of the chairs with arms were between 45.5 and 47 cm, and the height of arm chairs 
between 65 and 67.5 cm. Patients using a walking aid, performed the test using their 
walking aid. However, they used the same assistive device each time they performed the 
test to be able to compare scores between the study’s assessments. The starting and final 
position of the test was with the patients’ back against the chair, the arms resting on the 
chair’s arms, feet behind the tape marker, and the walking aid at hand (Podsiadlo and 
Richardson, 1991). Time to complete the test was measured to the nearest 100th of a 
second (Steffen and Seney, 2008). The end of the walking path was marked with a small 
red cone. The patients had to turn around the cone and not turning on the spot.  No 
instructions were given during the test performance, except the initial order ‘go’.  On a data 
sheet the time to complete the test was recorded, and qualitative aspects of walking (such 
as freezing, no arms swinging) were ticked. 
 
The researcher demonstrated first the test to the participants. Patients were advised to 
have their comfortable walking speed during the test. The patients had one practice trial, 
which was not included in the score, to become familiar with the test (Podsiadlo and 
Richardson, 1991). Although in many previous studies in PD, the average time of two 
(Brusse et al., 2005) or three (Dibble et al., 2008) trials was calculated and used in the 
analysis; in the current study, the patients had one practice trial and one timed trial for the 
test (Podsiadlo and Richardson, 1991). Despite the fact that the EPDA proposes to perform 
the test both during the on- and off-state to identify PD patients at high risk of falling (Keus 
et al., 2013), the assessments in the current RCT were  performed only during the on-state 
for safety reasons. 
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Appendix 8.37. Timed Up and Go (TUG) test form (Greek version).  
 
Δοκιμασία ‘σήκω και ξεκίνα’ (TUG) 
 
Όνομα:___________________________________________________________ 
 
Ημερομηνία:_______________ 
 
Bοήθημα βάδισης :__________________________________ 
 
Χρόνος TUG τεστ σε δευτερόλεπτα :___________ 
 
 
Αν ισχύει κάτι από τα παρακάτω, παρακαλώ σημειώστε με (Χ): 
□  Πάγωμα  
□  Αργά βήματα στην αρχή  
□  Μικρός διασκελισμός 
□  Έλλειψη ισορροπίας 
□  Ελλιπής ή μικρή αιώρηση των χεριών 
□  Μη σωστή χρήση βοηθήματος βάδισης 
□  Άλλο:  .............................................................................. 
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Appendix 8.38. Timed Up and Go (TUG) test form (English version).  
 
Timed Up and Go Test (TUG) 
 
Name:___________________________________________________________ 
 
Date:_______________ 
 
Type of walking aid :__________________________________ 
 
TUG time in seconds :___________ 
 
 
If any of the following is true, please tick (X): 
□  Freezing 
□  Slow steps in the beginning 
□  Small stride 
□  Lack of balance 
□  Reduced or not arms swings  
□  Inappropriate use of the walking aid 
□  Other:  .............................................................................. 
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Appendix 8.39. Description of the Falls Efficacy Scale International (FES-I)  
 
The FES-I is a self-report instrument, which includes 16 items about common activities that 
are scored on a four point ordinal scale from one (not at all concerned) to four (very 
concerned). The total score ranges from 16 to 64. Higher scores are associated with higher 
FOF. Scores more than 23 indicate high concern about falling (Yardley et al., 2005).  
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Appendix 8.40.  Falls Efficacy Scale International (FES-I) (Greek version) 
 
ΔΙΕΘΝΗΣ ΚΛΙΜΑΚΑ ΑΝΥΣΗΧΙΑΣ ΠΤΩΣΕΩΝ (FES-I) 
 
Όνομα:  …………………………………………………………………. 
Ημερομηνία:  ………………………. 
 
Θα θέλαμε να σας κάνουμε κάποιες ερωτήσεις σχετικά με το πόσο σας απασχολεί η 
πιθανότητα να πέσετε. Για κάθε μία από τις παρακάτω δραστηριότητες, παρακαλώ 
σημειώστε την απάντηση που σας εκφράζει καλύτερα, για το πόσο δηλαδή σας απασχολεί 
το γεγονός μιας πιθανής πτώσης. Παρακαλώ να απαντήσετε βάσει του τρόπου με τον 
οποίο συνήθως κάνετε την κάθε δραστηριότητα. Αν την περίοδο αυτή δεν κάνετε κάποια 
από τις παρακάτω δραστηριότητες (αν για παράδειγμα κάποιος άλλος ψωνίζει για εσάς), 
παρακαλώ απαντήστε δείχνοντάς μας πόσο θα σας απασχολούσε η πιθανότητα μιας 
πτώσης αν κάνατε αυτήν τη δραστηριότητα. 
 
 Δε με 
απασχολεί 
καθόλου 
1 
Με 
απασχολεί 
λίγο 
2 
Με 
απασχολεί 
αρκετά 
3 
Με 
απασχολεί 
πολύ 
4 
01 Όταν καθαρίζω το σπίτι 
(π.χ. σφουγγάρισμα, 
σκούπισμα ή ξεσκόνισμα) 
    
02 Όταν ντύνομαι ή γδύνομαι     
03 Όταν ετοιμάζω ένα απλό 
φαγητό 
    
04 Όταν κάνω μπάνιο ή ντους     
05 Όταν πηγαίνω για τα 
καθημερινά ψώνια 
    
06 Όταν κάθομαι ή 
σηκώνομαι από μια 
καρέκλα 
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 Δε με 
απασχολεί 
καθόλου 
1 
Με 
απασχολεί 
λίγο 
2 
Με 
απασχολεί 
αρκετά 
3 
Με 
απασχολεί 
πολύ 
4 
07 Όταν ανεβαίνω ή 
κατεβαίνω σκάλες 
    
08 Όταν κάνω βόλτα στην 
γειτονιά 
    
09 Όταν προσπαθώ να φτάσω 
κάτι που βρίσκεται ψηλά 
(π.χ. ράφι) ή στο έδαφος 
    
10 Όταν πάω να προλάβω το 
τηλέφωνο 
    
11 Όταν περπατάω σε μία 
επιφάνεια που γλιστράει 
(π.χ. με πάγο ή βρεγμένη) 
    
12 Όταν πάω για επίσκεψη σε 
ένα φίλο ή συγγενή 
    
13 Όταν περπατάω κάπου 
που έχει πολύ κόσμο π.χ. 
στη λαϊκή 
    
14 Όταν περπατάω πάνω σε 
ανώμαλο έδαφος (π.χ. 
πέτρες, κακοσυντηρημένο 
πεζοδρόμιο) 
    
15 Όταν περπατάω σε 
ανηφόρα ή κατηφόρα 
    
16 Όταν πηγαίνω σε μία 
κοινωνική εκδήλωση (π.χ. 
εκκλησία, οικογενειακή 
συγκέντρωση, καφενείο, 
ΚΑΠΗ) 
    
 
 
Σας ευχαριστούμε για την συμμετοχή σας. Ελέγξτε ότι έχετε απαντήσει όλες τις 
ερωτήσεις. 
 
 
                                                                       Συνολικό σκορ:  ……………. 
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Appendix 8.41. Falls Efficacy Scale International (FES-I) (English version) 
 
 
FALLS EFICACY SCALE-INTERNATIONAL (FES-I) 
Name:  …………………………………………………………………. 
Date:  ………………………. 
 
Now we would like to ask some questions about how concerned you are about the 
possibility of falling. For each of the following activities, please circle the opinion closest to 
your own to show how concerned you are that you might fall if you did this activity. Please 
reply thinking about how you usually do the activity. If you currently don’t do the activity 
(e.g. if someone does your shopping for you), please answer to show whether you think 
you would be concerned about falling If you did the activity. 
 
 Not at all 
concerned  
1  
Somewhat 
concerned 
 2 
Fairly 
concerned 
 3 
Very 
concerned 
4 
01 Cleaning the house 
(e.g. sweep, vacuum or 
dust) 
    
02 Getting dressed or 
undressed 
    
03 Preparing simple meals 
 
    
04 Taking a bath or shower 
 
    
05 Going to the shop 
 
    
06 Getting in or out of a chair     
07 Going up or down stairs. 
 
    
08 Walking around in the 
neighborhood 
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 Not at all 
concerned 
1  
Somewhat 
concerned  
2 
Fairly 
concerned 
 3 
Very 
concerned 
4 
09 Reaching for something 
above your head or on the 
ground 
    
10 Going to answer the 
telephone before it stops 
ringing 
    
11 Walking on a slippery 
surface (e.g. wet or icy) 
    
12 Visiting a friend or relative     
13 Walking in a place with 
crowds 
    
14 Walking on an uneven 
surface (e.g. rocky ground, 
poorly maintained 
pavement) 
    
15 Walking up or down a 
slope 
    
16 Going out to a social event 
(e.g. religious service, 
family gathering or club 
meeting) 
    
 
Please check you have answered all the questions. 
 
                                                                                             Total score:  ……………. 
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Appendix 8.42. Completion of the falls diary (FD) and falls questionnaire (FQ). 
 
Both the FD and FQ were self-report tools, completed by the participants. The patients had 
to circle the day(s) they experienced a fall, and write the number of falls in the appropriate 
date box of the FD. The fall definition was written in each FD. In case they had a fall, the FQ 
had to be completed (one FQ for each fall). The FD and the FQ were parts of the booklets 
(supplements 4-7) given to the participants during the intervention and follow-up period. 
Extra FQs were given to participants, if needed.  
 
Concerning the baseline assessment, the participants were asked to record the falls they 
experienced during the last two months. The assistant physiotherapist provided assistance 
for the completion of questionnaires, if needed. 
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Appendix 8.43. Falls Diary (FD) (Greek version)  
 
 
ΗΜΕΡΟΛΟΓΙΟ ΠΤΩΣΕΩΝ (FD) 
 
Όνομα:  …………………………………………………………………………… 
Ημερομηνία:  ……………………….. 
Στο παρακάτω ημερολόγιο, κυκλώστε την ημερομηνία που είχατε κάποια πτώση. Σε 
περίπτωση που είχατε τουλάχιστον 2 πτώσεις την ίδια ημέρα, παρακαλώ σημειώστε και 
τον αριθμό πτώσεων στο αντίστοιχο κουτί. Για κάθε πτώση, συμπληρώνετε και ένα 
«Ερωτηματολόγιο Πτώσης».  
 
Ορισμός πτώσης: «Η πτώση είναι ένα ξαφνικό, απροσδόκητο γεγονός που έχει ως 
αποτέλεσμα να ακουμπήσετε ή να πέσετε χωρίς την θέλησή σας στο έδαφος ή σε κάποιο 
άλλο χαμηλότερο επίπεδο» 
 
ΜΑΪΟΣ 2015 
Δ Τ Τ Π Π Σ Κ 
 
    1 
 
2 3 
4 5 6 7 8 
 
9 10 
11 12 13 14 15 
 
16 17 
18 19 20 21 22 
 
23 24 
25 26 27 28 29 
 
30 31 
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Appendix 8.44. Falls Diary (FD) (English version)  
 
FALLS DIARY (FD) 
 
Name:  …………………………………………………………………………… 
Date:  ……………………….. 
 
In the following calendar, circle the date you have a fall. If you have at least 2 falls on the 
same day, please write the number of falls in the date box. For each fall, you are requested 
to complete a "Fall Questionnaire".  
 
Fall definition: “Fall is a sudden, unexpected event that results in coming to rest 
unintentionally on the ground or at some other lower level” 
 
MAY 2015 
M Τ W T F S S 
 
    1 
 
2 3 
4 5 6 7 8 
 
9 10 
11 12 13 14 15 
 
16 17 
18 19 20 21 22 
 
23 24 
25 26 27 28 29 
 
30 31 
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Appendix 8.45. Falls Questionnaire (FQ) (Greek version) 
 
ΕΡΩΤΗΜΑΤΟΛΟΓΙΟ ΠΤΩΣΗΣ (FQ) 
 
‘Όνομα: …………………………………………………………………………………       
Ημερομηνία: …………………………………….. 
 
Αν  σημειώσατε μια πτώση στο «ημερολόγιο πτώσεων», παρακαλώ συμπληρώστε το 
παρακάτω ερωτηματολόγιο. Αν δεν θυμάστε κάτι, παρακαλώ αφήστε κενή την 
απάντηση. 
 
01 Ημερομηνία πτώσης 
 
 
02 Ώρα πτώσης 
 
 
03 Τόπος πτώσης 
 
 
04 Μπορείτε να περιγράψετε τι προκάλεσε 
τη πτώση; 
 
 
 
 
 
 
 
 
 
 
 
 
05 Κατεύθυνση πτώσης □ μπροστά         
□ πίσω            
□ πλάγια            
□ κατευθείαν κάτω 
 
06 Πόσο καλά λειτουργούσε η 
φαρμακευτική σας αγωγή για το 
Πάρκινσον την ώρα της πτώσης; 
□ λειτουργούσε καλά            
□ μέτρια             
□ δεν λειτουργούσε 
□ δεν έπαιρνα φαρμακευτική αγωγή 
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07 Είχατε κάποιο πάγωμα την ώρα της 
πτώσης (πχ νιώσατε ότι τα πόδια σα ήταν 
κολλημένα στο έδαφος); 
 
□ Ναι             
□ Όχι 
 
08 Χρησιμοποιούσατε κάποιο βοήθημα 
βάδισης όταν πέσατε; 
□ Ναι            
□ Όχι 
 
09 Είχατε κάποιον τραυματισμό εξαιτίας της 
πτώσης; 
□ Ναι            
□ Όχι 
 
Αν ναι, προσδιορίστε:   
 
 
 
10 Χρειαστήκατε ιατρική βοήθεια; □ Ναι             
□ Όχι 
11 Αν απαντήσατε ναι στη προηγούμενη 
ερώτηση, προσδιορίστε. 
□ Νοσοκομείο            
□ Ιδιωτικό ιατρείο 
□ Άλλο: ................................ 
12 Αν νοσηλευτήκατε σε νοσοκομείο, 
αναφέρατε πόσα βράδια παραμείνατε 
εκεί. 
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Appendix 8.46. Falls Questionnaire (FQ) (English version) 
 
FALLS QUESTIONNAIRE (FQ) 
 
Name:………………………………………………………………………………….. 
Date:……………………………………………………… 
 
If you ticked a fall in the “falls diary”, please complete the following questionnaire. If you 
do not remember any answer, please leave it blank. 
 
01 Date of fall 
 
 
02 Time of fall 
 
 
03 Location of fall 
 
 
04 Can you describe what caused the 
fall? 
 
 
 
 
 
 
 
 
 
 
 
 
05 Direction of fall □ forwards             
□ backwards             
□ sideways             
□ straight down 
06 How well was your medication 
working at the time of fall? 
□ working well              
□ wοrking moderate            
□ not working 
□ not under medication treatment 
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07 Did you experience any freezing at the 
time of the fall (i.e. did you feel like 
your feet were stuck to the floor)? 
 
□ Yes            
□ No 
 
08 Were you using a walking aid when 
you fell? 
□ Yes             
□ No 
09 Did you suffer any injuries? □ Yes             
□ No 
If ‘yes’, indicate:   
 
 
10 Did you seek medication attention? □ Yes             
□ No 
 
11 If you answered yes to the previous 
question, please indicate where 
□ Hospital           
□ Medical office 
□ Other:   
 
12 If you admitted to the hospital 
indicate the number of nights you 
stayed there. 
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Appendix 8.47. Protocol for the 2 Minute Walk Test (2MWT). 
 
Equipment  
The equipment of the 2MWT included: a stopwatch, two small cones to mark the 
turnaround points, a chair that could be easily moved along the walking course, an 
electronic shygmamanometre (microlife BP A3 PC), a pulse oximetre (NONIN 9570), one 
laminating sheet with the Borg scale. The ten-point Borg scale was selected, as it more 
commonly used in Greece; and it is both valid and reliable (Kendrick et al., 2000). 
 
Assessment parameters 
The 2MWT, assessed the 2MWD; and major cardiorespiratory parameters including the 
heart rate (HR), oxygen saturation (SpO2), systolic blood pressure (SBP), diastolic blood 
pressure (DBP), dyspnoea and fatigue of lower libs (ATS, 2002). The HR and SpO2 were 
assessed by the pulse oximetre; the SBP and DBP by the sphygmomanometre; and the 
dyspnoea and fatigue of lower libs by the 10-point Borg Scale. Four measures were 
performed in each trial: before the start of the test, at the first minute, at the end of the 
test, and two minutes after the test end. As it is not established whether the 2MWT can 
capture data of aerobic endurance, due to its limited time compared to the 6MWT 
(Bohannon et al., 2015), and as this was not the main outcome measure of the study; only 
the 2MWD was included in the analysis. 
 
Assessors’ responsibilities 
Two assessors participated in the 2MWT: the researcher and an assistant physiotherapist. 
The researcher measured the cardiorespiratory parameters before and after the test, 
demonstrated the test, gave all the verbal instructions and supervised the participant. The 
assistant physiotherapist recorded the cardiorespiratory parameters and the number of 
turns during the test on the 2MWT sheet. Then, the 2MWD was calculated and recorded, 
based on the number of turns and additional distance covered. The distance covered 
around the cones was estimated at 0.50 metres. As there were two trials, only the highest 
2MWD was used for the data analysis (ATS, 2002). 
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Protocol 
In the current study, the 2MWT was conducted following a modified standardised 
procedure, based on the ATS guidelines for the 6MWT (ATS, 2002). The absolute 
contraindications and the reasons for immediately stopping the test, were strictly followed. 
Few modifications were made due to: the lack of space to perform the test; restricted time 
of the 2MWT (2 minutes) compared to the 6MWT, and assessment session; and motor 
features of PD. These modifications are listed as follows: 
 
 Although the perfect walking path is 30-metre long (ATS, 2002); in the current study, 
the test was performed in a 12-metre walking path, and at least 2.5 metres wide, due 
to the lack of space. The length of the walking path was marked every two metres with 
a coloured tape. However, a shorter corridor than 30 metres requires more time for the 
patients to reverse directions, reducing the covered distance (ATS, 2002).  
 As the total test time was only two minutes, only four verbal instructions were given 
during the test: 1) ‘Go’ to start the test; 2) when one minute elapsed, the participants 
were told: ‘You are doing well; you have one minute left.’ (Bohannon et al, 2015). 3) 
When the timer was 15 seconds from completion: ‘In a moment I’m going to tell you to 
stop. When I do, just stop right where you are and I will come to you.’ 4) ‘Stop’ at the 
end of the test (ATS, 2002). 
 In the current study, two trials were performed. The subjects were given a 10-minute 
rest before the two trials to avoid fatigue (Light et al, 1997; Pin, 2014).  Due to the 
restricted time of assessment, it was impossible to leave the patients at least one hour 
to rest (ATS, 2002). 
 The subjects were instructed to turn wide around the cones in a half circle and extend 
the width of the hallway. This type of turn minimises the complications of freezing and 
instability. No cues were used, except the tapes and the cones on the floor (Light et al., 
1997). 
 
The procedure of the test was simple. The participants were instructed to walk on the flat 
level surface from end to end of the line, turn around the cones, and to cover as much 
distance as possible. Running or jogging were not allowed during the test. They were also 
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told not to worry if they had to slow down or rest; but, that if they stopped they should 
start walk again as soon as they feel ready to do so. Walking aids were used by some 
patients, but were kept consistent from test to test.  
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Appendix 8.48. 2MWT sheet (Greek version). 
 
ΔΟΚΙΜΑΣΙΑ 2 ΛΕΠΤΩΝ ΒΑΔΙΣΗΣ 
 
ΟΝΟΜΑ: 
ΗΜΕΡΟΜΗΝΙΑ: 
 
Κάθε φορά που ολοκληρώνεται μισός γύρος από τον ασκούμενο να κυκλώνεται ένα 
νούμερο.    ΠΡΟΣΟΧΗ: Κάθε δοκιμασία θα διακόπτεται εάν ο ασκούμενος αισθανθεί: 
πόνο στο στήθος, μη ανεκτή δύσπνοια, κράμπα στα κάτω άκρα, ζάλη, έντονη εφίδρωση, 
χλωμάδα στο πρόσωπο.    
 
 
ΜΙΣΟΣ 
ΓΥΡΟΣ 
1 2 3 4 5 6 7 8 9 10 11 
12 13 14 15 16 17 18 19 20 21 22 
23 24 25 26 27 28 29 30 31 32 33 
ΣΤΑΣΕΙΣ 1 2 3 4 5 6 7 8 9 10 11 
 
Επιπλέον απόσταση (μέτρα) 
Συνολικά Διανυόμενη Απόσταση 
 
 
 
 
Τερμάτισε τη δοκιμασία (βάλτε σε κύκλο):    ΜΕ       /     ΧΩΡΙΣ           ΔΙΑΚΟΠΗ  
 
Αν ΜΕ ΔΙΚΑΚΟΠΗ, ποιος ο ΛΟΓΟΣ:  
 
 
 KOΡ. Κ.Σ. ΔΥΣΠΝΟΙΑ  ΚΟΠΩΣΗ Δ.Α.Π. Σ.Α.Π. 
ΠΡΙΝ       
1       
2       
2 ΑΠΟΚ       
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Appendix 8.49. 2MWT sheet (English version). 
 
2 MINUTE WALK TEST 
 
NAME: 
DATE: 
 
 
When a half circle is completed by the trainee, please circle a number. 
ATTENTION:   Reasons for immediately stopping a 2MWT include the following: (1) chest 
pain, (2) intolerable dyspnea, (3) leg cramps, (4) staggering, (5) diaphoresis, and (6) pale 
or ashen appearance. 
 
 
 
HALF 
ROUND 
1 2 3 4 5 6 7 8 9 10 11 
12 13 14 15 16 17 18 19 20 21 22 
23 24 25 26 27 28 29 30 31 32 33 
STOPS 1 2 3 4 5 6 7 8 9 10 11 
 
Additional walking distance (metres): 
Total walking distance: 
 
 
 
 
Τhe patient completed successfully the test (circle):   Yes  /  No 
 
If ‘No’, state the reason: 
 
 
 SAT ΗR DYSPNOEA FATIGUE DBP SBP 
BEFORE       
1 MIN       
2 MIN       
2 MIN AFTER       
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Appendix 8.50. Borg scale (Greek version)  
 
ΚΛΙΜΑΚΑ BORG 
 
 
0 Καμία Αίσθηση Δυσκολίας 
0,5 
Πάρα πού ελαφριά 
 (μόλις αισθητή) 
1 Πολύ Ελαφριά 
2 Ελαφριά 
3 Μέτρια 
4 Λίγο Δύσκολη 
5 Δύσκολη (βαριά) 
6  
7 Πολύ Δύσκολη 
8  
9  
10 Πάρα πολύ δύσκολη (μέγιστη) 
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Appendix 8.51. Borg scale (English version). 
 
 BORG SCALE 
 
 
 
0 Nothing at all 
0,5 
Very, very slight 
(just noticeable) 
1 Very slight 
2 Slight (light) 
3 Moderate 
4 Somewhat severe 
5 Severe (heavy) 
6  
7 Very severe 
8  
9  
10 Very, very severe (maximal) 
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Appendix 8.52. Protocol for the spirometry. 
 
 The guidelines of the ATS and the European Respiratory Society were followed for the 
spirometry (Miller et al., 2005). Before the test, the patients were checked for absolute and 
relevant contraindications. Two types of measurement were performed: a forced and a 
slow spirometry. Firstly, the test was explained and demonstrated to participants (García-
Río et al, 2013; Miller et al,. 2005).  Then, details of the patients’ gender, age, height,  
weight, and ethnical background were entered to the device. The age was expressed in 
years; height in centimetres; and weight in kilos. Afterwards, the patients performed the 
spirometry tests. 
 
Spirometry was performed with the subjects in sitting position. The chair was with arms 
and without wheels for safety reasons (Miller et al., 2005). The head was held in a neutral 
position; both feet were on the ground and the elbows on armchairs (García-Río et al., 
2013). During the whole manoeuvre, lips were sealed around the mouthpiece; and nose 
clip was used to prevent possible air leaks on breathing through the nose. (García-Río et al, 
2013; Miller et al, 2005). Thus, inspiration and expiration was performed through the 
mouthpiece. The slow spirometry was performed first, because forced spirometry 
manoeuvres may cause muscular fatigue (Miller et al, 2005). Three manoeuvres were 
performed for the forced and slow spirometry, separated by a small rest period of one 
minute (García-Río et al., 2013).  
 
In the slow spirometry, the patients were asked to breathe calmly (tidal breathing) through 
the mouthpiece, at least three breaths were performed (to verify the functional residual 
capacity-FRC- is stable); then, to inspire until the total lung capacity (TLC), and exhale up to 
residual volume (RV). In the forced spirometry, the patients were asked to inhale though 
the mouthpiece to reach their TLC from their FRC; then to blow hard and fast through the 
mouthpiece, and prolong the expiration without stopping until told to do it (García-Río et 
al., 2013; Miller et al., 2005). Throughout the manoeuvres, the researcher guided the 
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participants, using appropriate body language and phrases: “take air” (πάρε αέρα), and 
“blow” (φύσα) (Miller et al., 2005).  
 
The best performed manoeuvre was selected automatically by the spirometre. The values 
of measured variables were recorded in L or L/sec, and in percentages of the predicted 
normal values. The results of the spirometry test for each patient was stored on the 
computer and printed. The following respiratory variables were included in the analysis 
section: forced expiratory volume in the first second (FEV1), forced vital capacity (FVC),  
FEV1/FVC ratio,  inspiratory vital capacity (IVC). FEV1, FVC and FEV1/FVC were recorded 
during the forced spirometry; whereas IVC during the slow spirometry. 
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Appendix 8.53. Satisfaction Questionnaire (SQ) (Greek version) 
 
ΕΡΩΤΗΜΑΤΟΛΟΓΙΟ ΣΧΕΤΙΚΑ  
ΜΕ ΤΟ ΠΡΟΓΡΑΜΜΑ ΑΣΚΗΣΗΣ (SQ) 
Το παρόν ερωτηματολόγιο αφορά τη γνώμη σας σχετικά με το ομαδικό πρόγραμμα 
άσκησης που παρακολουθήσετε. Η συμπλήρωση του ερωτηματολογίου και των 
ερωτήσεων του είναι προαιρετική. Παρακαλείσθε ανεξάρτητα από το αν 
συμπληρώσατε το ερωτηματολόγιο, να το τοποθετήσετε στον φάκελο που σας δόθηκε. 
Κλείστε καλά τον φάκελο και φέρτε το πίσω στο επόμενο ραντεβού. 
 
01 Πόσο εύκολο/δύσκολο ήταν το πρόγραμμα άσκησης; 
 
 
 
 
 
02 Παρατηρήσατε θετικά αποτελέσματα από τη συμμετοχή σας στο πρόγραμμα; Αν 
ναι, σημειώσατε. 
 
 
 
 
03 Παρατηρήσατε αρνητικά αποτελέσματα από τη συμμετοχή σας στο πρόγραμμα; 
Αν ναι σημειώσατε. 
 
 
 
 
 
04 Τι σας άρεσε περισσότερο στο πρόγραμμα; 
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05 Τι σας άρεσε λιγότερο στο πρόγραμμα; 
 
 
 
 
 
06 Τι θα αλλάζατε στο πρόγραμμα άσκησης; Έχετε κάποιες ιδέες να προτείνετε; 
 
 
 
 
 
07 Τι σας ώθησε να συμμετάσχετε στο πρόγραμμα; 
 
 
 
 
 
 
08 Τι σας ώθησε να ολοκληρώσετε το πρόγραμμα; 
 
 
 
 
 
 
09 Θα θέλατε να προσθέσετε κάτι άλλο; 
 
 
 
 
 
 
Σας ευχαριστούμε για τον χρόνο σας! 
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Appendix 8.54. Satisfaction Questionnaire (SQ) (English version) 
 
SATISFACTION QUESTIONNAIRE FOR THE EXERCISE (SQ) 
 
This questionnaire is relevant to your personal opinion about the group-based exercise 
programme you attended. The completion of the questionnaire and its questions is 
optional. Regardless you complete or not the questionnaire, you are requested it to place 
into the envelope given to you. Close the envelope and bring it back to us in you next 
appointment. 
 
01 How easy/hard was the programme? 
 
 
 
 
 
02 Have you noticed any positive effects from doing the programme? If yes, please 
report them. 
 
 
 
 
 
03 Have you noticed any negative effects from doing the programme? If yes, please 
report them. 
 
 
 
 
04 What did you like more about the programme? 
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05 What did you like less about the programme? 
 
 
 
 
 
06 What would you like to change in the programme? Any ideas to propose? 
 
 
 
 
 
07 What motivated you to participate to the programme? 
 
 
 
 
 
08 What motivated you to complete the programme? 
 
 
 
 
 
09 Do you have anything else you would like to add? 
 
 
 
 
 
 
 
 
Thank you for your time! 
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Appendix 8.55. Attendance form (AF)- group programme. 
 
 
M
U
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IP
A
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: 
Session 
8 
Education  
 
     
Exercise   
 
     
Session 
7 
Exercise        
Session 
6 
Education  
 
     
Exercise   
 
     
Session 
5 
Exercise        
Session 
4 
Education  
 
     
Exercise   
 
     
Session 
3 
Exercise        
Session 
2 
Education  
 
     
Exercise   
 
     
Session 
1 
Exercise        
  
N
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e 
 
     
  
C
o
d
e
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Appendix 8.56. Attendance form (AF)- individualised programme. 
 
 
 
Code 
 
 
Name W
ee
k 
1
 
W
ee
k 
2
 
W
ee
k 
3
 
W
ee
k 
4
 
W
ee
k 
5
 
W
ee
k 
6
 
W
ee
k 
7
 
W
ee
k 
8
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Appendix 8.57. Analytical description of the respiratory exercises. 
 
Diaphragmatic breathing 
The diaphragmatic breathing was performed for one minute. Full, deep breaths allow the 
diaphragm to lower and the lungs to expand deeply, ensuring that more oxygen is taken in 
with each breath. The technique involves taking a deep inspiration through nose with the 
mouth closed. The exhalation is slowly lasting for four to six seconds through pursed lips 
held in a whistling or kissing position. The technique starts with exhalation (Christara- 
Papadopoulou, 2009). 
 
Breathing-enhanced upper extremity exercises 
Similarly to the study by Mutluay et al. (2007) in Multiple Sclerosis, breathing-enhanced 
upper extremity exercises were included in the current project. One set of ten repetitions 
was performed. The exercise included two parts: inspiration while abducting horizontally 
both shoulders; expiration while returning the arms to the initial position. The technique 
started with exhalation. Furthermore, the patients were instructed to inspire through the 
nose and expire through the mouth with pursed-lip breathing. At the end of inspiratory, a 
sniff and an end-inspiratory hold were added gradually. One rapid nasal sniff at the end of 
inspiration may further augment collateral ventilation, because even after a full inspiration, 
the individual does not reach the TLC. Then, an end-inspiratory hold was followed, to boost 
collateral ventilation and distribute air more evenly between lung segments. The duration 
of the hold breath was three to four seconds (Christara- Papadopoulou, 2009). 
 
IMT using a Threshold IMT device 
The IMT was performed using an inspiratory muscle trainer (Threshold IMT). Threshold IMT 
is a hand-held, spring-loaded device designed to strengthen inspiratory respiratory 
muscles. The device incorporates a flow-independent, one-way valve to ensure consistent 
resistance during inhalation. The patients inhaled and exhaled through the device. The 
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participants had to wear the nose clips during the exercise. The mouthpiece had been 
sterilised prior the use for hygiene reasons (Christara- Papadopoulou, 2009). 
 
Previous effective trials examining the effectiveness of IMT in neurodegenerative disorders 
had either specific duration of treatment, measured in minutes (Inzelberg et al., 2005); or 
specific sets and repetitions (Klefbeck and Hamrah Nedjad, 2003; Fry et al., 2007). The 
training load and the progression of exercise were expressed based on the MIP (Klefbeck 
and Hamrah Nedjad, 2003). Furthermore, the total training length varied from four to 12 
weeks; and the exercise frequency from five to seven days a week (Reyes et al., 2013). In 
the current study, due to the total duration of each session, it was decided to perform two 
sets of ten repetitions (Klefbeck and Hamrah Nedjad, 2003). However, due to the lack of 
MIP device, the subjects started breathing at a low load (11cm H2O). There was an increase 
in the training load by 2 cm H2O every week.  
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Appendix 8.58. Signed consent for the photo shoot (Greek version).  
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Appendix 8.59. Signed consent for the photo shoot (English version).  
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Appendix 8.60. Ethical approval for the ‘Step two’ (RCT) granted by the HPDA. 
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Appendix 8.61. Indications for determination of exercise (adopted from ACSM, 2014). 
 
Absolute indications 
1. Suspicion of a myocardial infarction or acute myocardial infarction (heart attack) 
2. Onset of moderate-to-severe angina (chest pain) 
3. Drop in SBP below standing resting pressure or drop in SBP with increasing workload 
accompanied by signs or symptoms 
4. Signs of poor perfusion (circulation or blood flow), including pallor (pale appearance to the 
skin), cyanosis (bluish discoloration), or cold and clammy skin 
5. Severe or unusual shortness of breath 
6. Central nervous system symptoms: 
 e.g., ataxia (failure of muscular coordination), vertigo (An illusion of dizzying 
movement), visual or gait (pattern of walking or running) problems, confusion 
7. Serious arrhythmias (abnormal heart rhythms) 
 e.g.: second / third degree AV block, atrial fibrillation with fast ventricular response, 
increasing premature ventricular contractions or sustained ventricular tachycardia) 
8. Technical inability to monitor the electrocardiogram (ECG) 
9. Patient's request (to stop) 
 
Relative indications 
1. Any chest pain that is increasing 
2. Physical or verbal manifestations of shortness of breath or severe fatigue 
3. Wheezing 
4. Leg cramps or intermittent claudication (grade 3 on a 4-point scale) 
5. Hypertensive response (SBP >260 mm Hg; DBP>115 mm Hg) 
6. Pronounced ECG changes from baseline 
 >2 mm of horizontal or down sloping ST- segment depression, or >2 mm of ST-
segment elevation (except in aVR) 
7. Exercise-induced bundle branch block that cannot be distinguished from ventricular 
tachycardia 
8. Less serious arrhythmias (abnormal heart rhythms) such as supraventricular tachycardia 
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Appendix 8.62. Basic questions of the semi-structured interview for the pilot study. 
 
01 How easy or difficult was the programme? 
 
02 What did you like more? 
 
03 What did you like less? 
 
04 Did you experience pain or any other somatic symptoms, while doing the 
exercises or after the end of each session? 
05 Where the instructions of the group-based exercise understood? 
 
06 Where the instructions of the booklet and relevant images understood? 
 
07 What is your opinion about the: exercise diary, walking diary, FD and FQ? 
 
08 What would you like to change in the whole programme? 
 
09 Anything else you would like to add? 
 
10 If you have the chance, will you participate in the current study? 
 
 
 
 
 
 
 
 
 
 
 
Appendices 
540 
 
Appendix 9.1. All the co-morbidities of participants, plus previous surgical operations (for the whole 
sample). 
 
Type of co-
morbidities 
Co-morbidities 
 
 
Number of 
patients 
Notes 
 
Cardiovascular 
disease 
 
Hypertension  21  
Cardiac arrhythmia 3  
Cardiac valvulopathy 3  
Coronary artery disease 2  
Peripheral arterial disease 1  
Respiratory disease 
 
Bronchial asthma 1  
COPD 1  
 
 
 
Musculoskeletal 
disease 
Low back pain 23  
Osteoarthritis 19  
Osteoporosis 14  
Cervical syndrome 6  
Rheumatoid arthritis 2  
Carpal tunnel syndrome 1  
De Quervain syndrome 1  
Lateral epicondylitis 1  
Neurological disease  
(except PD) 
Stroke  2  
 
 
Other disease  
Hyperlipidemia  19  
Diabetes mellitus type 2  15  
Hypothyroidism  6  
Irritable bowel syndrome  4  
Hyperthyroidism  1  
Ulcerative colitis  1  
 
 
 
 
 
Most reported 
surgical operations 
Hernia surgery  17 inguinal hernia surgery  
(n= 12), umbilical hernia 
surgery (n= 5) 
Hysterectomy  12  
Joint replacement 8 knee replacement (n= 6), 
hip replacement (n= 2) 
Cancer surgery  7 breast cancer surgery     
(n= 5) 
Cholecystectomy  7  
Enlarged prostate surgery  6  
Surgery due to fracture  5  
Pacemaker surgery  2  
Bypass surgery  2  
Carpal tunnel surgery  2  
 
Acronyms. COPD: chronic obstructive chronic disease. 
 
 
